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“Natural selection (…) does not work as an engineer works. It works like a 
tinkerer - a tinkerer who does not know exactly what he is going to produce but 
uses whatever he finds around him whether it be pieces of string, fragments of 
wood, or old cardboards (…). In contrast with the engineer's tools, those of the 
tinkerer cannot be defined by a project. What these objects have in common is 
‘it might well be of some use.’ For what? That depends on the opportunities.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
François Jacob, French biologist and Nobel laureate, in “Evolution and tinkering”. Science, Volume 
196, Number 4295, 10 June 1977, 1161-1166 (quotation continues ahead of the Perspective section). 
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Statement to my Thesis 
 
This work was carried out in the group of Prof. Christoph Dehio in the Focal area Infection 
Biology at the Biozentrum of the University of Basel. My PhD thesis committee consisted of: 
 
Prof. Christoph Dehio 
Prof. Urs Jenal 
Prof. Tilman Schirmer 
 
I constructed my thesis in a cumulative format. It contains a broad introductory section 
followed by results chapters that are each dedicated to one article or coherent sets of 
unpublished data. My thesis contains in total six articles of which two are published review 
articles, another two are published research articles, and each one additional research article 
has been submitted or is under preparation, respectively. The different threads of research 
are taken up in a concluding “perspective” section that combines them in a working model 
and proposes the direction of future studies. 
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Bacterial secretion systems are machineries that allow one cell to take direct control of 
molecular processes in another one so that they are ubiquitously involved in the host 
interaction of mutualistic, commensal, and pathogenic bacteria. However, the evolutionary 
origin of these systems lies in genuine bacterial machineries. One of the most well-studied 
host-interacting secretion systems is the type IV secretion system (T4SS) that originally 
evolved to mediate bacterial conjugation, i.e., the interbacterial transfer of DNA. During 
conjugation, the DNA is transferred covalently linked to a protein called relaxase that is the 
actual substrate of the type IV secretion machinery. 
It is the common focus of most studies that come together in this thesis to unravel the 
adaptive path by which the host-interacting VirB/D4 T4SS of Bartonella and its secreted 
effectors evolved from conjugative ancestors. In short, these studies allowed to propose a 
two-step model in which an ancestral conjugation machinery first acquired an interbacterial 
effector protein and was later exapted for host interaction which resulted in the evolution of 
the VirB/D4 T4SS. 
In Review article I we comprehensively reviewed available literature regarding the molecular 
pathogenesis of the α-proteobacterial pathogen Bartonella and concluded that different 
phylogenetic lineages of this genus use partially divergent sets of virulence factors for 
essentially the same stealth infection strategy. Though the overall course of infection in their 
respective mammal reservoir hosts is similar, the bartonellae showed major differences in 
their host adaptability that correlated with the presence of the VirB/D4 T4SS in the 
promiscuous lineages. This machinery contributes to Bartonella virulence by secreting a 
cocktail of effector proteins (Beps) into mammalian host cells where they manipulate cellular 
signaling processes in favor of the pathogen. Previous studies had shown that all effectors of 
the VirB/D4 T4SS evolved from a single common ancestor that consisted of a FIC protein 
domain fused to a conserved type IV secretion signal which is also the most prevalent 
domain architecture among extant Beps. FIC domains are enzymatic domains that typically 
mediate adenylylation, the transfer of an adenosine 5’-monophosphate onto target proteins, 
suggesting that a prototypic effector of the VirB/D4 T4SS may have targeted host proteins by 
post-translational modification. Interestingly, a bacterial conjugation system called Vbh T4SS 
had been discovered in Bartonella and is encoded on a plasmid together with a Bep-like 
protein consisting of FIC domain and type IV secretion signal that had been named VbhT. 
In Research article I we investigated the phylogeny and regulation of Fic proteins (i.e., 
proteins containing FIC domains) and found that their adenylylation activity is controlled by a 
conserved mechanism of active site obstruction via an inhibitory α-helix (αinh). Depending on 
the positioning of αinh either in a separate polypeptide or N- or C-terminally of the FIC domain 
in the same protein we classified FIC domain proteins as class I, class II, and class III, 
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respectively. Fic proteins have repeatedly evolved into bacterial virulence factors, but the far 
majority of them are genuine bacterial proteins of unknown function. We showed that the 
mutational activation of bacterial Fic proteins of all three classes by abrogation of active site 
obstruction results in bacterial growth inhibition, suggesting that most Fic proteins may be 
some kind of toxins. Interestingly, the elusive Bep-like VbhT protein of the Vbh T4SS was 
found to inhibit bacterial growth via target adenylylation unless it is inhibited by a small 
protein VbhA that contains the αinh.as a hallmark of class I Fic proteins. This arrangement is 
reminiscent of toxin-antitoxin (TA) modules that are genetic elements consisting of a toxin 
that inhibits bacterial growth and an antitoxin that suppresses the toxin’s activity but can 
unleash it in order to induce a phenotypic switch to the dormant persister state. 
In Review article II we firmly established that class I Fic proteins form a new toxin-antitoxin 
(TA) module FicTA with FicT toxins being homologous to the VbhT FIC domain and FicA 
antitoxins being homologous to VbhA. A follow-up study described in Research article III 
characterized the FicTA toxin-antitoxin module and discovered that FicT toxins inhibit 
bacterial growth via the adenylylation and concomitant inactivation of DNA gyrase and 
topoisomerase IV (topo IV), the two bacterial type IIA topoisomerases. The resulting 
disruption of cellular DNA topology induced a phenotypic switch to the persister state. 
Although an important role of TA modules in persister formation is well established, 
previously known TA systems invariably induced dormancy by inhibiting translation or 
unsetting the proton-motive force. Our results therefore uncovered a new physiological path 
to the persister state that is likely involved in the inherent physiological heterogeneity of 
persisters as a main obstacle to their eradication. Furthermore, we found that the Vbh T4SS 
in Bartonella is sometimes associated to a functional FicTA module that is encoded at the 
locus where VbhTA would be expected but shows no trace of a type IV secretion signal.  
The concluding Perspective section of this work combines the results of the aforementioned 
articles with a considerable amount of unpublished data and proposes a model that can 
explain the evolution of the VirB/D4 T4SS and its effectors in Bartonella from conjugative 
ancestors. In short, it is evident that an ancestral conjugative T4SS as well as a FicTA 
module (supplying the FIC domain for effector evolution) entered the genus Bartonella via 
horizontal gene transfer, though likely not together. After sequence reshuffling events had 
resulted in a ficAT locus encoded next to a conjugative Vbh-like machinery (like in some 
extant bartonellae), one of the two type IV secretion signals of the relaxase was transferred 
onto the FicT toxin via terminal reassortment and created a situation identical to the Vbh 
T4SS with VbhT. Based on additional evidence, we propose that extant Vbh T4SS and VbhT 
represent such an ancestral evolutionary state as a “living fossil”. Furthermore, we suggest 
that VbhT is an interbacterial effector that is secreted via the Vbh T4SS during bacterial 
 Abstract 
v 
 
conjugation in order to promote complementary strand synthesis in the recipient. Like this, 
the Vbh T4SS with VbhT constitutes a “missing link” in the evolution of the host-interacting, 
effector secreting VirB/D4 T4SS from purely conjugative ancestors. The remarkable 
sequence similarity between Vbh T4SS and VbhT on one side and the VirB/D4 T4SS and 
Beps on the other side suggests that such a conjugative machinery with interbacterial 
effector may have been exapted for host interaction in a second step. During that process, a 
primordial vbhT-like effector gene served as the template for a series of gene duplication and 
diversification events that created the extant effector repertoires by gradual evolution. The 
different paralogous effectors created by this process were generally suspected to have 
different roles in host interaction. Among other evidence, I could show earlier that one 
effector (Bep1) targets the host protein Rac1 by adenylylation. In Research article II we 
followed up on these results and identified the adenylylated target of another effector, called 
Bep2, as vimentin. For this purpose we had developed a new technique that identifies 
adenylylated target proteins by mass spectrometry using a characteristic pattern of peaks 
upon adenylylation with a mixture of heavy-isotope labeled ATP. Together with additional 
data of others and myself, these results suggest that the diversified effector repertoires of the 
VirB/D4 T4SS evolved to promote the stealth infection strategy of Bartonella by fine-tuned 
manipulations of host cell signaling. In particular, the modular architecture of both the type IV 
machinery and its effectors conferred an inherent evolvability that is likely involved in the 
remarkable host adaptability of those bartonellae that encode VirB/D4 T4SS and effectors. 
The most important open point in this model is the biological function of VbhT as the first 
bona fide interbacterial type IV secretion effector. Future studies should address a possible 
role of VbhT in bacterial conjugation in order to strengthen the claim of a “missing link”. 
In Research article IV we expanded the understanding of FIC domain proteins without 
obvious connection to Bartonella. This study was focused on NmFicT of Neisseria 
meningitidis as a model for class III Fic proteins that encode the αinh at their C-terminus, but 
contain no additional domains or modules for their regulation. We reported strong evidence 
for a model in which NmFicT is controlled by a double-lock mechanism where the first level 
of control is tetramerization that generates an inactive storage form of the protein. Upon an 
unknown trigger, NmFicT monomers would be freed from oligomerization and then remove 
the second lock via intermolecular auto-adenylylation which abolishes αinh –mediated active 
site obstruction and unleashes the full catalytic activity of NmFicT. Furthermore, we showed 
that activated NmFicT adenylylates DNA gyrase at the same residue as FicT toxins, though 
these also adenylylate topo IV and primarily inhibit the latter target in vivo. The biological 
function of NmFicT is unclear, but may be related to DNA repair and protection as described 
for other proteic gyrase inhibitors. 
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3. Aim of the Thesis 
I started my PhD work in February 2011 with the aim to understand the explosive radiations 
of Bartonella species that had been triggered subsequent to the acquisition of 
host-interacting type IV secretion systems (T4SS). More precisely, it was my aim to unravel 
the adaptive path that transformed an ancestral conjugative T4SS into the effector-secreting 
and host-interacting VirB/D4 type IV secretion system. 
For that purpose, I performed a biochemical and functional analysis of effectors secreted by 
the VirB/D4 T4SS as well as the more ancestral Vbh (VirB-homologous) T4SS. Furthermore, 
I traced back the evolutionary origin of these effectors to a group of bacterial FIC domain 
proteins with no connection to type IV secretion and investigated the effectors and their 
ancestors using a wide range of microbiological techniques and structure-function analyses. 
Finally, I combined and interpreted my results to form a coherent model that describes how a 
primordial effector of an ancestral Vbh-like T4SS was generated de novo. Additionally, the 
model delineates how the secretion machinery and its effector repertoire co-evolved with 
their Bartonella host in two major steps into the extant VirB/D4 T4SS that promoted 
Bartonella evolution as a superior tool for host interaction. 
4. About this work 
The broad scope of my PhD project and its somehow paleo-microbiological topic implied that 
a wide range of techniques would be used and that, with increasing distance to Bartonella 
effectors, also a wide range of poorly connected fields of research were to be explored. 
In consequence, the theoretical and practical focus of this project shifted over time and 
comprised diverse topics such as toxin-antitoxin systems, protein evolution, DNA topology, 
and bacterial persistence, on top of research directly targeting Bartonella. For this reason I 
chose to assemble my PhD thesis in a cumulative format. Furthermore, the Introduction 
section had to be more selective and less comprehensive as it would have been appropriate 
in a contentually more restricted work, though a certain ample thoroughness inherent to the 
thesis format was of course implemented. The different Research articles forming the 
Results section each have a separate, more comprehensive introduction and are 
accompanied by Review articles that go deeper into their respective subjects. Readers with a 
primary interest in the big picture may appreciate the short Summary preceding each article, 
but should still have a brief look at Unpublished Results presented after the different 
sections. A concluding Perspective at the end of this work combines the different threads of 
research to form a coherent model of Bartonella / type IV secretion system coevolution. 
 Introduction 
1 
 
 
 
 
 
 
 
 
 
 
 
5. Introduction 
 Introduction – Toxin-antitoxin modules 
2 
 
5.1. Toxin-antitoxin modules 
5.1.1. Biological functions and classification of TA modules 
5.1.1.1. Classification and general features 
Bacterial toxin-antitoxin (TA) modules comprise a toxin that blocks bacterial growth via the 
inactivation of essential cellular functions and an antitoxin that protects the cell from the 
toxin’s activity. So far, five general types of TA modules have been defined based on the 
mode of action of the antitoxin (Figure 1A): 
• In type I TA modules the antitoxin is an RNA that prevents translation of the toxin, 
typically by antisense interaction with the toxin mRNA (e.g., Hok/sok12 or TisB/istR13).  
• In type II TA modules the antitoxin is a protein that inhibits the toxin’s activity via a 
direct interaction (e.g., RelBE14 or Doc/Phd15).  
• In type III TA modules the antitoxin is an RNA that inhibits the toxin’s activity via a 
direct interaction (e.g., ToxIN16 or TenpIN17). 
• In type IV TA modules the antitoxin is an RNA that interferes with the inactivation of 
cellular functions by the toxin in the absence of a direct interaction (e.g., CbeA-CbtA18 
or AbiEi/ii19) 
• In type V TA modules the antitoxin is a protein that prevents translation of the toxin by 
degrading its mRNA (GhoST20). 
Within the most abundant group of type II TA modules the nomenclature is systematically 
oriented at the different classes of toxins according to their fold and primary sequence, 
though a more simple terminology just by locus or toxin-antitoxin combination is prevalent in 
the literature. It is important to note that the same toxin “superfamily” can exhibit different 
molecular activities (e.g., poisoning of gyrase and cleavage of mRNAs for the CcdB / MazF 
family) and that toxin-antitoxin associations are rather flexible on a global scale21 (Figure 1B). 
 Introduction – Toxin-antitoxin modules 
3 
 
 
Figure 1: Introduction to toxin-antitoxin modules. A) Nomenclature of TA modules by the mechanism of 
antitoxin inhibition. Toxin and antitoxin (AT) are depicted in red and blue, respectively. See the running text for 
details (adapted from Schuster and Bertram22). B) Toxin-antitoxin associations of the twelve type II TA toxin 
superfamilies identified by a comprehensive bioinformatics study21. Toxin classes are shown as pie diagrams with 
the different antitoxin classes identified by color code (taken from Leplae et al.21). Novel toxin superfamilies that 
the authors identified in silico and validated experimentally are shown as GinA-D (growth inhibition). AG 
(associated by guilt) denotes novel, smaller families of toxins or antitoxins that are genetically associated to given 
toxin or antitoxin families. C) Plasmid addiction and plasmid competition model of post-segregational killing (taken 
from Van Melderen and de Bast23). 
 
The toxins of TA modules interfere with various aspects of bacterial physiology by 
manipulating a plethora of cellular targets in any imaginable molecular way (see table I and 
the recent review by Unterholzner et al.24). Of those systems that have been investigated in 
detail, many act via the inhibition of translation at any step which has also been proposed to 
be the predominant type in general21, but this conclusion may also be a sign of sampling bias 
or simply our limited understanding of the diversity of toxin-antitoxin modules. Typically, toxin 
and antitoxin are encoded together in a two-gene operon with the antitoxin being upstream, 
often featuring a few nucleotides of overlap between the open reading frames25. Together 
with transcriptional autoregulation via conditional cooperativity (see below) these genetic 
arrangements ensure that the antitoxin is always produced in excess of the toxin under usual 
conditions so that the default state of a TA module is “off”26. 
  
A B
plasmid addictionC plasmid competition
 Introduction – Toxin-antitoxin modules 
4 
 
Name type Molecular activity of toxin General concept Biological function 
RelBE27 
YefM/YoeB28 II 
Ribosome-dependent mRNA 
endonuclease 
Inhibition of 
translation Persister 
formation 
HicAB29 
MazEF30 
MqsRA31 
II Ribosome-independent mRNA endonuclease 
Doc/PhDa,33,34 II Phosphorylation and inhibition of elongation factor TU (EF-Tu) 
HipAB35 II Phosphorylation and inhibition of glutamyl-tRNA synthetase (GltX) 
VapBC36 II Cleavage of initiating tRNA(fMet) 
VapBC2037 II Cleavage of 23S rRNA at sarcin-ricin loop 
RatBA38 
PasTI39 II 
Prevention of 70S ribosome 
assembly 
TisB/istR13 I 
Disruption of membrane potential / 
proton-motive force 
Abrogation of 
ATP synthesis GhoST
20 V 
Hok/sok40 I 
Post-segregational 
killing CcdBA
41 
ParDE42 II Gyrase poisoning 
DNA 
fragmentation 
AbiEii/AbiEi19 
SanaTA43,44 IV Unknown (likely guanylylation) Unknown 
Abortive infection 
AbiQ45 
ToxIN46 III 
Ribosome-independent mRNA 
endonuclease 
Inhibition of 
translation 
CptIN17 III Unknown Unknown 
TenpIN17 III Unknown Unknown 
ζ/ε47 (“zeta / 
epsilon”) II 
Phosphorylation of peptidoglycan 
precursor UNAG Cell lysis unknown 
CbeA/CbtA18 
CptBA48 IV 
Interaction with MreB and FtsZ and 
inhibition of their polymerization 
Inhibition of 
cell division 
Stress tolerance 
(?) 
SocAB49 n.a. Binding to β sliding clamp DnaN 
Inhibition of 
DNA 
replication 
unknown 
Table 1: List of diverse TA modules and their molecular activities and biological functions. The formal type 
of the TA module is indicated in Roman numerals. This table is by far not exhaustive (e.g., in listing type II TA 
endonucleases) and the degree of how safely biological functions have been assigned to different TA modules 
varies (e.g., abortive infections with CptIN have not been directly demonstrated). Further information is provided 
in the following paragraphs of the Introduction section and the reader is referred to a rich literature of dedicated 
reviews22,24,26,50. 
                                                          
a The most well-investigated Doc-Phd module of bacteriophage P1 was described as a post-segregational killing 
system32, but the homolog in Salmonella Typhimurium plays an important role for persister formation33.  
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A switch to the “on”-state is achieved by a massive drop of the antitoxin / toxin ratio that frees 
a sufficient number of toxin molecules from antitoxin control. For example, the type I 
TisB/istR system is activated by the SOS response (see Box 1) which promotes degradation 
of the istR RNA antitoxin and in parallel up-regulates the expression of the TisB toxin13 
(compare Figure 1A). In case of type II TA modules the activation occurs via antitoxin 
degradation by specific proteases that respond to cellular signaling (recently reviewed by 
Brzozowska and Zielenkiewicz51). Most type II TA modules in Escherichia coli and related 
bacteria are under control of the 
protease Lon that is classically 
activated by starvation signaling via 
the second messenger ppGpp52 
(Figure 3B). However, the activation 
of Lon can also be triggered by other 
clues where the path of molecular 
signaling is less clear such as 
oxidative stress53 or bacteriophage 
infection (see recent work by the 
Sorek lab and literature cited 
therein43). Apart from Lon, a minority 
of type II TA modules in E. coli are 
under the control of the ClpP 
protease54,55, and dual degradation by 
both proteases has also been 
reported56,57. Notably, in other 
organisms such as gram-positives, 
ClpP and not Lon seems to be the 
main player in antitoxin 
degradation58,59. 
5.1.1.2. Biological functions of TA modules 
The first function of toxin-antitoxin systems described in literature was the stabilization of 
mobile replicons via post-segregational killing (PSK) as so-called addiction modules60. The 
concept of this “addiction” was envisioned in a way that, upon loss of a replicon encoding an 
addiction module, the rapid degradation of an intrinsically labile antitoxin would activate the 
more stable toxin and kill the host (see the scheme in Figure 1C and the comparative work of 
Jensen et al.61). Though intuitive at first glance, the general concept of acting as a plain 
“addiction module” has been refuted in more recent days in favor of a competitive function 
Box 1: The bacterial SOS response. The SOS 
regulon is a transcriptional program that gets 
activated in response to single-stranded DNA 
(ssDNA) in the bacterial cytoplasm which is an 
indicator of DNA damage. The SOS response is 
induced by the RecA protein that gets loaded on 
ssDNA by one of two presynaptic complexes, the 
RecBCD complex (acting on double-stranded 
DNA (dsDNA) ends) and the RecFOR complex 
(acting on ssDNA gaps). RecA loading results in 
the formation of a RecA-nucleofilament that 
promotes the auto-proteolysis of the LexA 
transcriptional repressor. LexA prevents the 
expression of SOS genes by tight binding to a 
cognate LexA box sequence in their promoters 
with different affinity. Therefore, increasing or 
persisting DNA damage causes the continuous 
degradation of LexA which activates more and 
more genes of the SOS response depending on 
the potency of their LexA box. In E. coli, 
approximately 40 genes belong to the SOS 
response and encode factors that are primarily 
involved in different pathways of DNA repair and 
recombination. Furthermore, the lytic programs of 
lysogenic bacteriophages as well as the 
activation of various other mobile elements are 
typically wired to the SOS response (see reviews 
by Baharoglu and Mazel7 or Erill et al.9. Note that 
the formation of RecA filaments does not only 
trigger the SOS response but also initiates 
homologous recombination as part of the 
recombinational repair program11. 
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where the TA module does not act in host-plasmid competition, but in plasmid-plasmid 
competition to eliminate incompatible replicons62,63 (see Figure 1C). Some TA modules acting 
in this context (e.g., CcdBA64) are the only ones where a bactericidal mode of action in vivo is 
more or less undisputed. 
In any case, the concept of PSK is unable to explain the remarkable abundance of TA loci on 
the chromosomes of all free-living bacteria which suggests that the action as “addiction 
modules” cannot be the primary function of toxin-antitoxin systems65,66. Instead, the field has 
now come to the conclusion that TA modules have important biological functions as abortive 
infection systems (triggering an altruistic suicide upon bacteriophage infection) or by 
promoting bacterial persistence, the ability to endure theoretically lethal conditions in a 
dormant state (see below). On top of these two main functions it is not surprising that 
secondary, specialized adaptations of some TA modules to other biological roles have been 
described, e.g., the control of gene expression via the differential degradation of mRNAs in 
the case of RNA endonuclease toxins (recently reviewed by Bertram and Schuster67) or 
different direct and indirect mechanisms influencing biofilm formation (see the review of 
Wang and Wood and rich literature cited therein68). 
Bacteriophages are ubiquitous in the environment and constitute a major evolutionary 
pressure for the bacteria that they infect, particularly since their rapid evolution allows them 
to frequently outpace their hosts in a coevolutionary arms race (see also the essay by Stern 
and Sorek69). Therefore, it is not surprising that bacteria evolved a whole arsenal of systems 
to block any step of phage infection from initial adhesion to the takeover of cellular 
machineries44,70,71. Among these, abortive infection (Abi) systems get activated upon 
bacteriophage infection and then prevent host takeover via elimination of the infected cell in 
some kind of altruistic “scorched earth strategy” (see Figure 2A). Interestingly, it has become 
clear that a number of Abi systems are simply specialized TA modules responding to 
bacteriophage infection16,17,19,43,45,56,72 (see Figure 2B), but the nominal discrimination 
between “Abi systems” and “toxin-antitoxin systems” acting in phage defense is maintained 
by some authors in the field for historical reasons (see, e.g., the recent review by the Fineran 
lab44). In most cases it is not known how bacteriophage infection provides a signal for the 
activation of Abi toxins, but some Abi systems were shown to respond to the presence of 
specific phage proteins or phage-induced changes in cellular physiology44. Mechanistically, a 
few Abi toxins have activities similar to those of other TA module toxins including mRNA 
degradation46,56 and unsetting of the proton-motive force73, but the molecular function of most 
Abi toxins is unknown. Ecological studies found that the Abi concept of altruistic suicide is 
quite effective in limiting the spread of phage infections74, but bacteriophages have evolved 
master key antitoxins75 as well as potent protease-inhibitors that prevent toxin 
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activation43,76,77 to overcome abortive infection. Furthermore, even the de novo evolution of 
an Abi antitoxin in a phage genome has been reported78, suggesting that Abi modules can 
always be only one piece in the bacterial defense line next to restriction-modification systems 
and different other active or passive strategies44,79. In addition to these TA modules that 
evolved for bacteriophage defense, a number of TA modules that are believed to have 
distinct primary functions can also exert abortive infection, likely because signaling triggered 
upon phage infection happens to inactivate their antitoxin80,81. 
 
Figure 2: Abortive infection by TA modules. A) Action of abortive infection (Abi) systems during phage 
infections compared to other mechanisms of antiviral defense. B) Two examples of Abi systems of which RexAB 
(top) acts different from TA modules in that RexA senses phage infection and then activates RexB, an ion channel 
disrupting the membrane potential. ToxIN is a type III TA module that gets activated upon bacteriophage infection 
and causes abortive infection via the RNA endonuclease activity of the ToxN toxin. Both panels were adapted 
from the recent review by Dy et al.44. 
 
Next to abortive infection, the second main biological role of TA modules is to act as 
phenotypic switches into the persister state (see Toxin-antitoxin modules and bacterial 
persistence below). In short, the activation of TA modules in response to certain triggers or 
stochastically in the population can induce a state of dormancy in which the bacteria do not 
grow but are highly tolerant to perturbations such as antibiotic treatment or immune 
functions82. Sacrificing a small subpopulation for stochastic persister formation constitutes a 
pre-adaptation of the community to sudden threats as a bet-hedging strategy and can thus 
be seen as a “social trait”83. Therefore, it is interesting to note that - although they had initially 
been described as mediators of “selfish” behavior in different ways – TA modules appear to 
mostly promote altruistic behavior in form of abortive infection and persister formation. 
A B
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During my PhD project I got interested in toxin-antitoxin systems because proteins 
representing a deeply ancestral state to effectors secreted by Vbh and VirB/D4 machineries 
of Bartonella turned out to show features of TA modules (see details in Research article I). 
Further investigations revealed a new class of toxin-antitoxin modules and biological 
functions in the context of bacterial persistence (see Review article II and Research 
article III).  
5.1.2. TA modules and bacterial persistence 
Bacterial persisters are phenotypic variants that display vastly increased stress tolerance via 
perseverance in a slow- or non-growing state which has been described as “dormancy”35,42 
(Figure 3A). Persister cells are notorious for their multidrug tolerance and, particularly if 
arising within biofilms, their resilience to clearance by the immune system84-87. Although 
persistence is a purely phenotypic phenomenona, the ability to form persister cells is 
genetically programmed in toxin-antitoxin modules that act as the switches into 
dormancyb,33,91. Importantly, persisters do not only survive lethal concentrations of antibiotics 
in laboratory test tubes but are important for the strategy of various pathogens to sustain 
chronic infections inside a hostile host. Many examples of TA-driven persistence of bacterial 
pathogens in vivo have been published, e.g., for Salmonella Typhimurium33,92, Haemophilus 
influenzae93,94, and uropathogenic E. coli39. It is likely that these cases are merely the 
proverbial tip of the iceberg, since the frequent redundancy of TA modules in a given 
bacterium often makes it difficult to pinpoint causal relationships. One example for such an 
organism is Mycobacterium tuberculosis whose around 80 TA modules have been proposed 
to play a critical role during its infamously persistent infections95,96. As a prerequisite for 
improved treatment options it is therefore important to understand how persisters are 
generated by toxin-antitoxin modules and which physiological changes in the bacterial cell 
allow persisters to survive under lethal conditions. 
                                                          
a Though persistence itself is by definition phenotypic, persisters can „behave as an evolutionary reservoir from 
which (genetically, A.H.) resistant organisms can emerge” (discussed by Cohen et al.88). 
b Depending on the organism and the environmental circumstances, factors beyond TA modules can play more 
or less important roles. For example, Pseudomonas aeruginosa – notorious for its persistent infections – 
encodes only very few TA modules and seems to primarily rely on other mechanisms for persister 
formation65,89,90. 
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Figure 3: Bacterial persister formation. A) Persister cells (red) are rare phenotypic variants that ensure survival 
of the population by tolerance to lethal stresses (“bet-hedging strategy”). B) Type II TA modules in E. coli and 
related bacteria are typically under the control of protease Lon. Lon gets activated by polyphosphate (PolyP) 
which is produced in response to the second messenger (p)ppGpp, a mediator of starvation signaling. The HipA 
toxin induces ppGpp signaling, making it a powerful switch to the persister state. C) Stochastic (1) and 
deterministic (2-5) stimuli inducing persister formation. Persistence can be triggered by environmental signals (2), 
quorum sensing (3), biofilm formation (4), or phagocytosis by host cells (5). All illustrations were taken from the 
recent review by Maisonneuve and Gerdes82.  
 
5.1.2.1. A switch to dormancy is genetically programmed in TA modules 
Both the dormant state that is characteristic of persisters and the transient as well as bistable 
nature of persistence in bacterial populations can be explained with inherent features of 
toxin-antitoxin modules: Beginning in the “off” state of the TA module, upstream signaling can 
induce a massive drop of the antitoxin / toxin ratio (e.g., by promoting antitoxin degradation) 
and consequently shift the cellular level of toxin activity above the threshold required for a 
phenotypic switch to dormancy. In this state, the bacteria persist until the recovery of 
antitoxin inhibition resuscitates growth97,98. Persister cells are constantly generated as a 
small subpopulation in bacterial communities in response to stochastic internal stimuli like 
the fluctuation of ppGpp levels in Escherichia coli which control the activity of the 
antitoxin-targeting protease Lon52 (see Figure 3B). The resulting bistability between a 
majority of growing cells and a few non-growing persisters is maintained by transcriptional 
control via conditional cooperativity which enables low random induction, strong amplification 
of stochastic signals, and quick removal of free toxin once the inducing signal is gone5,6,98 
(see Box 2). This heterogeneity ensures survival of the bacterial population in form of pre-
A B
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formed persisters that can endure rare, unpredictable threats following a “bet-hedging 
strategy” that is favored over adaptive “sensing” strategies under these conditions97,99,100. In 
addition to stochastic stimuli, persisters can also be generated in a deterministic manner by 
any signaling that causes the activation of TA modules, particularly sublethal levels of stress. 
As an example, the type I toxin TisB of E. coli is part of the SOS regulon and can therefore 
initiate persister formation in response to DNA damage101,102 (see also Box 1). Similarly, a 
whole arsenal of TA modules is activated in Salmonella Typhimurium upon entry into 
phagocytic vesicles in response to 
starvation and vacuole acidification to 
promote intracellular persistence33 
(Figure 3C). Another important trigger 
of TA module activation and persister 
formation is oxidative stress (via the 
activation of proteases Lon and 
ClpP)53,103. Additionally, the rate of 
persister formation is dependent on 
the bacterial growth state with 
elevated frequencies of persisters in 
stationary phase and within biofilms 
where persisters appear to be 
responsible for their notorious drug 
tolerance52,86,104,105. The concept of 
stochastic and deterministic persister 
formation is illustrated in Figure 3C. 
The most well investigated class of toxin-antitoxin systems are type II TA modules where the 
antitoxin is a protein that inhibits the toxin via direct interaction, and bacterial chromosomes 
often encode multiple different ones65. Interestingly, it has been noted that obligate 
intracellular bacteria lack type II TA loci, while free-living generalists or pathogens contain 
vast arsenals. This contrasting pattern can be explained with the propensity of toxin-antitoxin 
modules to spread via horizontal gene transfera among bacterial communities and their 
function in the protection against diverse stresses and unpredictably changing environments 
that are typical threats for free-living prokaryotes66. One study even found that a strong 
accumulation of TA modules in the genome was associated with particularly dangerous, 
pandemic bacterial pathogens107, but this could also be a secondary consequence of the 
infestation with mobile genetic elements during progressing genome deterioration66,108. The 
                                                          
a Interestingly, dedicated studies showed that type II21 and type III17 TA modules are frequently transmitted via 
horizontal gene transfer, while type I TA modules are not106. The reason for this discrepancy is unclear. 
Box 2: Conditional cooperativity. The joint 
regulation of type II TA locus expression by toxin-
antitoxin complexes of different stoichiometry is 
called conditional cooperativity. Depending on 
the ratio of toxin and antitoxin, the toxin can 
either act as a co-repressor (excess antitoxin) or 
a net-activator (excess toxin) of TA transcription, 
though the precise molecular mechanism differs 
between TA modules1-3. Consequently, 
conditional cooperativity dampens the expression 
of TA loci in the absence of activating stimuli to 
minimize their metabolic cost4. The onset of 
antitoxin degradation does not only result in toxin 
activation, but at the same time induces 
expression of the TA locus (thereby producing 
more toxin) because transcriptional repression is 
relieved. Strong transcription of TA loci in turn 
promotes rapid resuscitation of cellular growth by 
efficient toxin sequestration as soon as antitoxin 
degradation is abolished. Recent advances in the 
understanding of conditional cooperativity have 
been published by Cataudella et al.5,6. 
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model organism Escherichia coli K-12 as a host-associated generalist contains at least 37 
TA modules of different types109 and bacteria of the genus Bartonella as obligate 
host-associated parasites typically encode between ten and twenty (type II) TA modules per 
genome65 (but see Figure 36 in the Perspective). Although some degree of redundancy 
between TA modules has been observed in E. coli and was proposed for organisms with 
large numbers of them (like M. tuberculosis)91,95, comparative analyses often revealed that 
even closely related TA modules can have additive effects in various organisms which 
supports the adaptive role of accumulating TA modules in free-living bacteria33,39,110 (Figures 
4A and 4B). In addition to the different molecular functions of their toxins, the cumulative 
behavior of TA modules has been proposed to be a consequence of specialization to 
different upstream signaling68, though this remains to be shown on a broader scale. 
However, the main open question in the field of TA-dependent persistence is the nature of 
the “persistent” state itself beyond its phenotypic outcome of remarkable stress tolerance. 
 
Figure 4: Mechanisms of bacterial persister formation. A) The sequential deletion of ten RNA endonuclease 
TA toxins in E. coli K-12 reveals both redundant (Δ1-4) and cumulative (Δ5-10) behavior of TA modules. B) The 
deletion of lon results in a decrease in the proportion of persister cells similar to the deletion of the ten TA 
modules, illustrating the important role of Lon in type II TA module activation in E. coli. C) The figure illustrates the 
various metabolic aspects that have been related to persister formation. Panels (A) and (B) were adapted from 
Gerdes and Maisonneuve26 and panel (C) from Prax and Bertram111. 
 
5.1.2.2. Physiological basis of bacterial persistence 
Despite the first description of bacterial persisters already in 1944112, the physiological basis 
of this phenomenon has still remained elusive, although our understanding of TA modules as 
phenotypic switches and their upstream signaling has progressed remarkably (recently 
reviewed by Maisonneuve and Gerdes82). Precisely, it is completely unclear which changes 
in the cellular physiology would allow bacteria to survive a plethora of unrelated and clearly 
lethal conditions (discussed in a recent “Viewpoint article” by experts in the field85).  
In this respect, it is important to note that “persisters are not simply non-growing cells”87 but 
represent an evolved, specialized phenotypic state113. Transcriptomic studies on persister 
cells isolated from E. coli114 or M. tuberculosis115 revealed that persisters appeared similar to 
A B C
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exponentially growing cells rather than stationary phase cells, but displayed a strong 
downregulation of genes related to energy production, while the expression of various TA 
modules was increaseda. Consistently, mutants showing sustained upregulation of metabolic 
functions in both organisms exhibited considerably decreased frequencies of persister 
formation116,117. These results are in line with an important role of TA modules as well as 
some kind of metabolic rearrangements during persister formation, but they do not point 
towards the molecular mechanism(s) of multidrug tolerance. Initially, it was proposed that the 
targets of bactericidal antimicrobials may be inactive in dormant cells and thus not available 
for lethal poisoning113. However, this model appears too simplistic, because it is not 
supported by the exponential-cell like transcriptomes of persisters and cannot explain why, 
e.g., TA modules targeting translation can generally protect cells from fluoroquinolones that 
corrupt DNA gyrase52,113,118. 
Our lack of a conceptual understanding regarding the physiological basis of the persister 
state is not caused by a lack of studies on the topic: To cite only a few, it was found that 
different factors such as glycerol-3-phosphate metabolism (though only during stationary 
phase119) and indole signaling120 are involved in bacterial persistence. Furthermore, protein 
aggregation can play a role121, and persistence can be artificially induced by the 
overexpression of diverse “toxic” proteins118. The alternative sigma factor RpoS was shown 
to be involved in persistence for different organisms (though not under all conditions)122,123 
and is wired to TA modules in E  coli103. Additionally, spread-out networks involving the small 
RNA regulator Hfq, DNA replication inhibitor CspD, and various other factors were reported 
to mediate persister formation induced by the MqsRA TA module of E. coli53,124. To add even 
more complexity, it has recently been shown that a considerable number of these variables 
are involved in persister formation exclusively in aged or only in fresh cultures of E. coli125. 
Clearly, it is impossible to reconcile the results of these studies in the frame of a single “big 
picture” that would conclusively represent the molecular basis of the persister state (see the 
recent review on this topic by Prax and Bertram111 and Figure 4C). Therefore, it has been 
reasonably argued that there is likely not a single “persister state” and that bacteria employ 
different, parallel pathways to persistence126,127, even if one subtracts persisters formed by 
general cell malfunctioning (“persistence as stuff happens” model (PaSH)128). For example, it 
was shown that metabolic vitalization of the proton-motive force via different sugars enables 
the killing of persisters by aminoglycosides but not quinolones or β-lactams129,130. Similarly, 
the characteristic metabolic inactivity of persisters is neither necessary nor sufficient for 
persistence, but simply seems to be a shared feature of many persister cells33,131.  
                                                          
a Interestingly, Shah et al. found other TA modules to be upregulated than a second study that investigated a 
technically different population of persister cells87. 
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It is somehow intuitive that the multitude of molecular mechanisms by which TA modules flip 
the switch to persister formation may be the basis of this heterogeneity of persister cells. This 
idea is further supported by the observation that, under laboratory conditions, the ectopic 
expression of various “toxic” proteins and the treatment with diverse drugs can trigger 
persister formation via mechanisms both related and completely unrelated to the mode of 
action of known TA modules118,132. However, and despite the plethora of different molecular 
functions that have been reported, the conceptual way by which TA modules induce bacterial 
persistence have so far been limited to the inhibition of translation or, in a few cases, the 
abrogation of the proton-motive force20,27,34,133. This surprising result suggests that the 
function of TA modules as a phenotypic switch into dormancy may be defined by a number of 
physiological constrains so that not various paths, but rather only a few beaten tracks to the 
persister state exist within bacterial cells. The systematic, comparative analysis of the 
processes connecting the inhibition of translation or the depolarization of the membrane 
potential (and possibly others that remain to be discovered) with stress tolerance will reveal 
the nature of the persister state(s) in molecular details. These findings will be of critical value 
for the development and improvement of silver bullet drugs that hit persisters based on 
recent breakthroughs in the field134.  
During my PhD project I contributed to the discovery of a new type II toxin-antitoxin module 
(see Research article I and Review article II) that promotes bacterial persistence via a novel 
molecular pathway, the disruption of cellular DNA topology (see Research article III). An 
additional, toxin-antitoxin-like system with a similar biochemical (and biological?) function is 
presented in Research article IV. 
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5.2. FIC domain proteins 
5.2.1.  “filamentation induced by cAMP” in Escherichia coli 
The acronym “fic” has been introduced by Utsumi et al. more than thirty years ago to 
describe the phenotype of a peculiar mutant of E. coli which exhibited “filamentation induced 
by cAMP”135 (Figure 5A). Precisely, the temperature-dependent gain-of-function allele fic-1 of 
the fic gene136 causes a G55R substitution137 in the corresponding protein Fic and 
suppressed cell division at 43°C in the presence of 1.5 mM cAMP. Although a clean deletion 
of the fic gene had no phenotype and revealed that fic is “dispensable to the cell”136, findings 
that a fic deletion mutant became auxotrophic for p-aminobenzoate, a precursor of folic acid, 
let some researchers speculate that the fic gene may be involved in its biosynthesis138. 
Clearly, there is no tenable connection between fic and p-aminobenzoate, but the promoter 
of the downstream gene pabA (p-aminobenzoate synthetase) lies partially within the fic 
gene139. Although this trivial fact easily explains the auxotrophy of some fic deletion mutants 
(dependent on their construction), an involvement of fic homologs in p-aminobenzoate 
synthesis persists in databases like Pfam (Fic/DOC family being PF02661; accessed last on 
November 20th 2014) and diverse gene annotations. In addition to pabA, the fic gene is 
encoded together with a small ORF called yhfG that is positioned upstream of fic with a few 
nucleotides of overlap. This genetic arrangement is immediately reminiscent of TA modules, 
and while fic and yhfG homologs generally appear to be encoded together, the local synteny 
between yhfg-fic and pabA is only found in Enterobacteriaceae (see Figure 19A in the 
Unpublished Results related to Research article III). Consistently, a bioinformatics study 
explicitly proposed that yhfG-fic loci encode a novel type II TA module140, but this notion had 
remained speculative (particularly with respect to the E. coli homolog), though a direct 
interaction between YhfG and Fic has been demonstrated141. 
A lot of purely descriptive results have been published in the course of attempts to unravel 
the physiological basis of “filamentation induced by cAMP” and revealed that, e.g., fic 
expression is induced in stationary phase142 or that the phenotype is sensitive to high salt 
concentrations136 and correlates with the upregulation of an obscure membrane protein143. 
More importantly, it was shown that 1) the mutant Fic-1 protein as well as elevated 
temperature are necessary for fic, proving that fic-1 is a gain-of-function allele136, that 2) 
signaling triggered by CRP (cAMP receptor protein) bound to cAMP is necessary for the 
phenotype135, and that 3) the phenotype is sensitive to the addition of folate138. The latter 
finding indicates that “filamentation induced by cAMP” may not be caused by any 
biochemical activity of the Fic protein itself, but rather by a repression of pabA expression. It 
is tempting to speculate that the G55R substitution, being far from active site and target 
interaction surfaces of FIC domains (see below), may somehow influence the transcriptional 
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autoregulation of a TA-like yhfG-fic module and thereby affect transcription of pabA. 
However, further research would be necessary to understand the enigmatic “filamentation 
induced by cAMP” phenotype and connect the plethora of old data with fresh studies. 
During my PhD project we described a novel toxin-antitoxin module composed of yhfG-fic 
homologs, but not including fic and yhfG of E. coli themselves (see Research articles I and 
III). In Review article II we therefore introduced a nomenclature calling the Fic homologs 
“FicT” (for “Fic toxin”, e.g., “EcFicT” for Fic of E. coli) and the YhfG homologs “FicA” (for “Fic 
antitoxin”, e.g., “EcFicA” for YhfG of E. coli). So far, yhfG-fic of E. coli (“ecficAT”) has resisted 
all attempts to demonstrate “filamentation induced by cAMP” in E. coli K-12 (see 
Unpublished results related to Research article III) or any other biological activity reminiscent 
of TA models. 
 
Figure 5: Introduction to FIC domain proteins. A) “Filamentation induced by cAMP” of a fic-1 mutant of E. coli 
(top) and wildtype morphology (bottom) after two hours at 43°C with 10mM cAMP. The scale bar represents a 
length of 10 µm (taken from Utsumi et al.135). B) Biochemical plasticity and biological diversity of FIC domain 
proteins (adapted from Cruz and Woychik144). AMPylation (adenylylation) represents VopS and IbpA. 
 
5.2.2. FIC domains in host-targeted virulence factors of bacterial pathogens 
Fic of E. coli comprises a single protein domain that was accordingly named FIC 
(consistently written in capital letters in this work to avoid confusion with protein names). 
Although the far majority of FIC domains are found in genuine bacterial proteins (see the 
phylogenic distribution of the Fic/DOC family (PF02661) in the Pfam database or of Fido 
(IPR003812) in the InterPro database), the majority of research after the initial studies on 
“filamentation induced by cAMP” has focused on host-targeted virulence factors of bacterial 
pathogens. Though these proteins are clearly not representative for the bulk of FIC domains 
with regard to biological function, they were instrumental to the understanding of the 
biochemistry and structure-function relationship of Fic proteins. 
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The type III secretion (T3SS) effector protein VopS of Vibrio parahaemolyticus and the 
type V secreted surface protein IbpA of Histophilus somni both induce a collapse of the actin 
cytoskeleton and cell death upon translocation into eukaryotic host cells145,146. VopS and 
IbpA contain one and two closely related FIC domains, respectively, and studies by the Orth 
and Dixon labs revealed that both proteins target small GTPases of the Rho family via 
adenylylation (also called AMPylation), the transfer of an adenosine 5’-monophosphate, and 
established adenylylation / AMPylation as the conserved biochemical activity of FIC 
domains125,126 (Figure 5B). The adenylylation of small GTPases causes the cytotoxicity of 
VopS and IbpA by blocking the binding of downstream signaling partners and thereby also 
disrupts multiple cellular pathways besides the control of the actin cytoskeleton147. A 
considerable number of small GTPases including RhoA, Rac1, and Cdc42 are nearly 
indiscriminately adenylylated by VopS and IbpA148,149. Already the first study on VopS 
showed that its adenylylation activity is dependent on an invariant histidine within a 
conserved FIC domain signature motif HPFx(D/E)GNGR150. This sequence motif was later 
shown to constitute the active site of FIC domains with the histidine likely serving as a 
general base during the catalysis of target adenylylation151-153 (frequently referred to as 
“catalytic histidine” of FIC domain proteins151,154,155). 
Like VopS or IbpA, the FIC-domain containing T3SS effector protein AvrAC of Xanthomonas 
campestris is secreted into host cells to subvert signaling in favor of the pathogen, but in this 
case the target are plant cells. A study on AvrAC revealed that this effector lacked any 
detectable adenylylation activity and instead acts via the uridylylation (“UMPylation”) of two 
receptor-like kinases of plant cells that are involved in the sensing of pathogen-associated 
molecular patterns (PAMP)156 (see Figure 5B). Uridylylation occurs on a pair of neighboring 
serine / threonine residues that would need to be phosphorylated for the activation of the 
targets, so that AvrAC prevents the induction of immune responses by Xanthomonas. 
The FIC domain containing T4SS effector AnkX of Legionella pneumophila had long been 
known to induce fragmentation of the Golgi apparatus as well as to cause defects in 
vesicular transport in host cells157. These phenotypes depended on the integrity of the AnkX 
FIC domain and its active site histidine155,158. During the course of my PhD work, others 
showed that AnkX targets the small GTPases Rab1 and Rab35 via phosphocholination using 
CDP-choline as the substrate159 (Figure 5B). Phosphocholination blocks the interaction of the 
Rab GTPases with activating GTP/GDP exchange factors (GEFs) or GDP dissociation 
inhibitors (GDIs) and therefore results in their functional deactivation, since the active 
GTP-bound form cannot be regenerated160. 
The Pseudomonas syringae T3SS effector protein AvrB does not show significant sequence 
similarity to FIC domain proteins, but harbors a structural fold that is clearly related161. Upon 
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infection of plant cells, the AvrB protein interacts with a number of host proteins like the MAP 
kinase MPK4 and immune regulator RIN4162,163. It had therefore been suggested that AvrB 
may act in host plant immunomodulation, e.g., via disturbance of hormone signaling163, but 
this had remained speculative for a long time. Biochemically, the interaction of AvrB with 
RIN4 causes RIN4 phosphorylation by RIPK1, and this modification can induce effector-
triggered immunity in plant cells164. Such an activation of immune responses upon sensing of 
the activities of bacterial effectors is a common theme in the co-evolutionary arms race 
between plants and their pathogens165, but did not help to unravel the molecular function and 
biological role of AvrB. It has been revealed only very recently that the AvrB-mediated 
phosphorylation of RIN4 impairs the activation of plant immune responses. More specifically, 
this modification counteracts the immune-stimulatory signaling triggered by phosphorylation 
of RIN4 on another residue upon recognition of bacteria166 (Figure 5B). Intriguingly, a 
potential kinase activity of AvrB itself that may target RIN4 directly (instead or on top of 
phosphorylation by RIPK1 and other kinases) has been proposed repeatedly based on the 
structure of AvrB in complex with ADP and a peptide of RIN4152,162,167, but is now considered 
to be rather unlikely (discussed and reviewed by Roger W. Innes168). 
Similar to VopS, AnkX, or AvrAC, the far majority of effectors secreted by the host-interacting 
VirB/D4 T4SS of Bartonella (called Beps for Bartonella effector proteins) contain FIC 
domains that are likely involved in the manipulation of host cell functions169 (see below). 
Though no phenotypes of Bartonella infection could yet be unambiguously traced to the FIC 
domain of one or more effectors, research in our laboratory could demonstrate the 
adenylylation activity of a truncated construct of BepA of B. henselae that results in the 
modification of host factors of approximately 40 kDa and 50 kDa152. In parallel, I had 
developed a biochemical assay capable of the mid-throughput analysis of full-length effectors 
and demonstrated the adenylylation activity of two orthologous groups of effectors Bep1 and 
Bep2 that are only distantly related to BepA. Different orthologs of Bep1 all specifically 
modify Rac1 and a few closely related small GTPases at the same residue as IbpA, but with 
considerable target specificity (see Appendix: Further results). Bep2, a paralog of Bep1, 
modifies a different host target of approximately 50 kDa size (identified in Research article II), 
suggesting that effectors within one orthologous group may have the same activity while 
those from different orthologous groups have different activities. However, an additional in 
silico analysis performed during my Master project indicated that the far majority of 
Bartonella effectors with FIC domains may not act via adenylylation due to considerable 
deviations from the canonical FIC domain active site sequence (see Figure 28 in the 
Appendix: Further results section). 
 Introduction – FIC domain proteins 
18 
 
5.2.3. The Doc / Phd toxin-antitoxin module 
The Doc (death on curing) protein has first been described as the toxin of a post-
segregational killing system that enforces maintenance of the P1 lysogenic plasmid in 
bacteria (“plasmid addiction”)32. This toxin is characterized by an incomplete Fic core that can 
be complemented by the binding of its antitoxin Phd (prevents host death) which restores a 
complete FIC domain fold, but at the same time inhibits its activity15,170. Though the well-
studied Doc/Phd homolog encoded by E. coli phage P1 acts as an addiction module, 
Doc/Phd is abundant as a chromosomal TA module, e.g., in Salmonella Typhimurium where 
it was found to be the involved in macrophage-induced persister formation33. While the 
results in S. Typhimurium suggest that Doc/Phd would be activated by Lon like most TA 
modules in E. coli and related bacteria33, the homolog of phage P1 is under the control of 
ClpP55. Doc is a very potent toxin and inhibits growth via the inhibition of translation, but not 
transcription or chromosome replication171. A molecular mechanism in the context of 
ribosomes had been suspected for a long time171, and the dependence of Doc-mediated 
growth inhibition on the histidine within its FIC domain signature pointed towards a 
post-translational modification15. However, it has only recently been revealed that Doc is a 
kinase that uses the FIC domain active site to phosphorylate translation elongation factor 
EF-Tu. Phosphorylation makes EF-Tu unable to bind aminoacylated tRNAs and thus 
immediately stops the translation process34 (Figure 5B). Therefore, Doc is another TA 
module toxin that inhibits translation, but gives an important example how new catalytic 
functionalities can evolve from the FIC domain core (see below). Interestingly, it was 
proposed that Doc evolved via the deterioration of adenylylating FIC domain proteins and 
that Phd acquired the missing α-helix via a sequence shuffling event of illegitimate 
recombination15,170. 
5.2.4. Metazoan FIC domain proteins 
Proteins containing FIC domains are not restricted to prokaryotes, but can also be found in 
eukaryotic organisms. Interestingly, metazoans encode each one copy of a FIC domain 
protein with an N-terminal transmembrane helix followed by tetratricopeptide repeats172. An 
auto-adenylylation activity was shown in vitro for the homologs of humans (called HypE or 
FicD)173 and Drosophila melanogaster (CG9523)161. CG9523 is essential for the recycling of 
the visual neurotransmitter histamine in capitate projections of glia cells174. A recent study 
showed that CG9523 (and HypE) adenylylate BiP/GRP78, a chaperone of the endoplasmic 
reticulum, but it has remained elusive whether this activity is causal to the blindness of 
mutant flies or if additional targets exist175. Additionally, HypE has been found to adenylylate 
the same residue in small GTPases as IbpA173 as well as an unknown residue in histone 
H3176, but the relation of these activities to potential biological function(s) have remained 
elusive so far.  
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5.2.5. General features and structure-function relations of FIC domain proteins 
From a technical point of view, all FIC domain proteins share a conserved enzymatic core 
that can be extended via different accessory modules to guide substrate and target 
specificities (Figure 6). This molecular machinery has been recently reviewed by Garcia-Pino 
et al.170 who defined the minimal Fic core as a set of six α-helices containing the active-site 
loop with the Fic signature motif HxFx(D/E)GNGRxxR177. The FIC domain active site has 
evolved to perform the transfer of a phosphoryl group generated from the cleavage of a 
pyrophosphate bond onto a hydroxyl side chain of the target protein. A “catalytic histidine” 
within the active site of FIC domain proteins is critical for efficient catalysis because it 
deprotonates the target hydroxyl group in order to enable its nucleophilic attack on the 
pyrophosphate bond18,127,129. 
On top of this enzymatic core, FIC domain proteins can contain inserted accessory elements 
at three typical “grafting points” that serve to direct the enzymatic activity of the Fic core170. 
Modules responsible for target recognition are typically found at the N- and / or C-terminus of 
the enzymatic core and are largely unique for individual groups of FIC domain proteins, e.g., 
the N-terminal “arm subdomains” of IbpA and VopS FIC domains that bind to small 
GTPases151,153. Additionally, a β-hairpin between helices α2 and α3 (the “flap”) that is shared 
between all FIC domains sensu stricto170, but absent in Doc15, constitutes a target protein 
docking site that forms intermolecular antiparallel β-strand interactions with the target and 
thereby positions the attacking hydroxyl side chain towards the FIC domain active 
site152,153,162. These β-β-interactions are generally sequence-independent and can therefore 
be seen as part of the enzymatic machinery rather than a way of target recognition152,178. The 
different crystal structures of FIC domain proteins confirm this role of the β-hairpin flap in 
target accommodation by showing diverse conformations ranging from a partly disordered 
loop152 in a solitary Fic structure to a solid a β-sheet engaged in the interaction with stretches 
of target or surrogate target153,162,179. 
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Figure 6: FIC domain proteins comprise an enzymatic core with different functional extensions. The 
conserved FIC domain core is sketched in (1) with rainbow coloring of it secondary structure. Structures (2) to (6) 
show the Fic core of each protein (rainbow) with different accessory modules in white. Particular elements like the 
β-hairpin flap (b1-b2 in (1)) or a helix-turn-helix domain (4) are highlighted in grey and light green, respectively. 
The figure was adapted from Kinch et al.161 and the structures represent HpFicT of Heliciobacter pyloria (2), Doc 
with Phd (3; Phd in magenta), SoFicT of Shewanella oneidensis (4), BtFicT of Bacteroides thetaiotamicron (5), 
and AvrB of P. syringae (6) in complex with a peptide of its target RIN4 (magenta). Note that the definition of the 
“Fic core” in the source of this figure161 is slightly different from the one used by the new review of Garcia-Pino et 
al.170, but this divergence does not affect its illustrative power. The discussion of different opinions regarding the 
FIC domain “core” and a comparison of sensu stricto Fic proteins with the FIC domains of Doc or AvrB is mostly 
semantic and beyond the scope of this work. 
 
The conserved phosphoryl transfer machinery in the Fic core can catalyze diverse chemical 
reactions dependent on the small molecule substrate that donates the phosphoryl group. For 
the most prevalent group of FIC domains that mediate nucleotidyl transfer (“NMPylation”) the 
binding of their nucleotide substrate has been investigated in detail and involves parts both of 
the Fic signature motif as well as the β-hairpin flap152,153,178. For Doc (acting as a kinase) and 
AnkX (performing phosphocholination), their peculiar biochemical activities are catalyzed by 
basically the same enzymatic machinery as with classical nucleotidyl transfer, but the small 
molecule substrate binds in an inverted conformation relative to the nucleotide in their 
adenylylating FIC domain cousins. Consequently, the leaving group of the nucleophilic attack 
changes and a phosphate is transferred from ATP by Doc and a phosphocholine is 
transferred from CDP-choline by AnkX34,154. 
In addition to target modification, all FIC domains investigated so far also perform auto-
modification reactions like auto-adenylylation / auto-AMPylation, but the functional relevance 
of this phenomenon has not been explored in detail152,153,161. So far, only the hypothesis that 
                                                          
a For reasons of consistency I used a universal nomenclature of genuine bacterial FIC domain proteins 
throughout this thesis that follows one possible path of common sense in protein biology. For example, this Fic 
protein of Helicobacter pylori is called HpFicT with “Hp” denoting the species, “Fic” denoting the protein family, 
and “T” as the final capital letter giving information regarding the protein’s activity (compare “EcFicT” 
introduced above or “SoFicT”, “NmFicT”, and “YeFicT” appearing in later sections). However, the primary 
authors of different articles that are part of this work decided to apply different, more open nomenclatures 
(Research articles I and IV). 
(1) (2) (3)
(4) (5) (6)
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auto-adenylylation may represent the first step of an enzymatic ping-pong mechanism has 
been refuted by enzyme kinetics of VopS in favor of the formation of a ternary complex 
during catalysis151. 
Prior to the beginning of my PhD project and also over the course of it the field of FIC domain 
research has been repeatedly and comprehensively reviewed, particularly with respect to 
structure-function relations144,158,170,180. I had already contributed to the field during my Master 
project by an analysis of Bartonella effector proteins in silico and proposed auxiliary modules 
that may be involved in their remarkable target specificity and diversity (see Research 
article II and Appendix: Further results). Furthermore, I was involved in the elucidation of a 
conserved mechanism that regulates the adenylylation activity of the majority of FIC domain 
proteins (Research article I) and guided or contributed to different projects that largely 
expanded our biochemical and functional understanding of FIC domain proteins (Research 
articles I-IV and Review article II). 
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5.3. Control of cellular DNA topology in bacteria 
5.3.1. Basics of bacterial DNA topology 
The concept of two complementary strands of DNA that anneal to form the well-known 
helical structure of dsDNA is a brilliant answer to conceptual questions arising for the 
storage, transcription, and transfer of genetic information. However, it causes major 
topological problems that are inherent to the structure of the dsDNA helix (see the 
magnificent review by Deweese et al. for an introduction into DNA topology181). 
In short, the topology of a classical circular and covalently closed dsDNA molecule is 
described with three parameters twist (Tw), writhe (Wr), and linking number (Lk). While twist 
means the total number of helical turns, writhe describes the wrapping and buckling of the 
DNA strand and is numerically defined as the number of crossings upon 2D projection. 
Simply, Lk is the sum of Wr and Tw and cannot be changed as long as the DNA molecule 
stays intact, while Wr and Tw are interconvertable (see an example in Figure 7A). The 
storage of genetic information within a single strand of the double-stranded molecule makes 
it necessary to open up the dsDNA helix whenever the information is to be accessed. 
Therefore, the DNA in bacterial cells is by default underwound (i.e., „negatively“ 
supercoileda) which promotes its manipulation because the „negative“ writhe can be 
converted into local unwinding, i.e., a reduction in twist. Conversely, the progressive dsDNA 
melting inherent to DNA replication and transcription is a forced reduction of twist that causes 
compensatory overwinding or „positive“ supercoiling, an increase in writhe. This is big part of 
the dilemma of the DNA double helix: Its constant manipulation by vital processes consumes 
negative supercoils and produces positive supercoils that impede further manipulation 
(recently reviewed by Koster et al.182). 
                                                          
a By convention, overwinding and underwinding (relative the relaxed state with one helical turn per 10.5 base 
pairs) are referred to as „positive“ and „negative“ supercoiling, respectively. 
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Figure 7: Introduction to DNA topology. A) Exemplary illustration of the topological parameters Lk, Tw, and Wr 
of dsDNA molecules (taken from Koster et al.182). The dsDNA molecule with a length of 210 base pairs contains 
20 helical turns in a torsionally relaxed state (10.5 bp / turn) – the twist (Tw) is 20, writhe (Wr) is 0, and therefore 
Lk (linking number) is 20. A reduction in Lk to 16, e.g., via dsDNA breakage, four rotations, and resealing, can 
either partition to a reduction of Wr (top: “negative” supercoiling” with Wr = -4) or to a reduction of Tw (bottom: 
DNA unwinding with Tw = 16, i.e., only 16 instead of initially 20 helical turns). Note that the two dsDNA molecules 
shown to the right are topologically equivalent, i.e., negative supercoiling is interconvertible with local unwinding. 
B) Distortions of dsDNA topology upon DNA transcription (top) or DNA replication (bottom). The DNA rotation 
imposed by RNA polymerase causes positive supercoiling ahead of the transcription site and negative 
supercoiling behind it. Similarly, DNA replication causes positive supercoiling ahead of the progressing replisome, 
and the intertwining of the daughter chromatids results in (pre-)catenanes. The illustrations also show where 
type I and type II topoisomerases can intervene and remove topological distortions (see below). Figures adapted 
from the Website of Dr. Michelle Wanga.  
 
More precisely, the rotational drag imposed by transcribing RNA polymerase causes DNA to 
fold up to positive supercoils ahead of the transcription machinery and generates 
corresponding negative supercoils behind it („twin-domain effect“183). Similarly, the unwinding 
of the DNA duplex during DNA replication results in positive supercoiling ahead of the 
replication fork184 (Figure 7B). At first glance, the separation of bacterial chromosomes and 
other large dsDNA molecules into independent topological loopsb (ca. 400 with each around 
10‘000 base pairs for the chromosome of E. coli185) may confine such distortions to the DNA 
                                                          
a available on http://www.hhmi.org/research/dynamics-accessing-dna (last accessed on November8th, 2014) 
b The organization of chromosomal DNA into such topologically independent, negatively supercoiled loops is 
also a major aspect of nucleoid compaction that allows to fit the chromosomes into bacterial cells as discussed 
by Postow et al.185, though the causalities are likely more complex as previously assumed186. 
DNA replication
A
transcription
(«twin-domain model»)
B
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locus where they arouse. However, the ubiquity and simultaneity of DNA transcription is such 
a strong drain of DNA underwinding that it can even consume negative supercoils from 
adjacent loops, while positive supercoiling generated by DNA replication is more a local 
obstacle to fork progression itself187. But constant overwinding is not the only problem arising 
from cellular DNA manipulations: Additionally, the rotation of the replication complex relative 
to the DNA causes intertwining of the sister chromatids behind the replisome184,188 
(Figure 7B). It is intuitive that already a single crossing of these entanglements or 
„catenation“ would be sufficient to prevent chromosome segregation. Furthermore, 
intramolecular knots that arise from accidents during processes of DNA manipulation directly 
block unwinding of the dsDNA helix (recently reviewed by Schvartzman et al.189). DNA 
supercoiling, catenation, and knotting are illustrated in Figure 8. 
 
Figure 8: DNA supercoiling, catenation, and knotting. The three topological forms of circular dsDNA 
molecules are shown in comparison (catenated and knotted DNA can also be supercoiled in addition; adapted 
from Cozzarelli et al.190). While positive supercoiling stops DNA replication and transcription, excess negative 
supercoiling promotes the formation of harmful structures like R loops (annealing of a transcribed RNA with its 
template DNA behind the RNA polymerase; summarized by Pommier et al.191). Catenation impairs DNA 
segregation, while DNA knotting inhibits DNA unwinding and thereby productive manipulation of the dsDNA helix. 
 
In conclusion, it is clear that the constant assault of positive supercoiling, excess negative 
supercoiling, catenation, and knotting on the functionality of bacterial (as well as eukaryotic, 
for that matter) DNA needs to be counteracted by cellular machineries that can itself 
manipulate and adjust the topology of dsDNA – since they interconvert different isomers of 
DNA topology, they are called DNA topoisomerases. 
5.3.2. Control of DNA topology in bacterial cells 
Conceptually, DNA topoisomerases remove distortions in cellular DNA topology via 
manipulations of Lk during transient breaks in the double helix (recently reviewed by Vos et 
al.192). They are generally classified as type I or type II dependent on whether their 
mechanism involves the formation of a transient single-strand or double-strand DNA break 
which has different functional implications193 (Figure 7B). Since topoisomerases are generally 
essential for life as we know it, an “intelligent designer would have probably invented only 
Supercoiling Catenation Knotting
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one ubiquitous Topo I and one ubiquitous Topo II”a. Instead, the different domains and even 
lineages of life contain a zoo of topoisomerases with complex patterns of homology194. 
Type I topoisomerases cut a single strand of the dsDNA, move it around the complementary 
strand via controlled rotation, and religate the dsDNA helix which changes the linking number 
in increments of one192. E. coli contains two type I topoisomerases that are called 
topoisomerase I (topo I) and topoisomerase III (topo III). It is the main function of topo I to 
relax the flood of negative supercoils that are typically generated locally behind RNA 
polymerase at sites of strong transcription, but it also plays a role in the adjustment of global 
DNA topology via the relaxation of any excess of negative supercoiling195,196. The function of 
topo III was long debated, but it appears to be involved in the resolution of Holliday junctions 
during recombination and can participate in the decatenation of daughter 
chromosomes197,198. Structurally, topo I and topo III are nearly identical over most of their 
primary sequence, and minor differences in their biochemical properties underlie their 
different biological functions199. Next to the type IA family of type I topoisomerases 
(comprising topo I, topo III; and reverse gyrase) a type IB family (mostly eukaryotic) and type 
IC (only a single representative in an archaeon) exist192. 
Additionally, two types of type II topoisomerases have been described so that in total five 
distinct families of DNA topoisomerases are known today194. The type IIB family is mostly 
found in archaea and plants where they relax excess negative as well as positive supercoils 
and act in decatenation192,200. Type IIA DNA topoisomerases are found in all domains of life 
as well as viruses and comprise three homologous families of enzymes, eukaryotic topo II as 
well as prokaryotic topo IV and DNA gyrase. While eukaryotic topo II and prokaryotic topo IV 
share the ability to act as strong decatenases, DNA gyrase is unique in its ability to introduce 
negative supercoils193,194. 
DNA gyrase and topo IV are paralogous heterotetramers assembled from each two A and B 
subunits (GyrA2-GyrB2 respectively ParC2-ParE2) of which – in short – the A subunits contain 
the active site responsible for DNA manipulation while the B subunits contain an ATPase 
domain whose activity is generally required for the reaction mechanism193,201 (Figure 9A). 
While DNA gyrase is universally essential, a few bacteria are known to lack topo IV, but it 
appears that in these cases DNA gyrase may have taken over the functionality of its 
paralog202.  
DNA gyrase and topo IV act via a conserved “three-gate mechanism” involving transient 
double-strand breakage of a closed-circular DNA molecule via transphosphorylation onto 
                                                          
a ... „to facilitate the task of future biochemists“, as the authors feel obliged to add with some bitterness. 
Interestingly, they argue that the diversity of DNA topoisomerases among the phyla of cellular life is a strong 
hint that DNA topoisomerases as well as, ultimately, DNA itself are of viral origin. 
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active site tyrosines of the topoisomerase. The formation of this covalent complex is followed 
by unidirectional passage of the same (supercoiling / relaxation and knotting / unknotting) or 
a different (catenation / decatenation) DNA molecule through the resulting cleft. Finally, the 
phosphodiester bonds of the DNA backbone are resealed and the enzyme is reset for a new 
cycle of topoisomerisation (Figures 9A and 9B). Despite their different biological outcome, 
the activities of DNA gyrase and topo IV are therefore “based on the same structural and 
mechanistic framework (and) achieved by different fine-tuning of a common theme” (recently 
reviewed by Gubaev and Klostermeier203). In the case of DNA gyrase, the topoisomerase 
wraps ca. 150bp204 of the double strand around a gyrase-specific C-terminal β-pinwheel 
domain of GyrA and can thus pass it through a transient dsDNA break in the same molecule 
(Figures 9B). The wrapping around GyrA produces a dsDNA crossover with positive node 
sign that is inverted by the strand passage, thereby reducing the linking number in 
increments of two205. The canonical “GyrA-box” in the first blade of the GyrA β-pinwheel is 
essential for the functioning of DNA gyrase because it guides DNA wrapping and the 
formation of the positive node at the crossover206-208. The C-terminal domain of ParC lacks 
β-pinwheel and GyrA-box, but analogously controls the directionality of strand passages by 
topo IV via specificity for certain crossover geometries as substrates209,210. 
 
Figure 9: Bacterial type IIA topoisomerases as molecular machineries. A) In short, type II topoisomerases 
mediate the transfer of one piece of dsDNA (T-segment, green) through a cleft in another one (G-segment, red) 
via a “three-gate mechanism”. The T-segment enters the topoisomerase II holoenzyme (1) via the N-gate 
between the ATPase domains of the B subunits (2). Upon ATP binding, the N-gate closes (3). In coordination with 
ATP hydrolysis, the G-segment is cut open by the active site in the winged-helix domains (WHD) of the A subunits 
(“G-gate”) and strand passage takes place (4). Finally, the T-segment is released through the C-gate (5). B) In 
case of gyrase (left), T- and G-segment are part of the same dsDNA molecule that is wrapped around the 
C-terminal domain (CTD) of GyrA to allow strand passage. For decatenation by topo IV (right), T- and G-segment 
belong to different dsDNA molecules. Both panels were taken from Sissi and Palumbo211. 
A B DNA gyrase Topoisomerase IV
(1) (2)
(3)
(4)
(5)
 Introduction – Control of cellular DNA topology in bacteria 
27 
 
Importantly, all biologically relevant activities of type II topoisomerases depend on concurrent 
ATP hydrolysis, though the mechanistic basis for this requirement is still under 
investigation212,213. In case of DNA gyrase it is clear that the ATPase activity of GyrB fuels the 
energetically unfavorable negative supercoiling activity of the enzyme, but the precise 
mechanochemical basis of this requirement is not well understood. Others have shown that 
ATP binding is necessary to overcome a kinetic barrier in the wrapping of a positive supercoil 
but that ATP hydrolysis may be rather loosely coupled to the individual mechanical 
transitions of the strand passage214. Recently, Stanger et al. from our laboratory proposed 
that ATP hydrolysis may induce DNA cleavage as well strand passage215 (Figure 10A), but 
such a causal connection remains to be demonstrated experimentally. For topo IV (and also 
eukaryotic topo II) the strand passages itself are nearly isoenergetic216 so that ATP 
hydrolysis may power the enzymes in other ways and, e.g., serve to control the large protein 
domain movements inherent to the reaction mechanism in order to prevent free double 
strand break formation213. 
The biological functions of DNA gyrase and topo IV are mostly non-overlapping, but show 
considerable cooperation. Both enzymes act together during chromosome replication to 
support replication fork movement by clearing positive supercoils produced in front of the fork 
and resolving daughter strand intertwining behind it211. While DNA gyrase reverts most of the 
positive supercoils217, topo IV is the key player in daughter chromosome decatenation218 (see 
in Figure 7B). Unsurprisingly, the inhibition of both enzymes in E. coli rapidly stops DNA 
replication, and inhibition of DNA gyrase alone leads to a drop of replication fork movement 
to ca. 1/3 as well as a slow stop of chromosome replication217,218. During transcription, DNA 
gyrase intermittently removes the positive supercoils accumulating in front of the RNA 
polymerase at heavily transcribed loci which is responsible for the characteristic “bursting” of 
bacterial transcription219. In addition to its activity in decatenation, topo IV is also responsible 
for the removal of inter- and intrachromatid knots. DNA knots continuously arise in the 
tangled nucleoid from random strand passages that occur whenever cellular DNA handling 
cuts open the chromosome, e.g., during processes of replication, recombination, or repair, 
and they cannot be removed in the absence of functional topo IV220. The propensity to form 
knots increases with the chain length of the circular DNA molecule (see recent work by Witz 
and Stasiak and literature cited therein216). Chromosomal knotting blocks DNA replication 
and transcription, i.e., it “interferes with genetic metabolism”221. Importantly, both the 
decatenation and unknotting activities of topo IV are linked to the functionality of DNA gyrase 
because the negative supercoiling of substrate DNA acts as a “magnet” to find detrimental 
crossovers of knots and catenanes as the proverbial “needle in the haystack”216,222,223. 
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Figure 10: Further details of topoisomerase IIA mechanism and inhibition. A) The catalytic cycle of DNA 
gyrase (compare Figures 9A and 9B) as shown by Stanger et al224. They propose that ATP hydrolysis is coupled 
to strand passage via a concomitant 12° rotation of the transducer domains adjacent to the ATPase domains in 
GyrB. B) Topoisomerase poisoning traps the cleavable complex on the DNA template and causes dsDNA breaks 
upon collision of these “roadblocks” with DNA tracking complexes like replisomes. The illustration was uploaded 
by user Vtvu to the wiki commonsa. C) Another representation of the topoisomerase II reaction cycle with the 
steps at which the various poisons and inhibitors act (taken from Vos et al.225). Topoisomerase poisons lock the 
cleavable complex by inhibition of DNA cleavage (3), strand passage (4), or religation (5), while inhibitors typically 
target DNA binding (1) or ATP binding and hydrolysis (2). Bisdioxopiperazines like ICRF-187 are anti-cancer 
drugs that inhibit eukaryotic topo II by bridging and stabilizing a dimer interaction between the two ATPase 
domains of the holoenzyme226. 
 
In addition to DNA topoisomerases that mostly adjust the DNA topology against 
perturbations, DNA supercoiling and nucleoid compaction are also controlled on a more 
global level by nucleoid-associated proteins (“NAPs” such as H-NS (forming negative 
supercoils; recently reviewed by Rimsky and Travers227) or the structural maintenance of 
chromosome (“SMC”) proteins like MukBEF in E. coli (involved in nucleoid compaction and 
chromosome segregation; recently reviewed by Carter and Sjögren228). Multiple crosslinks 
between these layers of DNA organization and both DNA gyrase and topo IV have been 
described229-232. 
                                                          
a available at http://commons.wikimedia.org/wiki/File:Topoisomerase_Inhibitor.JPG (last accessed on 
November 8th 2014) 
A
C
B Topoisomerase I Topoisomerase II
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5.3.3. The inhibition and poisoning of type IIA topoisomerases in bacteria cells 
Due to their ubiquity in combination with essentiality and strong conservation194 
topoisomerases constitute important targets for inhibition and poisoning both as part of the 
coevolutionary warfare in natural environments and as drug targets for the treatment of 
human patients. While a bacteriostatic block of cellular DNA manipulations is intuitive as the 
consequence of topoisomerase inhibition, the concept of poisoning is different. Unlike 
inhibitors, poisons do not generally abolish the catalytic activity of their topoisomerase target, 
but instead use it to cause DNA damage. More specifically, topoisomerase poisons trap the 
normally only transient „cleavage complex“ in which the enzyme’s polypeptide bridges a DNA 
break that will be exposed upon removal of the topoisomerase, e.g., after collision of a 
replication fork with the cleavage complex acting as a „roadblock“233 (Figure 10B). 
Theoretically, the resulting double-strand breaks can be repaired, but their accumulation 
upon enforced topoisomerase poisoning easily overcomes the cellular repair pathways and 
causes cell death both in prokaryotes as well as in eukaryotes (see the article by Deweese et 
al. for an introductory summary181). Human topo I as well as topo II are targeted in anticancer 
chemotherapy by camptothecin and etoposide or anthracyclines (such as doxorubicin), 
respectively, that are all poisons (recently reviewed by Pommier et al.191). 
Unlike for human topo I, no clinically approved drug targeting bacterial topo I as an 
antimicrobial is available234, but the general feasibility of topo I poisoning with small 
compounds to kill bacteria has been demonstrated235. The situation is completely different for 
the bacterial type IIA topoisomerases DNA gyrase and topo IV that are targeted by a plethora 
of different drugs as well as bacteriocins and TA addiction toxins (recently reviewed by Collin 
et al.236). For an overview I catalogued the various poisons and inhibitors of bacterial type IIA 
topoisomerases in table II (see also Figure 10C). 
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Concept Drug class Examples Mechanism of action 
Inhibitors 
Aminocoumarins Novobiocin, 
coumermycin A1 
Competitive inhibitors of ATP 
binding and therefore hydrolysis 
at GyrB237,238 (and ParE)239  
Simocyclinones Simocyclinone D8 Blocking the DNA binding site 
in GyrA (not ParC)240 
Cyclothialidines Ro 09-1437, GR122222X Competitive inhibitors of ATP 
binding and therefore hydrolysis 
at GyrB241,242 
Cinodin Cinodin β Inhibition of supercoiling by 
DNA gyrase (at GyrA?)243 
Pyrrolamides Compounds not named Competitive inhibitors of ATP 
binding and therefore hydrolysis 
at GyrB244 
Gyramides Gyramide A Competitive inhibitors of ATP 
binding and therefore hydrolysis 
at GyrB245 
Proteic inhibitors Pentapeptide repeat 
proteins (PRPs), GyrI, 
YacG, glutamate 
racemase (MurI) 
prevent enyzme DNA binding, 
interaction with gyrase 
(GyrI246,247 and MurI248), gyrase / 
topo IV (PRPs249,250) or C-
terminus of GyrB (YacG)251,252  
Poisons 
(Fluoro)quinolones Nalidixic acid, 
ciprofloxacin  
Stabilization of a covalent 
complex with GyrA (or ParC) 
being covalently attached to 
dsDNA break, resulting in 
chromosome fragmentation and 
cell death253-255 
Clerocidin Clerocidin Stabilization of covalent 
enzyme-DNA complexes 
causing dsDNA breaks and cell 
death by poisoning at A subunits 
of gyrase256 and topo IV257 
Bacteriocine 
peptides 
Albicidin258, 
microcin B17259 
Different mechanisms of 
cleavage complex stabilization 
of gyrase (microcine B17) or 
gyrase and topo IV (albicidin) at 
A (albicidin) or C-terminus of B 
subunit (microcine B17) 
Addiction module 
toxins 
CcdB, ParE Different mechanisms of 
cleavage complex stabilization 
at GyrA42,260,261  
GSK299423 GSK299423 “Bridging” between DNA and 
GyrA dimer to induce ssDNA 
breaks262 
Table 2: The different classes of inhibitors and poisons of bacterial type IIA topoisomerases have been compiled 
based on the work of Collin et al.236 and additional literature mining. Emerging conclusions are discussed in the 
running text. 
 
Generally, it is the emerging picture that bacterial type IIA topoisomerases are either targeted 
by poisons or via one of two different mechanisms of inhibition, the prevention of DNA 
binding and the block of the ATPase cycle. Antimicrobial compounds are found in both major 
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classes with aminocoumarin drugs and quinolone antibiotics as the most important examples 
that both target DNA gyrase as well as topo IV. Aminocoumarins are bacteriostatic as 
competitive inhibitors of ATP binding to the targets’ B subunit237,238 and have either never 
been in clinical use (coumermycin A1) or are not in the market anymore (novobiocin). In 
direct contrast, quinolones and their derivatives act as topoisomerase poisons and “are 
among the most successful antimicrobials both clinically and economically”234. The molecular 
mode of action at the target for both classes of drugs has been well investigated on the 
atomic level255,263, but the downstream processes leading to chromosome fragmentation and 
cell death after quinolone-mediated cleavage complex stabilization are not fully 
understood253. 
Unsurprisingly, the bacteriocins as well as the toxins of TA addiction modules uniformly 
employ a poisoning mechanism similar to quinolone-mediated cleavage complex trapping 
because an irreversible, lethal mode of action is elemental for their biological functions. 
However, there are some differences in the precise molecular mechanism of topoisomerase 
poisoning such that, e.g., the CcdB toxin requires ATP hydrolysis and probably strand 
passage for gyrase poisoning while new generation fluoroquinolone antibiotics do not, 
suggesting that they target a pre-transport state of the topoisomerase208,264.  
An increasing number of small proteins are known to inhibit bacterial type IIA 
topoisomerases via a tight direct interaction which typically blocks the target’s DNA binding 
and therefore prevents topoisomerase poisoning. Among these proteins are biologically and 
mechanistically distinct factors such as GyrI that is part of the SOS response in E. coli247 or 
the abundant pentapeptide repeat proteins that act as DNA mimics and mediate quinolone 
resistance (recently reviewed by Shah and Heddle265). Interestingly, also the target inhibition 
by aminocoumarins has been reported to protect bacteria from gyrase poisoning266. 
During my PhD project I discovered that the FicTA family of TA modules inhibits DNA gyrase 
and topo IV via adenylylation at the ATPase domain of the B subunits which causes a 
disruption of cellular DNA topology characterized by DNA knotting, catenation, and relaxation 
(see Research article III). Furthermore, I could show that a distinct class of FIC domain 
proteins acts via the same molecular mechanism (Research article IV).  
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5.4. Bacteria of the genus Bartonella 
5.4.1. General features and virulence factors 
The α-proteobacterial genus Bartonella forms a monophyletic group of mammal pathogens 
within the mostly plant-associated order of Rhizobiales and comprises a growing number of 
currently around 30 species267. Bartonella bacteria cause characteristic biphasic infections in 
their respective reservoir hosts and are transmitted by blood-sucking arthropods (reviewed 
by Chomel et al.268). These infections are shaped by the stealth infection strategy of the 
pathogen that uses sophisticated tactics of immune evasion and immunomodulation to first 
pass through an enigmatic “primary niche” (probably involving replication within vascular 
endothelial cells) and then achieve intraerythrocytic persistence (recently reviewed by 
Pulliainen et al.269; see Figure 11). By definition, the “reservoir hosts” of a given Bartonella 
strain are the host species in which it can reach the intraerythrocytic niche and therefore be 
further transmitted. 
 
Figure 11: Common infection cycle of Bartonella spp. The model depicts the different stages of Bartonella 
infections in the mammalian reservoir host and the blood-sucking arthropod vector (adapted from Chomel et 
al.268; d.p.i. = days post-infection). Details are explained in the running text. 
 
Characteristically, infections of reservoir hosts cause no or only negligible disease despite 
long-lasting bacteremia, while accidental infections of non-reservoir hosts with Bartonella can 
result in mild and self-limiting, yet discernable sickness for immunocompetent individiuals. 
The infection of immunocompromised hosts often presents with vasoproliferative lesions as 
well as a range of variable symptoms both in animals as well as in humans270. While 
occasional zoonotic infections with many different Bartonella species have been described, 
most infections of human patients are caused by cat-adapted B. henselae (self-limiting “cat 
scratch fever”), closely related271 B.quintana, as well as B. bacilliformis272. Although the latter 
two species are both adapted to infect humans as their reservoir host, B. quintana typically 
causes only mild and self-limiting disease in immunocompetent patients (“trench fever”), 
while “Carrion’s disease” caused by B. bacilliformis can be lethal during its acute phase if 
untreated273. However, Bartonella infections are typically responsive to antimicrobials, though 
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a lengthy treatment can be required (see the recent review on human bartonelloses and their 
treatment by Angelakis and Raoult274). 
For the enforcement of their complex infection strategy the bartonellae use a wide range of 
different virulence factors most of which have been identified (or confirmed) in signature-
tagged mutagenesis (STM) screens275,276. Most prominently, Bartonella features classical 
bacterial virulence factors like a considerable arsenal of diverse type V secretion systems, 
numerous outer membrane proteins with different functions in host interaction, a specialized 
lipopolysaccharide, and two different type IV secretion systems with distinct functions during 
the infection cycle (reviewed by Minnick and Battisti277). Alongside, a panel of more obscure 
factors such as secreted GroEL chaperone that acts as a potent mitogen278 or deformin, an 
elusive small molecule that subverts the stability of red blood cell membranes279 have been 
described. However, the precise molecular functions and biological roles of most Bartonella 
virulence factors are unknown, not to speak of a big picture that would combine the different 
threads of research and assign the various virulence factors of Bartonella to different steps of 
the infection cycle.  
Only a few research groups in the Bartonella field are investigating the molecular aspects of 
Bartonella infectionsa with most contributions coming from the Kempf lab (focusing on a type 
V secretion system of B. henselae280), the Koehler lab (focusing on a group of type V 
secretion systems281 and some outer membrane proteins282 of B. quintana), the Andersson 
lab (focusing on the molecular evolution of Bartonella283,284), and our laboratory that uses 
Bartonella as a model system to study the coevolution of a bacterial pathogen and an 
effector-secreting type IV secretion system169,276. Some other research groups also made 
important contributions to our understanding of the molecular pathogenesis of 
Bartonella278,285-287. On the other side, most researchers in the Bartonella field are 
veterinarians and concerned with Bartonella as a frequent cause of disease in animals and 
an emerging pathogen of humans, though both aspects are typically seen as connected from 
the perspective of “One Health”288. These laboratories typically publish case studies289-291, 
sampling studies292-294, and occasionally also molecular biology research295 or experimental 
infections296-298 that are of particular importance because they allow to expand key concepts 
beyond small rodent models and their cognate Bartonella pathogens. 
In conclusion, at the beginning of my PhD project the Bartonella field was highly fragmented 
and lacked a fully conclusive picture describing how the different virulence factors of 
Bartonella act together at different stages of the infection strategy. Additionally, the few 
                                                          
a During the course of my PhD project the laboratory of Dr. Katharina Dittmar (University of Buffalo, The State 
University of New York, Buffalo, United States) joined the field with a series of significant publications on the 
molecular evolution of Bartonella (see Unpublished results related to Review article I). 
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comprehensive reviews on this topic were several years old and did therefore not embrace 
recent developments in the field277,299,300. It is clear that this situation was problematic for 
researchers concerned with treatment strategies for human bartonelloses such as trench 
fever and Carrion’s disease that are gaining ground due to alterations in society, ecology, 
and climate301,302. Furthermore, without a comprehensive understanding of how the different 
virulence factors of Bartonella act together during the infection strategy it was pointless for 
me to analyze the co-evolution of one of them, the VirB/D4 T4SS, with its bacterial host. I 
therefore started my PhD project with a systematic catalogization and analysis of Bartonella 
virulence factors based on available literature (see Review article I and a recent update in 
the Unpublished results related to Review article I).  
5.4.2. Bartonella as a model for the evolution of type IV secretion systems 
At the beginning of my PhD project it was the prevailing model in the field that the genus 
Bartonella is split into four phylogenetic lineages with lineage 3 (L3) and lineage 4 (L4) being 
sister clades and lineage 1 (L1) being the sister clade of a clade formed by the other three 
lineages (Figure 12). In this model, Bartonella bacilliformis as the only species in L1 
represents an ancestral evolutionary state. Though it employs the same overall infection 
strategy as the other species, it is less proficient in precise manipulation of its human host 
and thus can cause severe illness in patients. In contrast to B. bacilliformis which is restricted 
to infect humans, the species in L2-4 adapted to a huge variety of mammal hosts through 
explosive radiations and cause no or only mild symptoms in their respective reservoir hosts. 
The deep split between L1 and L2-4 (the “modern” bartonellae) correlates with the presence 
of at least one of three type IV secretion systems (T4SS) in the radiating lineages, but their 
complete absence in B. bacilliformis, suggesting that type IV secretion systems may have 
facilitated the host adaptation of Bartonella (evolutionary model described in detail by 
C. Dehio300)169,275. 
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Figure 12: Phylogenetic tree of the genus Bartonella as published by Engel et al.169. The phylogeny was 
constructed using a maximum likelihood analysis of an alignment of 487 genes of ten sequenced Bartonella 
species (bold and colored) as well as Brucella abortus (outgroup). Additional species were included based on the 
sequences of a number of housekeeping genes. Grey shading indicates presence of a VirB/D4 T4SS, and the 
primary mammalian host of the respective Bartonella species is shown to the right. The four lineages described in 
the running text are shown by color code. 
 
It is well known that host-interacting type IV secretion systems evolved multiple times 
independently from conjugative ancestors, i.e., from type IV secretion systems mediating the 
interbacterial transfer of genetic information typically in form of plasmids that encode the type 
IV machinery itself303. During bacterial conjugation, a protein called relaxase is covalently 
linked to a single strand of the conjugative plasmid and transferred from the donor bacterium 
to the recipient via type IV secretion, thus enabling DNA transfer304 (see more details in the 
Perspective section). Interestingly, the by far most species-rich L4 of Bartonella encodes a 
T4SS called Trw that is closely related to the conjugative machinery of R388, an 
enterobacterial plasmid (see also Figure 35). However, the Bartonella Trw T4SS has evolved 
to mediate adhesion to red blood cells via its extracellular pili and lost the conjugative 
relaxase as well as the associated DNA processing and transfer machinery completely305 
(Figure 13). Therefore, no effectors evolved that could be secreted into host cells, but instead 
the extracellular subunits of the type IV secretion pilus were shaped by gene duplication and 
diversification to mediate host-specific adhesion to erythrocytes276,283. The presumed co-
expression of the different copies suggests that their diversity may be an adaptation to the 
notorious polymorphicity of red blood cell surface structures in mammals rather than being 
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involved in some kind of phase variation or similar immune evasion mechanisms305-307. 
Interestingly, the presence of the Trw T4SS (in L4) is mutually exclusive with flagellation (in 
L1-3)169, suggesting that flagellation as an ancestral trait has somehow been functionally 
replaced by the Trw T4SS in a common ancestor of L4300. The flagella of Bartonella have 
been shown to be involved in erythrocyte infection, but also represent a major target for the 
host’s immune system despite TLR5 evasion308-310. Given the clear dominance of L4 within 
the genus Bartonella and their adaptation to diverse hosts it is tempting to speculate the 
modularity of the Trw machinery could make it superior to flagellation with regard to host 
adaptability and on top avoid the surface expression of a highly conserved bacterial 
protein300. 
 
Figure 13: Virulence-associated type IV secretion systems in Bartonella. Their genetic organization as well 
as models of their architecture are shown for VirB/D4 T4SS (left) and Trw T4SS (right) in the upper half of the 
illustration (taken from the review of Christoph Dehio300). Note that the VirB/D4 T4SS comprises a complete type 
IV secretion system while the Trw T4SS lacks both the coupling protein and any identifiable substrates. Instead, it 
displays tandem duplications of extracellular pilus subunits. These differences reflect the divergent biological 
functions of the VirB/D4 T4SS (effector secretion into nucleated host cells; bottom left) and of the Trw T4SS 
(erythrocyte adhesion; bottom right). EX = extracellular matrix, OM = outer membrane, PP = periplasm, IM = inner 
membrane, CY = cytoplasm 
 
The contribution of a type IV secretion system to host adaptation is particularly clear for L3 
and L4 that are both species-rich and have adapted to a multitude of different host species in 
two recent adaptive radiations, while the host range of L1 (B. bacilliformis limited to infect 
humans) and L2 (limited to infecting ruminants) is highly restricted169,268 (see Figure 12). In 
the prevailing model, two explosive radiations resulting in L3 and L4 were triggered by 
improvements of host-interaction after the acquisition of a host-interacting VirB/D4-like T4SS 
C
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and the evolution of host-targeted effector proteins called Beps (Bartonella effector 
proteins)169 (see Figures 12 and 14A). This implies that common ancestors of L3 and L4 had 
each acquired similar versions of a primordial VirB/D4-like type IV secretion system with a 
single ancestral effector. Subsequently, this effector evolved into the extant repertoires with 
seven and ten orthologous Beps in L3 and L4, respectively, via two independent series of 
gene duplication and diversification169,275 (see Figures 14A and 14B). The VirB/D4 T4SS is 
closely related to rhizobial conjugation systems like the AvhB type IV secretion machinery of 
Agrobacterium, suggesting that it initially evolved from such a machinery. Consistently, the 
secreted effectors of Bartonella employ a BID (Bep intracellular delivery) domain together 
with a positively charged C-terminus as their secretion signal, just like the relaxases of 
rhizobial conjugation systems311. On top of this secretion signal, the common ancestor of all 
Beps (and the majority of extant effectors) harbored a FIC domain as its putative “effector 
module” that may have served to manipulate host proteins by adenylylation169. Secondarily 
and independently in L3 and L4, a second class of effectors evolved in which the FIC domain 
was replaced with a block of sequence harboring tyrosine-containing motifs (Figure 14B). 
These tyrosine motifs get phosphorylated by host kinases and may serve as hubs to 
manipulate signaling in host cells169,275. Furthermore, the evolutionary pressure on the 
effector repertoires to mediate complex host interactions resulted in BID domains that, on top 
of serving as a secretion signal, took over functions in host interaction224,312,313. From a 
conceptual point of view it was generally assumed that orthologous groups of effectors share 
common biological functions, while paralogous effectors adapted to different roles in host cell 
manipulation. 
 
Figure 14: Bartonella effector proteins (Beps) evolved from a single common ancestor in two parallel 
series of gene duplication and diversification. A) The phylogeny of Beps was redrawn with arbitrary branch 
lengths from a maximum likelihood analysis that was based on the BID domain and the C-terminal extension that 
constitute the shared type IV secretion signal169. Different orthologous groups of effectors are shown as boxes 
and the typical functional architecture with an N-terminal FIC domain is indicated by a plain white box. The 
phylogeny shows that Beps of L3 (green frame) and L4 (blue frame) evolved independently from a common 
ancestor via series of gene duplication and diversification. Effectors containing tandem-repeated tyrosine-
phosphorylation motifs instead of a FIC domain evolved independently in L3 and L4 (grey shading and lateral 
shift). B) The model illustrates our current understanding of Bep evolution with the amplification and diversification 
of FIC domain containing effectors and the secondary emergence of Beps with tyrosine containing motifs (Br = 
B. rochalimae, Bc = B. clarridgeiae, Bh = B. henselae). Both panels were adapted from Engel et al.169. 
A B
 Introduction – Bacteria of the genus Bartonella 
38 
 
Considerable knowledge on the individual functions of effectors secreted by species of L4 
had already been gathered as my PhD project started, but it was considered a major riddle 
that none of them could be traced back to any effector’s FIC domain. Even for BepA of 
B. henselae that harbors a FIC domain with a canonical active site motif and was shown to 
adenylylate (unknown) host target(s)152 the leading phenotypes are solely mediated by its 
BID domain312. During my master project I systematically analyzed the FIC domains of 
Bartonella effectors in silico and started the functional investigation of effectors of L3 (see 
Appendix: Further results). My results showed that the most ancestral orthologous groups of 
effectors in L3 - Bep1, Bep2, and Bep3 – harbor a canonical FIC domain active site motif in 
every single known ortholog, suggesting that they act via adenylylation of host factors to 
subvert signaling in favor of the pathogen (see also Figure 28). Consistently, I demonstrated 
the adenylylation activity of Bep1 (targeting Rac1 and a few related proteins) and Bep2 
(targeting an unknown protein of approximately 50 kDa size; identified in Research article II). 
These findings stand in contrast to most of the other orthologous groups in L3 and all 
effectors of L4 where at most scattered representatives harbor a canonical FIC domain 
active site motif and where I failed to detect adenylylation. Taken together, available data 
support the hypothesis that – at least as a general principle - different orthologs of L3 
effectors share common activities or functions, while paralogous effectors have different 
molecular and biological functions. This emerging picture would be very similar to the 
situation in L4 (recently reviewed by Siamer et al.314) and could explain why the explosive 
radiations in both lineages had only been triggered after the evolution of a full effector 
repertoire. Furthermore, this principle of “specificity and diversification” of a fine-tuned 
repertoire of effectors is intuitive for a stealth pathogen like Bartonella as opposed to 
pathogens employing frontal attack strategies315 that deal with host defenses like 
V. parahaemolyticus316 (harboring VopS) or H. somni317 (harboring IbpA).  
As it is a common phenomenon among comprehensive models, the picture of Bartonella 
evolution that had been painted above has been obliterated in a number of details over the 
time of my PhD work. However, its general outlines were confirmed and even strengthened 
by new findings of others (see the considerations as part of Unpublished results related to 
Review article I). In any case, one of the most important questions had so far not been 
addressed – where did the ancestral VirB/D4-like machinery come from whose coevolution 
with Bartonella likely promoted the pathogen’s host adaptability? One hint that had already 
been noted previously is the presence of an additional type IV secretion system called Vbh or 
Vbl (for VirB-homologous or VirB-like; the denomination as “Vbh” will be consistently used in 
this work) in all species of L2 and a number of species of L4169. The Vbh T4SS is closely 
related to the VirB/D4 T4SS and sometimes encoded together with a bep-like gene of 
unknown function that displays a clear FIC-BID domain architecture169,275,318,319. The high 
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sequence similarity between the BID domains of these Bep-like proteins associated with the 
Vbh T4SS and their cognate relaxase makes it obvious that they are secreted by the Vbh 
T4SS, suggesting that they may somehow be evolutionarily related to the inferred ancestral 
VirB/D4 T4SS with a single ancestral effector protein. 
During my PhD project I characterized the molecular and biological function of genuine 
bacterial FIC domain proteins that are ancestrally related to secreted effectors of Vbh and 
VirB/D4 machineries in Bartonella (Research articles I and III as well as Review article II). 
Furthermore, my findings allowed to propose a coherent model that describes the de novo 
evolution of a secreted effector at an ancestral Vbh-like T4SS and the subsequent 
coevolution of effector, type IV secretion machinery, and Bartonella (see the Perspective at 
the end of this work). 
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6.1. Review article I (published) 
 
 
 
 
“Now what is the message here? The message is that there are no ‘knowns’. 
There are things we know that we know. There are known unknowns. That is to 
say there are things that we now know we don’t know. But there are also 
unknown unknowns. There are things we don’t know we don’t know. So when 
we do the best we can and we pull all this information together, and we then 
say well that’s basically what we see as the situation, that is really only the 
known knowns and the known unknowns. (…) 
It sounds like a riddle. It isn’t a riddle. It is a very serious, important matter.” 
 
 
 
 
 
 
 
 
 
 
 
 
Donald H. Rumsfeld, 21st US Secretary of Defense, Press Conference at NATO Headquarters in 
Brussels, Belgium, June 6th 2002; last accessed on October 21st 2014 from the online transcript 
available at http://www.defense.gov/transcripts/transcript.aspx?transcriptid=3490. 
  
 Results – Review article I 
42 
 
 
 
 
 
Intruders below the radar: molecular pathogenesis of 
Bartonella spp.  
 
Alexander Harms and Christoph Dehio 
 
Clinical Microbiology Reviews, Volume 25, Number 1, January 2012, 42-78. 
  
 Results – Review article I 
43 
 
Summary 
In this review article I compiled all available information on the pathogenesis of Bartonella 
bacteria with a focus on molecular mechanisms. 
Phylogenetically, the genus is split into four lineages with lineage 1 (L1, comprising only 
B. bacilliformis) and lineage 2 (L2, infecting ruminants) representing evolutionarily ancestral 
states compared to the more species-rich lineages 3 and 4 (L3 and L4) that arose from 
recent explosive radiations and infect a wide array of mammals as their primary hosts. It is 
the prevailing view in the field that the parallel adaptive radiations of L3 and L4 were 
triggered by a more subtle and fine-tuned host interaction as a key innovation which had 
been enabled by the acquisition and subsequent adaptation of the effector-secreting VirB/D4 
T4SS and the adhesin-like Trw T4SS. 
Despite some differences in the repertoires of virulence factors, a careful analysis of 
available data from research and clinics suggested that all species of Bartonella share a 
characteristic stealth infection strategy involving passage through an ill-defined “primary 
niche” that probably includes the infection of migratory cells and the vascular endothelium. 
From there, the bacteria are seeded into the bloodstream where they invade erythrocytes 
and persist intracellularly to promote transmission by blood-sucking arthropods. Throughout 
the infection cycle the bartonellae employ diverse tactics of immune evasion and 
immunomodulation to avoid clearance by host immune responses.  
Various Bartonella species that infect diverse primary hosts can cause accidental zoonotic 
infections in humans, but most human infections are caused by B. henselae (adapted to 
infect cats) and the two human-adapted species B. quintana and B. bacilliformis. Though 
infections with ancestral B. bacilliformis can be lethal if untreated, Bartonella typically causes 
only mild and self-limiting disease in accidental hosts and no or negligible symptoms in 
primary hosts (despite a long-lasting bacteremia), but infection rates far above 50% are not 
uncommon among wild mammals. Infections with B. bacilliformis and, particularly in 
immunocompromised hosts, also with other species can cause pathological angiogenesis as 
well as hemolytic anemia (rare beyond B. bacilliformis) that represent runaway 
consequences of improper host interaction during the two phases of Bartonella infections, 
respectively.  
In the primary niche, Bartonella invades nucleated cells using a zipper-like mechanism that 
appears to involve an interaction with β1-integrins and possibly ICAM-1 and is generally 
independent of type IV secretion. The bacteria enter their host cells in small vesicles that 
accumulate in the perinuclear region, but mechanisms of cellular egress have not been 
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described. Interestingly, in case of some variants of the Houston-1 strain of B. henselae the 
strong anti-endocytic effect of effectors secreted by the VirB/D4 T4SS transiently prevents 
bacterial uptake despite major cytoskeletal rearrangements and causes their aggregation on 
the cell surface in form of structure called invasome. Subsequently, the whole bacterial 
aggregate is taken up by the host cell. Interactions with Bartonella induce a complex 
transcriptional reprogramming of nucleated host cells that involves the induction of Ca2+, 
HIF-1, as well as NF-κB signaling and is caused by both secreted and contact-dependent 
activities of the pathogen which are amplified by auto- and paracrine signaling of the host. 
Furthermore, Bartonella promotes the secretion of immunomodulatory factors such as 
“master key” cytokine IL-10 to achieve a global attenuation of host defenses. 
From the primary niche, the bacteria are seeded into the bloodstream where they infect 
erythrocytes in a sequence of adhesion, deformation (impairing membrane tightness), and 
invasion. The entry into red blood cells has been described as “forced endocytosis”, but the 
molecular details of this process are not understood. Intracellular persistence of Bartonella 
for the remaining lifespan of the erythrocyte enables transmission by blood-sucking 
arthropods. 
The molecular contributions of Bartonella virulence factors to pathogenesis can be 
summarized as follows:  
• Trimeric autotransporter adhesins (TAAs) are found in all species of Bartonella and seem 
essential for productive infection in vivo. Single homologs were shown to mediate 
adhesion to the extracellular matrix, to manipulate host cells via β1-integrins to activate 
HIF-1 and NF-κB signaling, and to inhibit macrophage phagocytosis. 
• The VirB/D4 T4SS is found in all species of L3 and L4, but the repertoires of effectors 
(Beps) in both lineages evolved independently from a single common ancestor in parallel 
series of gene duplication and diversification prior to the onset of the adaptive radiations. 
While no data had been published on Beps of L3, broad literature on the effectors of L4 
demonstrated contributions to the inhibition of apoptosis and proinflammatory activation 
of host cells, the modulation of angiogenesis, and the inhibition of endocytosis. 
• The chaperone GroEL appears to have a moonlighting function as a secreted mitogenic 
as well as anti-apoptotic factor and likely acts via the induction of Ca2+ signaling. 
• Diverse outer membrane proteins (OMPS) of Bartonella were shown to interact with host 
cells, though their binding partners and biological functions are largely unknown. They 
may contribute both to adhesion and the manipulation of host cells, e.g., as obvious 
candidates for the invasin(s) causing Bartonella uptake in a zipper-like mechanism or as 
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the LPS-associated lipoprotein that manipulates cytokine secretion via toll-like receptor 2 
(TLR2). 
• The hemin binding proteins (Hbps) are one particular group of OMPs that is present as a 
series of paralogs in all species of Bartonella. Various molecular functions and biological 
roles have been proposed but not conclusively demonstrated, e.g., the participation in 
heme uptake, the formation of an antioxidant coat, or the direct participation in host cell 
manipulation.  
• The Trw T4SS of L4 mediates host-specific adhesion to erythrocytes and forms variable 
surface structures using an array of pilus subunits that evolved via gene duplication and 
diversification likely to cope with host polymorphisms on the erythrocyte surface. 
• Deformin is an elusive small molecule that causes the “pits” or “trenches” appearing on 
red blood cells upon contact with Bartonella and is believed to locally decrease the 
tightness of erythrocyte membranes as a prerequisite of “forced endocytosis”. 
• Flagellation is an ancestral trait of Bartonella conserved in L1-3 and was shown to be 
involved in erythrocyte invasion. Though a role in erythrocyte adhesion had been 
proposed earlier, it seems most likely that flagella contribute to the invasion of red blood 
cells by providing mechanical force. 
• The invasion-associated locus of Bartonella consists of ialA and ialB genes that are 
essential for erythrocyte invasion, but not adhesion. While IalA appears to be involved in 
cellular stress responses, IalB is an outer membrane protein and likely the factor directly 
responsible for the “forced endocytosis” of Bartonella into red blood cells. 
• The LPS of Bartonella is mostly (but not exclusively and homogenously) deep rough and 
of peculiar chemical structure so that it is not recognized by TLR4 and even acts as an 
antagonist of TLR4 signaling. 
• Classical autotransporters of Bartonella belong to two separate phylogenetic groups: 
o One of them (the iba group) is monophyletic in Bartonella but split into two 
subclades that diverged before the diversification of extant lineages. The first 
group comprises homologs of B. henselae Cfa and may be involved in the 
manipulation of membranes. The second group contains homologs of B. henselae 
Arp and may act as pertactin-like adhesins. Several representatives of the iba 
autotransporters were found to be individually essential for Bartonella infections in 
vivo.  
o The other, smaller group contains phylogenetically unrelated autotransporters that 
exhibit similarities to proteins found in Enterobacteriales. 
• Filamentous hemagglutinins are secreted via the two-partner pathway and present in 
form of two separate clades that were acquired independently from different sources. 
 Results – Review article I 
46 
 
• In addition to this catalogization of known virulence factors I also reported the discovery 
of a machinery to produce and secrete cyclic β-(1,2)-glucans that is highly conserved 
within Bartonella and constitutes a major virulence factor of closely related Brucella 
bacteria. 
In conclusion, the comprehensive compilation of available literature on the molecular 
pathogenesis of Bartonella in this review article was able to close some gaps in our 
understanding and connected many open threads of research to form a more coherent 
picture. However, this article also pointed at a disturbing number of open questions and even 
added a number of new ones that emerged from the systematic analysis of previous 
research. 
Recent developments in the field are shortly summarized as Unpublished results related to 
Review article I. 
 
Statement of the own participation 
I contributed to this publication by analyzing the scientific literature on the pathogenesis of 
Bartonella and systematically catalogued and interpreted the content with a focus on 
molecular mechanisms. Furthermore, I closed some minor gaps of knowledge by sequence 
analyses in silico and proposed the cyclic β-(1,2)-glucan synthesis and export machinery of 
Bartonella as a potential virulence factor that had not been proposed before. I drafted the 
manuscript and sketched the figures. 
Prof. Christoph Dehio mentored the work and gave hints regarding important publications 
that I had missed. Furthermore, he participated in the construction of the manuscript. Patrick 
Lane of ScEYEnce Studios performed the art enhancement on several figures prior to 
publication. 
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6.2. Unpublished results related to Review article I 
A considerable number of studies on Bartonella have been published in the time between the 
finalization of Review article I and this work that have broadened our understanding of the 
molecular pathogenesis of Bartonella. In particular, the research on Bartonella evolution and 
phylogeny has progressed with remarkable speed so that new hypotheses and models need 
to be embraced as a basis for Perspective on the evolution of VirB/D4 T4SS and its effector 
proteins. I therefore use the opportunity to shortly summarize recent developments in the 
Bartonella field as an update of Review article I:  
Bartonella infections in general 
• In Review article I I had pointed out that it was disputed if the bartonellae represent true 
emerging pathogens or whether rather the awareness of Bartonella infections is 
emerging320. A new study now revealed that ecological alterations caused by human 
interventions can promote the prevalence of zoonotic pathogens like (specifically) 
Bartonella in nature321. Similarly, the research community concerned with Carrion’s 
disease recently warned that the endemic area of this debilitating infection – so far 
generally confined to rural areas in the Andes highlands – is spreading, likely due to 
climate change and other anthropogenic factors influencing vector ecology301. 
• The remarkable adaptability of the radiating lineages of Bartonella (particularly L4) to new 
host species has been confirmed by the finding that – apart from mammals – not only 
reptiles like sea turtles, but also birds can be infected293. A newly identified species of 
Bartonella L2 confirms the ruminant-restricted host range of this lineage and is 
associated to camelids as its reservoir host322. 
• A pair of new studies showed that the host-interacting VirB/D4 T4SS of B. henselae can 
interact with the DNA processing and transfer machinery of enterobacterial R388 as well 
as a cryptic Bartonella plasmid and consequently transfer DNA into human cells where it 
may then integrate into the genome323,324. These findings reveal a remarkable 
conservation of the machinery providing the DNA substrate for bacterial conjugation and 
provide an interesting starting point to develop new tools for the genetic modification of 
eukaryotic cells.  
Different virulence factors 
• A recent study by Quebatte, Dick, et al. revealed that signaling of the BatR / BatS two-
component system modulates Bartonella virulence gene expression in coordination with 
the stringent response to regulate the expression pattern of pathogenicity factors during 
different stages of the infection cycle325. Furthermore, several other studies exploring the 
transcriptional regulation of Bartonella virulence factors have been published, e.g., on the 
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influence of temperature (and therefore host or vector state of the infection) on the 
transcriptome of B. quintana326. 
• New data on the BadA TAA of B. henselae suggest that the stalk of BadA is responsible 
for fibronectin binding, while head and stalk together mediate adhesion to collagen and, 
most importantly, host cells for transcriptional reprogramming327. 
• A pair of high-coverage transcriptome and proteome analyses of B. henselae str. 
Houston-1 complements genomic annotations with data on subcellular localization and 
differential regulation under conditions mimicking the primary niche interaction with host 
cells. Notably, the authors catalogued all OMPs of B. henselae and suggest a massive 
reorganization of the membrane proteome regarding OMPs as well as type IV and type V 
secretion systems upon host interaction328,329. 
• Review article I had proposed based on according suggestions in the literature that some 
Hbps of Bartonella may form an antioxidant surface coat via heme acquisition. This 
model has been confirmed by two studies: 
o The Koehler lab showed that HbpC is secreted together with HbpA on outer 
membrane vesicles (OMVs) to protect the bacteria against toxic 
concentrations of heme282. They demonstrate for the first time that Bartonella 
is shedding OMVs and uses them in the context of infections (which had 
already been proposed in Review article I, albeit with a different reasoning). 
Thereby, they reveal a previous confusion between these structures and the 
phage-like particles of the gene transfer agent which had been mistakenly 
seen as a single entity before, causing HbpA to be first described as Pap31 
(phage-associated protein of 31 kDa)330.  
o A comparative study exploring the Hbps of B. henselae showed that these 
proteins can be functionally expressed in E. coli and promote the uptake of 
heme via a heterologous heme transporter. The authors reveal that hbpA is 
essential in Bartonella and that all Hbps contribute to the protection against 
oxygen radicals. Furthermore, they provide evidence that HbpA and HbpD 
may be involved in host cell invasion331. 
Type IV secretion systems 
• The study by Deng et al. identified the host target of the Trw T4SS on erythrocytes as 
band 3 and showed its interaction with two copies of the TrwJ pilus component306. Band 3 
had been mentioned in Review article I as a potential target of Bartonella manipulations 
on red blood cells since it is critical for their surface tightness by connecting the 
membrane to the underlying cytoskeleton (and a known interaction partner of 
B. bacilliformis) It will therefore be interesting to see if additional roles of band 3 for 
Bartonella infections on top of plain adhesion via the Trw T4SS may be discovered. 
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• New data on the biological functions of Beps secreted by the VirB/D4 T4SS of L4 have 
been published: 
o Truttmann et al. revealed that the anti-endocytic effect of BepC in combination 
with BepF requires the two BID domains of BepF which likely act via the 
manipulation of small GTPases in the host cell. Furthermore, the study 
showed that the tyrosine motifs of BepF are phosphorylated upon 
translocation into host cells but have no contribution to the anti-endocytic 
phenotype224. 
o A study by Pulliainen, Pieles et al. found that the anti-apoptotic effect of the 
BID domain of BepA on host cells is mediated via a direct interaction with 
adenylyl cyclase (AC) and the Gα subunit of an AC-stimulating G protein 
causing an increase in cellular cAMP levels312. 
o The work of Okujava et al. showed that BepE is required for the dissemination 
of Bartonella from the dermal inoculation site to the bloodstream in vivo and 
for the migration of infected dendritic cells through a lymphatic endothelial cell 
layer in vitro. Interestingly, BepE counteracts a cell fragmentation phenotype 
of BepC that is caused by impaired cell migration. The authors therefore 
reasonably speculate that “infected dermal dendritic cells may be involved in 
disseminating Bartonella towards the blood stream”. Furthermore, they 
propose to split the old model of a “primary niche” into a “dermal niche” 
comprising the initial steps upon Bartonella inoculation and a “bood seeding 
niche” where Bartonella is primed for erythrocyte infection313. 
• Review article I had highlighted the problematic situation that the two main virulence 
factors of B. henselae, the BadA TAA and the VirB/D4 T4SS, have so far primarily been 
investigated in strains that lacked functional expression of the respective other one. A 
study by Lu, Franz, Truttmann et al. now investigated the phenotypes associated with 
these virulence factors in a strain expressing both and found that the dense surface layer 
formed by BadA somehow interferes with type IV effector secretion, probably by 
impairing physical contact between VirB/D4 T4SS and the host cell. Consistently, BadA 
as a remarkably long, filamentous protein was not affected by the presence of the 
VirB/D4 T4SS. The authors therefore conclude that the expression of the VirB/D4 T4SS 
and (particularly) the TAAs may be coordinated in Bartonella to enable optimal 
manipulation of host cells during infections332. 
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Open questions regarding the molecular pathogenesis of Bartonella 
Despite considerable progress in the field, a number of research questions and elusive gaps 
in our understanding of the molecular pathogenesis of Bartonella are still open for 
investigation:  
• the molecular functions of iba type autotransporters that appear to be essential for 
infection in vivo 
• the molecular identity of the invasin(s) responsible for the zipper-like uptake of 
Bartonella into host cells at the primary niche 
• the intracellular trafficking of Bartonella within nucleated cells (so far, only few elusive 
factors and HbpD have been shown to be essential for phagosomal escape in 
B. henselae333) 
• the molecular identity and mode of action of deformin 
• the mechanism(s) of erythrocyte invasion using flagella or Trw T4SS 
• the potential role of cyclic β-(1,2)-glucans as conserved host interaction factors of 
Rhizobiaceae334 in Bartonella infections 
It remains to be seen whether the dynamics of project development in the field will result in 
the exploration of one or more of these topics in the future.  
Bartonella evolution and phylogeny 
• In Review article I I had discussed that B. quintana, being actually a clone that emerged 
out of B. henselae, is still in the process of adaptation to humans as its primary host 
based on the presence of discernable disease symptoms in immunocompetent patients. 
New studies now revealed that B. quintana infections are common among macaque 
monkeys where they cause “long-lasting chronic bacteremia without apparent clinical 
abnormalities”335. The authors further showed that only a subset out of the diversity of 
B. quintana strains found in macaques is likely able to infect humans336. Taken together 
one may be able to state with some justification that B. quintana is rather a zoonotic than 
a true human pathogen. 
• The study by Guy et al.284 followed up on previous work focusing on the gene-transfer 
agent in Bartonella (BaGTA)318 whose importance and ubiquity had also been highlighted 
in Review article I. Importantly, the authors constructed a new phylogeny of Bartonella 
based on a considerable amount of new data and species that is partially not in line with 
the phylogeny published by Engel et al.169 (see a summary under the next bullet point). 
Furthermore, they claim that the acquisition of BaGTA in combination with a phage-
derived origin of run-off replication (ROR) by a common ancestor of all bartonellae was 
the original key innovation that kick-started the adaptive evolution of the genus. In their 
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model, the ROR origin serves to bias the exchange of chromosomal DNA via the BaGTA 
by amplification of a specific region of the genome that is accumulating various secretion 
systems and thereby prevents the emergence of cheaters that would lose these systems 
by enforcing constant re-acquisition. Like this, the BaGTA may constitute a true social 
trait and furthermore promote the horizontal exchange both of novel secretion systems as 
well as the evolution of established secretion systems (and other genes) via 
recombination. The results of this study readily explain old findings of remarkable 
diversity among Bartonella secretion systems and are confirmed by newer work showing 
widespread interspecies allelic recombination of various virulence factors in 
Bartonella225,337-339. 
• The recent landmark study by Zhu et al.267 also has to be seen in context of the work of 
Guy et al.284 who hypothesized that “the plasticity given to [the ROR region containing 
various secretion systems] by the BaGTA has rescued Bartonella from the reductive 
evolutionary processes that are operating on host-specialized bacteria adapted to 
otherwise sterile intracellular environments”. In short, Zhu et al. propose that Bartonella 
had been on an evolutionary track towards obligate intracellularity (likely in insects) but 
then turned around facilitated by the (re)acquisition of functions necessary for growth 
outside host cells. This view is strongly supported by studies reporting ancestral 
Bartonella-like bacteria as part of the microbiota that thrives within ants340,341 or 
bees342,343, though it is not finally known whether these represent symbionts, 
commensals, or pathogens. Furthermore, it was shown that bat flies are frequent carriers 
of Bartonella and that the four lineages of Engel et al.169 are merely islands within the 
diversity of bat fly associated bartonellae344. Additionally, ancestral mammal-infecting 
species of Bartonella that clearly stand outside of this four-lineage system have been 
described with B. australis345 (see phylogeny by Guy et al.284) and particularly B. tamiae. 
The latter species is apparently able to cause considerable sickness in infected hosts 
(including humans) and only distantly related to the other bartonellae, but was reported to 
be most closely related to the Bartonella bacteria found in bees346,347. The relations of 
these different species of Bartonella have been resolved by the congruent phylogenies 
published within the work of Guy et al.284 and Zhu et al.267 that confirmed the lineages 
described by Engel et al. (see figure 12). In short, the following picture is emerging 
regarding the bartonellae infecting mammal hosts (compare Figure 15):  
o B. tamiae holds an isolated position outside of the other species (for which 
Zhu et al. coined the term “eubartonellae”) 
o within the eubartonellae, B. australis forms an ancestral lineage outside of a 
monophyletic group formed by the four lineages of Engel et al.169 
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o within this group, L1 with B. bacilliformis is not a deep-branching ancestral 
lineage, but the sister clade of ruminant-infecting L2, thereby forming a clade 
of bartonellae that lack host-interacting type IV secretion systems and are 
restricted to infect a very limited host range 
o L3 is the sister clade of this group formed by L1 and L2 and not of L4, thus 
highlighting that the acquisitions of the VirB/D4 T4SS with a single primordial 
effector in common ancestors both of L3 and L4 were separate events 
o ancestral B. australis harbors a Trw T4SS at the same chromosomal locus as 
L4 while B. tamiae does not (personal observation), suggesting that this 
machinery was acquired in a common ancestor of the eubartonellae and later 
lost in a common ancestor of L1-3, possibly due to evolutionary instability in 
combination with flagellation 
o various representatives of L2-4 as well as B. australis (genomic copy) harbor 
a Vbh T4SS either plasmid-encoded and / or in form of a genomic island; in 
contrast, B. bacilliformis and the sequenced strains of B. tamiae lack such a 
machinery (personal observation; see also Figure 37 in the Perspective 
section) 
 
Figure 15: Current phylogeny of bartonellae infecting mammals. The phylogenic tree was adapted from Zhu 
et al.267 and is congruent with the phylogeny published by Guy et al.284. I indicated presence and absence of the 
established host-interacting type IV secretion systems VirB/D4 and Trw and color-coded the different lineages of 
Bartonella as presented by Engel et al.169 (compare Figure 12). The phylogeny had been constructed from a 
maximum likelihood analysis of “commonly used genetic markers of 28 Bartonella species, rooted to Rhizobiales”. 
Node labels indicate bootstrap support values (of 100 replicates) with asterisks representing 100% support. Note 
that only known animal or human pathogens within Bartonella are shown in the tree and that the seemingly 
homogenous group of mammal-infecting bartonellae is paraphyletic with respect to insect-associated species 
(see details in the running text). 
 
 
 
 
0.03 substitutions per site
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• Coming to the intracellularity of ancestors of Bartonella, the study by Zhu et al.267 
revealed that the glpK (glycerol kinase) gene had been lost together with the glp glycerol 
uptake system in a common ancestor of all bartonellae which firmly excludes the use of 
extracellular glycerol. In addition, a common ancestor of all eubartonellae lost the gene 
encoding GpsA (glycerol-3-phosphate (G3P) dehydrogenase), the protein that can 
regenerate G3P from the glycolysis. In consequence, the bacteria would have had to rely 
directly on the import of G3P which is a strictly intracellular metabolite, making it clear for 
the authors that all extant bartonellae evolved from ancestors with an obligate 
intracellular lifestyle. Conspicuously, glpK and gpsA have been re-acquired 
independently from each other in common ancestors of different clades of extant 
bartonellae from diverse sources: While B. tamiae regained glpK, the common ancestors 
of L4, of L1 and L2, as well as an ancestor of B. australis acquired gspA. Importantly, 
B. bacilliformis and L2 share the same heterologous allele of gpsA at the same locus 
which rules out an ancestral, isolated position of L1. The authors identified the sources of 
glpK and gpsA alleles acquired by Bartonella as different groups of proteobacteria that 
are mostly obligate endosymbionts of arthropods, especially keds and bat flies or aphids 
(suggesting horizontal transfer in a common arthropod host), while one gpsA was 
acquired from Helicobacter (suggesting horizontal transfer in a mammalian host). They 
therefore reasonably conclude that ancestral bartonellae lived in close association with 
arthropods that fed on mammal hosts.  
Interestingly, neither glpK nor gpsA has been regained in L3 of Bartonella which the 
authors use to explain the notoriously poor growth of these bacteria on artificial media.  
In summary, these new studies exploring the phylogeny and evolution of Bartonella strongly 
confirm the general conclusions drawn from previous work of our laboratory169,275 although 
some details now need to be seen from a different perspective. For example, the fact that L3 
and L4 are not sister clades makes it much clearer that they acquired a primordial VirB/D4 
T4SS with a single ancestral effector at two separate events. Furthermore, the newly 
structured phylogeny highlights the stark contrast between two species-rich clades L3 and L4 
that infect a wide range of host species and another clade of species-poor eubartonellae 
formed by L1 and L2. Since only L3 and L4 harbor a VirB/D4 T4SS and because their 
explosive radiations had only been triggered after the parallel evolution of host-secreted 
effector cocktails in common ancestors of both lineages, the critical role of this machinery for 
host interaction and adaptation is now even more apparent. 
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6.3. Research article I (published) 
 
 
 
 
“’If you want to understand function, study structure,’ I was supposed to have 
said in my molecular biology days. (I believe I was sailing at the time.) 
[…] In nature hybrid species are usually sterile, but in science the reverse is 
often true. Hybrid subjects are often astonishingly fertile, whereas if a scientific 
discipline remains too pure it usually wilts.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Francis Crick, English biologist and Nobel laureate, in “What Mad Pursuit: A Personal View of 
Scientific Discovery” (1988). Cited from page 150 of the paperback in the Alfred P. Sloan Foundation 
series (ISBN 0-465-09138-5) 
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Summary 
Previous research on FIC domain proteins had frequently revealed deleterious phenotypes 
caused by their adenylylation activity such as host cell death via destruction of the 
cytoskeleton by different bacterial virulence factors or “filamentation induced by cAMP” of the 
E. coli fic-1 allele. However, the absence of any obvious phenotype upon expression of 
wildtype E. coli Fic or human HypE (which shares the same biochemical activity as the cell-
killing bacterial virulence factors) made clear that the potent activities of FIC domain proteins 
are tightly regulated, though the underlying mechanism had remained elusive.  
During an investigation of a Bep-like protein of B. schoenbuchensis as a potential virulence 
factor we found that this protein (called VbhT) inhibited the growth of E. coli and Bartonella in 
dependence of the integrity of its FIC domain active site motif. This phenotype could be 
blocked by VbhA, a small protein encoded directly upstream of VbhT, and VbhA also 
inhibited the adenylylation activity of VbhT. We therefore concluded that VbhT causes 
bacterial growth inhibition via the adenylylation of cellular targets. A crystal structure of VbhT 
in complex with VbhA revealed that an α-helix of VbhA interacted with the active site of 
VbhT, indicating that VbhA interferes with the catalytic activity of toxin VbhT as a type II TA 
antitoxin. The tip of this inhibitory α-helix (αinh) in VbhA homologs contains an (S/T)xxxE(G/N) 
motif with the invariant glutamate pointing into the active site. 
Intriguingly, a comparison of the VbhTA complex with different FIC domain structures 
available in databases showed that an αinh was generally present, but usually part of the 
same protein as the FIC domain. Based on the positioning of the αinh either in a separate 
small protein or in the same polypeptide N- or C-terminally to the Fic core we categorized 
FIC domain proteins as class I, class II, or class III, respectively. For a deeper analysis, we 
predicted the structure of all FIC domain proteins listed in the Pfam database and analyzed 
the distribution of the three classes. Of all FIC domain proteins around 2/3 harbored a clearly 
recognizable αinh with inhibition motif, and this proportion rose to 90% when only Fic proteins 
with an active site motif presumably capable of adenylylation were considered, suggesting 
co-evolution of activity and regulation. Based on analyses of Fic sequences and structures 
we defined the canonical adenylylation-competent active site motif as HxFx(D/E)GNGRxxR 
and concluded that conserved groups of FIC domain proteins harboring different active site 
motifs (like the Doc family) may have evolved different catalytic activities. Among the bona 
fide adenylylation-competent FIC domain proteins 80% belong to class II and roughly each 
5% can be categorized as class I and class III. Furthermore, we performed an in-depth 
analysis of the phylogenetic distribution of FIC domain sequences which revealed that 
proteins assigned to classes I and III form monophyletic groups that arose as secondary 
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branches within a tree dominated by class II proteins. FIC domain proteins with degenerate 
active site motifs are found scattered all over the tree, suggesting that they have recurrently 
arisen from adenylylation-competent FIC domain proteins by sequence deterioration or 
adaptive evolution. The Doc family is an exception to this pattern since it lacks an 
adenylylation-competent active site motif and forms a large cluster of sequences that is 
separate from all other FIC domain proteins as a deep-branching lineage. 
A comparative structural and biochemical analysis of different FIC domain mutants showed 
that the invariant glutamate of the (S/T)xxxE(G/N) motif interacts with an arginine at the 
active site that normally binds the γ-phosphate of the ATP substrate. This interaction 
displaces the γ-phosphate of the ATP and thereby causes a reorientation of the α-phosphate 
in a way that is not permissive for an in-line nucleophilic attack by the target residue, thus 
preventing adenylylation. Consistently, mutational abrogation of αinh-mediated FIC domain 
inhibition in VbhTA of B. schoenbuchensis, SoFicT of Shewanella oneidensis, and NmFicT of 
Neisseria meningitidis as models for Fic classes I, II, and III, respectively, resulted in growth 
arrest upon ectopic expression in E. coli. In all cases, this growth inhibition correlated with an 
activation of the proteins’ adenylylation activity regarding both auto-adenylylation and, for 
VbhT and NmFicT, detectable target adenylylation in E. coli lysates. While VbhT showed 
adenylylation of a ca. 80 kDa target, the NmFicT adenylylation activity resulted in three 
bands at 80 kDa, 100 kDa, and 150 kDa. Similarly, the abrogation of FIC domain inhibition 
boosted both auto-adenylylation and target adenylylation of human HypE.  
In summary, the research presented in this article uncovered a regulatory mechanism that is 
broadly conserved among adenylylating FIC domain proteins and that controls their 
enzymatic activity by preventing the binding of ATP in an adenylylation-competent 
conformation. Our findings posed two major questions that may guide future researcha: 
• What are the enzymatic targets of the adenylylation activity of bacterial FIC domain 
proteins that results in bacterial growth arrest, and what is their biological function? 
While VbhTA shows features of type II TA modules, there is no easy hint at the 
biological role of class II and class III FIC domain proteins. 
• What is the functional relevance of the auto-adenylylation activity that seems to be a 
universal feature of FIC domain proteins? We could map the auto-adenylylation of 
NmFicT to an invariant tyrosine of the αinh in class III Fic proteins close to the 
(S/T)xxxE(G/N) motif, suggesting that auto-adenylylation 1) is inter-molecular (given 
its positioning relative to the active site) and 2) may have a regulatory role in relieving 
inhibition by the αinh. 
                                                          
a Further results shedding light on the biological functions of FIC domain target adenylylation and auto-
adenylylation are presented in Research articles III and IV. 
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Statement of the own participation 
I contributed to this publication by the development of an adenylylation assay that greatly 
facilitated the explorative work on FIC domain proteins because it allowed to visualize both 
auto- and target adenylylation using processed lysates of ectopically expressing E. coli 
instead of purified proteins. I performed the majority of adenylylation assays shown in this 
publication. Furthermore, I analyzed diverse Fic protein constructs regarding their ability to 
inhibit E. coli growth. Additionally, I cloned a number of plasmid constructs and had 
established a protocol for site-directed mutagenesis in our laboratory that was instrumental 
for the construction of the vast amount of plasmid mutants used in this publication. The other 
authors performed all bioinformatic analyses and expressed and purified all recombinant 
protein constructs. They carried out all structural studies, performed the mass spectrometry 
analysis, and had discovered the mechanism of active-site obstruction. All authors 
contributed to experimental design, participated in data analysis, and wrote the manuscript. 
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Additional supplementary data are available online: 
 a classification of all analyzed Pfam FIC domain proteins as class I, class II, or class III 
 a movie that illustrates the mechanism of active site obstruction in FIC domains 
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6.4. Unpublished results related to Research article I 
During the initial phase of my PhD project I generated a considerable amount of data related 
to Research article I that had not been published in this article but were instrumental for 
different follow-up projects such as Research articles III and IV. I therefore decided to 
present these data in the context of these later publications in order to make the progress of 
the different projects transparent. 
Bacterial class II Fic proteins 
Our research published in the frame of Research article I showed that only each around 5% 
of the (bona fide adenylylation-competent) FIC domain proteins belong to class I and class III 
that we investigated in more detail in Research articles III and IV, respectively. However, 
around 80% belong to class II (see Supplementary Figure 7 and Supplementary Table 2 in 
Research article I), but no coherent research project to investigate their molecular functions 
and biological roles had been initiated. Among these proteins are the metazoan orthologs of 
human HypE or CG9523 of Drosophila (see in the Introduction section), but these only make 
up a rather small part of the sequences. 
My personal interest in class II Fic proteins arose when I realized that the far majority of them 
are bacterial proteins that share a common domain architecture with an N-terminal FIC 
domain (preceded by a regulatory subdomain with αinh, called FicNa) linked to a C-terminal 
winged helix-turn-helix (wHTH) domain (Figure 16A). A typical representative of this protein 
family is SoFicT (NP_719793.1) that we used as a model class II Fic protein in Research 
article I. The crystal structure of SoFicT had been solved previously by a structural genomics 
consortium and revealed a (likely physiological) dimer in which FIC domain and wHTH 
domain of the monomers are connected by a long, α-helical linker that is positioned at the 
dimerization interface179 (Figure 16B). The two wHTH domains are arranged in a way that is 
compatible with a joint dsDNA interaction similar to structurally related transcription factors, 
suggesting that SoFicT is a bifunctional protein capable of adenylylation and DNA binding. 
                                                          
a The N-terminal regulatory module containing the αinh of these class II Fic proteins is present in the databases 
as Pfam PF13784 and InterPro IPR025758, respectively, but not consistently detected (personal observation). 
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Figure 16: In silico analysis of structure-function relations in SoFicT Homologs. A) The alignment of some 
1’000 class II Fic proteins with SoFicT as reference sequencea was created in Geneious (v.7.1.7., BioMatters) 
and sequence logo as well as consensus identity are represented graphically. All sequences have canonical 
active site and αinh motifs, and the domain architecture predicted by InterPro (for SoFicT; FicN 30-111, Fic core 
138-216) or deduced by Das et al.179 from their structure (wHTH, 290-370) is indicated below. The alignment is by 
far not exhaustive for SoFicT homologs, and repeating it with any of the more distant hits results in completely 
different hit lists but the same overall picture. B) FicN, Fic core, and wHTH domains were highlighted in the 
structure of Das et al.179 by color code as in the model depicted in (A). Note that the regulatory FicN domain 
connects the dimer interface with the active site of the Fic core. C) Three tyrosines are highly conserved among 
class II Fic proteins and never substituted by phenylalanines or histidines, indicating that they are possible auto-
adenylylation sites. These tyrosines protrude towards αinh and active site in a way that auto-adenylylation would 
likely abolish FicN inhibition and induce domain movements that could activate the Fic core. Furthermore, a 
threonine within the wHTH domains is universally conserved and could be an(other) auto-modification site. The 
protein structures in (B) and (C) were visualized using Pymol v1.4.1. (Schrödinger LLC). 
 
In Research article I we showed that mutational activation of the SoFicT FIC domain results 
in growth inhibition in E. coli, but the biological relevance of these findings had remained 
unclear. The protein was expressed ectopically from a high-copy vector using a PT7 system, 
and the construct (that had also been used by the structural genomics consortium) carries a 
G109C substitution in the regulatory FicN domain. We also failed to detect any target 
adenylylation by the activated SoFicT_E73G construct, but this could as well be caused by a 
low-abundance or non-proteic target (compare target adenylylation in Figure 2A of Research 
article III). 
                                                          
a The alignment was created using a blastP search against the non-redundant NCBI protein database with 
maximal E-value of e-30, gap cost (open / extended) of 7 / 2, and hits were aligned using the BLOSUM62 matrix. 
Columns with more than 75% gaps were hidden for simplicity. Coloring reflects amino acid similarity according 
to the cost matrix with black = 100% identity and white = <60% identity 
inhibition site active site
FicN Fic core wHTH
DNA binding?
linker region
B C
  
 
 
A
 Results – Unpublished results related to research article I 
131 
 
SoFicT-like Fic proteins have remained largely uncharacterized, but a literature search 
revealed two articles with valuable contributions. In the first publication the authors show that 
the knockout of a soficT homolog in Sinorhizobium meliloti is lethal, which – particularly in the 
light of our findings – made it likely that these proteins may be some kind of toxins that can 
impair bacterial cell functioning upon activation348. Furthermore, another study reported that 
homologs of SoFicT are frequently found genetically associated to type I restriction-
modification systems and consequently established the nomenclature as MloA 
(methyltransferase-linked ORF A)349. I performed a large-scale sequence analysis which 
indeed confirmed a conspicuous accumulation of restriction-associated functions in the 
vicinity of genes homologous to soficT including soficT itself. However, the by far large 
majority of the several thousand homologs appear to be placed randomly in bacterial 
genomes with no signs of synteny or phylogenetic pattern, indicative of frequent horizontal 
gene transfer as part of the mobilome (see Figure 17). This analysis further revealed a lack 
of considerable differences in protein length and domain composition as well as a strong 
conservation of the canonical sequence motifs in Fic active site and αinh despite major 
differences in overall primary sequence (see Figure 16A). In the absence of additional 
evidence it is therefore reasonable to accept the starting hypothesis that SoFicT homologs 
form one big protein family with shared molecular activities and biological functions. 
 
Figure 17: Genomic associations of SoFicT homologs. The illustration was created using the microbesonline 
resource (available at www.microbesonline.org) with SoFicT (SO_4266) as a query for the “tree browser” function. 
Representative loci encoding soficT homologs (yellow, in center) are shown. A number of genes encoding 
restriction-modification functions can easily be spotted (red frames), but no systematic association or local 
syntenies are apparent. Various traces indicative of horizontal gene transfer such as transposases, integrases, 
and antibiotic resistance genes are found scattered around the soficT homologs (not highlighted).  
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Generally, the ubiquity of soficT homologs in bacterial genomes is remarkable for a non-
housekeeping gene family and points towards biological functions with high selective 
advantage, yet considerable gene evolution and turnover promoted by horizontal gene 
transfer. In my opinion such a pattern is indicative of a role in antiviral defense as a new type 
of abortive infection (Abi) system which is consistent with all available data. Already the 
“toxic” homolog in Sinorhizobium meliloti made the authors speculate that it may use the 
wHTH domains for transcriptional autoregulation as kind of a single-gene TA module348. It is 
easily conceivable that, in a default state, SoFicT homologs are dimers that control their own 
transcription and – upon receiving an unknown signal – switch towards a monomeric form 
that is active in target adenylylation and thereby impairs bacterial physiology. Such a 
mechanism of autoregulation would recapitulate the conditional cooperativity of class II toxin-
antitoxin modules (Box 2) in a single protein. The results of Frédéric Stanger regarding the 
important role of auto-adenylylation for the activation of class III Fic proteins (see Research 
article IV) suggest that, analogously, the switch to a monomeric, active form of SoFicT 
homologs may depend on auto-adenylylation. Early attempts to identify the adenylylated 
sites in SoFicT have remained inconclusive (Frédéric Stanger, personal communication), but 
a number of hydroxyl residues are highly conserved among SoFicT homologs and may very 
well serve as molecular switches triggered by auto-modification (see Figure 16C).  
Strikingly, the domain architecture of SoFicT homologs is similar to the AbiE / SanaTA family 
of abortive infection systems that act as a type IV TA module19 (see Table I in the 
Introduction section). The AbiEii / SanaT toxins comprise an N-terminal 
nucleotidyltransferase domain analogous to FIC domains and a C-terminal helix-turn-helix 
domain, but – in contrast to what is known for SoFicT homologs – are encoded together with 
an antitoxin of unknown molecular function. 
In order to evaluate the feasibility of a potential research project on the biological function of 
SoFicT homologs I chose two suitable model proteins encoded by organismsa more closely 
related to E. coli K-12. One of them, tentatively named UtiFicT (YP_543089), is encoded in 
the genome of E. coli UTI89350, a uropathogenic isolate that I had worked on previously in the 
laboratory of Prof. Urs Jenal. The second one – tentatively named Y2FicT (YP_001008253) 
to avoid confusion with class I Fic protein YeFicT characterized in Research article III – is 
encoded in the genome of Yersinia enterocolitica strain 8081351. While SoFicT and Y2FicT 
share 63.6% protein sequence identity, UtiFicT and SoFicT have largely divergent primary 
sequences (16.3% identity). Preliminary experiments could so far not detect an activity of 
class II Fic proteins as an Abi system (data not shown), but a dedicated study with a greater 
                                                          
a Interestingly, homologs of SoFicT are also found in Bartonella and typically encoded together with the “tra” 
T4SS system (see Perspective at the end of this work).  
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variety of bacteriophages, positive controls, and an array of different expression systems 
would be necessary to draw any conclusion. Interestingly, the ectopic expression even of 
wildtype SoFicT homologs from a single-copy vector caused considerable growth inhibition of 
E. coli (which is not uncommon for Abi proteins352) while the supposedly active E/G mutant in 
the αinh did not (data not shown). These initial experiments clearly indicate that a more ample 
investigation of class II Fic proteins would be required to understand their molecular 
function(s) and biological role(s). It would be particularly helpful to identify the adenylylated 
target(s) – e.g., using the technique that we described in Research article II – which would 
allow to deduce the molecular mechanism of growth inhibition. Furthermore, one could use 
promoter-gfp fusions to demonstrate a potential transcriptional autoregulaton of SoFicT 
homologs, e.g., by flow cytometry. 
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6.5. Review article II (published) 
 
 
 
 
“We believe that the order to which we would reduce our ideas has a 
foundation in the nature of things. And it is this belief that encourages us to 
reduce our knowledge of things into systematic order. The doing so is attended 
with many advantages. At the same time a spirit of systematizing may be 
carried too far. It is only in so far as it is in accordance with the order of nature 
that it can be useful or sound.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
William Fleming, British philosopher, in “The vocabulary of philosophy, mental, moral, and 
metaphysical; with quotations and references; for the use of my students” (1857). The quotation was 
cited from p. 507 of an edition available online at the Internet Archive 
(https://archive.org/details/vocabularyofphil00fle; last accessed on November 19th, 2014) 
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Type II Toxin-Antitoxin Loci: The fic Family 
 
Arnaud Goepfert, Alexander Harms, Tilman Schirmer, and Christoph Dehio 
 
K. Gerdes (ed.), Prokaryotic Toxin-Antitoxins, Springer Berlin Heidelberg, 2013, 177-
187. 
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Summary 
Research in the field of FIC domain proteins had so far mostly focused on a few host-
targeted virulence factors of bacterial pathogens, but recent publications showed that these 
had evolved secondarily out of a big pool of genuine bacterial Fic proteins of unknown 
function. Among these, VbhTA of B. schoenbuchensis displays features of a type II TA 
module. We therefore reviewed published literature on bacterial FIC domain proteins in 
general and formally described VbhTA and homologs as a new type II TA module.  
Although a series of early research papers by Japanese groups had shown that a gain-of-
function mutant of the E. coli K-12 Fic protein can suppress cell division as some kind of 
toxin, the underlying molecular mechanism had remained elusive and no follow-up studies 
had been published. Fresh impetus to the field was given only recently as research on a 
number of bacterial virulence factors with FIC domains established their conserved 
enzymatic activity as the adenylylation of target proteins, i.e., the covalent transfer of an 
adenosine 5’-monophosphate moiety. 
A new study of our laboratory could show that the adenylylation activity of FIC domain 
proteins is generally regulated by a mechanism of active site obstruction in which a 
glutamate finger on the tip of a conserved inhibitory α-helix (αinh) points into the active site 
(Research article I). This glutamate is strictly conserved as part of an (S/T)xxxE(G/N) motif 
and blocks adenylylation by forcing the ATP substrate to bind in a way is not permissive for 
an in-line nucleophilic attack of the target hydroxyl residue on the α-phosphate. Furthermore, 
we had classified FIC domain proteins depending on whether αinh was present in a separate 
small protein (class I) or encoded together with the FIC domain in one polypeptide either 
N-terminally (class II) or C-terminally of the Fic core (class III). 
As a model for class I FIC domain proteins we had described VbhT of B  schoenbuchensis 
that satisfies the basic definition of a type II toxin-antitoxin module together with its partner 
VbhA (containing αinh): 
• the VbhT toxin inhibits bacterial growth via the adenylylation of unknown target(s) 
• the VbhA protein inhibits VbhT via a direct protein-protein interaction 
• VbhT and VbhA are encoded together in an operon structure where vbhA is upstream 
of vbhT with slight overlap 
Of the typical features that have been described for functionality of a type II TA module only 
the transcriptional autoregulation via conditional cooperativity had not been addressed yet. 
Despite that, it was still apparent that class I Fic proteins should be considered a new family 
of type II TA modules with the toxins named “FicT” and the antitoxins named “FicA”. We 
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identified 150 potential members of the FicTA family that included Fic of E. coli as a potential 
toxin (EcFicT) together with a small protein YhfG as a potential antitoxin (EcFicA). 
The Doc toxin of the Doc-Phd type II TA module had been shown to inhibit bacterial growth 
by blocking translation elongation via an unknown mechanism. These earlier studies had 
also established that Doc represents a distinct type of FIC domain and features a 
non-canonical active site motif, though the invariant histidine is present and essential for 
growth inhibition. Furthermore, Doc was known have the same overall topology FIC domains 
sensu stricto, but it misses one α-helix that is generally found in all other Fic proteins and 
also lacks the β-hairpin flap that is considered to mediate target docking. We noted that its 
antitoxin Phd is largely different from FicA homologs and does not contain an αinh, but binds 
Doc in an overall similar (though different) way. The DNA binding domain at the C-terminus 
of Phd had been shown to be essential for transcriptional autoregulation of the phd-doc locus 
by conditional cooperativity. We considered it plausible that Doc could carry out an 
enzymatic activity (not adenylylation) to modify cellular target(s) as the underlying cause of 
translation inhibition and therefore act conceptually similar to FicT toxins. Other FIC domain 
proteins had secondarily evolved phosphocholination of uridylylation as their primary 
enzymatic activities. 
Our analyses indicated that the primordial FicTA module of E. coli K-12 seemed to be 
vertically inherited in Enterobacteriaceae which is not typical for type II TA modules, because 
these tend to be spread via horizontal gene transfer as it is also apparent for the FicTA 
family. Furthermore, the lack of an adenylylation-competent active site motif and the absence 
of detectable phenotypes with the wildtype protein raised suspicion whether it could act in a 
biochemically or biologically similar way as other FicTA modules. More generally, we 
concluded that class I Fic proteins act as a type II TA module and are likely activated via 
antitoxin degradation. However, it was unknown how class II or class III proteins could be 
activated in vivo or which biological functions they may have. 
Summarizing, we described class I of FIC domain proteins as toxins of the new FicTA type II 
TA module and compared the FicTA family to the related Doc-Phd type II TA module. Future 
research may identify the enzymatic targets of FicT toxins and unravel if FicTA modules act 
in the context of bacterial persistence or abortive infection like most type II TA modules. 
Furthermore, elucidating the targets adenylylated by class II and class III Fic proteins may be 
a good starting point to find out their biological functions. 
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Statement of the own participation 
I contributed to this publication by reviewing the literature regarding the biological functions of 
Fic proteins sensu stricto as well as the Doc-Phd toxin-antitoxin module and wrote the 
corresponding sections of text. Arnaud Goepfert focused on the structure-function 
relationship of FIC domain proteins and generated the figures with my occasional assistance. 
Prof. Christoph Dehio and Prof. Tilman Schirmer guided the construction of the publication. 
All authors participated in the finalization of the manuscript. 
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6.6. Unpublished results related to Review article II 
I did not generate unpublished results directly in the context of my contribution to Review 
article II because all information regarding class I FIC domain proteins and their biological 
function in FicTA toxin-antitoxin modules is given in Research article III and the Unpublished 
results related to Research article III.  
However, it appears necessary to me to correct the wrong claim in Review article II that 
VopS would have two FIC domains (it has only one – IbpA has two FIC domains).  
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6.7. Research article II (published) 
 
 
 
 
“I once made the remark that two things disappeared in 1990: one was 
communism, the other was biochemistry, and that only one of these should be 
allowed to come back. Of course, biochemistry never really went away but 
continued to flourish in the thousands of unread pages of biochemical journals. 
Protein interactions will not be solved by proteomics or protein chips but by 
protein biochemistry. (…) We do not have to resurrect biochemistry, and it will 
flourish because it provides the only experimental basis for causal 
understanding of biochemical mechanisms.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sydney Brenner, South African biologist and Nobel laureate, in “Biochemistry strikes back”. Trends in 
Biochemical Sciences, Volume 25, Issue 12, December 1st 2000, page 584 
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An experimental strategy for the identification of AMPylation 
targets from complex protein samples 
 
Kathrin Pieles*, Timo Glatter*, Alexander Harms, Alexander Schmidt, and Christoph 
Dehio 
 
*These authors contributed equally to this work 
 
Proteomics, Volume 14, Issue 9, May 2014, 1048-1052. 
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Summary 
Facing the riddle that none of the Bep-related phenotypes of Bartonella infection could be 
traced back to any effector’s FIC domain as the most prevalent and ancestral “effector 
module”, we understood that it was necessary to identify their molecular targets as a starting 
point for functional analyses. In this publication we therefore developed a generic strategy to 
identify adenylylated proteins using stable-isotope labelled ATP substrates and show that the 
adenylylation target of Bep2 of B. rochalimae is vimentin. 
Previous work had described the used of antibodies raised against adenylylated residues or 
click chemistry approaches to enrich and finally identify adenylylated proteins by mass 
spectrometry. However, these approaches are afflicted with technical difficulties and biases. 
We therefore developed a novel technique for the identification of adenylylated proteins in 
cell lysates that is technically easy and largely unbiased. As the core of our development we 
performed classical in vitro adenylylation assays by supplementing cell lysates known to 
contain the targets of adenylylation with the adenylylation donor of interest as well as a 
3-plexed mix of heavy-isotope labelled ATP. This mix contained unlabeled ATP 
(15N013C0-ATP), medium-labeled ATP (15N513C0-ATP), and heavy-labeled ATP 
(15N513C10-ATP) that we found to be used equally well by FIC domain proteins for 
adenylylation. The adenylylation of target proteins with this mix of isotopes results in three 
different adenylylated peptides with characteristic mass shifts relative to unmodified peptide 
(+ 329, + 334, + 344). The resulting pattern of peaks corresponding to these mass shifts 
could be detected by mass spectrometry and provided an additional level of information for 
the identification of adenylylation. 
As a general proof-of-principle for our technique we analyzed the adenylylation of RhoA by 
the V. parahaemolyticus effector VopS which is known to target T35 on the small GTPase. 
The adenylylation with 3-plexed heavy-isotope labeled ATP resulted in the predicted ion 
triplet for a peptide encompassing the adenylylation site, and thorough inspection of the 
peptide fragment spectra confirmed T35 as the residue carrying the modification. 
Subsequently, we analyzed the adenylylation activity of Bep2 of B. rochalimae that targets an 
unknown host protein with an apparent molecular weight of approximately 50 kDa. For Bep2 
we identified a triplet of adenylylation mass shifts on a peptide belonging to the intermediate 
filament protein vimentin, but could not unambiguously unravel the residue which is modified. 
Using a catalytically inactive mutant of Bep2 we demonstrated that it was indeed the 
Bartonella effector which caused the modification. Furthermore, we confirmed the 
adenylylation using recombinant Bep2 as well as vimentin with [α-32P]-ATP in a classical in 
vitro adenylylation assay. 
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In summary, our results proved that a 3-plexed mix of heavy-labeled small molecule 
substrates can be used to trace biochemical reactions with high detectability and reliability 
particularly if the resulting protein modification is rare. Given the complexity of eukaryotic 
cells, it is the only prerequisite of our technique to know the apparent molecular weight of the 
adenylylated target(s) which allows to cut out specific areas of the cell lysate separated by 
SDS-PAGE. Our technique was of obvious relevance for the field of FIC domain proteins 
where no molecular target or biological function had been assigned to the far majority of 
representatives. The results obtained with Bep2 were interesting also from a more general 
point of view because we identified the first FIC domain adenylylation target that is not a 
small GTPase. However, any functional consequence of the adenylylation of vimentin as well 
as a possible biological role during Bartonella infection remained to be demonstrated.  
 
Statement of the own participation 
I contributed to this publication by showing that Bep2 of B. rochalimae displays an 
adenylylation activity dependent on the integrity of its FIC domain active site and that this 
adenylylation activity targets host protein(s) with an apparent molecular weight of 
approximately 50 kDa. As a prerequisite for these results I had adapted my previously 
published adenylylation assay using bacterial cell lysates (see Research article I) to 
mammalian cell lysates and developed a technique for their preparation. The other authors of 
this publication performed all other experiments, developed the biochemical procedure of 
adenylylation detection by ion triplets with heavy-labeled ATP, and wrote the manuscript.
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Supplementary data are available online 
• a table listing all peptides detected by LC-MS analysis after in-gel digest (Table S1) 
• a figure showing data that validate the workflow described in Research article II using 
the adenylylation of RhoA by VopS (Figure S1) 
• a figure that shows ion series and MS/MS spectrum of the adenylylated vimentin 
peptide SLYSSSPGGGAYVTR (Figure S2) 
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6.8. Unpublished results related to Research article II 
I did not generate unpublished results in the context of my contribution to Research article II. 
Additional data in the context of Bartonella effector proteins are summarized in the section 
Appendix: Further results.  
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6.9. Research article III (submitted) 
 
 
 
 
 
 
 
“Chance favors the prepared mind.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Louis Pasteur, French microbiologist, at his inaugural lecture as he was appointed dean of the new 
faculty of sciences at Lille University (December 5th 1854); original “(dans les champs de 
l'observation, ) le hasard ne favorise que les esprits préparés", i.e., “(whenever observation is 
concerned, ) chance favors the prepared mind” 
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Disruption of DNA topology via topoisomerase adenylylation 
–a new path to persistence 
 
Alexander Harms, Frédéric Valentin Stanger, Patrick Daniel Scheu, Imke Greet de 
Jong, Timo Glatter, Kenn Gerdes, Tilman Schirmer, and Christoph Dehio 
 
Submitted to Cell 
  
NOTE ADDED IN PROOF - This manuscript has finally been published as 
Alexander Harms, Frédéric V. Stanger, Patrick D. Scheu, Imke G. de Jong, Arnaud 
Goepfert, Timo Glatter, Kenn Gerdes, Tilman Schirmer, and Christoph Dehio (2015). 
Adenylylation of gyrase and topo IV by FicT toxins disrupts bacterial DNA topology. Cell 
Rep 12(9):1497-507. 
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Summary 
One major function of toxin-antitoxin (TA) modules is to serve as a phenotypic switch that 
converts bacteria into multidrug tolerant persister cells. Interestingly, in all cases examined 
so far the activation of TA modules induced persistence by inhibiting translation or unsetting 
the proton-motive force. We previously described class I Fic proteins as toxins of the new 
FicTA toxin-antitoxin module that acts via the adenylylation of unknown targets (Research 
article I and Review article II). 
In this study we comprehensively characterized the FicTA family of toxin-antitoxin modules 
and showed that they act by adenylylation and concomitant inactivation of DNA gyrase and 
topo IV which arrests bacterial growth and causes a phenotypic switch to persistence. 
Using VbhT as a model toxin we found that this protein adenylylates GyrB and ParE, the B 
subunits of DNA gyrase and topo IV, at a conserved tyrosine in the ATP lid loop that borders 
the ATP binding site. Adenylylation fully blocked the signature activities of recombinant DNA 
gyrase as well as topo IV in vitro. Mechanistically, we found that the adenylylation of a GyrB 
ATPase model construct resulted in the inhibition of ATP hydrolysis which was sufficient to 
explain the inactivation of DNA gyrase and, by inference, topo IV. 
We characterized the VbhTA system along with two other representatives of Y. enterocolitica 
(YeFicTA) and P. aeruginosa (PaFicTA) in which the FicT toxins are classical single domain 
class I Fic proteins, while VbhT harbors an additional BID domain. The expression of all FicT 
toxins suppressed E. coli growth which depended on the integrity of their FIC domain active 
site and could be abolished by the coexpression of cognate FicA antitoxins. We assessed 
changes in cellular DNA topology upon FicT toxin expression in vivo and could show that the 
expression of any FicT toxin causes a strong inhibition of topo IV, evidenced by chromosome 
segregation defects and considerable catenation as well as knotting of reporter plasmids. 
Interestingly, in our experimental system in vivo the expression of different FicT constructs 
was divergently potent in the inhibition of DNA gyrase activity which we assessed using flow 
cytometry with a relaxation-inducible gfp promoter fusion and by the topological analysis of 
reporter plasmids using chloroquine agarose gel electrophoresis. While PaFicT caused a 
strong inhibition of DNA gyrase, the expression of YeFicT or only the FIC domain of VbhT 
had at most a moderate effect, and VbhT in full length did not cause detectable gyrase 
inhibition. Genetic experiments confirmed severe distortions in cellular DNA topology upon 
FicT expression which appeared to greatly affect DNA replication.  
Unlike the CcdB or ParE toxins that are part of post-segregational killing TA systems, 
topoisomerase targeting by FicT toxins does not result in poisoning of the enzymes and 
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consequent cell death. Instead, FicT toxins cause a reversible inhibition of their targets that 
results in bacterial growth arrest. Consistent with the role of toxin-antitoxin modules as major 
players in bacterial persister formation, we found that the ectopic expression of any FicT 
toxin converted E. coli into multidrug tolerant persister cells. We therefore concluded that the 
robust inhibition of topo IV – shared among all FicT toxins – is the primary driving force of the 
physiological effects of FicTA toxin-antitoxin modules. These results strongly suggested that 
the subversion of cellular DNA topology would be a new path of bacterial persister formation 
next to the inhibition of translation or the disruption of the proton-motive force. We therefore 
confirmed that also the treatment with novobiocin, a bacteriostatic inhibitor of DNA gyrase 
and topo IV, induced the formation of persister cells in E. coli. Similarly, the near-
physiological activation of the genuine yeficAT locus upon antitoxin sequestration resulted in 
bacterial persistence.  
In conclusion, our work revealed the molecular function and biological role of the FicTA toxin-
antitoxin family and demonstrated that the disruption of cellular DNA topology is a new path 
to the persister state. We therefore expanded the understanding of the inherent physiological 
heterogeneity of persister cells formed in bacterial populations that may be a major obstacle 
to their complete eradication Furthermore, we anticipate that our results will help to 
understand the molecular basis of multidrug tolerance during different variants of the 
persister state and thereby provide new impulses for the development of dedicated 
treatments. 
 
Statement of the own participation 
I contributed to this publication by identifying DNA gyrase and topo IV as the molecular 
targets of the adenylylation activity of class I FIC domain proteins. Furthermore, I 
characterized the resulting inhibition of the topoisomerases in vitro and in vivo using various 
techniques to analyze changes in DNA topology. I generated various plasmid constructs and 
bacterial strains, and additional plasmids and strains were contributed by other authors. I 
discovered the biological function of class I Fic proteins in bacterial persister formation. The 
manuscript was primarily written by me, but all authors contributed ideas and advice at all 
stages. Other authors purified all protein constructs and investigated the ATPase activity of 
GyrB43 in vitro, assisted with the microscopy of Escherichia coli as well as the associated 
data processing, and performed the mass spectrometry analysis. Patrick Scheu and 
Prof. Kenn Gerdes joined the project with initial data on PaFicTA of Pseudomonas 
aeruginosa.  
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Summary 
Bacterial persisters are multidrug tolerant cells generated from a phenotypic switch to 
dormancy that is typically exerted by toxin-antitoxin (TA) modules. All TA modules 
examined so far induce bacterial persistence by inhibiting translation or unsetting the proton-
motive force. Here we characterize a group of FIC domain proteins as toxins of the conserved 
and abundant FicTA family of TA modules and reveal that they cause persister formation via 
a new mechanism, the disruption of DNA topology. FicT toxins act via the adenylylation and 
concomitant inactivation of DNA gyrase and topoisomerase IV (topo IV), the essential 
bacterial type IIA topoisomerases. Consequently, FicT activity results in major distortions of 
cellular DNA topology that cause reversible growth arrest and a phenotypic switch to the 
persister state. Our findings underline the inherent heterogeneity of persister cells formed by 
different types of TA modules that needs to be overcome by treatments aiming at complete 
eradication.
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Highlights 
• FicT toxins inhibit DNA gyrase and topoisomerase IV activities via adenylylation 
• Topoisomerase adenylylation subverts cellular DNA topology and causes growth 
arrest 
• FicT toxin activation causes formation of multidrug-tolerant persister cells 
• Disruption of DNA topology is a newly identified path to bacterial persistence 
eTOC blurb 
Bacterial persister cells are notoriously multidrug-tolerant and generated by toxin-antitoxin 
modules; these were so far only known to act by inhibiting translation or unsetting the proton-
motive force. Harms et al. present the disruption of cellular DNA topology as new way to 
persistence that is opened by the FicTA toxin-antitoxin module. FicT toxins inactivate gyrase 
and topoisomerase IV by adenylylation which causes the topological collapse of cellular 
DNA. These findings highlight the physiological diversity of bacterial persister cells. 
  
168 
 
 Results – Research article III 
 
Graphical Abstract 
  
169 
 
 Results – Research article III 
 
Introduction 
Within a clonal population of bacterial cells, persisters are phenotypic variants that survive 
concentrations of antibacterials way above the minimal inhibitory concentration (MIC) and 
thus represent a major cause of treatment failure and relapse of bacterial infections (Balaban 
et al., 2013; Dhar and McKinney, 2007; Lewis, 2010). Unlike mere drug avoidance, persisters 
survive via real drug tolerance in a non-growing, non-dividing state that has been described as 
dormancy (Balaban et al., 2004; Maisonneuve et al., 2013). Therefore, unlike antibiotic 
resistance, bacterial persistence typically manifests in tolerance to various antimicrobials and 
may thus not be overcome by the development of new conventional drugs, although 
promising approaches to target these cells pharmacologically have been described in the 
literature (Conlon et al., 2013). Bacterial persistence is a non-inherited phenomenon, but 
genetically programmed in toxin-antitoxin modules (Keren et al., 2004; Maisonneuve et al., 
2011).  
Toxin-antitoxin (TA) modules comprise a toxin that blocks bacterial growth via the 
inactivation of essential cellular functions and an antitoxin that prevents functionality of the 
toxin. In the most abundant group of type II TA modules the antitoxin is a protein that inhibits 
the toxin via tight binding until it is degraded by proteases in response to cellular signaling 
(Brzozowska and Zielenkiewicz, 2013). Among other functions (reviewed by Unterholzner et 
al. (2013)), TA modules play a prominent role in persister formation where their activation 
serves as the phenotypic switch into dormancy (Balaban et al., 2004; Lewis, 2010; 
Maisonneuve and Gerdes, 2014). In the absence of extrinsic signals, stochastic stimuli cause 
the formation of a small subpopulation of persisters, e.g., via the fluctuation of ppGpp levels 
in Escherichia coli which control the activity of the protease Lon that activates a plethora of 
type II TA modules (Maisonneuve et al., 2013). This inherent heterogeneity ensures survival 
of bacterial populations in case of rare, unpredictable threats as a bet-hedging strategy 
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(Balaban et al., 2004). In addition to stochastic events, different stimuli can trigger the 
phenotypic switch to dormancy in a deterministic manner. For example, DNA damage can 
induce persister formation of E. coli (via the SOS response and type I TA toxin TisB; (Dörr et 
al., 2010; Tripathi et al., 2012)), and the uptake of Salmonella Typhimurium into phagocytic 
vacuoles induces persistence by activating a whole arsenal of TA modules (Helaine et al., 
2014). Bacterial chromosomes usually encode multiple different TA modules that may 
display some redundancy, but often cumulatively contribute to persister formation (Helaine et 
al., 2014; Maisonneuve et al., 2013; Norton and Mulvey, 2012) 
Despite considerable knowledge about the upstream signaling, the downstream 
processes initiated when TA modules flip the switch to dormancy and how they cause 
multidrug tolerance are not well understood (Maisonneuve and Gerdes, 2014). Conspicuously, 
although a multitude of different molecular targets have been described, the general concepts 
by which TA modules induce persister formation have so far been limited to the inhibition of 
translation or, in a few cases, the abrogation of the proton-motive force (Castro-Roa et al., 
2013; Christensen and Gerdes, 2003; Unoson and Wagner, 2008; Wang et al., 2012; Winther 
et al., 2013). This remarkable limitation confirms that persisters are not just random non-
growing bacteria and instead generated by dedicated mechanisms as specialized survivor cells 
(Keren et al., 2004). The extent of heterogeneity among persisters as a critical obstacle to their 
complete eradication has not yet been resolved, but it likely depends on the diversity of 
different physiological pathways available for persister formation (Balaban et al., 2013; 
Kester and Fortune, 2014). Here we describe the subversion of cellular DNA topology as a 
third and new path to the persister state and characterize a family of FIC (filamentation 
induced by cAMP) domain proteins as toxins of the FicTA type II toxin-antitoxin module that 
converts bacteria into persisters via dual topoisomerase inhibition. 
Proteins containing FIC domains are found in all kingdoms of life and typically 
catalyze adenylylation (also known as AMPylation), the covalent transfer of an adenosine-5’ 
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monophosphate (AMP) moiety onto target proteins (Engel, Goepfert et al., 2012; Kinch et al., 
2009). Previous research on FIC domain proteins has focused on a few representatives that are 
host-targeted virulence factors of bacterial pathogens (Mukherjee et al., 2011; Yarbrough et 
al., 2009), but the far majority FIC domain proteins are genuine bacterial proteins of unknown 
function. We recently described the adenylylation activity of bacterial FIC domain proteins 
and discovered its inhibition by a conserved regulatory module that interferes with productive 
binding of the ATP substrate. Interestingly, we found the regulatory module of one group of 
bacterial FIC domain proteins to be part of a separate small protein that inhibits its cognate 
FIC domain via a tight interaction (Engel, Goepfert et al., 2012). Such a regulatory 
arrangement satisfies the core definition of type II toxin-antitoxin modules so that we 
introduced a new nomenclature and named the toxins “FicT” (for “FIC domain toxin”) and 
their cognate antitoxins “FicA” (Engel, Goepfert et al., 2012; Goepfert et al., 2013). However, 
the enzymatic targets and biological functions of this new FicTA toxin-antitoxin module had 
remained elusive. 
In this study, we characterize different representatives of the FicTA type II TA family 
and show that FicT toxins inactivate DNA gyrase and topoisomerase IV via adenylylation at 
their ATP binding site, causing reversible growth arrest. Using a wide range of different 
techniques we demonstrate that FicT toxin expression results in strong DNA knotting and 
catenation combined with a varying degree of DNA relaxation in E. coli, indicating that FicT 
toxins can inactivate both targets in vivo. Remarkably, we find that the disruption of cellular 
DNA topology upon activation of a FicTA module as well as by novobiocin, a chemical 
inhibitor of DNA gyrase and topo IV, converts bacteria into multidrug-tolerant persister cells. 
We therefore establish the subversion of DNA topology as a new mechanism to form 
persisters and believe that our findings will help to elucidate the molecular basis of multidrug 
tolerance as well as the inherent heterogeneity of these notoriously treatment-resistant cells. 
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Results 
Ectopic expression of FicT toxins results in a reversible inhibition of bacterial growth  
We previously established VbhTA of Bartonella schoenbuchensis as a model for the 
FicTA family and demonstrated that the antitoxin VbhA inhibits the adenylylation activity of 
the VbhT toxin and relieves the associated growth arrest in Escherichia coli (Engel, Goepfert 
et al., 2012). Since VbhT is unique among FicT homologs in that it harbors a C-terminal type 
IV secretion signal (called BID domain), we decided to investigate the molecular and 
biological functions of VbhT along with more typical representatives of Yersinia 
enterocolitica str. 8081 (YeFicTA module) and Pseudomonas aeruginosa PAO1 (PaFicTA 
module; see Extended Results in the Supplemental Information and Figure S1).  
The expression of different FicT toxins from a single-copy vector in the absence of 
their cognate FicA antitoxins resulted in strong inhibition of E. coli growth (Figures 1A and 
1B). This effect required the FicT toxins’ adenylylation activity because mutation of the 
catalytic histidine within the FIC domain signature motif HXFX(D/E)GNGRXXR into 
alanine (“H/A” mutants) abolished the growth inhibition (Figure 1A). Subsequent expression 
of the cognate antitoxins reversed the growth inhibition (Figure 1C), demonstrating that FicT 
toxin activity leads to a classical bacteriostatic condition that is a common feature of many 
TA systems (Pedersen et al., 2002). We note that the ectopic expression of VbhT appears to 
be less potent in growth inhibition than that of YeFicT, PaFicT, or only the FIC domain of 
VbhT alone (VbhT(fic); Figure 1B), possibly due to differential expression of the constructs 
or because the BID domain of VbhT sterically reduces toxin activity. 
FicT toxins adenylylate GyrB and ParE, the B subunits of DNA gyrase and topo IV 
 To unravel the molecular mechanism of the reversible growth inhibition caused by the 
FicT toxins’ adenylylation activity we next aimed at uncovering the identity of the 
adenylylated target(s). For this purpose we performed in vitro adenylylation assays with 
lysates of E. coli that had expressed VbhT and used a pull-down approach similar to the one 
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published by Grammel et al. (2011) for target identification. Though we failed to achieve 
significant enrichment of potential targets, we serendipitously discovered an adenylylated 
peptide that belonged to GyrB of E. coli (data not shown). The theoretical molecular weight 
of GyrB (89.95 kDa) fits well with the apparent molecular weight of the bona fide 
endogenous target adenylylation detected by autoradiography in adenylylation assays with 
VbhT (Figure 2A and our previous work (Engel, Goepfert et al., 2012)) which we calculated 
to be approximately 90 kDa using the ImageQuant software (Molecular Dynamics). Ectopic 
expression of GyrB both of E. coli or B. schoenbuchensis unambiguously showed that these 
proteins are adenylylated by VbhT in bacterial lysates in vitro (Figure 2A). Given the very 
high similarity in sequence, structure, and function to GyrB (Bellon et al., 2004) we further 
suspected that its paralog ParE may also be targeted by VbhT. Indeed, like for GyrB, ectopic 
expression of ParE of E. coli and B. schoenbuchensis clearly demonstrated adenylylation by 
VbhT (Figure 2A). However, unlike for GyrB, no adenylylation of endogenous ParE is 
detectable by visual inspection of autoradiographs of our adenylylation experiments with 
cleared lysates of E. coli expressing VbhT (Figure 2A). We believe that this discrepancy is 
caused by largely different target abundances because E. coli cells contain approximately 10 
times more molecules of GyrB than of ParE (Dr. Alexander Schmidt, personal 
communication). 
 GyrB and ParE are the B subunits of the two bacterial type IIA topoisomerases DNA 
gyrase and topoisomerase IV (topo IV) that control cellular DNA topology by maintaining 
negative supercoiling respectively removing DNA catenation and knotting (Sissi and 
Palumbo, 2010). Therefore, their activities are generally essential for all processes in bacterial 
cells that involve the manipulation of closed circular DNA such as chromosome replication, 
segregation, and transcription (Vos et al., 2011). Due to their remarkable conservation and 
essential functions the bacterial type IIA topoisomerases are targets of several groups of 
antimicrobials, bacteriocins, as well as the CcdBA and ParDE type II TA systems. These 
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toxins, the bacteriocins, as well as quinolone-based antimicrobials are poisons that prevent 
resealing of the DNA cleavage inherent to type II topoisomerase activity and ultimately result 
in cell death (Chen et al., 1996; Deghorain et al., 2013; Vos et al., 2011). In contrast, 
gyramide A and aminocoumarin drugs like novobiocin merely inactivate the enzymes as 
competitive inhibitors of their ATP hydrolysis activity which abrogates the cellular control of 
DNA topology but does not directly trigger cell death (Hardy and Cozzarelli, 2003; 
Rajendram et al., 2014). 
Adenylylation at the ATP binding site inhibits DNA gyrase and topo IV in vitro  
Using mass spectrometry, we found that VbhT adenylylates Y109 and its homolog 
Y105 in GyrB and ParE of E. coli, respectively (Figure S2). This highly conserved residue is 
part of the “ATP lid” and borders the ATP binding site (Brino et al., 2000). Since ATP 
hydrolysis is generally required for the cellular activities of DNA gyrase and topo IV (Bates et 
al., 2011), we assayed the hydrolysis of ATP by a GyrB ATPase model construct and found 
that adenylylation indeed completely inhibited the target’s ATPase activity (Figure 2B). 
Subsequently, we used recombinant DNA gyrase and topo IV to assess the effect of 
adenylylation on the signature activities of both targets on suitable DNA substrates in vitro. 
As expected, adenylylation prevented supercoiling of a relaxed reporter plasmid by DNA 
gyrase and decatenation of kDNA, a meshwork of catenated DNA rings, by topo IV (Figure 
2C).  
FicT toxins cause varying levels of DNA gyrase inhibition in vivo 
 We then investigated whether FicT toxins also inactivate DNA gyrase and topo IV in 
vivo. Any inhibition of DNA gyrase would decrease the negative supercoiling of cellular 
DNA. We therefore used DNA of plasmid pAH160, a high-copy number vector originally 
designed for rhamnose-inducible protein expression, isolated from E. coli expressing FicT 
toxins to directly visualize changes in DNA topology via high-resolution agarose gel 
electrophoresis with chloroquine to resolve negative supercoiling (see Experimental 
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Procedures in the Supplemental Information). As expected, the treatment of E. coli with a 
high concentration of novobiocin that completely inactivates DNA gyrase resulted in collapse 
of the negative supercoiling (Figure 3A). However, a dose of VbhT, VbhT(fic), or YeFicT 
expression that strongly impaired bacterial growth (two hours of full induction; see Figure 
1B) caused only a slight stretch of the topoisomer distribution towards DNA relaxation, while 
the expression of PaFicT resulted in full relaxation of the reporter plasmid (Figure 3A). These 
divergent findings lead us suspect that the transient nature of local DNA relaxation for the 
single topological domain of our simple reporter plasmid may have masked more prominent 
effects of a potential partial inhibition of DNA gyrase upon expression of our VbhT and 
YeFicT constructs. We therefore used another reporter plasmid encoding a relaxation-induced 
PgyrB::gfpmut2 GFP promoter fusion to record any DNA gyrase inhibition inside single cells 
by flow cytometry. For validation, we confirmed that E. coli harboring this plasmid showed 
dose-dependent induction of GFP fluorescence upon inhibition of DNA gyrase with different 
concentrations of novobiocin (Figure 3B). In this system the expression of VbhT or YeFicT 
resulted in a rather weak, but detectable induction of GFP fluorescence, while VbhT(fic) 
elicited a stronger response and the expression of PaFicT had a similar effect as the highest 
concentrations of novobiocin (Figure 3B). Furthermore, we constructed a chromosomal 
PgyrB::gfpmut2 reporter in order to directly assess the supercoiling of the nucleoid and avoid 
potential artifacts from analysing reporter plasmids which can be misleading (Rovinskiy, 
Agbleke et al., 2012). Like with the plasmid-based assay (Figure 3B), the treatment with 
different concentrations of novobiocin caused a dose-dependent induction of GFP 
fluorescence, while FicT toxin expression resulted in weak (VbhT and YeFicT), moderate 
(VbhT(fic)), or strong DNA relaxation (PaFicT; Figure 3C). These findings mirror our results 
from high resolution agarose gel electrophoresis and thus indicate that the expression of our 
VbhT and YeFicT constructs is unlikely to achieve levels of DNA gyrase inhibition in vivo 
that would greatly contribute to growth inhibition. The more prominent effect with VbhT(fic) 
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compared to VbhT in full length may be due to differences in expression or reflect an 
evolution of the VbhT FIC domain to stronger activity in order to partially compensate for the 
hindrance by its BID domain. Despite that, neither VbhT(fic) nor PaFicT are more potent 
toxins than YeFicT (Figure 1B), suggesting that DNA gyrase inhibition is not the primary 
driving force of FicT-mediated growth inhibition. 
FicT toxins robustly inhibit topo IV in vivo 
 The inactivation of topo IV is known to result in DNA knotting and catenation which 
induce a classical phenotype called par hallmarked by cell filamentation and the sequestration 
of unsegregated DNA at the cell center (Kato et al., 1990). We therefore used fluorescence 
microscopy to study cell shape and DNA partitioning in E. coli expressing FicT toxins 
(Figure 4A). As expected from our biochemical data with VbhT, the expression of any FicT 
toxin greatly inhibited DNA segregation and bacterial cell division which was a first 
indication of topo IV inactivation in vivo (Figure 4A). In deviation from a classical par 
phenotype, the cells expressing VbhT(fic), YeFicT, and PaFicT – but not VbhT – displayed a 
highly condensed nucleoid morphology. These findings were immediately reminiscent of the 
phenotype that others had reported for gyramide A treatment, suggesting that the compaction 
was caused by DNA gyrase inhibition coming on top of the inactivation of topo IV 
(Rajendram et al., 2014). As an independent readout of topo IV inhibition in vivo we re-
analyzed the pAH160 samples that we had used for the detection of DNA relaxation by high 
resolution agarose gel electrophoresis (see Figure 3A). After nicking to release all 
supercoiling, the samples were run on plain agarose gels to resolve DNA knotting and 
catenation. Plasmid isolated from E. coli that had expressed any of the FicT toxin constructs 
showed detectable DNA knots evidencing robust topo IV inhibition (Figure 4B). The 
seemingly weak extent of all DNA knotting with pAH160 is caused by the small size of this 
reporter plasmid (4359 bp) and hints at considerable knotting of the nucleoid, since the 
topological entanglement and size of chromosomal DNA greatly favors knotting and 
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complicates unknotting compared to small plasmids (Witz and Stasiak, 2010). Additionally, a 
clear ladder of catenanes with various node numbers is detected for VbhT and YeFicT as well 
as – more weakly – VbhT(fic), but not for PaFicT or the novobiocin treatment (dimeric 
catenanes appear between nicked monomeric and dimeric DNA; Figure 4B and see also 
Figure S3). The absence or reduction of catenation with VbhT(fic) and PaFicT compared to 
VbhT or YeFicT expression confirms the stronger gyrase inhibition that we detected earlier, 
because a concomitant inactivation of DNA gyrase and topo IV (but not the latter alone) 
causes a rapid arrest of DNA replication and therefore prevents the formation of catenanes 
(Khodursky et al., 2000). 
 In order to investigate the molecular mechanism of target inactivation by FicT toxins 
in more detail we next assayed whether the overexpression of GyrB and / or ParE could 
rescue the growth inhibition caused by FicT expression. Such reversion of the growth arrest 
would confirm a purely inhibitory mechanism for FicT toxins and has been shown, e.g., for 
the overexpression of GltX that is phosphorylated and concomitantly inactivated by the HipA 
toxin (Germain et al., 2013). In contrast, for the gyrase poison CcdB it was shown that the 
presence of a susceptible, wildtype gyrase is dominant over the co-expression of even a 
resistant mutant (Bernard and Couturier, 1992). Our results show that the growth inhibition 
caused by VbhT could be prevented by the overexpression of ParE, confirming an inhibitory 
mechanism (Figure 5). No effect was observed for the overexpression of GyrB, confirming 
our previous findings that the inactivation of DNA gyrase has no major contribution to growth 
inhibition by VbhT. 
Topoisomerase inhibition by FicT toxins reveals a new path to the persister state 
 Our experiments investigating the effects of FicT toxin expression on DNA topology 
in bacterial cells strongly suggested that the obstruction of topological control upon 
topoisomerase inhibition was the cause of the growth arrest observed with FicT toxins. We 
therefore explored the consequences of FicT activity inside bacterial cells more deeply and 
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genetically confirmed that the expression of FicT toxins caused major problems with DNA 
processing, particularly chromosome replication, via the inhibition of replication fork 
progression and chromosome segregation (see Figure S4 and Extended Results in the 
Supplemental Information). In conclusion, the FicTA family constitutes the first TA module 
that inhibits bacterial growth via topoisomerase inhibition. 
Toxin-antitoxin modules have long been recognized as the primary genetic basis of 
bacterial persistence but have so far only been shown to promote persister formation via the 
inhibition of translation or abrogation of the proton-motive force (Keren et al., 2004; Lewis, 
2010; Maisonneuve et al., 2011). We therefore reasoned that the disruption of cellular DNA 
topology caused by FicT toxins could constitute a new way to trigger persister formation. To 
test this hypothesis, we treated E. coli with a high concentration of bacteriostatic novobiocin 
that inhibits DNA gyrase as well as topo IV and subsequently challenged the bacteria with 
either of three antibiotics (ciprofloxacin, kanamycin, or ampicillin) that kill via entirely 
different mechanisms. In all cases the treatment with novobiocin greatly increased the fraction 
of surviving persisters in the population (Figure 6A). Admittedly, others had shown before 
that a variety of treatments causing reversible growth inhibition in E. coli from bacteriostatic 
antimicrobials to the heterologous expression of different toxic proteins can induce multi-drug 
tolerance (Kwan et al., 2013; Vazquez-Laslop et al., 2006). The biological relevance of our 
results with novobiocin is therefore largely dependent on whether a natural TA module 
exploits this mechanism to induce bacterial persistence. We thus repeated the experiment 
described above and replaced the novobiocin treatment with the expression of FicT toxins to 
assay their effect on bacterial persistence. Remarkably, while the antibiotic challenge 
eliminated all but 1 in 10’000 of the cells in the vector control, 1 in 10 of the bacteria 
expressing FicT toxins survived any drug treatment (Figure 6B). This increase in the 
proportion of persisters was independent of the SOS response triggered by some FicT 
constructs (Figure S5) and quantitatively similar to the effects that others had observed upon 
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overexpression of toxins targeting translation or the proton-motive force (Dörr et al., 2010; 
Keren et al., 2004; Maisonneuve et al., 2011; Vazquez-Laslop et al., 2006). 
Consequently, we asked whether the activation of a genuine ficAT locus instead of the 
ectopic expression of FicT could also induce bacterial persistence. For this purpose we cloned 
the yeficAT and paficAT loci including approximately 300 bp upstream of their start codon (to 
ensure control by their genuine promoter regions) on a low-copy plasmid. The functional 
expression of these TA modules in E. coli was tested via the co-expression of catalytically 
inactive FicT toxin mutants to titrate out the FicA antitoxin expressed from the ficAT locus 
(see model shown in Figure 7A). While we readily detected an activation of the yeficAT 
module, no significant growth inhibition was found with paficAT, suggesting that this TA 
module is not properly expressed in E. coli (Figure 7B). However, a comparable assay in its 
natural host organism Pseudomonas aeruginosa unambiguously detected an activation of 
PaFicT and thus functional expression of the paficAT module (Figure S6). We therefore chose 
yeficAT as our model FicTA module in E. coli and tested whether its activation via the 
overexpression of catalytically inactive YeFicT_H136A would trigger a phenotypic switch to 
bacterial persistence. Consistent with our earlier findings, the sequestration of YeFicA in the 
presence of an intact yeficAT module resulted in an increased fraction of persisters in the 
bacterial population (Figure 7C). 
 Under physiological conditions the activity of type II TA toxins is unleashed via 
protease-mediated antitoxin degradation in response to certain triggers or stochastically in a 
subpopulation of cells (Brzozowska and Zielenkiewicz, 2013; Maisonneuve et al., 2013). 
Thus, we finally asked whether any of the proteolytic systems of E. coli K-12 is able to target 
FicA antitoxins and thereby to activate ficAT modules. To address this question we took 
advantage of the observation that ectopic expression of the yeficAT module results in 
detectable growth inhibition, suggesting that one or more of the resident proteases in E. coli 
degrade part of the YeFicA pool inside the cells (Figure 7D; see lamB control). Since the 
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biochemical investigation of YeFicA degradation in vivo was not conclusive (data not shown), 
we tested E. coli deletion mutants lacking ClpP, HslV, or Lon protease for susceptibility to 
the ectopic expression of yeficAT. While no or only a partial attenuation of growth inhibition 
was observed in clpP and hslV mutants, the effect was completely absent in the lon mutant 
(Figure 7D; see also Figure S7). These results suggest that Lon is the primary protease 
targeting YeFicA in E. coli and are consistent with the role of Lon as the main player in TA 
module activation in E. coli and related bacteria (Brzozowska and Zielenkiewicz, 2013; 
Helaine et al., 2014; Maisonneuve et al., 2013). 
 
Discussion 
FicT adenylylates DNA gyrase and topo IV to promote persistence 
In this study we characterized a diverse sample of TA modules belonging to the 
conserved and abundant FicTA family and determined their common molecular mechanism as 
the adenylylation and concomitant inactivation of DNA gyrase and topo IV. The expression 
of VbhT, YeFicT, and PaFicT toxins consistently caused a robust inhibition of topo IV 
activity in E. coli, but the extent of DNA gyrase inhibition differed, possibly reflecting 
divergent histories of host adaptation or a quantitative limitation of our single-copy 
expression system. Though a robust inhibition of topo IV alone is sufficient to inhibit 
bacterial growth, any additional inhibition of DNA gyrase aggravates this effect because both 
decatenation and unknotting activities of topo IV are guided by the gyrase-dependent negative 
supercoiling of the nucleoid (Witz and Stasiak, 2010). The other known topoisomerase-
targeting TA systems CcdBA and ParDE are bactericidal plasmid addiction modules that 
trigger lethal DNA double-strand breaks by poisoning gyrase activity via non-covalent 
interaction with the A subunit (Bernard and Couturier, 1992; Deghorain et al., 2013). 
Conversely, the growth arrest caused by FicT toxins is largely reversible (Figure 1C) and 
relies on the covalent modification of the B subunit of both DNA gyrase and topo IV (Figure 
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2), resulting in mere target inactivation and not poisoning: Target overexpression could 
prevent the growth arrest caused by VbhT (Figure 5A), and we did not observe the 
appearance of diffuse nucleoids upon FicT expression that would have indicated DNA 
double-strand breaks ((Rajendram et al., 2014), see Figure 4A). This functional contrast 
between the FicTA family that promotes persister formation and gyrase-poisoning addiction 
modules reflects their opposing roles as life-saving and life-taking machineries, respectively. 
The addiction modules of mobile elements evolved to kill bacterial cells that have lost the 
respective replicon and therefore fail to replenish the pool of instable antitoxin (Deghorain et 
al., 2013). Instead, FicTA modules are functionally more related to a variety of small proteins 
that inhibit gyrase by tight binding which blocks the DNA binding of the enzyme and thus 
prevents DNA damage caused by poisoning (Sengupta and Nagaraja, 2008; Tran and Jacoby, 
2002). Mechanistically, FicT toxins resemble the structurally related Doc toxin that blocks 
translation via the phosphorylation of elongation factor EF-Tu and reversibly arrests bacterial 
growth (Castro-Roa et al., 2013). 
The disruption of DNA topology is a new path to bacterial persistence 
It is a main obstacle to the development of efficient strategies against bacterial 
persisters that we do not understand the meaning of “persistence” on the physiological or 
molecular level, i.e., how precisely bacteria can survive under a diversity of unrelated, clearly 
lethal conditions (Balaban et al., 2013). Initially, it was proposed that persisters evade killing 
via the direct inactivation of antimicrobial targets to prevent bactericidal poisoning (Keren et 
al., 2004), but this model appears to be too simplistic since it fails to explain why, e.g., TA 
modules that inhibit translation can protect cells from antibiotics that corrupt topoisomerases 
(Lewis, 2010; Maisonneuve et al., 2011). Nevertheless, the repeated finding that diverse 
bacteriostatic treatments can induce a multidrug-tolerant “persister-like state” in laboratory 
test tubes appeared to support the hypothesis that persistence may simply be the opposite of 
bacterial growth (Kwan et al., 2013; Vazquez-Laslop et al., 2006). On the other hand, the 
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intriguing limitation of TA modules to form persisters only via targeting the proton-motive 
force or, in most cases, inhibiting translation indicated that persisters may not be generated by 
accidental dormancy but rather by specialized mechanisms (Leplae et al., 2011; Unterholzner 
et al., 2013). Our discovery that the disruption of DNA topology constitutes a third path to the 
persister state does not generally change that notion. It is therefore important to stress that 
persisters are “not simply non-growing cells” but rather employ evolved strategies to survive 
lethal stress in a dedicated phenotypic state (Keren et al., 2004; Lewis, 2005). Furthermore, a 
number of recent studies have shown that persisters exhibit an inherent heterogeneity that is 
likely a consequence of the distinct molecular mechanisms employed by TA modules to 
induce dormancy (Helaine et al., 2014; Kester and Fortune, 2014; Norton and Mulvey, 2012). 
Additionally, it has been proposed that bacteria may be able to alternately activate TA 
modules even if they are wired to the same upstream signaling (Maisonneuve et al., 2011). 
This inherent heterogeneity of persistence as a collection of divergent physiological 
states is important for the arising perspective of drugs designed to kill persister cells (Conlon 
et al., 2013) because it urges to ensure that these drugs can break both the stacking and the 
redundancy of the diverse TA modules that underlie persister formation. Therefore, we must 
explore the molecular mechanisms of different TA modules with regard to the downstream 
changes in cellular physiology that can all cause multidrug tolerance. The subversion of DNA 
topology as a third path to the persister state greatly widens the perspective of such a 
comparative analysis and brings us one step closer to understand how persister cells can 
survive antimicrobial treatment and – most importantly – how we can still kill them. 
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Experimental Procedures 
Bacterial strains and plasmids 
Bacterial strains and plasmids used and constructed over the course of this study are described 
in the Supplemental Information. All oligonucleotide primers are listed in Table S1. All 
vectors and details of their construction are listed in Table S2. 
 
Toxicity tests 
Unless stated differently, the effect of FicT toxin expression on bacterial viability was 
investigated in E. coli K-12 MG1655 ΔecficAT (AHE573) and derivatives using a two-
plasmid system with toxin genes under Plac control (pNDM220 derivatives) and antitoxin 
genes under Para control (pBAD33 derivatives) as well as occasional other plasmids to co-
express enzymatic targets or mutants of FicT toxins. Detailed procedures are described in the 
Supplemental Information. 
 
Persister assays 
The fraction of bacterial persisters in exponentially growing cultures of E .coli and the effect 
of different experimental interventions were quantified by forming the ratio of c.f.u. / ml after 
and before the exposure to lethal doses of antimicrobials. The procedures are described in 
detail in the Supplemental Information. 
 
Protein expression and purification 
Different VbhT constructs (Engel, Goepfert et al., 2012) and GyrB43 (Stanger et al., 2014), 
an N-terminal fragment of GyrB containing the ATPase domain (Ali et al., 1993), were 
expressed and purified as described previously. Further details on the expression and 
purification of VbhT constructs are given in the Supplemental Information. 
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ATP hydrolysis assay 
The ATPase activity of GyrB43 was monitored by FPLC-based nucleotide quantification 
using the conditions described by Brino et al. (2000). For details, see the Supplemental 
Information. 
 
Identification of AMPylation sites by LC-MS analysis 
Recombinant E. coli DNA gyrase and topo IV (TopoGEN Inc.) were adenylylated in vitro 
with purified VbhT(fic)/VbhA(E/G), tryptically digested, C18-purified, and analysed by LC-
MS/MS as described previously (Engel, Goepfert et al., 2012). Mass tolerance was set to 15 
ppm for precursor ions and 0.6 Da for fragment ions. Converted MS data were searched using 
Mascot against a SwissProt E. coli decoy database containing target sequences of VbhTA. 
Search results were evaluated using Scaffold 3 (Proteome Software). 
 
In vitro adenylylation assays 
The adenylylation activity of FicT constructs was assessed using cleared lysates of ectopically 
expressing E. coli and [α-32P]-ATP (Hartmann Analytic) as described previously (Engel, 
Goepfert et al., 2012). 
 
In vitro topoisomerase assays 
In vitro supercoiling or decatenation assays of recombinant DNA gyrase or topoisomerase IV 
of E. coli (TopoGEN Inc.) were performed according to the supplier’s recommendations. 
Details of the experimental procedure are described in the Supplemental Information. 
 
Flow cytometry with gfp promoter fusions 
The response of PgyrB (for DNA relaxation (Menzel and Gellert, 1983)) and PsulA (for SOS 
induction) promoters to FicT toxin expression was probed using plasmid-encoded gfpmut2 
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promoter fusions of the collection created by Zaslaver et al. (2006) and pUA139, the parental 
plasmid without promoter, or chromosomal derivatives thereof (AHE1156 and AHE1158; see 
Strain Construction in the Extended Experimental Procedures). Experimental details are 
given in the Supplemental Information. 
 
High-resolution agarose gel electrophoresis 
Changes in cellular DNA topology upon FicT toxin expression were assessed using the 
pAH160 reporter plasmid isolated from snap-frozen samples of E. coli AHE938 cultures with 
the Wizard Plus SV Minipreps DNA Purification kit (Qiagen). Details of the experimental 
procedure for high-resolution agarose gel electrophoresis to resolve DNA supercoiling, 
knotting, and catenation are described in the Supplemental Information. 
 
Fluorescence microscopy 
E. coli AHE573 that had expressed FicT toxins for 2 hours were stained with membrane dye 
FM4-64 (Molecular Probes) ad 2.5 µg/ml and DNA dye DAPI (4’,6’-diamidino-2-
phenylindole, Roche) ad 5 µg/ml for 30 minutes in LB medium in the dark and then 
transferred onto microscopy slides coated with 1% agarose. Images were acquired using an 
Olympus IX71 microscope equipped with a CoolSnap HQ2 camera, LED illumination, and a 
100x phase contrast objective (all from Applied Precision). Filter sets were Ex: 390/18, Em: 
435/48 (DAPI) and Ex: 542/27, Em: 594/45 (TRITC). Snapshots were taken using SoftWorx 
5.5 software and the pictures were adjusted for publication using ImageJ 
(http://rsbweb.nih.gov/ij/download.html) and Photoshop CS5 extended 12.0.4x64 (Adobe). 
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Figure 1 
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Figure 1. FicT toxins reversibly inhibit bacterial growth 
(A) FicT toxins, but not catalytically inactive mutants (”H/A” with a H136A substitution at 
the active site), inhibit E. coli growth on LB agar plates in the absence of cognate FicA 
antitoxins. The signature motifs of all FicTA modules investigated in this study are compared 
in Figure S1. 
(B) We followed the colony forming units (c.f.u. / ml) of exponentially growing E. coli 
cultures in which FicT expression had been induced with 2000 µM of isopropyl 
β-D-thiogalactopyranoside (IPTG). The curves show a marked growth inhibition by YeFicT, 
PaFicT, or only the FIC domain of VbhT (VbhT(fic)) and a lower potency of VbhT. 
(C) The c.f.u. / ml of exponentially growing E. coli cultures harboring plasmids for the 
expression of toxins under Plac and cognate antitoxins under Para control were monitored 
over time after the induction of FicT expression by spotting on LB agar plates containing D-
glucose (to inhibit toxin expression) or L-arabinose (to induce antitoxin expression). We find 
that the growth inhibition by FicT toxins, but not gyrase-poisoning toxin CcdB, is reversed by 
subsequent antitoxin expression. Weaker growth inhibition by FicT toxins in (C) compared to 
(B) is likely the consequence of leaky antitoxin expression. 
All data points and error bars are mean and s.d. of biological triplicates. 
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Figure 2 
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Figure 2. FicT toxins adenylylate DNA gyrase and topo IV which results in target 
inhibition in vitro. 
(A) Cleared lysates of E. coli that had expressed different VbhT (full length) constructs or 
target candidates were mixed, incubated with [α-32P]-ATP to trace adenylylation, and then 
analyzed using SDS-PAGE and autoradiography.  
The autoradiograph (top) shows VbhT auto-adenylylation (58 kDa; green arrow) and 
adenylylation of endogenous GyrB (90 kDa; red arrow) as well as ectopically expressed GST-
fusions of GyrB and ParE of E. coli and B. schoenbuchensis, respectively (black arrows). The 
Coomassie stain (bottom) of the same gel shows the presence of all ectopically expressed 
proteins (green: VbhT, magenta: VbhA, black: GST-GyrB and GST-ParE). Using mass 
spectrometry we mapped the adenylylation sites to be tyrosine 109 in E. coli GyrB and 
tyrosine 105 in E. coli ParE (Figure S2). 
(B) The curves represent ATP hydrolysis by a GyrB ATPase model construct as monitored by 
ADP production. Addition of the VbhT/VbhA complex (VbhTA) has no effect on GyrB-
mediated ATP hydrolysis (compare blue and green curves), whereas adenylylation of GyrB 
by the VbhTA* construct (see below) progressively inhibits ATP hydrolysis, with full 
inactivation achieved after about one hour of incubation (red curve). Novobiocin immediately 
blocks ATP hydrolysis (purple curve). Data points and error bars are mean and s.d. of 
biological triplicates. 
(C) The supercoiling and decatenation activities of recombinant DNA gyrase and topo IV 
were probed by monitoring the supercoiling (sc) of relaxed pBR322 (rel) and the decatenation 
of highly catenated kDNA (cat) into monomers (Mrel) in vitro, respectively. The targets were 
pre-incubated with different VbhT constructs for one hour prior to the addition of DNA 
substrates. The agarose gel resolving the reaction products shows that both enzymes are fully 
inhibited by adenylylation as well as by novobiocin. oc = open circular (nicked) plasmid 
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In (B) and (C) VbhTA* as opposed to VbhTA indicates the presence of mutant VbhA(E24G) 
that is unable to inhibit VbhT, resulting in an active, adenylylation-competent construct 
(Engel, Goepfert et al., 2012); see also Extended Experimental Procedures in the 
Supplemental Information). 
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Figure 3 
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Figure 3. FicT toxins achieve only partial inhibition of DNA gyrase in vivo. 
(A) Reporter plasmid pAH160 was analyzed by high resolution agarose gel electrophoresis 
(in presence of 12.5 µg/ml chloroquine to resolve negative supercoiling) following isolation 
from E. coli that had expressed different FicT constructs for two hours. The gel shows only a 
slight stretching of the pAH160 topoisomer distribution towards DNA relaxation with VbhT 
or YeFicT (arrows), indicative of weak inhibition of DNA gyrase, while high concentrations 
of novobiocin (Nov; 100 µg/ml) or the expression of PaFicT fully abrogate the negative 
supercoiling. 
(B) The induction of a relaxation-sensitive PgyrB::gfpmut2 module on a reporter plasmid was 
analyzed by flow cytometry in E. coli that had expressed different FicT constructs for two 
hours. As expected, the treatment with novobiocin elicited a dose-dependent response 
(10 µg/ml fully inhibit DNA gyrase in acrA-deficient E. coli (Khodursky et al., 2000)). 
Different FicT constructs induced weak (VbhT and YeFicT), intermediate (VbhT(fic)), or 
strong (PaFicT) expression of GFP (p<0.01, unequal variance t-test). 
(C) A chromosomal PgyrB::gfpmut2 module was used to assay nucleoid relaxation as 
described for the plasmid sensor in (B). Similarly, our set of FicT constructs differentially 
induced the expression of GFP (all (p<0.05, unequal variance t-test). 
All data points and error bars are mean and s.d. of biological triplicates. 
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Figure 4 
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Figure 4. FicT expression results in robust inhibition of topo IV in vivo. 
(A) E. coli cells that had expressed different FicT constructs for two hours were stained with 
FM4-64 (membranes; red) and DAPI (DNA, blue) and analyzed by fluorescence microscopy; 
representative images are shown. FicT toxin expression induces a “par” phenotype with cell 
filamentation and unsegregated nucleoids, indicative of strong topo IV inhibition. The 
nucleoid compaction observed with VbhT(fic), YeFicT, and PaFicT is likely a consequence of 
DNA gyrase inhibition (Rajendram et al., 2014). 
(B) Nicking of the DNA samples used for Figure 3A separates nicked (nic) / linear (lin) 
dimers (D) and monomers (M) and reveals catenation (Dcat) and knotting (Mknt, arrows) 
upon FicT expression. High concentrations of novobiocin (100 µg/ml, Nov100) or PaFicT 
expression also inactivate DNA gyrase (note collapsed supercoiling in Figure 3A), leading 
primarily to DNA knotting in the absence of DNA replication. A lane plot that highlights the 
bands representing knotted topoisomers is shown in Figure S3. 
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Figure 5 
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Figure 5. VbhT-induced growth inhibition can be blocked by target overexpression  
E. coli harboring plasmids for the expression of VbhT under Plac control as well as target(s) 
under Para (low copy vectors, denoted by “+” expression level) or Prha (high copy vectors, 
denoted by “+++” expression level) control were spotted in serial dilutions onto different agar 
plates. The plates contained no inducer, 2000 µM IPTG, 0.2% L-arabinose and D-rhamnose 
(for Para and Prha), or all inducers, and the bar diagram shows the difference in c.f.u. 
obtained between no inducer and all inducers conditions. It is apparent that a strong induction 
of ParE expression can prevent the growth inhibition caused by VbhT (p<0.05, unequal 
variance t-test against vector control of target expression). The data are in line with genetic 
findings that FicT toxins act via topoisomerase inhibition to subvert cellular DNA processing 
(Figure S4). Data points are mean values of three independent experiments with error bars 
denoting s.e.m. 
 
  
205 
 
 Results – Research article III 
 
Figure 6 
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Figure 6. The disruption of DNA topology by novobiocin or FicT expression induces 
bacterial persister formation 
(A) Exponentially growing E. coli of strain AHE938 (novobiocin-sensitive due to acrA 
genotype) were treated with a high concentration of novobiocin for one hour (200 µg/ml) and 
then challenged with a lethal concentration of one of three different antibiotics for three more 
hours so that only persisters would survive. C.f.u. / ml were determined before and after drug 
challenge. The data show a 2-3 log increase in the proportion of persisters upon novobiocin 
treatment (p<0.05, unequal variance t-test against no-treatment control). This effect does not 
involve an activation of the SOS response, suggesting that it is caused by the disruption of 
cellular DNA topology itself (Figure S5D). 
(B) Exponentially growing E. coli were induced to express FicT toxins for two hours and then 
challenged with a lethal concentration of one of three different antibiotics for three more 
hours so that only persisters would survive. C.f.u. / ml were determined before and after drug 
challenge; the data show a 1,000 fold increased proportion of persisters in E. coli expressing 
FicT toxins (p<0.001, unequal variance t-test). This effect is largely independent of the SOS 
activation caused by FicT expression (Figures S5A and S5E). 
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Figure 7 
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Figure 7. The yeficAT module can be activated by sequestration or Lon-mediated 
degradation of YeFicA and promotes persister formation 
(A) The model illustrates the experimental activation of ficAT modules by antitoxin 
sequestration. Catalytically inactive FicT_H/A toxin mutants expressed from a high-copy 
vector upon D-rhamnose induction (left; with “A” instead of “H” in the stylized active site) 
titrate out cognate FicA antitoxins (blue) that are expressed together with wildtype FicT from 
a genuine ficAT locus on a low-copy vector. Free FicT toxins are active and cause bacterial 
growth inhibition via target adenylylation (see Extended Experimental Procedures in the 
Supplemental Information). 
(B) E. coli harboring yeficAT or paficAT modules including their 300 bp upstream regions 
were induced to overexpress catalytically inactive FicT_H/A mutants for one hour (see A) and 
c.f.u. were recorded before and afterwards. The data show an activation of the intact yeficAT 
module upon antitoxin sequestration, but effects of paficAT were not significant (n.s.). A 
similar experiment in its natural host organism Pseudomonas aeruginosa PAO1 readily 
detected activation of paficAT (Figure S6). 
(C) The genuine yeficAT module on a low-copy vector was activated by antitoxin 
sequestration as described in (A) and the bacteria were challenged with a lethal concentration 
of ampicillin or ciprofloxacin for three more hours so that only persisters would survive. 
C.f.u. / ml were determined before and after drug challenge, showing that this near-
physiological activation of yeficAT significantly increases the proportion of persisters in the 
population (p<0.05 for unequal variance t-test against vector or H/A controls). This phenotype 
is largely independent of a potential SOS induction upon YeFicT activation (Figure S5F). 
(D) E. coli protease mutants harboring a plasmid-encoded yeficAT module under Plac control 
were induced with 2000 µM IPTG and c.f.u. were recorded before and after two hours of 
expression. It is apparent that the ectopic co-expression of yeficAT from a heterologous 
promoter results in growth inhibition unless lon is inactivated, while the clpP mutant showed 
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only a partial rescue (both p<0.05 against lamB control, unequal variance t-test). The 
inactivation of hslV had no effect (n.s. = not significant). We confirmed that growth inhibition 
by YeFicT is not generally reduced in the lon mutant and did not detect a similar effect with 
vbhAT(fic) or paficAT (Figure S7A-C). All data points are mean values of three independent 
experiments with error bars denoting s.d. 
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Supplemental Information 
Extended Results 
Using a panel of diverse model proteins to study FicT toxins 
We had previously shown that VbhT and VbhA of Bartonella schoenbuchensis fulfill 
the central definition of type II TA modules since the small VbhA protein inhibits both the 
adenylylation activity of FIC domain containing VbhT as well as the associated growth 
inhibition in E. coli via a direct protein-protein interaction (Engel, Goepfert et al., 2012). 
However, while the far majority of FicT homologs solely comprise a FIC domain, VbhT 
uniquely harbors a discernable type IV secretion signal at its C-terminus, a BID (Bep 
Intracellular Delivery) domain. BID domains are present in relaxases of a number of 
conjugation systems as well as the closely related host-targeted effectors of the genus 
Bartonella (Schulein et al., 2005), suggesting that VbhT may be secreted into a target cell 
(prokaryotic or eukaryotic) by the Vbh type IV secretion system (T4SS) encoded close-by. It 
was therefore possible that VbhT could have secondarily acquired a new function which may 
or may not rely on a different / altered biochemical activity than that of other FicT toxins. We 
therefore decided to study VbhTA along with more typical homologs to elucidate the 
molecular function and biological role FicTA modules. 
The prototypic EcFicT protein of Escherichia coli was the first FIC domain protein to 
be described and the “filamentation induced by cAMP” phenotype of its fic-1 allele gave the 
name to the domain family (Utsumi et al., 1982). Being a genuine E. coli protein, EcFicT 
would have been an ideal candidate for a biological characterization in this classical model 
organism along with VbhT. However, we found that EcFicT is unlikely to be representative of 
the bulk of FicT homologs because it belongs to an atypical subgroup that is only found in 
Enterobacteria and harbors a secondarily deteriorated FIC domain active site motif (Figure 
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S1). Consequently, EcFicT did not show adenylylation activity or inhibit bacterial growth 
(our unpublished results). However, we still used a ΔecficAT derivative of E. coli str. K-12 
substr. MG1655 for most experiments to exclude functional crosstalk of any kind between 
endogenous EcFicTA and our model systems. 
Instead of EcFicTA we decided to characterize YeFicTA of Yersinia enterocolitica str. 
8081, an organism closely related to E. coli (Thomson et al., 2006). YeFicT has 37% protein 
sequence identity to EcFicT and 32% protein sequence identity to the FIC domain of VbhT of 
B. schoenbuchensis. Most importantly, YeFicT appears to be an average FicT homolog with a 
conserved FIC domain active site motif. Though not originally annotated in genome of 
Y. enterocolitica str. 8081, we identified the small ORF yeficA encoded upstream of yeficT 
with slight overlap as a candidate antitoxin with inhibitory α-helix and identical length to 
vbhA. 
Furthermore, we studied a rather distant relative of our other model proteins to assess 
whether our findings may apply to FicT homologs in general. For this purpose we chose 
PaFicT of Pseudomonas aeruginosa PAO1 with 22.1%, 16.6%, and 22.0% protein sequence 
identity in the conserved regions to YeFicT, EcFicT, and VbhT, respectively. Like for 
YeFicT, we identified the small ORF paficA encoded upstream of paficT with slight overlap 
that may serve as an antitoxin. Interestingly, the signature motifs of both the FIC domain in 
PaFicT (HXFX(D/E)GNGRXXL with a leucine instead of the final arginine) and PaFicA 
(SXXXD(G/N)) with an aspartate instead of the glutamate) slightly diverge from the 
canonical motifs as defined by Engel, Goepfert et al. (2012) (see Figure S1). 
FicT expression impairs replication fork progression and DNA segregation  
It is intuitive that the inhibition of chromosome decatenation upon topo IV inhibition 
by FicT would impair DNA segregation and cell division (Adams et al., 1992; Zechiedrich 
and Cozzarelli, 1995). Consistently, we found that the inactivation of topoisomerase III or 
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XerCD recombination which can both partially complement a topo IV deficiency in DNA 
segregation made E. coli hypersensitive to growth inhibition by FicT toxins (Figure S4A). 
Moreover, others have shown that the inactivation of topo IV results in an inhibition of DNA 
replication and transcription via DNA knotting as well as an impaired topological control of 
replication forks that is aggravated in different ways by DNA gyrase inhibition (Deibler et al., 
2007; Khodursky et al., 2000; Lopez et al., 2012; Witz et al., 2011; Witz and Stasiak, 2010). 
DNA knots continuously arise in the tangled nucleoid from random strand passages that occur 
whenever cellular DNA handling cuts open the chromosome, e.g., during processes of 
replication, recombination, or repair, and they cannot be removed in the absence of functional 
topo IV (Deibler et al., 2001). Similarly, positive supercoiling arises ahead of DNA 
replication forks as well as transcription complexes and inhibits their progression unless it is 
continuously removed by DNA gyrase and topo IV (Chong et al., 2014; Khodursky et al., 
2000). We therefore expected that the viability of bacteria expressing FicT toxins should 
depend on replication fork repair and restart via fork reversal and various recombination 
pathways. Indeed, we found that E. coli deficient in the recABCD or ruvABC machineries 
were hypersensitive to growth inhibition by FicT toxins (Figure S4A). Importantly, the same 
genes are also involved in a number of different DNA repair pathways on top of 
recombinational fork repair, e.g., the processing of double-strand breaks. We therefore 
verified that the single inactivation of recA (which is essential for double-strand break repair 
(Wigley, 2013)) does not abolish the reversibility of a FicT toxin-mediated growth arrest in 
our experimental system (Figure S4B). However, the dual inactivation of exonuclease V and 
homologous recombination which represent the two branches of replication fork restart after 
fork reversal results in detectable lethality upon FicT toxin expression (recB as well as recDA 
mutant in Figure S4B). We therefore conclude that frequent replication fork arrest impairs 
chromosome replication during growth arrest by FicT toxins (De Septenville et al., 2012). 
Fork arrest is a main trigger of the SOS response, a cascade of genes whose expression is 
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induced upon DNA damage (Erill et al., 2007). We indeed detected an activation of the SOS 
response upon FicT toxin expression that varied between the different constructs from not 
significant (VbhT) to similarly strong as with gyrase poisons ciprofloxacin or CcdB 
(VbhT(fic) and PaFicT) in rough correlation with the extent of DNA gyrase inhibition, but not 
growth arrest (Figure S5A; compare Figures 3 and 1B). These results are in line with previous 
work that demonstrated an activation of the SOS response with gyramide A, an inhibitor of 
ATP hydrolysis of DNA gyrase but not topo IV (Rajendram et al., 2014). Though most 
factors encoded by SOS genes are more or less directly involved in DNA repair, the SulA 
protein expressed in response to strong SOS induction blocks cell division via the inhibition 
of septation (Huisman et al., 1984), thus buying overtime for DNA repair functions. 
Irreversible blocks of cell division via SOS activation and SulA were proposed to be involved 
in a number of toxicity phenomena like thymineless death (Fonville et al., 2010). Similarly, 
we find that – at the relatively low level of FicT activity that we used in this experimental 
system – the inability to launch the SOS response (in a lexA3 mutant) or the inactivation of 
sulA made the bacteria considerably more tolerant to FicT toxin expression than the control 
strain (Figure S4A). However, the contribution of the SOS response to growth inhibition is 
only minor at the higher levels of FicT activity that we generally used for phenotypic 
characterization (Figure S5B and S5C), suggesting that SulA-mediated growth inhibition is no 
necessary component of growth inhibition by FicT toxins. Furthermore, the SOS response 
was also not relevantly involved in the induction of persister formation upon the disruption of 
DNA topology by FicT toxins or novobiocin (Figure S5E-G). 
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Extended Experimental Procedures 
Escherichia coli handling and growth conditions. 
Escherichia coli was transformed with one or more plasmids using TSS transformation 
(Chung et al., 1989) and always handled in LB liquid or solid medium containing appropriate 
antibiotics as well as 1% w/v D-glucose to suppress basal expression of any construct prior to 
the inoculation of experimental cultures. Unless stated differently, experiments were 
performed with exponentially growing derivatives of E. coli K-12 harboring pNDM220 
derivatives (encoding FicT toxin constructs under Plac control) and, whenever indicated, 
pBAD33 derivatives (encoding FicA antitoxins) as well as occasional other plasmids. 
Repeatedly, derivatives of pAH160 (encoding enzymatic targets or mutants of FicT toxins 
under Prha control) were used. For the enumeration of colony forming units (c.f.u.) bacterial 
cultures were serially diluted and spotted on LB agar plates which were thereafter incubated 
at 37°C for up to several days before counting. Selection for different genotypes or plasmid 
maintenance was performed with ampicillin ad 30 µg/ml (pNDM220 and derivatives) or 100 
µg/ml (pGex-6p1 and derivatives), chloramphenicol ad 34 µg/ml, gentamicin ad 20 µg/ml, 
kanamycin ad 50 µg/ml, and tetracycline ad 12 µg/ml. 
 
Plasmid Construction 
Plasmids were constructed using standard procedures of restriction-based cloning or 
sequence- and ligation-independent cloning (SLIC) with enzymes obtained from New 
England Biolabs. For phenotypic analyses, toxin genes or ficAT modules were cloned into 
pNDM220 (Gotfredsen and Gerdes, 1998) under control of a particularly tight Plac (for 
pAH154 or pAH157 series, respectively) and antitoxin genes were cloned into pBAD33 under 
control of Para (for pAH153 series), resulting in a two-plasmid expression system as it was 
used previously for the analysis of toxin-antitoxin interactions (Jørgensen et al., 2009). 
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Experiments investigating the effect of target (over)expression on growth inhibition by FicT 
toxins used gyrB and parE of E. coli cloned into pBAD33 (pAH153 series) and pAH160 
backbones for Para or Prha control, respectively. For the analysis of complete FicTA 
modules the ficAT loci including approximately 300 bp of upstream (promoter) region were 
cloned into pBAD33 (pAH176 series) and their activation by antitoxin sequestration was 
investigated using the co-expression of catalytically inactive FicT_H/A mutants from 
pAH160. For biochemical analyses and protein purification, toxins and / or antitoxins were 
cloned into pRSFDuet-1 (Novagen) and target candidates as glutathione S-transferase (GST) 
fusions into pGex-6p-1 (GE Healthcare). 
The yeficA and paficA antitoxin genes were identified as ORFs encoded by nucleotides 
1’867’230-1’867’042 and 1’480’066-1’479’788 in the genomes of Yersinia enterocolitica str. 
8081 (NC_008800) and Pseudomonas aeruginosa PAO1 (NC_002516.2), respectively. 
YeFicT and PaFicT are proteins YP_001005954.1 and NP_250057.1. Point mutations and 
deletions were introduced via PCR into suitable template plasmids as described by Liu and 
Naismith (2008). Occasional sub-cloning of PCR products was performed using the 
StrataClone blunt PCR cloning kit (Agilent). Plasmid construction was always confirmed by 
DNA sequencing.  
 
Strain Construction 
E. coli strains used for phenotypic analyses were generated from E. coli str. K-12 substr. 
MG1655 and protein expression was performed in E. coli BL21 or derivatives. Strains were 
constructed using the method of Datsenko and Wanner (2000). For the deletion of ecficAT in 
E. coli K-12 MG1655 the original locus was amplified with prAH361/362, sub-cloned, and 
the deletion allele was produced via amplification with prAH359/360. Subsequent allelic 
replacement via a kanR / sacB cassette (amplified from pJM05 of MacKichan et al. (2008) 
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with prAH363/364) in the ecficAT locus resulted in strain AHE573 (E. coli str. K-12 substr. 
MG1655 ΔecficAT. The deletion allele was constructed in a way to not affect expression of 
downstream gene pabA by leaving the last 55bp of the ecficT gene. The lexA3 allele was 
moved via P1vir transduction from E. coli K996 (CGSC#: 7786) into AHE573 or, to yield a 
strain isogenic with the KEIO collection (Baba et al., 2006), into E. coli BW25113 (CGSC#: 
7636) with selection for the malE::tn10 marker close-by, resulting in AHE961 (E. coli K-12 
ΔecficAT lexA3 malE::tn10) and AHE963 (E. coli BW25113 lexA3 malE::tn10). The endA 
gene in AHE573 was replaced by the inactive endA* allele of BL21 (DE3) Gold (Agilent) to 
inactivate endonuclease I and improve the quality of isolated plasmids for high resolution 
agarose gel electrophoresis, resulting in AHE745 (E. coli K-12 ΔecficAT endA*). Primers 
were prAH351/352 to amplify endA or endA* and prAH366/367 for the locus-specific 
double-selectable cassette. The acrA gene in AHE745 was replaced with a gentamicin 
resistance cassette (amplified with prAH559/560 from pRS96 of Schulein et al. (2005)) to 
obtain a highly novobiocin-sensitive strain as it was used by Hardy and Cozzarelli (2003) 
(AHE938, E. coli K-12 ΔecficAT endA* acrA::genR). An SOS-deficient derivative of 
AHE938 was created by P1 transduction from E. coli K996 as described above, resulting in 
strain AHE1263 (E. coli K-12 ΔecficAT endA* acrA::genR lexA3 malE::tn10). For the 
construction of a chromosomal DNA relaxation sensor we first trimmed the promoter 
fragment of the pPgyrB::gfpmut2 vector of Zaslaver et al. (2006) down to the PgyrB promoter 
as listed by RegulonDB (Salgado et al., 2013) by site-directed mutagenesis with primers 
prAH909/910, creating plasmid pPgyrB::gfpmut2_v1. A cassette containing a kanamycin 
cassette as well as the PgyrB::gfpmut2 module was amplified from pPgyrB::gfpmut2_v1 
using primers prAH925/926 and integrated into the gapC locus of AHE938 using lambda Red 
recombineering, creating strain AHE1158 (E. coli K-12 ΔecficAT endA* acrA::genR 
gapC::PgyrB::gfpmut2_v1). A promoterless control was created analogously using plasmid 
pUA139 as the template for amplification, creating strain AHE1156 (E. coli K-12 ΔecficAT 
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endA* acrA::genR gapC::pUA139). The construction of all strains was confirmed by DNA 
sequencing. 
 
Toxicity tests 
Experiments were generally performed with E. coli K-12 MG1655 ΔecficAT (AHE573) and 
derivatives or, when indicated, single gene mutants of the KEIO collection (Baba et al., 2006). 
The growth of E. coli expressing FicT toxins was qualitatively assessed on LB agar plates 
inducing FicT toxin expression with 2000 µM of Isopropyl β-D-thiogalactopyranoside (IPTG) 
in presence or absence of 0.2% w/v L-arabinose to induce antitoxin expression. When 
indicated, gyrB and parE of E. coli where co-expressed from additional plasmids under Para 
control (low-copy pBAD33 derivatives) and Prha control (high-copy pAH160 derivatives). 
For growth curves, FicT toxin expression was induced at t = 0 with 2000 µM of IPTG and the 
change in c.f.u. (on LB agar plates containing 1% D-glucose) was quantified by normalization 
to the c.f.u. at t = 0. When appropriate, the c.f.u. counts on plates containing 0.2% L-
arabinose were enumerated in parallel. Differences in the susceptibility of various E. coli 
single gene mutants of the KEIO collection to growth inhibition by FicT toxins were assessed 
using the continuous expression of VbhT with 400 µM IPTG induction and the lamB mutant 
as an isogenic control. We chose this relatively low level of lac promoter induction and VbhT 
instead of YeFicT to avoid problems with saturating toxicity, leaky expression (especially in 
hypersensitive mutants), and an insufficient dynamic range to detect both increased and 
decreased susceptibility. The reversibility of FicT toxin expression by antitoxin induction 
upon plating on 0.2% L-arabinose with different E. coli mutants (Figure S4B) was tested after 
90 minutes of FicT toxin induction to reliably detect both VbhT and YeFicT toxicity (see 
Figure 1C). We induced the near-natural activation of complete ficAT loci on low-copy 
vectors (pAH176 series) via the co-expression of according FicT_H/A mutants from high-
218 
 
 Results – Research article III 
 
copy plasmids under Prha control (pAH160 derivatives). In this system, the pool of FicA 
antitoxin is sequestered by an excess of FicT_HA mutant which results in the activation of 
FicT toxins expressed from their natural promoter at the ficAT locus (see Figure 7A). Changes 
in c.f.u. / ml after one hour of FicT_H/A expression were quantified by plating on LB agar 
plates containing 1% D-glucose. 
 
Persister assays 
Generally, the proportion of persisters in exponentially growing cultures of E. coli was 
determined as the surviving fraction after lethal treatment with one of three different 
antibiotics (ciprofloxacin, kanamycin, or ampicillin). After drug challenge, the bacteria were 
washed extensively in sterile PBS, plated in serial dilutions on LB agar plates containing 1% 
D-glucose, and the c.f.u. counts were compared to those obtained with the same cultures 
before the addition of antibiotics.  
The effects of changes in DNA topology and FicT activity on the fraction of persisters were 
assayed by specific treatments of the exponentially growing cultures prior to antibiotic 
challenge. A disruption of DNA topology was assayed in E. coli AHE938 (novobiocin-
sensitive due to acrA genotype) in form of a pre-treatment with 200 µg/ml of novobiocin for 
one hour to inhibit both DNA gyrase and topo IV. Changes in the proportion of persisters 
caused by FicT activity were explored both by the expression of FicT toxins for two hours or 
the activation of complete ficAT loci by FicT_H/A overexpression for one hour in E. coli 
AHE573 (see above). In presence of pNDM220 and derivatives we added ampicillin in 
combination with 10 µg/ml clavulanate to inactivate the β-lactamase encoded on this vector 
(Vakulenko et al., 1998).  
 
Protein Expression and Purification 
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All VbhT constructs were generally expressed and purified as described previously (Engel, 
Goepfert et al., 2012). For purification, VbhT was expressed in form of truncated constructs 
devoid of the BID domain and always together with its VbhA antitoxin for technical reasons 
(Engel, Goepfert et al., 2012). The asterisk in VbhTA* indicates the presence of mutant 
VbhA(E24G) that is unable to inhibit the adenylylation activity of VbhT, resulting in a 
construct representing active VbhT.  
 
ATP hydrolysis assay 
GyrB43, an N-terminal fragment of E. coli GyrB containing the ATPase domain (Ali et al., 
1993), at a concentration of 50 μM was incubated with 1 mM ATP, 1 mM MgCl2, and 10 µM 
of purified VbhTA constructs or 200 µM of novobiocin for up to 120 minutes. At 0, 2, 10, 60 
and 120 minutes, an aliquot of each reaction was boiled for 5 minutes at 99°C and spun down 
at 16,000 g for 5 minutes to pellet the precipitated proteins. The supernatant composed of 
nucleotides was loaded on a Resource Q column (GE Healthcare) equilibrated with 5 mM 
ammonium bicarbonate pH 9.0. Nucleotides were eluted with a gradient of elution buffer 
containing 1 M ammonium bicarbonate pH 9.0. Samples were analyzed by FPLC and 
nucleotide peak areas were integrated using the Unicorn software (GE Healthcare). The 
ATPase activity of GyrB was visualized as the production of ADP over time. 
 
In vitro topoisomerase assays 
Supercoiling and decatenation activities of recombinant type IIA topoisomerases of E. coli 
(TopoGEN Inc.) were performed according to the supplier’s recommendations with one unit 
of enzyme per reaction and supplemented with novobiocin ad 5 µg/ml (to fully inhibit both 
topoisomerases) or 50 pmol of different purified constructs of VbhT(fic)A as indicated. 
Reactions were incubated for 30 minutes at 30°C and then 0.54 µg of relaxed pBR322 (DNA 
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gyrase / supercoiling assays) or kDNA (topo IV / decatenation assays) was added. After 
incubation at 37°C for one hour the reactions were stopped with Universal Stop Buffer and 
treated with proteinase K to resolve any potential DNA – protein linkages. The DNA was 
purified by chloroform – isoamyl alcohol extraction, resolved by electrophoresis in 1.1% 
agarose gels, stained with the GR Green Nucleic Acid Stain (Biolabo SA), and imaged at a 
Safe Imager (Invitrogen) equipped with an EOS 40D camera (Canon). Recombinant DNA 
gyrase and topo IV, DNA substrates, and 5x Universal Stop Buffer were obtained from 
TopoGEN Inc. (Columbus, Ohio). 
 
Flow cytometry with gfp promoter fusions 
GFP fluorescence (excited at 488 nm) and forward scatter of exponentially growing E. coli 
AHE938 (with plasmid reporters) or AHE1156 / AHE1158 (chromosomal reporters) were 
recorded with a FACSCalibur flow cytometer (Becton Dickinson) two hours after drug 
treatment or the induction of FicT toxin expression. Data of ca. 25’000 cells per sample were 
analyzed using the FlowJo software (Tree Star) to obtain mean GFP fluorescence and mean 
forward scatter values. Fluorescence values were corrected for background fluorescence at the 
given experimental condition (determined with E coli AHE938 harboring pUA139 or 
AHE1156). Subsequently, we removed distortions of apparent fluorescence caused by 
differences in cell size via normalization to the forward scatter because Renggli et al. (2013) 
recently demonstrated that the distortions of both values show a strong linear correlation. 
 
High-resolution agarose gel electrophoresis 
For the analysis of DNA supercoiling, topoisomers of our pAH160 plasmid reporter were 
separated in gels containing 1% of agarose (Eurogentec) and 12.5 µg/ml of chloroquine 
(AppliChem) at 1.5 V/cm in the dark. Gels were washed extensively in water to remove 
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chloroquine, stained with the GR Green Nucleic Acid Stain (Biolabo SA), and imaged at a 
Safe Imager (Invitrogen) equipped with an EOS 40D camera (Canon). As a control for DNA 
relaxation we treated reporter pAH160 with topoisomerase I (New England Biolabs) as 
suggested by the supplier. For the analysis of DNA catenation and knotting, plasmid 
supercoiling was removed by nicking with Nt.BbvCI (New England Biolabs) and topoisomers 
were resolved and visualized as described above without chloroquine. The presence of 
pNDM220 derivatives (size > 10’000 bp) in all samples did not impede analysis due to their 
low abundance and the huge size difference to pAH160 (4359 bp). 
 
Investigation of paficAT in Pseudomonas aeruginosa 
Pseudomonas aeruginosa PAO1 and derived strains were cultured on LB-Miller agar plates 
or in LB-Miller broth at 37°C. Derivatives of plasmid pHERDT30T (Para vector / selection 
with gentamicin ad 20 µg/ml, (Qiu et al., 2008)) and pME6032 (Plac vector / selection with 
tetracycline ad 125 µg/ml, (Heeb et al., 2002)) were used for the expression of paficT and 
paficA constructs, respectively (see Table S2). 
The paficAT module was deleted in P. aeruginosa PAO1 via allelic exchange with pPS16, a 
derivative of suicide plasmid pME3087 conferring tetracycline resistance (Voisard et al., 
2007). pPS16 was constructed to contain fused homology sites corresponding to the sequence 
extending 500bp upstream and downstream of the paficAT module. The suicide vector was 
mobilized to P. aeruginosa PAO1 via conjugation with selection for chromosomal integration 
using tetracycline ad 125 µg/ml. The second crossover to loop-out the plasmid was selected 
by the susceptibility of deletion mutants to bacteriostatic tetracycline (20 µg/ml) via the 
killing of fast-growing resistant cells with 2 mg/ml of carbenicillin. Surviving cells were 
screened for tetracycline sensitivity and the clean deletion of paficAT was confirmed by PCR, 
resulting in strain P. aeruginosa PDS4 (P. aeruginosa PAO1 ΔpaficAT). 
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For the microscopy experiment shown in Figure S6, exponentially growing cultures of 
P. aeruginosa PAO1 or PDS4 harboring plasmids for the expression of paficT and paficA 
constructs were induced with IPTG ad 1 mM or L-arabinose ad 0.2% w/v for 90 minutes. 
Subsequently, 10 µl of culture were stained with Hoechst 33342 (Invitrogen) and microscopy 
images were acquired using a Sony Cool-Snap HQ cooled CCD camera (Roper Scientific) 
attached to a Zeiss Axiovert 200 M microscope (Zeiss Ltd., Oberkochen, Germany). Image 
acquisition and analysis was performed using Metamorph (v6, Molecular Devices).  
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Figure S1 
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Figure S1. Comparison of FicA and FicT signature motifs of FicTA modules 
investigated in this study, Related to Figure 1 
Protein sequences of FicA and FicT homologs were aligned using ClustalW (implemented in 
Geneious v.7.0.5), manually curated, and the signature motifs were extracted for illustration. 
Shading of amino acids indicates the degree of conservation according to the Blosum62 score 
matrix. The sequence alignments show that only EcFicT largely diverges from the canonical 
HXFX(D/E)GNGRXXR motif of FicT proteins as defined by Engel, Goepfert et al. (2012) 
and that PaFicT contains a leucine instead of the final arginine of the Fic signature motif (see 
also Extended Results in the Supplemental Information). All four FicA homologs contain an 
(S/T)XXXE(G/N) motif with the inhibitory glutamate being a chemically similar aspartate in 
PaFicA. 
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Figure S2 
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Figure S2. VbhT adenylylates Tyr109 and Tyr105 of E. coli GyrB and ParE, 
respectively, Related to Figure 2 
Ion series and MS/MS spectra for detected adenylylated residues on GyrB (A, B) and ParE 
(C, D) are shown (see Experimental Procedures). The identified modified residue is marked 
in red. SEQUEST Xcorr search scores, peptide charge states and peptide sequence are shown 
in (B) and (D). 
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Figure S3 
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Figure S3. Lane plots of the nicked DNA agarose gel shown in Figure 4B, Related to 
Figure 4 
A lane plot was created for the left agarose gel shown in Figure 4B using ImageJ 
(http://rsbweb.nih.gov/ij/download.html). Two bands of monomeric, knotted pAH160 reporter 
plasmid (arrows) are clearly visible for VbhT, VbhT(fic), and YeFicT expression as well as 
upon treatment with 100 µg/ml novobiocin (inhibiting topo IV) but are absent in controls. 
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Figure S4 
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Figure S4. FicT expression impairs cellular DNA processing, Related to Figure 5 
(A) The differential susceptibility of various E. coli K-12 single gene mutants and an isogenic 
lexA3 strain harboring FicT toxin as well as FicA antitoxin vectors (to improve plasmid 
stability in hypersensitive strains via leaky expression) was quantified by forming the ratio of 
c.f.u. obtained on LB agar supplemented with 400 µM IPTG (to induce FicT expression) over 
those on LB agar without IPTG. We detect an increased sensitivity to VbhT expression in 
mutants defective for XerCD recombination (xerC / xerD) or topoisomerase III (topB) which 
can partially complement topo IV regarding decatenation  (Cox et al., 2000; Grainge et al., 
2007; Perez-Cheeks et al., 2012). Moreover, bacteria with defects in replication fork reversal, 
homologous recombination, and Holliday junction processing (recA, recB, ruvA, ruvC) are 
hypersensitive to VbhT expression, while the sole inactivation of recD, part of Exonuclease 
V, or recG, one of the factors that can drive replication fork reversal, did not have a clear 
effect. Conversely, the inability to induce the SOS response (lexA3) or suppress cell division 
following SOS induction (sulA) makes E. coli more tolerant under the conditions tested 
(p<0.05, unequal variance t-test). Data points are mean values of three independent 
experiments and s.d. is indicated by error bars. n.s. = not significant 
(B) The reversibility of FicT-mediated growth inhibition (see Figure 1C) was assayed in 
different E. coli mutants by induction of antitoxin expression on LB agar plates subsequent to 
FicT toxin expression in liquid culture. FicT-mediated growth inhibition is reversible in the 
lamB control and recA / recD / ruvC single mutants (log change of c.f.u. ≥ 0), while dual 
inactivation of exonuclease V as well as homologous recombination activities in recB or 
recDA mutants results in detectable lethality (values ≤ 0), indicative of replication fork 
reversal driving fork repair after blockade (De Septenville et al., 2012). Data bars represent 
mean values of three independent experiments and error bars denote s.e.m. 
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Figure S5 
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Figure S5. SOS induction upon topoisomerase inhibition by FicT toxins does not greatly 
contribute to growth inhibition or persister formation, Related to Figures 4, 6, and 7 
(A) The destabilization of replication fork progression is a main trigger of the SOS response 
and therefore potentially involved in phenotypes related to FicT activity (see Figure S4 and 
Extended Results in the Supplemental Information). We therefore probed the activation of the 
SOS response upon FicT expression using flow cytometry recording fluorescence from a 
plasmid-encoded PsulA::gfpmut2 module with a procedure identical to the detection of DNA 
relaxation via a PgyrB::gfpmut2 reporter (Figure 3B). The results show that FicT expression 
results in divergent induction of the SOS response that is qualitatively similar to the DNA 
gyrase inhibition achieved (Figure 3). While SOS induction with VbhT is not significant 
(n.s.), VbhT(fic) and PaFicT cause levels of GFP expression similar to those observed with 
gyrase poisons CcdB or ciprofloxacin (all p<0.05, unequal variance t-test). The expression of 
inactive toxin mutants (FicT_H/A or CcdB_G100E) had no effect. 
(B and C) We quantified the differential susceptibility of E. coli lexA3 and sulA mutants as 
well as the lamB control to FicT expression by forming the ratio of c.f.u. obtained on LB agar 
supplemented with different concentrations of IPTG (to induce FicT expression) over those 
on LB agar without IPTG. Both for VbhT (B) and YeFicT (C) the data show that the SOS 
response contributes to growth inhibition only at low levels of FicT expression and plays no 
role at 2000 µM of IPTG that we generally used for phenotypic characterization.  
(D, E, and F) The persister formation of a lexA3 derivative of AHE938 (D) or AHE573 (E, F) 
was quantified as described for the parental strains (Figure 6 and Figure 7C) and still revealed 
greatly increased fractions of persister cells upon novobiocin treatment or FicT toxin 
expression, showing that an inability to launch the SOS response does not greatly affect the 
phenotype. We note an unexpectedly increased tolerance of the AHE573 lexA3 vector control 
to ampicillin compared to the parental strain (see Figures 6B and 7C), but an identical effect 
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can also be seen in the data of Dörr et al. (2009) (figure 1, panel D) with the same 
concentration of ampicillin (100 µg/ml) and the same duration of drug challenge (3h).  
All data points are mean values of three independent experiments with error bars denoting s.d. 
Stars indicate p<0.05 (unequal variance t-test). 
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Figure S6. Activation of the paficAT module by antitoxin sequestration results in growth 
inhibition of its natural host Pseudomonas aeruginosa PAO1, Related to Figure 7 
Pseudomonas aeruginosa PAO1 wildtype (A, B, and D) or PDS4 (ΔpaficAT) (C) expressing 
different PaFicT constructs were imaged by phase microscopy. As expected, the expression of 
PaFicT in P. aeruginosa wildtype cells inhibited cell division (A, leading to cell chain 
formation), while the co-expression of PaFicA and PaFicT had no discernible phenotype (B). 
The expression of catalytically inactive PaFicT_H136Y did not induce growth inhibition in 
P. aeruginosa ΔpaficAT (D), but showed a phenotype similar to PaFicT expression in the 
wildtype strain. We therefore conclude that PaFicT_H136Y activates the endogenous paficAT 
module in P. aeruginosa by antitoxin sequestration. 
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Figure S7. Additional results on FicT toxin activation by antitoxin degradation in vivo, 
Related to Figure 7 
(A) The experiment of Figure 7D was repeated with yeficT instead of yeficAT expression. The 
data show that the lon mutant is not less susceptible to growth inhibition by FicT toxins than 
the other mutants. 
 (B and C) The experiment of Figure 7D was repeated with vbhAT(fic)(B) or paficAT (C) 
instead of yeficAT. No growth inhibition that would evidence toxin activation in vivo can be 
detected. 
 
 
  
239 
 
 Results – Research article III 
 
Supplemental References 
Adams, D.E., Shekhtman, E.M., Zechiedrich, E.L., Schmid, M.B., and Cozzarelli, N.R. 
(1992). The role of topoisomerase IV in partitioning bacterial replicons and the structure of 
catenated intermediates in DNA replication. Cell 71, 277-288. 
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K.A., Tomita, 
M., Wanner, B.L., and Mori, H. (2006). Construction of Escherichia coli K-12 in-frame, 
single-gene knockout mutants: the Keio collection. Mol Syst Biol 2, 2006 0008. 
Chong, S., Chen, C., Ge, H., and Xie, X.S. (2014). Mechanism of transcriptional bursting in 
bacteria. Cell 158, 314-326. 
Chung, C.T., Niemela, S.L., and Miller, R.H. (1989). One-step preparation of competent 
Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl 
Acad Sci USA 86, 2172-2175. 
Cox, M.M., Goodman, M.F., Kreuzer, K.N., Sherratt, D.J., Sandler, S.J., and Marians, K.J. 
(2000). The importance of repairing stalled replication forks. Nature 404, 37-41. 
Datsenko, K.A., and Wanner, B.L. (2000). One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640-6645. 
De Septenville, A.L., Duigou, S., Boubakri, H., and Michel, B. (2012). Replication fork 
reversal after replication-transcription collision. PLoS Genet 8, e1002622. 
Deibler, R.W., Mann, J.K., Sumners de, W.L., and Zechiedrich, L. (2007). Hin-mediated 
DNA knotting and recombining promote replicon dysfunction and mutation. BMC Mol Biol 
8, 44. 
240 
 
 Results – Research article III 
 
Deibler, R.W., Rahmati, S., and Zechiedrich, E.L. (2001). Topoisomerase IV, alone, unknots 
DNA in E. coli. Genes Dev 15, 748-761. 
Erill, I., Campoy, S., and Barbe, J. (2007). Aeons of distress: an evolutionary perspective on 
the bacterial SOS response. FEMS Microbiol Rev 31, 637-656. 
Fonville, N.C., Bates, D., Hastings, P.J., Hanawalt, P.C., and Rosenberg, S.M. (2010). Role of 
RecA and the SOS response in thymineless death in Escherichia coli. PLoS Genet 6, 
e1000865. 
Gotfredsen, M., and Gerdes, K. (1998). The Escherichia coli relBE genes belong to a new 
toxin-antitoxin gene family. Mol Microbiol 29, 1065-1076. 
Grainge, I., Bregu, M., Vazquez, M., Sivanathan, V., Ip, S.C., and Sherratt, D.J. (2007). 
Unlinking chromosome catenanes in vivo by site-specific recombination. EMBO J 26, 4228-
4238. 
Heeb, S., Blumer, C., and Haas, D. (2002). Regulatory RNA as Mediator in GacA/RsmA-
Dependent Global Control of Exoproduct Formation in Pseudomonas fluorescens CHA0. 
J Bacteriol 184, 1046-1056. 
Huisman, O., D'Ari, R., and Gottesman, S. (1984). Cell-division control in Escherichia coli: 
specific induction of the SOS function SfiA protein is sufficient to block septation. Proc Natl 
Acad Sci USA 81, 4490-4494. 
Jørgensen, M.G., Pandey, D.P., Jaskolska, M., and Gerdes, K. (2009). HicA of Escherichia 
coli defines a novel family of translation-independent mRNA interferases in bacteria and 
archaea. J Bacteriol 191, 1191-1199. 
241 
 
 Results – Research article III 
 
Liu, H., and Naismith, J.H. (2008). An efficient one-step site-directed deletion, insertion, 
single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol 8, 91. 
Lopez, V., Martinez-Robles, M.L., Hernandez, P., Krimer, D.B., and Schvartzman, J.B. 
(2012). Topo IV is the topoisomerase that knots and unknots sister duplexes during DNA 
replication. Nucleic Acids Res 40, 3563-3573. 
MacKichan, J.K., Gerns, H.L., Chen, Y.T., Zhang, P., and Koehler, J.E. (2008). A SacB 
mutagenesis strategy reveals that the Bartonella quintana variably expressed outer membrane 
proteins are required for bloodstream infection of the host. Infect Immun 76, 788-795. 
Perez-Cheeks, B.A., Lee, C., Hayama, R., and Marians, K.J. (2012). A role for topoisomerase 
III in Escherichia coli chromosome segregation. Mol Microbiol 86, 1007-1022. 
Qiu, D., Damron, F.H., Mima, T., Schweizer, H.P., and Yu, H.D. (2008). PBAD-Based Shuttle 
Vectors for Functional Analysis of Toxic and Highly Regulated Genes in Pseudomonas and 
Burkholderia spp. and Other Bacteria. Appl Environ Microbiol 74, 7422-7426. 
Rajendram, M., Hurley, K.A., Foss, M.H., Thornton, K.M., Moore, J.T., Shaw, J.T., and 
Weibel, D.B. (2014). Gyramides prevent bacterial growth by inhibiting DNA gyrase and 
altering chromosome topology. ACS Chem Biol 9, 1312-1319. 
Renggli, S., Keck, W., Jenal, U., and Ritz, D. (2013). Role of autofluorescence in flow 
cytometric analysis of Escherichia coli treated with bactericidal antibiotics. J Bacteriol 195, 
4067-4073. 
Salgado, H., Peralta-Gil, M., Gama-Castro, S., Santos-Zavaleta, A., Muniz-Rascado, L., 
Garcia-Sotelo, J.S., Weiss, V., Solano-Lira, H., Martinez-Flores, I., Medina-Rivera, A., et al. 
(2013). RegulonDB v8.0: omics data sets, evolutionary conservation, regulatory phrases, 
cross-validated gold standards and more. Nucleic Acids Res 41, D203-213. 
242 
 
 Results – Research article III 
 
Schulein, R., Guye, P., Rhomberg, T.A., Schmid, M.C., Schroder, G., Vergunst, A.C., Carena, 
I., and Dehio, C. (2005). A bipartite signal mediates the transfer of type IV secretion 
substrates of Bartonella henselae into human cells. Proc Natl Acad Sci USA 102, 856-861. 
Thomson, N.R., Howard, S., Wren, B.W., Holden, M.T., Crossman, L., Challis, G.L., 
Churcher, C., Mungall, K., Brooks, K., Chillingworth, T., et al. (2006). The complete genome 
sequence and comparative genome analysis of the high pathogenicity Yersinia enterocolitica 
strain 8081. PLoS Genet 2, e206. 
Utsumi, R., Nakamoto, Y., Kawamukai, M., Himeno, M., and Komano, T. (1982). 
Involvement of cyclic AMP and its receptor protein in filamentation of an Escherichia coli fic 
mutant. J Bacteriol 151, 807-812. 
Vakulenko, S.B., Geryk, B., Kotra, L.P., Mobashery, S., and Lerner, S.A. (1998). Selection 
and characterization of β-lactam-β-lactamase inactivator-resistant mutants following PCR 
mutagenesis of the TEM-1 β-lactamase gene. Antimicrob Agents Chemother 42, 1542-1548. 
Voisard, C., Bull, C.T., Keel, C., Laville, J., Maurhofer, M., Schnider, U., Défago, G., and 
Haas, D. (2007). Biocontrol of Root Diseases by Pseudomonas fluorescens CHA0: Current 
Concepts and Experimental Approaches. In Molecular Ecology of Rhizosphere 
Microorganisms (Wiley-VCH Verlag GmbH), pp. 67-89. 
Wigley, D.B. (2013). Bacterial DNA repair: recent insights into the mechanism of RecBCD, 
AddAB and AdnAB. Nat Rev Microbiol 11, 9-13. 
Witz, G., Dietler, G., and Stasiak, A. (2011). DNA knots and DNA supercoiling. Cell Cycle 
10, 1339-1340. 
Zechiedrich, E.L., and Cozzarelli, N.R. (1995). Roles of topoisomerase IV and DNA gyrase in 
DNA unlinking during replication in Escherichia coli. Genes Dev 9, 2859-2869. 
243 
 
 Results – Research article III 
 
Table S1. List of DNA oligonucleotides, Related to Experimental Procedures 
 only available digitally 
Table S2. List of plasmids, Related to Experimental Procedures 
 only available digitally 
244 
 
 Results – Unpublished results related to research article III 
245 
 
6.10. Unpublished results related to Research article III 
6.10.1. Towards the mechanism of type II topoisomerase inhibition upon adenylylation 
In our publication we demonstrated that adenylylation of the B subunits inhibits the signature 
activities of recombinant DNA gyrase and topo IV holoenzymes in vitro (Figure 2C of 
Research article III) and causes corresponding phenotypes in vivo (Figures 3 and 4 of 
Research article III). Using VbhT of B. schoenbuchensis as a model we identified the 
adenylylation sites as conserved Tyr109 (E. coli GyrB) or Tyr105 (E. coli ParE) in the ATP lid 
loop at the ATP binding site (Figure S2 of Research article III). In this context we showed that 
the ATPase activity of an N-terminal fragment of GyrB (“GyrB43”) comprising ATPase and 
transducer domains is inhibited upon adenylylation (Figure 2B of Research article III) which 
was sufficient to explain the inactivation of DNA gyrase and, by inference, topo IV. 
However, preliminary biochemical and structural analyses of Frédéric Stanger indicate that 
an abrogation of the ATPase activity may not be generalized as the mechanism of target 
inhibition by FicT toxins, suggesting that adenylylation of the ATP lid loop must interfere with 
topoisomerase functioning in additional ways (Frédéric Stanger, unpublished). The 
generation of reasonable hypotheses that could explain the precise mode of target inhibition 
is hampered by the lack of a consistent, molecular understanding of the type II 
topoisomerase cycle despite recent advances in the field214,215. Generally, it is “assumed that 
the central DNA strand-passage mechanism is common to gyrase and non-supercoiling type 
IIA enzymes”213 like topo IV, so that adenylylation may inactivate both targets in a similar 
way. It is the current model that ATP binding closes the N-gate between the ATPase 
domains and thereby encircles the T-segment inside the topoisomerase holoenzyme 
(Figure 10A). Subsequent ATP hydrolysis is likely coupled to strand passage, and the final 
ejection of ADP resets the enzyme. Previous studies showed that – despite its physical 
distance to the actual enzymatic center – the ATP lid loop is important for the catalytic 
function of DNA gyrase, probably via a role in the coupling of DNA remodeling and ATPase 
activities (see, e.g., the work of Lamour et al.263 and literature cited therein). It is therefore 
easily conceivable that the adenylylation of the ATP lid loop by FicT toxins could directly 
inhibit the catalytic activity of gyrase and topo IV, but the molecular mechanism remains 
enigmatic. 
Another interesting aspect is that the adenylylation by FicT toxins causes an inhibition of the 
catalytic activity of gyrase and topo IV without an inhibition of ATP binding (Frédéric Stanger, 
unpublished). Therefore, adenylylation could easily result in topoisomerase poisoning 
because the T-segment may pass through the N-gate and get trapped inside the 
holoenzyme. However, our findings do not support a locking of cleavable complexes on the 
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DNA, because the expression of VbhT (causing strong inhibition of topo IV, but not gyrase in 
vivoa) did not activate the SOS response as it would be expected for dsDNA break formation 
(Figure S5 in Research article III). Furthermore, we did not observe bacterial killing upon 
FicT toxin expression (see, e.g., Figures 1C and 5 in Research article III). It is interesting to 
note that YacG, a small proteic inhibitor of DNA gyrase, converts “the gyrase holoenzyme 
into an inactive, ATP-trapped configuration” similar to what our results indicate for 
adenylylated topoisomerases, but additionally prevents DNA binding by “sterically occluding 
the (…) DNA-binding site”252. These findings indicate that such a dual inhibition may be 
advantageous for a robust topoisomerase shut-off and urge to investigate whether 
adenylylation may also prevent DNA binding in some (likely indirect) way. 
In order to draw firm conclusions on the molecular basis of topoisomerase inhibition by 
adenylylation future studies should use full gyrase and topo IV holoenzymes and investigate 
the properties of modified and unmodified enzymes in vitro. Most importantly, it would be 
interesting to see whether adenylylation affects DNA binding and which step of the catalytic 
cycle precisely is inhibited. For this purpose one could additionally use fluorescence 
resonance energy transfer (FRET) experiments to study domain movements within the 
topoisomerases as it has been reported previously by Lanz and Klostermeier206 (see also the 
recent review by D. Klostermeier353). 
6.10.2. The EcFicTA module is not functionally related to other FicTA modules 
Several decades after the discovery of “filamentation induced by cAMP” the molecular basis 
of this phenotype and its causal connection to the fic-1 allele of ecficT have still remained 
enigmatic (see Introduction). In Research article III we had initially planned to show a number 
of basic experiments with the EcFicTA module of E. coli str. K-12 substr. MG1655 in order to 
demonstrate that it is not part of the FicTA family of toxin-antitoxin modules. However, we 
later decided to omit these data in the final version for reasons of clarity. 
                                                          
a The data particularly with VbhT are relevant at this point, because a (considerable) inhibition of DNA gyrase 
always activates the SOS response due to replication fork stalling (independent of topoisomerase poisoning; 
see Box 1 and also the considerations in the Extended Results in the Supplemental Information of Research 
article III). 
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Figure 18: EcFicTA phylogeny and active site conservation of EcFicT orthologs. A) The “tree browser” 
function of microbesonline (www.microbesonline.org) was used to visualize the genomic environment of ecficAT 
and homologous loci (centered on ecficT in yellow). It is clear that species more closely related to E. coli (upper 
half) encode modules homologous to ecficAT at loci that are highly syntenic, suggesting vertical transmission 
within Enterobacteriales. On the other hand, more distant homologs are encoded in diverse genomic 
environments, suggesting frequent horizontal gene transfer as it is typical for FicTA modules. B) The Fic signature 
motifs of EcFicT and different homologs shown in (A) were aligned using ClustalW implemented in Geneious 
v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM cost matrix. Coloring reflects amino acid similarity 
according to the cost matrix with black = 100% identity and white = <60% identity. A comparison of the sequences 
shows that the peculiar HxFxxGSGLxxR motif of EcFicT is conserved among relatives of E. coli (top), while 
homologs of more distantly related species display the canonical HxFxxGNGRxxR Fic signature motif (bottom). 
Note that Pantoea ananatis appears to encode a FicT-like protein with canonical active site motif in a locus 
syntenic with ecficAT loci of other Enterobacteriales (see (A)). 
 
EcFicTA is different from other FicTA modules like YeFicTA of PaFicTA in that it appears to 
be vertically transmitted in the Enterobacteriales (Figure 18A) while the FicTA modules 
typically show strong signs of horizontal gene transfer. Furthermore, the FIC domain active 
A
B
Escherichia coli str. K-12 substr. MG1655
Escherichia coli str. UTI89
Citrobacter rodentium str. ICC168
Enterobacter cancerogenus str. ATCC35316
Klebsiella variicola str. At-22
Escherichia coli albertii str. TW07627
Shigella flexneri 2a str. 2456T
Cronobacter turicensis str. z3032
Enterobacter cloacae str. ATCC13047
Pantoea ananatis str. LMG20103
Pseudomonas fluorescens str. Pf-5
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site motif of EcFicT deviates considerably from the canonical Fic signature sequence (see 
Figure S1 of Research article III and Figure 18B), suggesting that it may not be able to 
perform adenylylation. Consistently, I failed to detect any auto-adenylylation or target 
adenylylation activities of EcFicT (Figure 19A). The expression of EcFicT (and, similarly, of 
its fic-1 derivative) did not result in detectable growth inhibition of E. coli ΔecficAT which rules 
out that “filamentation induced by cAMP” could simply be caused by some kind of “activation” 
of EcFicT (Figure 19B). 
 
Figure 19: EcFicT does not display adenylylation activities or cause growth inhibition in E. coli. A) EcFicT, 
EcFicTA, or VbhT were expressed and tested for adenylylation in cleared lysates as described for full length VbhT 
in Research article III (Figure 2A). Different ecficT constructs were expressed from pPE0036 (ecficT in 
pRSFDuet-1) and pPE0038 (ecficT and ecficA in pRSFDuet-1) in BL21 (DE3) ΔecficAT do avoid crosstalk with 
the endogenous EcFicTA module. The autoradiograph shows the adenylylation activity of VbhT 
(auto-adenylylation at orange arrow, endogenous GyrB adenylylation at green arrow, and GST-GyrB or 
GST-ParE of E. coli at red arrows), while no signal is detected for EcFicT. Note that the diffuse band above 
25 kDa (close to the molecular weight of EcFicT) is often observed in adenylylation assays with bacterial lysates 
and does not point towards any activity of EcFicT. These results could be confirmed by Arnaud Goepfert using 
purified proteins (data not shown). B) The colony forming units (c.f.u.) of exponentially growing E. coli ΔecficAT 
expressing ecficT or its fic-1 derivative were monitored over time using an identical expression system and 
experimental procedure as it is described in Research article III (Figure 1B). No growth inhibition can be detected. 
Similarly, no effect of cAMP or 43°C on E. coli growth upon ecficT expression could be found (not shown). 
 
In conclusion, we did not find evidence pointing towards the (or any) biological function of the 
EcFicTA module. Future studies may approach this problem from the biochemical site and 
try to identify a molecular activity of EcFicT as a starting point for further analyses. In my 
opinion, it is important to approach EcFicTA with an unbiased view, because the biological 
function of this module may very well be unrelated to “filamentation induced by cAMP” (see 
in the Introduction section). In order to unravel the molecular basis of this enigmatic 
phenotype it would probably be necessary to use exactly the same strains that showed 
“filamentation induced by cAMP” in previous studies and to determine their genome 
sequences. By comparison to the parental wildtype one may be able to identify mutations 
that could be involved in growth inhibition together with fic-1 and help to resolve the cellular 
processes underlying the “fic” phenotype. 
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6.10.3. Another type of FicTA modules: Mobile Mystery Proteins 
During our work on the characterization of class I Fic proteins as toxins of the FicTA 
toxin-antitoxin module others have published studies on FicT homologs of Clostridium difficile 
and M. tuberculosis but did not add substantial novelties to the field354,355. We had also 
performed a number of experiments on FicT of M. tuberculosis but failed to detect any 
growth inhibition in E. coli, suggesting that this protein is unable to target E. coli GyrB and / 
or ParE (sufficiently) or that it has a different molecular function (data not shown). 
More relevantly, I uncovered that a subfamily of FicTA modules exists in which the antitoxins 
contain an additional helix-turn-helix (HTH) DNA binding domain. These proteins are found in 
the databases under the term “mobile mystery proteins” with the FicT homologs being 
“mobile mystery protein B” (InterPro family IPR013436) and the antitoxins being “mobile 
mystery protein A” (InterPro family IPR013435). There are around 100 different mobile 
mystery FicTA modules listed in the InterPro database, and their description concludes that 
these are “more often encoded within mobilisation-related contexts than not” and “always 
found together” in the classical genetic arrangement of ficAT loci (last accessed on 
November 11th, 2014). A comparative sequence analysis of all available FicT homologs of 
this family (“mobile mystery protein B”) revealed that they consistently contain a canonical 
Fic signature motif, suggesting adenylylation as their molecular function (see Figure 20). The 
antitoxins (“mobile mystery protein A”) cannot be reasonably aligned with classical FicA 
homologs and are much longer (typically around 150 aa compared to around 60 aa of FicA) 
due to their N-terminal HTH domain. In their C-terminal domain that supposedly acts to 
inhibit their cognate toxins I detected a conspicuous (S/T/N/H)MxLExQ motif with a 
universally conserved glutamate (Figure 20), indicating that they may regulate the toxins’ 
activity by active site obstruction similar to FicA antitoxins (see Research article I). 
 
Figure 20: Domain architecture and signature motifs of mobile mystery proteins. The approximately 100 
representatives of mobile mystery protein A and B families were each aligned using ClustalW implemented in 
Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM cost matrix. For illustration, the 
sequence logos of the FicT signature motif (right) and a bona fide FicA-like inhibition motif (left) were extracted. It 
seems likely that mobile mystery B proteins act as FicT toxins via target adenylylation, while mobile mystery A 
proteins possibly inhibit their cognate toxins by active site obstruction with αinh. 
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The presence of a HTH domain in the antitoxins of “mobile mystery” FicTA modules is a clear 
indication of transcriptional autoregulation via conditional cooperativity (see Box 2). It would 
therefore be interesting to see if also the classical FicTA modules investigated in Research 
article III exhibit such an autoregulation (either directly or indirectly, e.g., by influences of 
DNA topology), particularly because conditional cooperativity is instrumental for efficient 
recovery from the persister state into bacterial growth6 (see also Box 2). Such experiments 
could easily be done, e.g., with gfp promoter fusions of ficAT modules and different 
combinations of antitoxins, toxins, or other stimuli. Furthermore, it would be interesting to 
investigate how mobile mystery A antitoxins bind and inhibit their cognate mobile mystery B 
toxins, i.e., if they really act via active site obstruction (see Figure 20) or via a different 
mechanism.  
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6.11. Research article IV (in preparation) 
 
 
 
 
 
 
 
“As soon as you go into any biological process in any real detail, you discover 
it’s open-ended in terms of what needs to be found out about it.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Joshua Lederberg, American geneticist and Nobel laureate, unsourced yet frequently attributed 
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Summary 
Fic proteins were previously shown to inhibit bacterial growth by target protein adenylylation 
which is controlled by a conserved mechanism of active site obstruction via a glutamate 
finger located at the tip of an inhibitory α-helix (αinh; see Research article I). This inhibition 
was found to be relieved for some Fic proteins by the extrinsic proteolysis of a separate 
αinh-containing polypeptide (Research article III). However, other Fic proteins like our model 
NmFicT of Neisseria meningitidis harbor the cognate αinh at their own C-terminus and were 
therefore likely to be controlled by different molecular mechanisms. 
In this research article we proposed that the adenylylation activity of NmFicT is regulated by 
a two-level control system that, upon signaling input, first unchains NmFicT from its storage 
in an inactive tetrameric form and then activates the monomers by auto-adenylylation. 
NmFicT activation causes bacterial growth inhibition via the inhibition of DNA gyrase. 
Different crystal structures of NmFicT had consistently been obtained in a tetrameric form 
that comprised of “dimer of dimers” in which the four subunits made contact via two different 
interfaces on each monomer. Using size exclusion chromatography coupled to multi-angle 
laser light scattering (SEC-MALLS) we confirmed that NmFicT forms tetramers in solution. 
Structural studies revealed that these tetramers are catalytically inactive due to αinh-mediated 
active site obstruction and because the active site as well as the β-hairpin flap are buried 
inside the complex. We therefore reasoned that oligomerization may be involved in the 
regulation of NmFicT and created mutants unable to oligomerize via either each one or both 
of the contact interfaces of the tetramer, thus primarily forming the two different dimers or 
monomeric NmFicT in solution. Further structural studies showed that the remaining subunit 
interface of each of the single-contact mutants was virtually identical to the same interface in 
the tetramer. The dissociation constants of oligomerization via either of the interfaces were 
found to be the same for a given interface in the dimer and the tetramer, indicating that there 
is no cooperativity in NmFicT oligomerization. Furthermore, we found that monomeric and 
tetrameric forms of wildtype NmFicT predominated in solution and were favored at low and 
high concentrations of the protein, respectively. 
Mutationally activated NmFicT had previously been shown to cause bacterial growth 
inhibition and to adenylylate an unknown protein in E. coli lysates (Research article I). In this 
article we identified the target of NmFicT adenylylation as GyrB, the B subunit of DNA 
gyrase, while its paralog ParE was not targeted. We had previously demonstrated that VbhT, 
a Fic protein only distantly related to NmFicT, adenylylates GyrB (but also ParE) at the same 
residue as NmFicT and that this adenylylation causes target inactivation (Research 
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article III). Consistently, activated NmFicT was able to collapse the supercoiling of the 
cellular DNA in E. coli which is likely the underlying cause of the growth inhibition. 
Interestingly, both growth inhibition and GyrB adenylylation were also observed with 
oligomerization-deficient mutants of NmFicT, but not the wildtype protein, which confirmed 
that the oligomerization of NmFicT is involved in its regulation. Furthermore, any mutational 
activation of NmFicT correlated with strongly increased auto-adenylylation which we had 
previously mapped to two tyrosines in the αinh. Given that one of these was known to be 
positioned towards the inside of the Fic core in wildtype NmFicT, we reasoned that 
auto-adenylylation must involve conformational changes of the protein. The investigation of 
such effects by nuclear magnetic resonance (NMR) spectroscopy confirmed that 
auto-adenylylation caused movements of the αinh as well as a neighboring helix and the 
β-hairpin flap. We therefore concluded that the auto-adenylylation of NmFicT relieves its 
active-site obstruction by repulsing the αinh from the Fic core. Furthermore, we wondered 
whether this regulation was connected to the oligomerization that we had identified as 
another level of NmFicT regulation. Our experiments showed that the mutational abrogation 
of auto-adenylylation abolished growth inhibition by the activated NmFicT_E/G mutant in 
which the glutamate finger of αinh was absent. These results proved a connection between 
the two layers of regulation of NmFicT. Consistently, the E/G mutation impaired the 
tetramerization of NmFicT, while an abrogation of auto-adenylylation favored oligomerization. 
We therefore concluded that NmFicT may be controlled by a double-lock mechanism in 
which the protein is stored in an inactive form as a tetramer from which unknown stimuli 
could liberate the NmFicT monomers. These would then amplify their initially weak catalytic 
activity by intermolecular auto-adenylylation in order to alleviate αinh-mediated active site 
obstruction and achieve robust inactivation of cellular DNA gyrase. 
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Abstract 
Fic proteins containing the HxFx[D/E]GNGRxxR motif catalyze adenylylation, the transfer of 
an AMP moiety from ATP onto target proteins. This activity has severe consequences on the 
cellular stability and thus has to be tightly controlled. Expression of the class III Fic protein 
NmFic of Neisseria meningitidis in Escherichia coli causes a severe growth defect. Recently, 
it has been shown that adenylylation-competent Fic proteins are specifically inhibited by an 
α-helix (αinh), which can be found at different locations relative to the Fic active site. Mutation 
of the conserved glutamate of the inhibitory motif relieves the inhibition of Fic proteins. Yet, it 
has remained unclear how intrinsic and extrinsic factors contribute to the control of Fic 
protein activation.  
Here, we report the structural and functional characterization of a Fic protein and its 
activation mechanism. We find that NmFic undergoes a monomer–tetramer equilibrium. Both 
the target binding site and the active site are located towards the center of this tetramer and 
are accessible only in the monomeric form. Consequently, mutation of crucial residues at the 
interfaces disrupts the tetramer formation and activates the protein. Furthermore, we show 
that trans-auto-adenylylation of NmFic leads to significant conformational changes and that 
the presence of the auto-adenylylated tyrosine Y183, part of the αinh helix, is required for the 
activity of the Class III Fic protein. We also show that adenylylation of the bacterial target 
GyrB from the DNA gyrase complex by NmFic blocks the negative supercoiling and bacterial 
cell division.  
Overall, these data provide the first intrinsic regulatory mechanism of a Fic protein via 
oligomerization and auto-adenylylation.  
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Introduction 
Fic proteins containing FIC domains (pfam 02661) are found in all kingdoms of life as well as 
in viruses. They have originally been described to be involved in filamentation induced by 
cAMP (1), but until recently, their molecular role had remained elusive. Yarbrough et al. (2) 
deciphered the catalytic activity of the Type III effector protein VopS from Vibrio 
parahaemolyticus as adenylylation of the host cell Rho GTPases, resulting in collapse of the 
actin cytoskeleton and subsequent cell death. Enzymatically, Fic proteins containing the 
canonical HxFx[D/E]GNGRxxR motif catalyze adenylylation (or AMPylation), the covalent 
transfer of an AMP moiety from an ATP substrate onto a target protein (3, 4).  
Fic proteins with an active site deriving from this consensus sequence likely catalyze other 
post-translational modifications. AnkX from Legionella pneumophila harbouring an 
HxFxDANGRxxV motif has been shown to catalyze the phosphocholination of the small 
GTPase Rab1 (5, 6). Doc of bacteriophage P1, a protein related to the Fic family proteins, 
contains the HxFxDANKRxxL active site motif, conferring a kinase activity and the 
phosphorylation of the translation elongation factor EF-Tu (7, 8). 
The crystal structures of several FIC domain proteins have been determined (3, 9-12). 
Fic/Doc proteins contain a conserved central core of four helices that is flanked by additional 
Fic elements found in different positions (13). A loop joining the third and fourth helix of the 
Fic core forms the Fic active site motif. The complex structure of the Fic protein from 
Histophilus somni (IbpA) with its cognate target (Cdc42) reveals the stabilization of the 
modified residue by the β-hairpin region of the Fic protein, thus making the FLAP (or 
β-hairpin) a critical region of the Fic protein for target binding. The catalytic mechanism of 
Fic-mediated adenylylation has been inferred from this structure, where the catalytic histidine 
of the active site motif acts as a general base and deprotonates the attacking hydroxyl group, 
which in turn performs a nucleophilic attack on the α-phosphate of the ATP substrate. This 
results in the formation of a covalent phosphodiester bond between the AMP moiety and the 
modified amino acid. 
The activity of Fic proteins is tightly regulated. A conserved inhibition motif, part of an 
inhibitory alpha-helix (αinh), is located in the close vicinity of the active site (3). It has been 
demonstrated that the strictly conserved glutamate of this motif plays a key role in 
obstructing the γ-phosphate position of the ATP substrate, therefore inhibiting competent 
substrate binding in adenylylating Fic proteins. Interestingly, this inhibition motif is either 
found on a separate small protein that forms a tight complex with the Fic protein, or at the N-
terminus or C-terminus compared to the Fic active site within the same polypeptide chain (3, 
12). These three possibilities lead to a classification of Fic proteins into class I, II and III, 
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respectively (3, 12). The mutation of this glutamate residue to glycine relieves the inhibition 
of Fic proteins, thus increasing the adenylylation activity (3, 12).  
Yet, the intrinsic or extrinsic factors that affect the conformation of this inhibitory α-helix and 
therefore the catalytic activity have not been investigated. This regulation may depend on 
additional domains found in multi-domain Fic proteins or localization of Fic proteins fused to 
a signal sequence. For the single domain class III Fic proteins, scattered through all classes 
of proteobacteria likely due to horizontal gene transfer, the regulation mechanism is most 
probably inherent. Interestingly, the class III Fic protein NmFic from Neisseria meningitidis 
(N. meningitidis) is auto-adenylylated on two tyrosine residues, Y183 and Y188, located in 
the vicinity of the inhibition motif (3). The strictly conserved tyrosine Y183 is buried, pointing 
towards the Fic core. Modeling of auto-adenylylation of this residue results in steric clashes, 
suggesting a conformational change upon auto-adenylylation. 
Recently, it has been shown that Fic proteins also target bacterial proteins (3) which results 
in bacterial growth arrest. ParE of the topoIV complex and GyrB of the DNA gyrase complex 
are adenylylated by the Class I Fic protein VbhT from Bartonella schoenbuchensis (Harms et 
al., in preparation).  
We here show that the class III Fic protein NmFic, containing the αinh helix at the C-terminus, 
specifically adenylylates GyrB, resulting in growth arrest. We report the structure-function 
characterization of the regulation mechanism of the class III Fic protein NmFic via a new 
double-lock mechanism. Interestingly, NmFic forms a tetramer with the active site and target 
binding-site buried in the center of the tetramer, inaccessible for target binding. NmFic 
undergoes a monomer-tetramer equilibrium where the active and target binding sites are 
accessible in the monomeric form. Disruption of the tetramer by repellant mutations results in 
bacterial growth arrest by activation of the Fic protein. Ultimately, we show that auto-
adenylylation of the conserved tyrosine Y183 leads to drastic conformational changes, e.g. of 
the αinh helix, that are crucial for the class III Fic protein activity. We anticipate that this 
double-lock mechanism by oligomerization and auto-adenylylation is conserved through all 
class III Fic proteins.  
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Material and Methods 
Plasmid construction 
pRSF-Duet1 derivatives were cloned as described previously (3) and used for over-
expression of proteins for purification. For phenotypic analyses, nmfic genes were cloned 
into pNMD220 (14) under the control of a particularly tight Plac. Site-directed mutagenesis 
was performed following the protocol described by Zheng et al. (15). A list of used plasmids 
and respective oligonucleotides can be found in Table S1 and Table S2.  
Expression – Isotope labeling – Purification 
Plasmids pFVS0015, pFVS0051, pFVS0083, pFVS0109, pFVS0135, pFVS0137, pFVS0138, 
pFVS0143 were transformed into E. coli BL21 (λDE3) cells. Plasmids pFVS0059, pFVS0125, 
pFVS0126 and pFVS0134 were transformed into E. coli BL21 AI cells. NmFic and GyrB43 
(residues 1-392) proteins were expressed and purified as described previously in (3) or (16), 
respectively. For NMR analysis, [U-13C,15N]-labeled NmFic was obtained by growing the 
expression cells in M9 minimal media (17) supplemented with (15NH4)Cl (Cambridge Isotope 
Labs) and D-[13C]-glucose (Sigma Aldrich) using standard NmFic expression and purification 
conditions. 
SEC-MALLS analysis 
Size exclusion chromatography coupled to multi-angle laser light scattering (SEC-MALLS) 
was employed for the determination of the oligomeric state and elution concentration of 
NmFic wild-type and various mutants at different concentrations. SEC-MALLS analysis was 
performed as described previously (18). The column was equilibrated in 10 mM Tris pH 7.6 
and 100 mM NaCl at 4°C.  
SEC-MALLS derived apparent mass values (MWapp) for NmFicwt, NmFicE102R (mutant 1) and 
NmFicE156R (mutant 2) measured in a range of various elution concentrations were fitted 
simultaneously to obtain the dimerization affinities (KD1 and KD2), assuming that both 
interaction interfaces are independent. Therefore, NmFicE102R and NmFicE156R are assumed 
to form only dimers, as one of the interfaces was mutated, and NmFicwt is in monomer-
tetramer equilibrium, which involves both interfaces. The equilibria were modeled as fast-
exchange processes with respect to the timescale of chromatographic separation, since all 
the samples yielded a single MALLS peak. The theoretical MWapp values were calculated 
from mass concentrations (cm,i) and molecular weights (MWi) of populated species (monomer 
and dimer for the interface mutants; monomer, dimers, trimer and tetramer for the other 
NmFic variants): 
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𝑀𝑀𝑀𝑀𝑎𝑎𝑎𝑎𝑎𝑎 = ∑ 𝑐𝑐𝑚𝑚,𝑖𝑖𝑀𝑀𝑀𝑀𝑖𝑖𝑖𝑖
∑ 𝑐𝑐𝑚𝑚,𝑖𝑖𝑖𝑖        (1) 
The global non-linear least-squares fitting was performed using Levenberg-Marquardt 
algorithm (19, 20). All routines were implemented in the Python language using NumPy and 
SciPy numerical libraries (21). 
Monomer-tetramer equilibrium analysis 
The equilibrium concentrations of individual species for NmFicwt were calculated using 
numerical solution of the set of mass action law equations (22) describing the monomer-
tetramer oligomerization scheme (Fig. S3). The reaction extents were used as state variables 
and inequality constraints were imposed to ensure the correctness of the results. 
Optimization of reaction extents values was accomplished using Sequential Least SQuares 
Programming (SLSQP) method (23) as implemented in the SciPy library (21). 
Spotting experiment 
Escherichia coli K-12 MG1655 were transformed with pNDM220 derivative plasmids using 
TSS transformation (24) and handled in LB liquid medium containing appropriate antibiotics 
as well as 1% (w/v) D-glucose to suppress basal expression before the inoculation of 
experimental cultures. For the counting of colony forming units (CFU/mL), bacterial cultures 
were serially diluted and spotted on LB agar plates containing 0, 50 µM, 100 µM, 250 µM, 
500 µM, 1000 µM or 2000 µM of isopropyl β-D-thiogalactopyranoside (IPTG) and 30 µg/mL 
ampicillin which were then incubated at 37°C.  
In vitro adenylylation assay 
Adenylylation assays were performed using crude cell lysate of ectopically expressing E. coli 
as described previously (3) or using purified proteins as described in (12). Adenylylation 
activity of NmFic was assessed by incubating 5 µM NmFic protein with 10 µCi [α-32P]-ATP 
(Hartmann analytic) and 25 µM GyrB43. In addition to radioactively labeled ATP, 62.5 µM of 
cold ATP was added and 200 µM of novobiocin, a potent inhibitor of GyrB43 to prevent 
immediate hydrolysis of ATP by GyrB43. 
In vivo Supercoiling assay 
In vivo supercoiling assays were performed as described previously (Harms et al., in 
preparation). 
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NMR spectroscopy 
NMR experiments were performed on a Bruker AscendII 700 MHz spectrometer running 
Topspin 3.0 and equipped with a cryogenically cooled triple-resonance probe. All 
experiments were performed in NMR-buffer (25 mM MES, 150 mM NaCl, pH 6.5) at 25°C. 
For the sequence-specific backbone resonance assignments of NmFic and adenylylated-
NmFic, the following experiments were recorded: 2D 15N-1H TROSY-HSQC (25), 3D HNCA 
(26, 27), 3D HNCACB (26-28), 3D HNCO (29), and 3D HN(CA)CO (30). For the analysis of 
the dynamic properties of NmFic and adenylylated-NmFic the following experiments were 
measured: 15N{1H}-NOE (31), T1(15N) (32), TRACT (33). NMR data were processed with 
PROSA (34) and analyzed with CARA, XEASY (35), and Topspin3.0 (Bruker Biospin). 
Nonlinear least-square fits of relaxation data were done with Matlab (MathWorks). R2(15N) 
values were derived from Rα(15N) and Rβ(15N). Error bars for R1(15N), Rα(15N), and Rβ(15N) 
were calculated by a statistical bootstrapping scheme and error bars for the 15N{1H}-NOE 
from the spectral noise. Secondary chemical shifts were calculated relative to the random-
coil values of Kjaergaard and Poulsen (36). 
The chemical shift changes of the amide moiety upon ATP were fitted by non-linear 
regression analysis to Equation 2 by using standard software. ∆obs corresponds to the 
chemical shift difference at a given titration point and ∆max is the maximal chemical shift 
difference at the last titration point. 
∆𝑜𝑜𝑜𝑜𝑜𝑜= ∆𝑚𝑚𝑎𝑎𝑚𝑚 (𝐾𝐾𝐷𝐷 +  [𝐴𝐴𝐴𝐴𝐴𝐴]0 + [𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑐𝑐]0) − �(𝐾𝐾𝐷𝐷 + [𝐴𝐴𝐴𝐴𝐴𝐴]0 + [𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑐𝑐]0)2 − (4[𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑐𝑐]0[𝐴𝐴𝐴𝐴𝐴𝐴]0) 2[𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑐𝑐]0        (2) 
Crystallization 
NmFicE156R and NmFicE156R,Y183F (10 and 8 mg/mL, respectively) crystallized in 500 µL of 
precipitant solution containing 10 mM Tris pH 7.8 and 100 mM NaCl using the batch 
crystallization method at 4°C. 
All other crystals were obtained using the sitting-drop vapor-diffusion method by mixing 
0.2 µL protein solution with 0.2 µL reservoir solution equilibrating against a reservoir of 80 µL 
at 20°C except NmFicwt (tetramer form) that crystallized in 7% (v/v) 2-propanol, 0.1 M MES 
pH 6.0, 0.05 M calcium acetate at 4°C. NmFicE102R crystallized after one month in 8% (v/v) 
Tacsimate pH 6.0, 20% (w/v) PEG 3350 and NmFicE102R,E156R crystallized after ten days in 
8% (v/v) Tacsimate pH 5.0, 30% (w/v) PEG 1500. NmFicY183F,E186G crystallized in 0.1 M Tris 
pH 8.0, 30% (w/v) Jeffamine M-600 pH 7.0. For data collection, crystals were cryoprotected 
by soaking into a reservoir solution supplemented with 15-30% glycerol and subsequently 
flash-frozen in liquid nitrogen.  
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Structure determination 
X-ray data were collected at the Swiss Light Source (Villigen, Switzerland) on beamline 
X06SA (PXI) or X06DA (PXIII) at 100 K and a wavelength of 1.000 Å or 0.800 Å (Table 1). 
Diffraction data were indexed and integrated using iMosflm (37) or XDS (38) and 
subsequently merged and scaled using XSCALE (38) or aimless (39). NmFicwt diffracted to 
3.10 Å. NmFicE156R, NmFicE102R and NmFicE102R,E156R diffracted to 0.99 Å, 2.35 Å and 1.90 Å, 
respectively. NmFicY183F,E186G and NmFicE156R,Y183F respectively diffracted to 2.20 Å and 
1.00 Å. Data collection and processing statistics are summarized in Table 1. Structures were 
determined by molecular replacement using Phaser (40) with NmFicwt (PDB: 3S6A (3)), 
devoid from ligand or ordered solvent, as search model. Several rounds of model building 
and refinement were performed using Coot (41) and Refmac5 (42) or phenix.refine (43). 5% 
of the data were excluded from refinement and used for cross-validation. The geometry of 
the final model was assessed using MolProbity (44) showing > 99% of the residues in the 
core and allowed regions of the Ramachandran plot. Final refinement yielded NmFic models 
with reasonable Rwork/Rfree values for their respective resolution ranges (45). Refinement 
statistics are summarized in Table 2. 
Figures were prepared with Dino (A. Philippsen unpublished, http://www.dino3d.org). 
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Results 
NmFic undergoes a monomer–tetramer equilibrium 
Crystals of NmFicwt grown at high protein concentration belong to the space group P65 and 
contain four molecules per asymmetric unit. These four molecules form a non-
crystallographic 222 tetramer that contains two equivalent dimers (Fig. 1 (a,b) and Fig. S1 
(b)). The same tetramer form is observed for NmFic∆8, a deletion mutant of the αinh helix (α8) 
that had been previously determined from non-isomorphous crystals (3). Isologous contacts 
are observed at the interfaces of NmFicwt between subunits A-B, C-D and A-D, B-C, 
respectively (Fig. 1). The first interface (buried surface area of 420.3 +/- 1.1 Å2) forms 
hydrophobic interactions and two symmetrical salt-bridges between residues R149 and E156 
of two neighboring monomers (Fig. 1 (d)). The second interface (826.1 +/- 11.3 Å2) forms the 
same type of interactions, with salt-bridges between residues R71 and E102 (Fig. 1 (c)). The 
residues involved in these interfaces are conserved in class III Fic proteins as shown by the 
multiple sequence alignment (Fig. S2). Consequently, analysis of the oligomeric state of 
NmFicwt in solution revealed the presence of multimeric forms in a concentration dependent 
manner Fig. S1 (a)). Size exclusion chromatography coupled to multi-angle laser light 
scattering (SEC-MALLS) was performed, revealing a single peak that varies in elution 
volume and apparent molar mass (from 22 kDa to 88 kDa) with varying total protein 
concentration. This shows that the protein is in a monomer–tetramer equilibrium in fast 
exchange with respect to the timescale of chromatographic separation (Fig. 2 (a)).  
The Fic active site is located in the center of the tetramer and the β-hairpin forming the 
target-binding site (FLAP) is deeply buried (Fig. 1 (a,b,e), yellow and light blue, respectively). 
Modeling of the binding of a small target fragment based on the superimposition of the 
IbpA/Cdc42 complex structure (PDB: 4ITR (10)) on the FLAP region of NmFic reveals 
several steric clashes (depicted by stars on Fig. 1 (e)). It is therefore well conceivable that 
NmFic in this tetrameric form is incompetent for target binding and that a lower oligomeric 
state, i.e. monomer or dimer, is the active species. 
To test this hypothesis, we engineered variants of NmFic carrying single amino acid 
mutations (glutamic acid to arginine) of the salt-bridges formed at both dimerization 
interfaces, NmFicE102R and NmFicE156R. The crystallographic structures of NmFicE102R and 
NmFicE156R were determined (Tables 1-2). These structures reveal that the dimerization 
interfaces are maintained as in the tetrameric wild-type protein (Fig. 3). The interface areas 
for NmFicE102R and NmFicE156R are 418.6 Å2 and 779.4 Å2, respectively, and thus virtually 
identical to the tetramer (420.3 ± 1.1 Å2 and 826.1 ± 11.3 Å2, respectively). Residue E102 is 
involved in a salt-bridge with E71 of the FLAP in the wild-type protein and the mutation 
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NmFicE102R leads to an increase in flexibility of the FLAP region as evidenced by the lack of 
electron density for residues 62–77. The high-resolution structure (0.99 Å) of NmFicE156R 
reveals the exact same dimer as observed within the tetrameric crystal form (RMSD of 0.989 
Å for Cα atoms).  
The multimerization equilibrium of these two proteins, as well as the double mutant, was 
assessed by SEC-MALLS. As expected, these mutants do not form a tetrameric species, but 
undergo a monomer–dimer equilibrium (22 kDa – 44 kDa) via the remaining interface (Fig. 2 
(a)). The combination of both mutations in NmFicE102R,E156R reveals a constant mass of 22 
kDa (monomer) at various protein concentration (Fig. 2 (a)). From these data, the 
dimerization constants (Kd) for NmFicE102R (mutant 1) and NmFicE156R (mutant 2) were 
determined to Kd1 = 7.4 ± 1.4 µM and Kd2 = 59.9 ± 11.8 µM, respectively. Note that the 
smaller dimerization interface features the higher affinity. The independent global fitting of 
the monomer–dimer–tetramer equilibrium of the wild-type protein yielded 7.6 ± 1.1 µM and 
61.3 ± 8.8 µM for KD1 and KD2, respectively (Fig. S3, Fig. 2 (a) and Table 3). These values 
are virtually identical in the precision of the experiment, indicating directly that the two 
interfaces are not connected by cooperativity. Based on the dissociation constants, the 
concentration-dependences of monomeric, dimeric, trimeric and tetrameric species of 
NmFicwt were calculated (Fig. 2 (b)). At total NmFic concentrations below 2 µM, NmFic is 
mostly present as monomers, whereas above this threshold, tetrameric species populate. 
Importantly, since most protein is sequestered as tetramers, the monomer concentration 
reaches a value of just 5 µM at a total NmFic concentration of 1 mM (Fig. 2 (b)). In contrast, 
the monomer concentrations in the Fic mutants are much larger, with 60 µM and 150 µM for 
mutant 1 (NmFicE102R) and mutant 2 (NmFicE156R) respectively at 1 mM total concentration 
(Fig. 2 (c) and S4). As monomer and tetramer are the predominant species, the monomer-
tetramer equilibrium of NmFicwt can also be fitted with a single effective dissociation constant 
KDef of 21.8 ± 1.0 µM (Table 3). 
NmFic targets GyrB of the DNA gyrase complex 
As the next step, we aimed to identify the target of NmFic within E. coli. VbhT, a Fic protein 
from the α-proteobacteria Bartonella schoenbuchensis adenylylates its own ParE and GyrB, 
as well as the homologous proteins from E. coli (Harms et al., in preparation). In turn, though 
VbhT adenylylates both proteins, the in vivo supercoiling activity of GyrB is only faintly 
affected by VbhT when the decatanation activity of ParE is drastically inhibited by the 
expression of the Fic protein VbhT. Because of the similar growth defect phenotype of E. coli 
induced by expression of VbhT and the inhibition-relieved mutant of NmFic (NmFicE186G) (3, 
12), we tested the adenylylation of E. coli GyrB and ParE by NmFicE186G. Interestingly, this 
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inhibition-relieved mutant of the class III Fic protein from N. meningitidis (3, 12) specifically 
adenylylates E. coli GyrB but not ParE, suggesting a different mechanism of the bacterial 
growth inhibition (Fig. 4 (a)). Furthermore, NmFicE186G adenylylates GyrB of N. meningitidis 
stronger than the homologous in E. coli (Fig. 4 (a)). Mutation of the adenylylated tyrosine 109 
from E. coli GyrB (to alanine or phenylalanine) completely abolishes the adenylylation of 
GyrB, showing that GyrB is specifically adenylylated on this residue. The tyrosine 109 from 
GyrB is located in the N-terminal ATPase domain of GyrB and conserved in bacterial 
topoisomerases. This residue is part of the ATP lid-loop (46) and involved in a weak contact 
with the N3 of the adenine ring of the ATP substrate of GyrB (47). The adenylylation of GyrB 
results in the inhibition of ATP hydrolysis (Harms et al., in preparation), which is required for 
the DNA supercoiling activity of DNA gyrase that is essential for bacterial growth (48, 49).  
Like novobiocin at the high concentration of 100 µg/mL, the expression of NmFicE186G in 
E. coli results in collapse of the negative supercoiling of a reporter plasmid (Fig. 4 (b)). No 
effect can be observed with the catalytically inactive NmFicH107A,E186G mutant, showing that 
the observed loss of supercoiling activity directly results from the adenylylation of GyrB by 
the inhibition-relieved mutant NmFicE186G (Fig. 4 (b)). This is in contrast with the effect of 
VbhT on GyrB, which does not inhibit the in vivo supercoiling activity of GyrB (Harms et al., in 
preparation).  
Tetramerization deficient mutants induce growth defects and adenylylate GyrB  
Knowledge of the target enabled us to evaluate the activity of NmFic mutants of the 
dimerization interfaces in vitro by adenylylation assay. For in vivo characterization (E. coli 
model), bacteria (E. coli K12 MG1655) were transformed with plasmids containing nmfic 
genes, grown in liquid culture, and serial dilutions of exponentially growing bacteria were 
spotted on LB-agar plates supplemented with increasing amounts of IPTG (form none to 2 
mM) (Fig. 5 (a)). Colony forming units were counted allowing the quantification of bacterial 
growth defect upon expression of the different NmFic mutants. Compared to the wild-type or 
the catalytically inactive mutant in which the first histidine of the Fic active site motif has been 
mutated (2), NmFicE102R (mutant 1), NmFicE156R (mutant 2) and NmFicE102R,E156R (monomer) 
mutants show a severe growth defect in dependence of the induction level (Fig. 5 (a,b)). This 
growth defect was quantified for each mutant, resulting in the loss of 1.5, 3.0, and 1.5 log10 
CFU/mL of viability for NmFicE102R, NmFicE156R and NmFicE102R,E156R, respectively. In addition 
to the loss in colony number, the colonies exhibited a drastically smaller size (Fig. 5 (a)). 
Furthermore, expression of the combination of the dimerization interface mutants with the 
H107A mutation (catalytically inactive) abolishes the growth defect of E. coli, similarly to the 
expression of wild-type tetrameric NmFic (Fig. 5 (a,b)). These observations evidence that the 
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catalytic activity of NmFic is responsible for the growth defect of bacteria expressing the 
dimerization interface mutants. In vitro, an adenylylation assay revealed that purified NmFic 
mutants of the dimerization interface adenylylate the target GyrB (N-terminal fragment 
containing the ATPase and transducer domains). These results are in agreement with the in 
vivo results, clearly showing that the catalytically inactive mutants are unable to transfer 
radioactively labeled α-32P-AMP on GyrB (Fig. 5 (c) and Fig. S5). These observations rely so 
far on the total concentration of NmFic proteins expressed for in vivo quantification or the 
total concentration of pure protein in the in vitro assays. 
It is interesting to compare the growth defect to the NmFic monomer concentration rather 
than the total concentration. For that purpose, a conversion factor (ratio) between IPTG and 
total NmFic concentration was applied, with a concentration of 100 µM of inducer (IPTG) 
leading to 1 µM of total NmFic protein (Fig. 6 (a)), based on different IPTG/NmFictotal ratios 
that were tested graphically (Fig. 6 (b) and Fig. S6 (a-c)). At this ratio, the concentration of 
monomer in the NmFicwt (forming tetramer) stays rather low (< 1 µM) at a total NmFic 
concentration of 10-20 µM. This is in contrast with the mutant 1, mutant 2 and monomer 
mutant, in which the monomer concentration is very close to the total NmFic concentration. 
Fig. 6 (b) shows that for NmFicwt, a sufficient concentration of monomeric Fic protein cannot 
be achieved with the maximal level of induction that can be used experimentally. This points 
towards a threshold level of NmFic that can be tolerated by the cell and here not obtained in 
wild-type NmFic, where the tetramer acts as a sponge that stores the active NmFic species. 
Taken together, these results reveal a first level of regulation of NmFic by oligomerization. 
Structural investigation of auto-adenylylated NmFic by NMR 
To understand the effect of auto-adenylylation of NmFic, we investigated the changes 
induced by auto-modification of a catalytically inactive monomer mutant 
(NmFicE102R,H107A,E156R) in solution using high-resolution nuclear magnetic resonance (NMR). 
NmFic is auto-adenylylated on two tyrosines positioned in the close vicinity of the conserved 
inhibitory glutamate, that is part of the αinh helix (helix 8) (3). Modeling of auto-adenylylation 
on tyrosine 183 and 188 results in steric clashes with the Fic core, suggesting a putative 
conformational change upon auto-adenylylation of NmFic. Intriguingly, tyrosine Y183 is 
strictly conserved in class III Fic proteins. We obtained well-dispersed NMR spectra for a 
native and an auto-adenylylated sample (inactive monomer mutant that was adenylylated by 
the addition of trace amounts of hyperactive NmFicΔ8, Fig. S7). Sequence-specific resonance 
assignments were obtained for 95% and 93% for native and adenylylated 
NmFicE102R,H107A,E156R, respectively. Analysis of the chemical shift changes upon auto-
adenylylation revealed that the helix 1, the inhibitory helix 8 (αinh) and the FLAP region (Fig. 
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7) are the most affected regions upon adenylylation. The changes in the helix 1 are highly 
likely a direct result of the auto-adenylylation of helix 8 possibly leading repulsion of both 
helices from the Fic core. This movement will then lead to the activation of NmFic by active-
site opening, with auto-adenylylation being the intrinsic factor that expulses the inhibition 
motif from the ATP binding site, relieving the inhibition of class III Fic proteins. We used the 
chemical shifts of the backbone 13Cα and 13Cβ nuclei to identify the secondary-structure 
elements of both NmFic forms in solution. NmFic features eight α-helices in solution, that 
corresponds in their number and positioning to the crystalline structure (Fig. S8). In addition, 
residues 62–66 of the FLAP region, exhibit a small β-sheet. These secondary elements 
remain upon adenylylation, showing only a slight decrease of about 15% percent of helical 
content in helix 1. 
The opening of the γ-phosphate binding site upon adenylylation, leads to a two-fold increase 
of the affinity of ATP binding compared to the native unadenylylated form, with respective 
dissociation constants of 4.0 ± 1.2 mM and 7.8 ± 1.1 mM (Table 4 and Fig. S9). These 
constants are rather high, but are in excellent agreement with similar observations for Doc, 
the toxin of bacteriophage P1 that phosphorylates EF-Tu, with a KD of 7.2 mM for an ATP 
analog in the absence of target. Strikingly, upon pre-formation of a Doc–EF-Tu complex, the 
affinity for the substrate increases by ~ 105-fold to 0.26 µM (7). This effect can be deduced to 
the fact that the FLAP region is responsible for target binding but also needs to provide 
important residues for ATP binging and the base-binding pocket. We observed a high degree 
of flexibility in the FLAP-region on the picosecond–nanosecond timescale by measurement 
of 15N{1H}-NOE measurements. This dynamic behavior was further evidenced by a reduction 
in the T1-relaxation time as well as by the absence of electron density in this region in crystal 
structures. Therefore a significant increase of the substrate affinity upon GyrB binding and 
subsequent stabilization of the FLAP to enhance ATP binding in-line with the Doc–EF-Tu 
interaction can be expected. 
Presence of the auto-adenylylated tyrosine 183 of NmFic is required for activity 
To investigate further the role of auto-adenylylation, we mutated the tyrosine 183 and tested 
the effect in vivo. Since NmFicwt is known to be inhibited by a tight tetramer formation, we 
investigated the effect of Y183 on the inhibition-relieved mutant NmFicE186G (3, 12). 
Comparison of NmFicE186G to NmFicY183F,E186G shows that the growth defect phenotype of 
NmFicE186G is completely abolished by the Y183F mutation (Fig. 8 (a)). To rule out any 
significant structural changes upon Y183F mutation, we compared the crystal structures of 
both aforementioned proteins. Both structures are very similar, with root mean square 
deviation (RMSD) of 0.306 Å for the Cα atoms (0.684 Å for all atoms) after superimposition 
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(50) (Fig. 8 (b)). These in vivo and structural results clearly indicate that the auto-
adenylylation of residue Y183 is crucial for the activity of the protein. Additionally, the 
combination of mutants of the dimerization interface (mutant 1, mutant 2 and monomer 
mutant) with the mutation of Y183 also re-established normal growth of E. coli cells (Fig. 8 
(a)), while leading to no structural changes as evidenced by the RMSD of 0.228 Å for the Cα 
atoms (0.428 Å for all atoms) for the mutant 2 (NmFicE156R) and the mutant 2 Y183F 
(NmFicE156R,Y183F) obtained at 1.0 Å resolution (Fig. 8 (c)). 
The SEC-MALLS analysis of the inhibition-relieved NmFicE186G mutant reveals a less stable 
tetramer that NmFicwt (Fig. 9 (a) and Table 3) with a tetramerization KDef of 190.0 ± 9.5 µM 
(NmFicE186G) compared to 21.8 ± 1.0 µM (NmFicwt), albeit the mutation is far away from 
oligomerization interfaces. A double mutation Y183F,E186G has an opposite effect, making 
the tetramer much tighter (Table 3). There may be an effect of auto-adenylylation on the 
lower affinity of NmFicE186G since the purified protein is expected to be partially auto-modified, 
as revealed by an increased A260/A280 ratio (data not shown). The monomer concentration of 
the E186G mutant compared to the total concentration reveals that this mutant, even though 
still forming a tetramer, has monomer levels very close to the dimer mutants (Fig. 9 (b)).  
Altogether, combination of solution NMR analysis, crystallographic analysis and in vivo 
growth analysis reveals that the auto-adenylylation of NmFic is a required mechanism of 
relief of inhibition in class III Fic proteins. This layer of control is accompanied by the 
regulation through tetramerization to tightly control the adenylylation of the target GyrB. 
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Discussion 
Fic proteins need to be tightly regulated due to their highly toxic activity both in the 
prokaryotic and eukaryotic cells (2, 3) (Harms et al., in preparation). The crystal structure 
shows that tetrameric Fic can not be competent for target binding, due to burying of the 
target binding site in the core of the tetramer. On a first level of regulation, disassembly of the 
tetrameric state is thus essential for activation of the Fic protein. Our activation model 
assumes that the cell can compensate for the deleterious effects of a small intracellular 
concentration of monomeric NmFic, up to a level at which the inhibition of DNA gyrase by 
NmFic is not bacteriostatic. In vitro oligomerization analysis yields a maximal level of 2 µM 
for monomeric Fic. This value could be modulated in vivo, due to molecular crowding effects 
in the cytosol or additional binding partners that would facilitate the tetramer formation. A 
level of 1-2 µM of monomer, corresponding to 600-1200 molecules per bacteria, would be 
sufficient to inhibit the 1300 GyrB molecules (A. Schmidt, personal communication), thus the 
DNA gyrase machinery and negative supercoiling in the cell, resulting in cell growth arrest. 
Dimers and monomers of NmFic are toxic for E. coli, but the toxicity does not accumulate 
from dimers to monomer (Fig. 5). At rather low concentration, the concentration of monomer 
is very close to the total protein concentration (Fig. 2 (c)), and therefore no significant 
difference is expected. The mutant 1 and monomer are less toxic than the mutant 2, which 
can not be rationalized from the interfaces. Nonetheless, both mutant 1 and monomer mutant 
harbor the E102R mutation, residue that is located below the target binding site (FLAP) and 
may contribute to target binding, since it is unlikely that three main chain–main chain 
hydrogen bonds of the FLAP are sufficient for target binding and specificity. Alternatively, this 
mutation may also slightly alter GyrB binding. We can not exclude that a dimer (mutant 1, 
mutant 2 or both) is/are also active in a natural environment. Nonetheless, the low 
abundance of these species within the monomer-tetramer equilibrium of wild-type NmFic 
(Fig. 2 (b)) makes it highly unlikely that the dimers have a major role in the activity of NmFic 
in the cell.  
The neutralization of toxic proteins is a common scheme in biology. Binding of antitoxins to 
toxins is a quite common way to neutralize toxins of all kind prior to their intended activation 
in time or location. The E. coli relB/RelE protein complex is a characteristic example of such 
a toxin-antitoxin system (14). The relBE toxin-antitoxin system acts as transcriptional 
autoregulation system. In the case of nutritional starvation, transcription from the relBE 
operon gets dramaticaly increased and the level of RelB antitoxin is reduced by Lon-
dependent proteolysis, a common mechanism of antitoxin degradation (51). The liberation of 
the RelE toxin results in cellular growth arrest (52). Keeping a protein in an inactivated 
oligomeric state, like tetramerization for NmFic, is an elegant way to control protein function 
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that can be activated directly by an external trigger. In this case, the protein acts as its own 
antitoxin. Similar activation mechanism can also be found for the bacterial chaperone trigger 
factor, directly interacting in the monomeric form with a large variety of nascent chains on the 
ribosome (53), which is in the cytosol in a monomer-dimer equilibrium that can be modulated 
depending on the growth conditions (54, 55). Trigger factor dimerizes with an apparent KD of 
18 µM, in the same range as the effective KDef of NmFicwt (21.8 ± 1.0 µM). Furthermore, the 
plant Ultraviolet-B radiation photoreceptor UVR8, responsible for adaptation to UV, is inactive 
as a dimer but active as a monomer. In the ground state, inactive, UVR8 is present as a 
homodimer that monomerizes within seconds of UV-B irradiation (56). The active monomer 
then interacts with COP1, resulting in changes in gene expression, acclimation and UV-B 
tolerance (57).  
A second level of control is provided by auto-adenylylation of NmFic. We propose that this 
auto-adenylylation is the intrinsic factor that expulses the strictly conserved glutamate of the 
inhibition motif, thus relieving the inhibition of class III Fic proteins. This is evidenced by in 
vivo effects of the mutation of the strictly conserved Y183 within class III Fic proteins. 
Additionally, the investigation of the auto-adenylylation in solution by NMR reveals chemical 
shifts changes of residues belonging to the αinh helix, the helix that is responsible for the 
inhibition of competent ATP binding (3, 12). Changes in the chemical shifts of the helix α1 
are likely an effect of the movement of helix α8, since this is the adjacent helix that will be 
affected by the introduction of the adenylylation on Y183. The observed changes within the 
FLAP is likely due to the binding of the target in the auto-adenylylated form, whereas the 
target here is the intermolecular helix α8. 
Is there a link between the oligomerization and auto-adenylylation? First, it is worth noting 
that a target cannot bind to the tetrameric form of NmFic, i.e. here the helix 8 acting as an 
intermolecular target. Auto-adenylylation occurs via binding of the helix α8 (αinh) on the FLAP 
of another monomer and covalent transfer of AMP on the tyrosine 183. Once auto-
adenylylated, the helix α8 cannot fold back to its original inhibitory position, relieving the 
auto-inhibition. Interestingly, the NmFicE186G mutant of the inhibitory glutamate has a much 
lower affinity for both forms of dimers within the tetramer as observed by the shifted 
monomer-tetramer equilibrium towards higher concentration (Table 3). The helix α8 lies on 
the surface of the tetramer and is not involved in dimerization interfaces. Additionally, 
NmFicE186G is found endogenously auto-adenylylated. This observation indicates a putative 
link between oligomerization and auto-adenylylation, where adenylylation has an enhancing 
effect on monomerization. The auto-adenylylation of the mutant 1, mutant 2 and monomer 
mutant are required for the activity of these proteins, as evidenced by the experimental in 
vivo growth data. The monomer and dimer mutants are also active, showing that the auto-
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adenylylation is not only involved in disrupting the oligomer but rather in an own activity. 
Altogether, the information obtained on auto-adenylylation show that the auto-adenylylation 
per se is required for the activity of the protein, expulsing the inhibitory helix from the ATP 
binding site, but most likely needs the monomerization of NmFic beforehand. Commonly, 
auto-adenylylation has been observed for most Fic proteins investigated so far (10, 11, 13, 
58-60) but its putative role within the functional cycle of these proteins was not yet 
addressed. Therefore, the regulatory function of auto-adenylylation for class III Fic proteins 
may indicate that auto-modification is also involved in the control of catalytic activities of 
class I and class II FIC domains and could thus be a general feature of Fic proteins. 
In summary, our experiments suggest a model for Fic activation (Fig. 10). Upon an initiation 
signal that remains still elusive, the NmFic tetramer is disrupted which liberates the FLAP, 
enabling target binding. The disruption of the tetramer is followed by a second layer of 
regulation, auto-adenylylation. This modification of monomers leads to full activation of the 
protein by expulsion of the inhibitory alpha helix. Once a certain level of auto-adenylylated 
monomer is present in the cell, adenylylation of GyrB from the DNA gyrase subunit blocks 
efficiently the bacterial growth, resulting in a bacteriostatic effect. Our study revealed the tight 
two-step regulation of class III Fic proteins and identified its biological role as a negative 
regulator of the DNA-gyrase machinery. 
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Table 1. Data collection statistics. 
 wt E102R E156R E102R-E156R Y183F-E186G E156R-Y183F 
X-ray source SLS X06DA (PXIII) SLS X06SA (PXI) SLS X06DA (PXIII) SLS X06DA (PXIII) SLS X06DA (PXIII) SLS X06DA (PXIII) 
X-ray detector MAR225 CCD Pilatus 6M Pilatus 2M Pilatus 2M Pilatus 2M Pilatus 2M 
Wavelength (Å) 1.00853547/6  1.000 0.800 1.000 1.000 0.800 
Space group P 65 P 2 21 21 P 2 21 21 P 2 21 21 P 64 2 2 P 2 21 21 
Cell dimensions (Å) 
a, b, c  
131.92, 131.92, 
167.74  
48.56, 81.91, 
97.53,  
35.33, 50.54, 
130.14  
35.40, 39.75, 
132.75  
148.64 148.64 
75.98  35.38 50.70 129.78  
Matthews coeff. (Å3/Da) 5.06 2.53 2.73 2.45 5.84 2.74 
Solvent content (%) 75.50 50.98 54.67 49.39 78.79 54.79 
Mol. per asym. unit 4 2 1 1 1 1 
Resolution limits (Å) 14.95 - 3.10 (3.21 - 3.10) 
62.72 - 2.35 
(2.43 - 2.35) 
47.15 - 0.99 
(1.02 - 0.99) 
66.37 - 1.50 
(1.55 - 1.50) 
53.13 - 2.20 
(2.28 - 2.20) 
32.91 - 1.00 
(1.04 - 1.00) 
Total reflections 58397 (5680) 120000 (12268) 839576 (79738) 53547 (2947) 560845 (53518) 784149 (73569) 
Unique reflections 29964 (2991) 16808 (1666) 129866 (12557) 8894 (474) 25596 (2494) 122935 (11501) 
Multiplicity 1.9 (1.9) 7.1 (7.4) 6.5 (6.4) 6.0 (6.2) 21.9 (21.5) 6.4 (6.4) 
Completeness (%) 99.74 (99.70) 99.89 (100.00) 99.47 (97.58) 74.68 (99.57) 99.93 (99.76) 96.84 (91.52) 
Mosaicity 1.22 0.19 0.10 0.27 0.47 0.21 
⟨ I/σ(I) ⟩ 11.08 (3.35) 21.93 (4.57) 29.81 (3.47) 26.97 (19.17) 20.95 (1.91) 25.42 (3.43) 
Rmerge † (%) 6.35 (24.31) 7.52 (47.95) 3.16 (54.76) 4.59 (5.64) 16.73 (212.70) 3.90 (49.68) 
Rmeas ‡ (%) 8.98 8.12 3.43 5.03 17.13 4.26 
CC1/2 (%) 99.0 (84.4) 99.9 (93.0) 100.0 (86.9) 99.9 (99.9) 99.9 (84.1) 100.0 (85.0) 
CC* (%) 99.7 (95.7) 100.0 (98.2) 100.0 (96.4) 100.0 (100.0) 100.0 (95.6) 100.0 (95.9) 
Number in parentheses belong to the outer shell.  
† Rmerge = ∑hkl∑i |Ii(hkl) - ⟨I(hkl)⟩| / ∑hkl∑i Ii(hkl), where Ii(hkl) is the observed intensity for a reflection and ⟨I(hkl)⟩ is the average intensity obtained from multiple observations of symmetry-related 
reflections.  
‡ Rmeas = ∑hkl [N/(N-1)]1/2 ∑i |Ii(hkl) - ⟨I(hkl)⟩| / ∑hkl∑i Ii(hkl), where Ii(hkl) is the observed intensity for a reflection, ⟨I(hkl)⟩ is the average intensity obtained from multiple observations of symmetry-related 
reflections and N is the number of observations of intensity I(hkl). 
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Table 2. Refinement statistics. 
 wt E102R E156R E102R-E156R Y183F-E186G E156R-Y183F 
PDB code N/A N/A N/A N/A N/A N/A 
Resolution limits (Å) 14.95 - 3.10 (3.21 - 3.10) 
62.72 - 2.35 
(2.43 - 2.35) 
47.15 - 0.99 
(1.02 - 0.99) 
66.37 - 1.50 
(1.55 - 1.50) 
53.13 - 2.20 
(2.28 - 2.20) 
32.91 - 1.00 
(1.04 - 1.00) 
Rwork * (%) 18.20 (23.94) 21.43 (23.08) 12.24 (16.21) 20.83 (25.58) 17.31 (31.92) 14.65 (18.21) 
Rfree ** (%) 22.82 (30.82) 25.84 (26.76) 13.13 (16.98) 25.59 (36.61) 20.97 (34.82) 15.50 (19.19) 
Number of non-H atoms 5967 2705 1848 1449 1608 1847 
  - macromolecules 5860 2685 1619 1342 1459 1618 
  - ligands 107 - 8 - 31 8 
  - water - 20 221 107 118 221 
Protein residues 712 326 181 162 178 181 
RMSD bond lengths (Å) 0.014 0.014 0.026 0.019 0.012 0.028 
RMSD bong angles (°) 1.79 1.46 2.22 1.80 1.28 2.45 
Ramachandran 
favored/allowed *** (%) 96.7 / 99.7 99.7 / 100.0 100.0 / 100.0 99.4 / 100.0 100.0 / 100.0 100.0 / 100.0 
Ramachandran outliers 
*** (%) 0.3 0.0 0.0 0.0 0.0 0.0 
Clashscore *** 1.79 1.87 6.61 3.73 5.10 6.26 
Wilson B-factor 34.97 33.80 8.36 16.72 34.72 7.95 
Average B values (Å2) 29.90 37.50 12.00 22.10 46.10 11.40 
  - macromolecules 29.20 37.60 10.80 21.50 45.50 10.10 
  - ligands 71.00 - 18.30 - 45.40 18.60 
  - solvent - 28.00 20.90 28.70 54.00 20.50 
Numbers in parentheses refer to the outer shell. 
* Rwork = ∑hkl|| Fobs| - |Fcalc|| / ∑hkl|Fobs| 
** Rfree is the R value calculated for 5% of the data set that was not included in the refinement. 
*** Molprobity 
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Table 3. Dissociation constants for the dimerization of NmFic via the interface 1 (KD1) 
or interface 2 (KD2). 
 
 KD1 [µM] KD2 [µM] Effective KD [µM] ** 
NmFicE102R 
Local fitting 7.4 ± 1.1 - - 
Global fitting 7.6 ± 1.1 - - 
NmFicE156R 
Local fitting - 59.9 ± 11.8 - 
Global fitting - 61.3 ± 8.8 - 
NmFicwt 7.6 ± 1.1 61.3 ± 8.8 21.8 ± 1.0 
NmFicY183F * 7.2 ± N/A 56.2 ± 2.7 20.4 ± 1.0 
NmFicE186G * 66.1 ± N/A 511.9 ± 25.9 190.0 ± 9.5 
NmFicY183F,E186G * 3.6 ± N/A 28.1 ± 1.9 10.3 ± 0.7 
 
* Both dissociation constants were not fitted individually, but with a ratio of KD2 = 7.74 * KD1, 
assuming both interfaces are affected similarly by the mutations that are not part of the 
interface. 
** The effective KD (KDef) represents a value of the dissociation constant where KD1 = KD2.  
 
 
Table 4. Dissociation constants for the interaction of NmFic or auto-adenylylated 
NmFic with ATP for selected residues. 
 
Residue Native NmFic KD [mM] Auto-adenylylated NmFic KD [mM] 
K140 7.0 ± 0.7 5.7 ± 0.8 
T141 9.0 ± 1.4 4.8 ± 1.3 
I105 6.7 ± 0.3 3.0 ± 0.9 
G69 9.0 ± 0.4 3.2 ± 0.4 
G68 7.3 ± 0.7 3.2 ± 0.5 
Median 7.8 ± 1.1 4.0 ± 1.2 
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Figure 1. Tetrameric structure of the class III Fic protein NmFic. (a) Crystal structure of 
the NmFic 222 tetramer in P65 crystal form shown in surface representation. Local symmetry 
axes are indicated by black lines: monomer A in pink, B in brown, C in blue and D in green. 
The Fic active site motif is highlighted in yellow and the FLAP in light blue. Equivalent dimers 
within the tetramer are formed by AB, CD and AD, BC (b) Cartoon representation as in (a). 
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(c) Close-up view of the AD dimerization interface, with contact area of ~ 826 Å2. (d) Close-
up view of the AB dimerization interface, with contact area of ~ 421 Å2. Hydrogen-bonds are 
depicted as dashed black lines. Indices of the labeled residues refer to the respective 
monomers. (e) Superimposition of the switch 1 region of cdc42 (violet) on NmFic based on 
the IbpA/cdc42 complex structure (PDB: 4ITR (10)). The main-chain of the target sterically 
clashes with the other subunits (shown as blue and green surfaces) of the NmFic tetramer 
(clashes indicated by black stars).  
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Figure 2. Dynamic monomer–oligomer equilibrium of NmFic. (a) Concentration 
dependence of the effective molecular weight as determined by MALLS for different variants 
of NmFic. The points are experimental data points, the lines are the result of a non-linear fit 
of the monomer–oligomer model of Figure S3. The resulting dissociation constants are 
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shown in Table 3. (b) Molecular concentrations of oligomeric species of NmFicwt as a 
function of the total protein concentration, as calculated from the dissociation constants KD1 
and KD2. (c) Concentration of monomeric protein as a function of total protein concentration 
for different variants of NmFic, as indicated. 
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Figure 3. Crystal structures of NmFicE102R and NmFicE156R. (a) Structure of NmFicE102R 
(pink/orange) superimposed with the AB dimer as part of the NmFicwt tetramer (dark/light 
gray). The active site is colored in yellow in both structures. The FLAP region is not observed 
in the crystal structure due its flexibility and absence of crystal contacts (top). Only the 
corresponding molecules are shown for clarity. (b) Close-up view of the conserved 
hydrophobic and hydrophilic interactions between the tetramer form and the NmFicE102R form. 
(c) Structure of NmFicE156R (pink/green) superimposed with the AD dimer as part of the 
NmFicwt tetramer (dark/light gray). (d) Details of the conserved interaction site.  
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Figure 4. In vitro adenylylation of DNA gyrase by NmFic and in vivo inhibition of 
negative supercoiling. (a) Autoradiogram of in vitro adenylylation assay using α-32P-ATP 
with crude cell lysates of E. coli ectopically expressing full-length and GST-tagged GyrB or 
ParE constructs from various organisms, incubated with pure inhibition-relieved NmFicE186G. 
The red arrow indicates the auto-adenylylation of NmFic, the blue arrow the adenylylation of 
endogenously expressed GyrB, the yellow arrow the adenylylation of GST-tagged GyrB from 
E. coli, the green arrow the adenylylation of GST-GyrB from N. meningitidis and black arrows 
the adenylylation of GST-GyrB from Bartonella species . (b) Complete in vivo inhibition of the 
negative supercoiling ((-)sc) activity of DNA gyrase by the inhibition-relieved NmFicE186G 
protein at a similar level as the potent inhibitor novobiocin revealed by chloroquine agarose 
gel electrophoresis.  
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Figure 5. Growth defect of E. coli expressing NmFic variants. (a) Spotting experiment of 
E. coli MG1655 (λDE3) expressing NmFic derivatives on plates containing 0 or 2000 µM of 
the expression inducer IPTG. Note the remarkable growth defect, both in colony number and 
colony size, of the NmFicE102R, NmFicE156R and NmFicE102R,E156R mutants. (b) Quantification of 
E. coli growth defect. The bars represent the average of three independent experiments and 
the error bars represent the standard deviation. (c) In vitro adenylylation assay with purified 
NmFic proteins and purified GyrB43 (N-terminal 43-kDa fragment comprising the ATPase 
and transducer domains).  
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Figure 6. Bacterial growth defect correlates with the concentration of monomeric 
NmFic. (a) E. coli growth defect depending on IPTG concentration or equivalent of NmFic 
total concentration, assuming 100 µM IPTG correspond to 1 µM NmFic total protein (2nd 
horizontal axis). (b) E. coli growth defect depending on the monomer concentration of NmFic, 
assuming the same ratio as in (a).  
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Figure 7. Structural perturbations of NmFic by auto-adenylylation. (a) Combined 
chemical shifts difference of the backbone amide moiety, ∆δ(HN) between unmodified and 
auto-adenylylated NmFicE102R,H107A,E156R as function of the residue number. Unassigned 
residues are colored in black and residues exhibiting significant line-broadening in the 
adenylylated form are depicted in white. (b) Plot of the same chemical shift differences on the 
structure of monomeric NmFic using the same color code as in panel (a). The largest 
chemical shift differences cluster in helices α1 and α8 (αinh), and in the FLAP region. 
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Figure 8. Mutation of Y183 abolishes the growth defect of NmFic without affecting the 
local protein structure. (a) Quantification of the E. coli growth defect. The bars represent 
the average of two independent experiments and the error bars the standard deviation. (b) 
Superimposition of NmFicE186G (beige) and NmFicY183F,E186G (violet) with an RMSD of 0.306 Å 
for the Cα positions. (c) Superimposition of NmFicE156R (light gray) and NmFicE156R,Y183F 
(orange), with an RMSD of 0.228 Å for the Cα positions.  
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Figure 9. Dynamic monomer–oligomer equilibrium of NmFic mutants. (a) SEC-MALLS 
analysis of the oligomeric state of NmFic mutants of the auto-adenylylated tyrosine (Y183F, 
purple), of the inhibitory glutamate (E186G, black) or combination of both mutations (Y183F 
E186G, yellow). Respective dissociation constants are reported in Table 3. For comparison, 
wild-type, mutant 1, mutant 2, and monomer mutant are shown in the same colors as in Fig. 
2. (b) Comparison of the monomer concentration (NmFicmonomer) versus total protein 
concentration (NmFicTotal) for the wild-type protein and mutants of the dimerization interface 
or of the auto-adenylylated tyrosine 183, using the same color code as in panel (a). 
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Figure 10. Regulation mechanism of class III Fic proteins. (a) In normal conditions, the 
monomer-tetramer equilibrium is in favor of the tetramer formation. (b) Upon a certain signal, 
the monomer-tetramer equilibrium is pushed towards the monomer. The monomer is then 
auto-adenylylated, which results in a conformational change of the helix α8 (αinh) and the 
neighboring helix α1. The Fic protein is now active and able to adenylylate its target GyrB, 
leading to the inhibition of negative supercoiling and inhibition of bacterial growth. 
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Table S1. List of Plasmids. 
Plasmid Backbone Description Primer (fw) Primer (rv) 
Restriction 
sites 
Source 
pRSF-Duet1 pRSF-Duet1 Empty vector (RSF1030 ori, PT7)    Novagen 
pFVS0015 pRSF-Duet1 NmFicwt    Engel et al. 
pFVS0051 pRSF-Duet1 NmFicH107A prFVS149 prFVS150  this study 
pFVS0059 pRSF-Duet1 NmFicE186G    Goepfert et al. 
pFVS0083 pRSF-Duet1 NmFicY183F,E186G prFVS096 prFVS092  this study 
pFVS0109 pRSF-Duet1 E. coli GyrB 1-392 Nter His6-tag prFVS107 prFVS114 NdeI/XhoI this study 
pFVS0117 pRSF-Duet1 NmFicH107A,E186G prFVS082 prFVS083  this study 
pFVS0125 pRSF-Duet1 NmFicE102R prFVS119 prFVS120  this study 
pFVS0126 pRSF-Duet1 NmFicE156R prFVS121 prFVS122  this study 
pFVS0134 pRSF-Duet1 NmFicE102R,E156R prFVS119 prFVS120  this study 
pFVS0135 pRSF-Duet1 NmFicE156R,Y183F prFVS091 prFVS092  this study 
pFVS0137 pRSF-Duet1 NmFicE102R,H107A prFVS149 prFVS150  this study 
pFVS0138 pRSF-Duet1 NmFicH107A,E156R prFVS149 prFVS150  this study 
pFVS0143 pRSF-Duet1 NmFicE102R,H107A,E156R prFVS149 prFVS150  this study 
pNMD220 pNDM220 Empty vector (mini-R1 ori, PLac)    Gotfredsen et al. 
pAH154_NmFic_wt pNDM220 NmFicwt prAH525 prAH526 BamHI/EcoRI this study 
pAH154_NmFic_E186G pNDM220 NmFicE186G prAH537 prAH538  this study 
pFVS0146 pNDM220 NmFicY183F prFVS091 prFVS092  this study 
pFVS0147 pNDM220 NmFicY183F,E186G prFVS096 prFVS092  this study 
pFVS0149 pNDM220 NmFicE102R prFVS119 prFVS120  this study 
pFVS0150 pNDM220 NmFicE156R prFVS121 prFVS122  this study 
pFVS0151 pNDM220 NmFicH107A prFVS149 prFVS150  this study 
pFVS0173 pNDM220 NmFicE102R,E156R prFVS119 prFVS120  this study 
pFVS0174 pNDM220 NmFicE102R,Y183F prFVS091 prFVS092  this study 
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Plasmid Backbone Description Primer (fw) Primer (rv) 
Restriction 
sites 
Source 
pFVS0175 pNDM220 NmFicE156R,Y183F prFVS091 prFVS092  this study 
pFVS0177 pNDM220 NmFicE102R,H107A prFVS149 prFVS150  this study 
pFVS0178 pNDM220 NmFicE102R,E156R,Y183F prFVS091 prFVS092  this study 
pFVS0179 pNDM220 NmFicH107A,E156R prFVS149 prFVS150  this study 
pFVS0197 pNDM220 NmFicE102R,H107A,E156R prFVS149 prFVS150  this study 
 
Table S2. List of DNA oligonucleotides and their respective sequences. 
Primer Sequence (5’-3’) 
prFVS082 GTATTATTACGGCGGGTATGAAAAAGGCTGAC 
prFVS083 CATACCCGCCGTAATAATACGACTGCTCG 
prFVS091 GAGCAGTCGTTTTATTACGAAGGGTATGAAAAAG 
prFVS092 GTAATAAAACGACTGCTCGATACCTTTAAAG 
prFVS096 GAGCAGTCGTTTTATTACGGCGGGTATGAAAAAG 
prFVS107 GGGAATTCCATATGCATCACCATCACCATCACTCGAATTCTTATGACTCCTCCAG 
prFVS114 CGACCTCGAGTTAGGTCATTTCACGCGCGCGACG 
prFVS119 CAAATATGTTCGTATGAACATTGCCCATCC 
prFVS120 CAATGTTCATACGAACATATTTGGCGATGATTTC 
prFVS121 CAACGATTTACGUCTGCGCTTTTTGTTAAAG 
prFVS122 CAAAAAGCGCAGACGTAAATCGTTGACGGGGCTG 
prFVS149 GAACATTGCCGCCCCGTTTTTGGAGGGTAATGGCAG 
prFVS150 CAAAAACGGGGCGGCAATGTTCATTTCAACATATTTG 
prAH525 GAGCGGGGATCCATAGGAGGAACAATTTTATGAAATCCATAGACGAACAAAG 
prAH526 CTCCCGCGAATTCTCAGCCTTTTTCATACCCTTC 
prAH537 TTATTACGGCGGGTATGAAAAAGGCTGAGAA 
prAH538 TTCATACCCGCCGTAATAATACGACTGCTCG 
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Figure S1. Dynamic equilibrium of NmFicwt from monomer to tetramer. (a) Dynamic 
equilibrium of NmFicwt on the time-scale of the Size Exclusion Chromatography (SEC) 
experiment. SEC analysis using an analytical S75 16/60 column (GE Healthcare) with a 
flowrate of 0.5 mL/min loaded with 50 µL of wild-type NmFic at various loading 
concentrations (gray-scale from dark-gray [1680 µM] to light-gray [1.7 µM]). (b) The NmFic 
222 tetramer observed in the P65 crystal form shown as ribbon representation (same as 
Fig. 1).  
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Figure S2. Amino acid conservation in class III Fic proteins. The alignment contains one 
representative sequence for each of 41 organisms. The alignment was calculated using 
MUSCLE (Multiple Sequence Comparison by Log-Expectation) (61) 
(http://www.geneious.com). 
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Figure S3. Thermodynamic model of NmFic multimerization. (a) Schematic view of the 
equilibrium and (b) set of mass action law equations. (M = monomer, D1 = dimer 1, D2 = 
dimer 2, T = trimer, Q = tetramer). 
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Figure S4. Dynamic equilibrium of NmFic tetramerization-deficient mutants. Species 
profile calculated with the equilibrium constants (a) KD1 for NmFicE102R, (b) KD2 for NmFicE156R 
and (c) NmFicE102R,E156R. The red curves represent the fitted experimental MALLS data.  
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Figure S5. Adenylylation assay with pure NmFic proteins and pure GyrB43. (a) SDS-
PAGE and (b) autoradiography of the SDS-PAGE gel after incubation of NmFic variants with 
[α-32P]-ATP and pure GyrB proteins. The dimerization interface mutants catalyze the 
adenylylation of the target protein GyrB. 
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Figure S6. Calculated IPTG/[NmFicmonomer] ratios. Different equivalence and the resulting 
plots as in Figure 6 (b), with (a) 100 µM IPTG = 0.01 µM NmFic, (b) 100 µM IPTG = 0.1 µM 
NmFic and (c) 100 µM IPTG = 10 µM NmFic. 
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Figure S7. NMR fingerprint spectra of unmodified and auto-adenylylated NmFic. 
Overlay of 2D [15N,1H]-HSQC spectra of 0.5 mM [U-13C,15N]-labelled monomeric, inactive 
NmFic (NmFicE102R,H107A,E156R) (blue) and of 0.25 mM [U-13C,15N]-labelled adenylylated 
monomeric inactive NmFic (NmFicE102R,H107A,E156R) (red). Measurements were performed at 
700 MHz in  25 m M  M E S             
assignment is indicated.  
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Figure S8. Secondary structure analysis of unmodified and adenylylated NmFic. 
Combined secondary chemical shifts for 13Cα and 13Cβ of (a) unmodified and (b) 
adenylylated NmFicE102R,H107A,E156R, plotted against the amino acid residue number. A 1–2–1 
weighting function for residues (i-1) – i – (i+1) has been applied to the raw data. Consecutive 
stretches of positive and negative values indicate α-helix and β-sheet secondary structure 
elements, respectively. Heteronuclear NOE (left) and T1 relaxation (right) experiment of (c) 
unmodified NmFic and (d) auto-adenylylated NmFic.  
 297 
 Results – Research article IV  
 
 
 
 
 
Figure S9. Effect of ATP binding on the NmFic monomer. Backbone amide chemical shift 
perturbations for selected residues upon titrating of (a) ATP to [U-13C,15N]–
NmFicE102R,H107A,E156R (starting concentration 500 μM) and (b) ATP to adenylylated [U-
13C,15N]–NmFicE102R,H107A,E156R (starting concentration 250 μM). The lines represent nonlinear 
least–squares best–fits of the normalized changes in the 1H and 15N chemical shifts using a 
bimolecular equilibrium binding model. The optimized value of the equilibrium dissociation 
constant is 7.8 ± 1.2 mM for (a) and 4.0 ± 1.1 mM for (b). Chemical shift differences of the 
amide moiety of (c) native monomeric NmFic and (d) auto-adenylylated monomeric NmFic 
with Δδ(HN) as a function of the ATP concentration, relative to apo NmFic with a gradient 
from yellow (unchanged chemical shift) to purple (chemical shift change of 0.05 ppm and 
above). (c) Native monomeric NmFic and (d) auto-adenylylated monomeric NmFic.   
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6.12. Unpublished results related to Research article IV 
Over the course of my PhD project I generated different sets of data that are related to 
Research article IV but have so far not been included in any manuscript. 
6.12.1. A “cold” adenylylation assay using biotinylated ATP 
Adenylylation assays using [α-32P]-ATP are not convenient and inflexible due to restrictions 
caused by radioactivity, and the radioactive labeling of adenylylation is also not easily 
compatible with downstream applications that could, e.g., identify adenylylated target 
proteins. Therefore, it seemed reasonable to investigate different forms of labeled ATP that 
would allow to visualize AMP transfer more effectively. At the beginning of my PhD project I 
examined whether biotinylated ATP could be an alternative to radioactivity, because the 
resulting biotinylation of adenylylated target proteins would be easy to detect in a procedure 
technically similar to Western Blotting and could also be used for pulldown experiments 
aimed at target identificationa. Two compounds were tested based on a structural analysis of 
Arnaud Goepfert and Tilman Schirmer, EDA-ATP-biotin (labelled at the hydroxyl groups of 
the ribose) and N6-(6-Amino)hexyl-ATP-biotin (labeled at the adenine ring; see molecular 
structures in Figure 21A). 
 
Figure 21: A “cold” adenylylation assay with biotinylated ATP. A) EDA-ATP-biotin and N6-(6-Amino)hexyl-
ATP-biotin are biotinylated at the hydroxyl groups of the ribose or at the adenine ring, respectively (adapted from 
the website of Jena Bioscience, www.jenabioscience.de. B) Classical adenylylation assays with E. coli lysates 
(like, e.g., in Figure 2A of Research article III) were performed with GST-VopS and Rac1-Q61L (left) or 
NmFicT_SE/AA and plain E. coli lysate (right). NmFicT_SE/AA had been obtained as purified protein from 
Frédéric Stanger and was added to reactions ad 0.3 µg/µl. Reactions were supplemented with cold ATP ad 
150 µM (or not) and biotinylated ATP at 7.5 µM (“+”) or 75 µM (“++”) and incubated at 30°C for 1h. Subsequently, 
they were separated by SDS-PAGE and proteins were transferred on nitrocellulose membranes (semi-dry). 
                                                          
a These experiments had been performed before the adenylylated targets of VbhT or NmFicT were identified. 
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Biotinylation was detected using HRP-coupled streptavidin (Thermo Scientific) and visualized by 
chemoluminescence. The blots clearly show that only N6-(6-Amino)hexyl-ATP-biotin was successfully used by Fic 
proteins for auto- and target adenylylation (arrows). It appears that 75 µM of labeled ATP in the absence of cold 
ATP is the optimal reaction condition. Background bands at 15 kDa and 20 kDa are also present in the absence 
of labeled ATP (“ctrl” reactions) and likely represent E. coli proteins that are biotinylated as part of cellular 
processes. 
 
In my initial experiments I performed classical adenylylation assays using cleared lysates of 
E. coli that had expressed well-known VopS or NmFicT_SE/AA, a NmFicT construct that had 
previously been shown to adenylylate unknown targets in E. coli lysates (Research article I). 
While no biotinylation could be detected with EDA-ATP-biotin, N6-(6-Amino)hexyl-ATP-biotin 
readily labeled the targets both of VopS as well as NmFicT_SE/AA with a clarity that had 
rarely been achieved using radioactivity (see Figure 21B). Unfortunately, VbhT or Bartonella 
effector proteins were apparently unable to use biotinylated ATP as a substrate for 
adenylylation (data not shown), but the success with NmFicT_SE/AA should pave the way 
towards the identification of the adenylylated targets of bacterial Fic proteins. 
Interestingly, the improved sensitivity of detection of adenylylation with biotinylated ATP 
compared to radioactivity showed that not only NmFicT_Δ8, but also NmFicT_SE/AA 
adenylylates several different target proteins in E. coli lysates (compare Figure 3D of 
Research article I to Figure 21B). 
6.12.2. Target adenylylation and biological function of NmFicT 
Independent of their biological relevance, it was interesting to identify the diverse target 
proteins adenylylated by NmFicT in E.coli because they would provide valuable information 
on the target recognition of FIC domain proteins. Furthermore, both NmFicT as well as VbhT 
caused the adenylylation of a protein that we initially estimated to be of ca. 80 kDa molecular 
weight (see Research article I, but compare the analysis in Figure 22), indicating that the 
identification of targets adenylylated by NmFicT may also promote the research on VbhT 
which was not directly accessible for assays with biotinylated ATP. 
Using NmFicT_Δ8, the construct that appeared to have the largest target range, I therefore 
performed adenylylation reactions with N6-(6-Amino)hexyl-ATP-biotin in order to identify the  
target proteins by enrichment in subsequent biotin-streptavidin pulldown experiments. The 
visualization of input adenylylation reactions allowed to quantify the apparent molecular 
weight of the target proteins as a reference for the results of the pulldown experiments 
(Figure 22). For unknown reasons, I never achieved any reliable and reproducible 
enrichment of any protein in the pulldown experiments, but the mass spectrometry analyses 
repeatedly detected adenylylated peptides of different E. coli proteins. These were cloned 
and tested in E. coli lysate adenylylation assays, confirming that NmFicT_Δ8 adenylylates 
AtpD (ATP synthase F1 complex β subunit), GyrB (DNA gyrase B subunit), and RpoB/C 
(RNA polymerase β and β’ subunits). However, the far majority of targets adenylylated by 
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this protein have still remained elusive (see Figure 22B). Parallel experiments that tried to 
exploit the minimal adenylylation activity of VbhT with N6-(6-Amino)hexyl-ATP-biotin also 
identified an adenylylated peptide of GyrB (not shown; see Research article I). 
 
Figure 22: NmFicT_Δ8 adenylylates a wide range of targets in E. coli. A) An adenylylation reaction with 
N6-(6-Amino)hexyl-ATP-biotin was processed as described for Figure 21B. I analyzed the apparent molecular 
weight of the different adenylylation bands using the GelAnalyzer software (available at www.gelanalyzer.com) by 
fitting a logarithmic calibration curve on the bands of the molecular weight marker. B) Seventeen bands were 
clearly detected, and the three major target adenylylation bands visible in Figure 21B as well as the auto-
adenylylation of NmFicT_Δ8 are highlighted in grey. Additional experiments (accidental detection of adenylylated 
peptides by mass spectrometry and / or the analysis of candidate proteins in lysate adenylylation assays) 
confirmed a number of proteins as adenylylation targets of NmFicT_Δ8, but the majority has remained unknown. 
 
Interestingly, a series of follow-up experiments showed that the most wildtype-like construct 
NmFicT_E/G exclusively adenylylates GyrB of E. coli and not AtpD, RpoB/C, or any of the 
multiple unknown proteins targeted by NmFicT_Δ8. Because the latter construct is not more 
toxic than NmFicT_E/G (see Supplementary Figure 1B of Research article I) it seems likely 
that the various targets of NmFicT_Δ8 are not biologically relevant and rather simply reflect a 
relaxed target specificity upon deletion of the complete αinh helix. 
In contrast, it is of much greater biological relevance whether the NmFicT protein really 
evolved to target only GyrB (which, in E. coli, causes only mild growth inhibition; see 
Supplementary Figure 1B of Research article I and Figures 5 and 8 of Research article IV). I 
therefore tested a panel of type II topoisomerase B subunits in E. coli lysates for 
 
 
   
  
A
 
 
 
B
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adenylylation by VbhT (known to target both GyrB and ParE; see Research article III) and 
NmFicT_E/G (Figure 23). 
 
Figure 23: Target and host specificity of NmFicT_E/G and VbhT. The autoradiographs of a lysate 
adenylylation assay with NmFicT_E/G, VbhT, and different type II topoisomerase B subunits show that 
NmFicT_E/G adenylylates all GyrB orthologs that were tested, but ParE only of B. schoenbuchensis. VbhT 
adenylylates GyrB and ParE of E. coli and B. schoenbuchensis, but not of N. meningitidis or M. tuberculosis (the 
latter organism lacks topoisomerase IV). The experiment has been performed just as described for the lysate 
adenylylation assay in Figure 2A of Research article III. Target proteins (as GST fusions) are highlighted with red 
arrows, and Fic proteins are highlighted with orange arrows. The presence of all protein constructs was confirmed 
by Coomassie staining (not shown). 
 
The results strongly suggest that NmFicT_E/G does not target ParE of its host organism 
Neisseria meningitidis, but this notion would need to be confirmed with purified proteins for 
certainty. While a biological function similar class I Fic proteins may be expected for the dual 
targeting of GyrB and ParE (see Research article III), a sole inhibition of DNA gyrase would 
point towards a role in the protection against DNA damage similar to, e.g., the GyrI protein of 
E. coli356. However, preliminary experiments so far failed to detect such an effect of NmFicT 
expression, while it was readily observed with GyrI. Nevertheless, future studies should focus 
on this aspect and test different experimental techniques as well as possibly other class III 
Fic proteins on top of NmFicT to thoroughly assess a potential function in DNA protection. 
Closely linked to the question of its biological function is the search for a physiological trigger 
that would activate NmFicT in vivo as proposed in Research article IV. The GyrI protein of 
E. coli and a number of similar factors are typically controlled by the SOS response that is 
induced upon detection of DNA damage (see Box 1), but N. meningitidis appears to lack this 
signal transduction pathway357. Assuming a role in DNA damage protection, it is therefore 
more likely that NmFicT may somehow directly sense DNA damage without mediating 
cellular signaling, e.g., via effects on a potential transcriptional or translational autoregulation 
which could very well affect the monomer-tetramer equilibrium. Future studies should 
therefore investigate the activity of the nmficT promoter or homologous sequences in 
response to, e.g., DNA damage caused by mitomycin C or ciprofloxacin. Furthermore, it 
would be interesting to see if NmFicT interacts with parts of the cellular core machinery that 
could also provide signaling input. 
 
 
 
 
 
 
 
 
 
 
 
 
A
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6.13. Appendix: Further results 
Over the course of my PhD work I generated data that cannot be directly linked to any 
Research article in the Results section. Furthermore, I shortly recapitulate some unpublished 
findings that I had already included in my Master thesis but that are nevertheless relevant for 
the Perspective developed further below. 
6.13.1. Bartonella encodes FicTA toxin-antitoxin modules closely related to VbhTA 
Early in my PhD work I discovered that Bartonella encodes classical FicTA modules (with 
single domain FicT toxins) that are closely related to VbhT. Interestingly, they are typically 
encoded together with Vbh type IV secretion machineries (see also Figure 38 in the 
Perspective section), suggesting that these FicTA modules may represent an evolutionary 
state preceding the acquisition of a type IV secretion signal by an ancestor of VbhTA. A 
sequence analysis revealed canonical Fic signature and Fic inhibition motifs and high overall 
primary sequence similarity among each other and also to other FicTA modules like YeFicTA 
(Figure 24A). Therefore, it was likely from the beginning that these FicTA modules would act 
as a toxin-antitoxin system targeting GyrB and ParE by adenylylation. 
As a model for further investigation I chose BtrFicTA, a FicTA module encoded on the 
chromosome of Bartonella tribocorum CIP 105476 together with the remnants of a Vbh T4SS 
and a number of plasmid-associated genesa, suggesting that the whole locus originates from 
the collapse of pVbh-like conjugative plasmid (see Figure 38). Like VbhT (Figure 2A in 
Research article III), BtrFicT adenylylates both GyrB and ParE of E. coli (Figure 24B) and of 
Bartonella (not shown).The expression of btrficT in E. coli results in growth arrest that 
depends on the toxin’s adenylylation activity and can be inhibited by co-expression of the 
cognate antitoxin btrficA (see Figure 24C). 
  
                                                          
a BtrFicT had independently been disovered by Marius Liesch who described it in a side note of his Master 
thesis as a “FIC-encoding hypothetical protein of B. tribocorum (BT2350) which is encoded downstream of the 
Vbh T4SS […] but not coupled to a BID domain”319. 
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Figure 24: FicTA modules in Bartonella and the activities of BtrFicTA. A) Three putative FicTA modules were 
identified in B. tribocorum (BtrFicT is YP_001610356.1), B. elizabethae (BelFicT is WP_005774621), and 
B. birtlesii (BbiFicT is WP_006590445.1) by tblastn with different FicT toxins against several databases. An 
incomplete sequence of a homologous module was obtained for B. washoensis (not shown). The sequence 
alignment of the FicT homologs of Bartonella with YeFicT reveals high sequence similarity among the Bartonella 
FicT proteins (> 70% shared primary sequence) and considerable similarity to YeFicT (approximately 35% 
primary sequence identity). All FicT proteins display a canonical Fic signature motif and all cognate FicA 
homologs display a canonical Fic inhibition motif (not shown). This alignment was created using ClustalW 
implemented in Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM cost matrix. Coloring 
reflects amino acid similarity according to the cost matrix with black = 100% identity and white = <60% identity. 
B) The adenylylation activity of BtrFicT was tested in a lysate adenylylation assay as shown in, e.g., Figure 2A of 
Research article III. It is clear from the autoradiograph that auto-adenylylation is detectable for both VbhT and 
BtrFicT, but no clear adenylylation of endogenous targets can be seen with BtrFicT (orange arrows). Ectopically 
expressed GST-GyrB and GST-ParE (of E. coli) are adenylylated both by VbhT and BtrFicT (red arrows). 
Adenylylation activities of VbhT and BtrFicT are consistently abolished in H/A active site mutants or in presence of 
cognate FicA antitoxins. C) The growth inhibition by BtrFicT was assayed in an experiment similar to the one 
described in Figure 1B of Research article III. While the expression of BtrFicT from a single-copy plasmid impairs 
the growth of E. coli ΔecficAT, no such effect can be observed with the H/A active site mutant or upon co-
expression of the cognate BtrFicA antitoxin. 
 
In conclusion, my preliminary characterization of BtrFicTA made it apparent that FicTA 
modules in Bartonella are typical representatives of the FicTA toxin-antitoxin family just like 
YeFicTA or PaFicTA that I characterized in Research article III. From another perspective, 
they strongly resemble VbhT with the difference that they lack a type IV secretion signal. 
6.13.2. Bep-associated FicA antitoxins in Bartonella and potential functions 
Technically, it is relevant to mention that I continuously failed to obtain detectable amounts of 
BtrFicT in the “soluble” fraction of the cleared E. coli lysates that I typically used for 
adenylylation assays (Figure 25A). It had long been noted in our laboratory that the 
co-expression of cognate FicA antitoxins greatly improved the expression and solubility of 
FicT toxins or Beps with FIC domains, but this of course complicates the functional analysis 
of any adenylylation activity of these proteins. 
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Figure 25: Improved expression of BtrFicT with BtrFicA under “restrained expression”. A) The expression 
of btrficT alone (pAH134a) for different periods of time does not result in detectable BtrFicT in the cleared E. coli 
lysate as observed by Coomassie staining, while btrficT supposedly expressed together with btrficA (pAH134b) 
yields a considerable amount of BtrFicT (compare band at green arrow to the red arrows). However, no BtrFicA 
can be detected (red box). B) This expression experiment compared different btrficTA constructs (pAH134 series) 
with vbhT expressed from the isogenic pPE0017 plasmid in BL21-AI (“AI”) or BL21-star (DE3) (“star DE3”). As 
expected from previous experiments (not shown), the yield of “soluble” VbhT in the cleared lysates is superior 
with BL21-star (DE3) (green arrow to the right). Similar to the result shown in (A), plasmid pAH134b (encoding 
btrficT and btrficA) results in considerable expression of BtrFicT but not BtrFicA, and the same is true for the 
catalytically inactive derivative pAH134b_H/A (green arrows). The deletion of a few base pairs in pAH134b 
restores expression of BtrFicA (in pAH134b_cor2; orange arrows) and abolishes growth inhibition (not shown). 
Active “BtrFicT” as well as “BtrFicT_H/A” shown in Figure 24 have been expressed from pAH134b vectors, while 
lysates generated with original pAH134a did not result in detectable adenylylation activity (not shown). C) Plasmid 
pAH134b encodes a start codon directly upstream of the HA-btrficA construct that causes translation of a small 
peptide of different frame (start codons are highlighted in red boxes). Because translation initiation at the 
ribosome binding site (RBS) typically uses the first available start codon, the translation of HA-BtrFicA in 
pAH134b is highly inefficient (see also the absence of detectable BtrFicA with this plasmid in (A) and (B)). 
Plasmid pAH134b_cor2 has been created by deletion of a few base pairs and linked the start codon of HA-btrficA 
to the ribosome binding site. 
 
Interestingly, my first attempt to co-express btrficT and btrficA from the two multiple cloning 
sites of pRSFDuet-1 (as we did it, e.g., for the lysate adenylylation assays with VbhTA in 
Research articles I and III) resulted in a plasmid that caused growth inhibition comparable 
the absence of btrficA (data not shown). I was therefore not surprised to see that no BtrFicA 
was detectable by visual inspection of Coomassie stains of lysates obtained from these 
cultures, but quite excited by the considerable amount of BtrFicT (Figure 25B). A thorough 
analysis of the sequence of this co-expression plasmid (pAH134b) revealed a cloning 
mistake that resulted in an aberrant start codon a few base pairs upstream of the start codon 
of the antitoxin construct, but not in frame (Figure 25C). This genetic arrangement would 
allow only occasional expression of btrficA whenever a ribosome accidentally skips the first 
start codon, explaining both the growth inhibition and the absence of detectable BtrFicA. 
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Consistently, the repair of this cloning mistake abolished the growth inhibition and resulted in 
typical amounts of BtrFicA in cleared lysates (Figure 25B). In order to investigate the 
biochemical properties of BtrFicT I made use of the improved expression of this toxin under 
“restrained expression” of btrficA and routinely used plasmid pAH134b for the expression of 
“active” BtrFicT and analogously BtrFicT_H136A. The lysates generated from these 
expressions were later used to demonstrate auto-adenylylation and target adenylylation of 
BtrFicT (see above in Figure 24B).  
From a general point of view, these results indicate that FicA antitoxins may aid the folding of 
FicT toxins, e.g., by preventing their aggregation via transient binding to some hydrophobic 
patches on their surface. Such a function could also explain why Bartonella effector proteins 
with FIC domains – in their majority not exhibiting any “toxicity” (personal observation) – are 
accompanied by at least one FicA-like antitoxin in all species (see Figure 26 for a 
comparison) that may act as a chaperone similar to effector chaperones in type III secretion 
(recently reviewed by Thomas et al.358). The bona fide effector “antitoxins” in Bartonella are 
generally not encoded directly together with any bep gene in a similar genetic arrangement 
as ficAT loci, but are found at a separate locus which may indicate that their expression level 
is adjusted to serve for the chaperoning of several or all Beps with FIC domains. In addition 
to effector binding, it is easily conceivable that the sequestration by FicA antitoxins inside 
Bartonella would also keep the Bep FIC domains in an inactive state, thereby preventing 
futile ATP hydrolysis prior to secretion into the host cell. Future studies should investigate the 
competitive index of Bartonella ficA mutants (including deletions of potential ficAT toxin-
antitoxin modules) in vivo and try to unravel the precise biological function of these 
conserved proteins, e.g., upon challenge with different levels of stress in in vitro infections. 
 
Figure 26: Sequence alignment of effector “antitoxins” in Bartonella. FicA homologs were identified by 
blastp with the ortholog of B. rochalimae that I had investigated in my Master project359. The sequences were 
aligned with VbhA of B. schoenbuchensis using ClustalW implemented in Geneious v7.1.7 with gap open / extend 
costs of 10 / 0.1 and a BLOSUM cost matrix. Coloring reflects amino acid similarity according to the cost matrix 
with black = 100% identity and white = <60% identity. Columns with >75% gaps were hidden (red). The far 
majority of sequences displays a canonical (S/T)xxxE(G/N) inhibition motif (see the invariant glutamate at position 
39). 
L3
L4
VbhA (L2)
B. clarridgeiae str. 73
B. clarridgeiae str. 73
B. sp. 1-1c
B. rochalimae str. ATCC BAA-1498
B. sp. AR 15-3
B. vinsonii subsp. berkhoffii str. Winnie
B. vinsonii
B. rattaustraliani
B. doshiae
B. washoensis
B. washoensis
B. henselae str. Houston-1
B. tribocorum str. CIP 105476
B. elizabethae
B. grahamii str. as4aup
B. rattimassiliensis
B. taylorii
B. sp. DB5-6
B. birtlesii
B. alsatica
B. quintana str. Toulouse
B. schoenbuchensis str. R1
 Results – Appendix: Further results 
311 
 
6.13.3. The OB-fold in Beps and VbhT was acquired en bloc with the BID domain 
Bartonella effector proteins typically contain an OB-fold (oligonucleotide / oligosaccharide 
binding) between the FIC domain and the BID domain that has so far not been assigned to 
any function and whose origin had remained elusive152. Interestingly, my in silico analyses 
showed that the VbhT homologs of B. grahamii also contain an OB-fold, while VbhT of 
B. schoenbuchensis seems to lack the corresponding primary sequence (Figure 27). Over 
the course of additional sequence comparisons I discovered that not only Bartonella effector 
proteins, but also conjugative relaxases encode an OB-fold ahead of their BID domain 
(Figure 27). Given that these proteins are likely the evolutionary source of the type IV 
secretion signal of Bartonella effector proteins311 it is plausible that the common ancestor of 
extant VbhT proteins and all Beps has been generated by a single sequence reshuffling 
event that fused an OB-BID module of a conjugative relaxase en bloc to the 3’ end of a ficT 
gene (see further considerations in the Perspective at the end of this work). 
 
Figure 27: Alignment of the OB-fold region in VbhT homologs and a conjugative relaxase. The protein 
sequences of four VbhT homologs and the C-terminus of the TraA relaxase of B. schoenbuchensis R1 were 
aligned using ClustalW implemented in Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM 
cost matrix. Coloring reflects amino acid similarity (ignoring gaps) according to the cost matrix with black = 100% 
identity and white = <60% identity. Protein domains were assigned by comparison to Bep domain annotations 
performed by Philipp Engel and Arnaud Goepfert in our laboratory. The alignment clearly shows that the protein 
sequence of the OB-fold in VbhT homologs is homologous to the corresponding sequence in the TraA relaxase. 
VbhT homologs and relaxase can be aligned continuously from the end of the FIC domain down to the C-termini 
of the proteins, suggesting that OB-fold and BID domain were acquired en bloc by a FicT-like ancestor of VbhT 
from a conjugative relaxase. Curiously, the primary sequence corresponding to the OB-fold is missing in VbhT of 
B. schoenbuchensis R1. 
 
6.13.4. Broad analysis of Bartonella effector proteins 
During my Master project I performed an extensive in silico analysis of Bartonella effector 
proteins and compared the Bep orthologs of four species of L3 and four species of L4 to get 
an overview of the conservation of critical residues as a basis for the subsequent functional 
investigation (Figure 28)359. 
----------
VbhT of B. schoenbuchensis str. R1 pVbh
VbhT of B. sp. TT0105 pTT0105
VbhT of B. grahamii str. as4aup (chrom.)
TraA of B. schoenbuchensis str. R1 pVbh
VbhT of B. grahamii str. as4aup (pBGR3)
VbhT of B. schoenbuchensis str. R1 pVbh
VbhT of B. sp. TT0105 pTT0105
VbhT of B. grahamii str. as4aup (chrom.)
TraA of B. schoenbuchensis str. R1 pVbh
VbhT of B. grahamii str. as4aup (pBGR3)
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Figure 28: Bep FIC domain show mutations at particular positions and confined to certain orthologous 
groups. The FIC domains of Bartonella effector proteins were aligned using ClustalW implemented in Geneious 
as described in the original work and residues critical for adenylylation were indicated by green arrows (Figure 32 
in my previous work359). Red boxes highlight deviations of Bep sequences at such positions, and it is apparent 
that these are distributed highly unevenly between the different orthologous groups. Bartonella species are 
indicated with a short three-letter code (Bcl = B. clarridgeiae, Bro = B. rochalimae, B11c = B. sp. 1-1c, B15-3 = 
B. sp. AR15-3, Bgr = B. grahamii, Btr = B. tribocorum, Bhe = B. henselae, Bqu = B. quintana). The results are 
summarized up and discussed in the running text. 
 
In short, my analysis showed that no ortholog of VbhT or Bep1, Bep2, and Bep3 families 
deviates from the canonical Fic signature sequence, indicating that these proteins might 
have a conserved function in target adenylylation (Figure 28). The situation is completely 
different for the other groups of effectorsa that display alternative sequence motifs at the 
active site which are often conserved among orthologs. It is well possible that at least some 
of these divergent active site motifs may have evolved to perform novel catalytic activities as 
it was shown, e.g., for Doc and AnkX (see in the Introduction section). 
                                                          
a However, I explicitly do not exclude that single orthologs of other Bep families that contain a canonical Fic 
active site motif might act via target adenylylation, e.g., for Bep clades 6 and 7. 
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As model species for a biochemical analysis of Bartonella effectors with FIC domains I chose 
well investigated B. henselae str. Houston-1 for L4 and B. rochalimae for L3a. Host-targeted 
effectors of all orthologous groups could be detectably expressed into the cleared lysates 
that I used for adenylylation assays throughout my Master project (not shown). I therefore 
investigated potential adenylylation activities but failed to detect any adenylylation with all 
effectors except for Bep1 and Bep2. Bep1 caused the adenylylation of small target proteins 
in host cell lysates (approximately 20 kDa) that I later identified as Rac1 and a few closely 
related small GTPases (Figure 29A). Interestingly, Bep1 targets Rac1 at the same residue as 
IbpA (Tyr32) but displays considerable specificity compared to VopS or IbpA in that it does 
not adenylylate RhoA or Cdc42 (Figure 29B). While all orthologs of Bep1 seem to target 
Rac1, its paralog Bep2 was found to adenylylate a different target of approximately 50 kDa 
molecular weight (Figure 29C; later identified as vimentin in Research article II). 
  
                                                          
a B. rochalimae was chosen because initial experiments had found superior expression of some of its effectors 
in E.  coli compared to orthologs of other species (not shown). 
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Figure 29: Specificity and diversification of the adenylylation activities of Bep1 and Bep2. The 
adenylylation activity of FIC domain proteins was investigated using cleared lysates of E. coli expressing different 
constructs with a procedure that we later published for VbhT (see, e.g., Figure 2A in Research article I). Targets 
were supplied either ectopically expressed as GST-fusions in E. coli lysates or in form of host cell lysates (see the 
protocol described in Research article II). A) Bep1 of B. rochalimae shows auto-adenylylation (orange arrows) 
and causes a double band of target adenylylation around 20 kDa in host cell lysates (here: J774 mouse 
macrophage; red arrow). Such a double band is characteristic of the electrophoretic migration of small GTPases 
that were shown to be adenylylated by distantly related FIC domain proteins IbpA and VopS. I therefore cloned 
different small GTPases as GST-fusions (with “*” indicating constitutively active mutants) and tested their 
adenylylation by Bep1. Unlike VopS or IbpA, Bep1 only adenylylates Rac1 and not Cdc42 or RhoA (green arrow). 
B) Bep1 targets Tyr32 of Rac1 since it is unable to adenylylate a Y32F mutant, while VopS (targeting T35) can 
adenylylate this construct. Different Rac1 constructs (“°” denoting the dominant-negative T17N mutant) were 
tested for adenylylation together with Rac2, Rac3, and RhoG that are closely related to Rac1. All these constructs 
were adenylylated by Bep1 (not visible for RhoG in this experiment due to weak expression). Generally, the 
adenylylation activity of Bep1 depended on the integrity of its active site motif (catalytic histidine mutated in 
H170A) and was inhibited by the FicA homolog of B. rochalimae. C) The four orthologs of Bep1 all adenylylate 
Rac1 while its paralog Bep2 does not and instead targets a protein of approximately 50 kDA in host cell lysates 
(here: MDCK dog cells for technical reasons). Figure panels were adapted from Figures 25-27 of my previous 
work359. 
 
No adenylylation was detected for any effector except for VbhT (see Research article I), 
Bep1, and Bep2 (not shown). These results are in line with the predictions of my in silico 
analysis, though an adenylylation activity of Bep3 would have been expected. I therefore 
investigated the protein sequence of Bep3 orthologs in more detail and discovered that the 
 
  
  
A
B
C
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extended N-termini characteristic of this family of effectors (as well as most orthologs of 
Bep4 and Bep5) contain FicA-like modules with αinh-like sequences (Figure 30). From an 
evolutionary perspective, the fact that FicA orthologs and Beps are typically encoded 
together in the genomes of Bartonella makes it easily conceivable that a simple point 
mutation in a stop codon of ficA would result in a fusion protein similar to Bep3-5. 
 
Figure 30: The N-terminus of Bep3-5 contains a FicA-like module. FicA of B. rochalimae was aligned to the 
N-termini of four Bep3 orthologs using ClustalW implemented in Geneious v7.1.7 with gap open / extend costs of 
10 / 0.1 and a BLOSUM cost matrix. Coloring reflects amino acid similarity according to the cost matrix with black 
= 100% identity and white = <60% identity. It is clear that the N-terminus of Bep3 is homologous to FicA 
antitoxins, and all orthologs display a canonical (S/T)xxxE(G/N) inhibition motif (highlighted below the alignment; 
see the invariant glutamate at position 34). A similar alignment can be created with most orthologs of Bep4 and 
Bep5 (not shown). 
 
It is likely that my failure to detect any adenylylation activity with Bep3 was caused by the 
FicA-like module of this effector which may either – as a conservative hypothesis – control 
the FIC domain similar to FicA antitoxins or – given that the αinh manipulates substrate 
binding – rather modulate the enzymatic activity. The biological and biochemical role of these 
FicA-like modules in Bep3-5 could be investigated by future studies using targeted protein 
mutants and classical protein biochemistry. Notably, a similar module has been described for 
the RalF family of host-targeted effectors of Legionella pneumophila and Rickettsia 
prowazekii. In these proteins the GEF activity of the N-terminal “effector domain” is controlled 
by a C-terminal “capping domain” that also serves to localize the effector to divergent target 
pools inside the host cell in order to promote different biological functions360. 
The remarkable specificity and diversification of Bartonella effector proteins despite a high 
protein sequence similarity in their FIC domains raises the question how the target 
recognition of these proteins is mediated on the molecular level. Bartonella effector proteins 
lack obvious, large accessory modules like the arm sub-domain of VopS or IbpA153, but my in 
silico analyses uncovered two sequence elements that appear to be candidates for a role in 
target recognition. First, I found that the FIC domains of Bartonella effectors contain a 
(nearly) Bep-specific β-hairpin adjacent to the “flap” that I had deliberately named 
“Bep-element” in my previous work359 (highlighted in cyan in Figure 31). Second, the “flap” 
itself greatly differs in protein sequence and contains insertions of difference size (highlighted 
in violet in Figure 31). The considerable sequence conservation among Bep elements of 
FicA of B. rochalimae 
Bep3 of B. clarridgeiae
Bep3 of B. sp. AR15-3
Bep3 of B. sp. 1-1c
Bep3 of B. rochalimae
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effector paralogs in Bartonella makes it unlikely that this region is directly involved in 
divergent target recognition, but the length and primary sequence of the β-hairpin flap differs 
between paralogous groups of Beps (Figure 31D). Future studies should therefore 
investigate the contribution of Bep-element and flap region to the target recognition of 
Bartonella effector proteins in more detail. For example, it would be interesting to exchange 
these modules between orthologs and paralogs of Bep1 and Bep2 for which the target 
spectrum is known (see above and in Research article II). 
 
Figure 31: Two sequence features of Bartonella effector proteins that could be involved in target 
recognition. A) The FIC domains of five different proteins had been aligned to visualize the nearly Bep-specific 
“Bep-element” (cyan) and a Bep-specific elongation of the flap (violet). In (B) and (C) I highlighted the structural 
correlates of Bep-element (cyan) and β-hairpin flap (violet) on the structures of HpFicT and BepA of B. henselae, 
respectively. The active site loop of the FIC domains is shown in red for orientation. This figure was adapted from 
my Master thesis that contains additional details regarding the technical analysis359. D) FIC domain containing 
Beps of L4 as well as presumably adenylylation-competent effector clades of L3 (see Figure 28) were aligned 
using ClustalW implemented in Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM cost 
matrix. Coloring reflects amino acid similarity according to the cost matrix with black = 100% identity and white = 
<60% identity. Bep element and the β-hairpin flap are highlighted in cyan and violet as shown in (A). The 
alignment makes clear that the primary sequence of the Bep element is very similar between Beps, while the 
N-terminal side of the flap as well as Bep-specific insertions at its tip are highly conserved among orthologous 
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B15-3 Bep3
B1-1c Bep3
Bro Bep3
Bcl Bep3
B15-3 Bep2
B1-1c Bep2
Bro Bep2
Bcl Bep2
B15-3 Bep1
B1-1c Bep1
Bro Bep1
Bcl Bep1
Bhe BepA
Bgr BepA
Btr BepA
Bqu BepA
Bhe BepB
Bhe BepC
Bgr BepC
Btr BepC
Bqu BepC
Bgr VbhT(pl)
Bsb VbhT
Bel FicT
Btr FicT
Bbi FicT
Yen FicT
β-hairpin flapBep-element
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groups, but differ among paralogs (amino acid sequence highlighted in color). By comparison, it is clear that VbhT 
and Bartonella FicT homologs as well as YeFicT lack the Bep-element and contain only a relatively short flap. 
Species names were abbreviated like in Figure 28 (Bel = B. elizabethae, Bbi = B. birtlesii, Yen = Y. enterocolitica). 
Only one of the two copies of Bep1 in B. sp. 15-3 is shown, and a six-amino-acid insertion after the variable 
region of the flap in Bep3 of B. sp. 15-3 was omitted for reasons of clarity. Additional data on the Bep-element are 
illustrated in Figure 43 that is part of the Perspective section. 
6.13.5. Developing new tools for Bartonella genetics and microbiology 
Over the course of my PhD project our laboratory repeatedly encountered problems with the 
plasmid-driven expression of toxic constructs in Bartonella. Together with Simone Eicher I 
discovered that these issues were caused by a pair of direct repeats flanking the Plac 
promoter region of the most common plasmid backbones that were used for gene expression 
in Bartonella, and Maxime Quebatte identified additional repeats that greatly aggravated the 
instability of these vectors (not shown). In short, the considerable leaky expression of genes 
cloned into these plasmids selected for the emergence of clones which lacked the promoter 
region as a consequence of recombination events. 
Maxime Quebatte therefore decided to repair the well-established plasmid backbone 
pCD341361 and systematically modified the Plac promoter to remove the repeat regions and at 
the same time achieve lower leaky expression. Using flow cytometry with a gfp-encoding 
derivative of pCD341, he could show that his construct with promoter variant #5 displayed 
very weak background expression and a smooth dose-dependent response to the inducer 
isopropyl-β-D-thiogalactopyranoside (IPTG) on the single-cell level (Maxime Quebatte, 
unpublished). The availability of such a superior tool motivated me to add another 
modification to it, because the use of the pCD341 backbone had so far been limited due to 
inherent problems with molecular cloning caused by topological peculiarities and its large 
size (>10’000 base pairs). In order to overcome this obstacle I cloned a ccdB toxin gene into 
the end of the multiple cloning site of the vector created by Maxime Quebatte and added a 
second multiple cloning site that I had designed de novo behind it, resulting in plasmid 
pBZ485_a. (Figure 32A). The CcdB toxin causes the formation of double-strand breaks in the 
cellular DNA41 which is lethal already at low levels in E. coli cloning strains that are 
technically recA-deficient and therefore greatly impaired in double-strand break repaira (see 
Box 1 and in the Extended Results in the Supplemental Information of Research article III). 
The directional cloning of an insert using restriction sites in both multiple cloning sites 
replaces ccdB, so that a transformation of the ligation reaction allows the formation of 
colonies only for clones that obtained the desired ligation product and not uncut or re-ligated 
vector backbone. This strategy of negative selection has been first described more than 
twenty years ago362 and is widely used in high-throughput cloning kits. As a proof-of-principle 
I transformed commercially available chemocompetent E. coli with 100 ng of uncut 
                                                          
a For this reason, the vector backbone with ccdB needs to be propagated in E. coli DB3.1 that is resistant against 
CcdB due to the gyrA462 genotype. 
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pBZ485_a (i.e., an amount of backbone that is typically the upper limit used for ligations) and 
reproducibly obtained no colonies. Others have started to use pBZ485_a for their 
experiments and could confirm the convenience of cloning with ccdB counterselection as well 
as reliable expression of insert genes in Bartonella (not shown). One potential risk of 
pBZ485_a is that it encodes the mobilization functions of plasmid RSF1010 which are known 
to inhibit the function of a number of different type IV secretion systemsa, but no such effects 
have so far been observed in Bartonella with its ancestors that are isogenic in this respect 
(Maxime Quebatte, personal communication). 
 
Figure 32: New gene expression vectors for Bartonella. A) The figure shows part of plasmid pBZ485_a with 
the Plac(#5) promoter created by Maxime Quebatte upstream of the ccdB gene which his flanked by two multiple 
cloning sites. B) The tetR  / Ptet module described by Nakashima and Tamura367 contains the terR gene under 
the control of a weak, constitutive promoter facing opposite of Ptet. 
 
Encouraged by the success of pBZ485_a, Maxime Quebatte and I came to the conclusion 
that it would be useful to create a second expression plasmid as a replacement for previously 
used pPG100311 that should be compatible with pBZ485_a. Furthermore, we decided to use 
a different promoter system than Plac in order to enable the divergent expression of two 
genes in Bartonella. Preliminary experiments with L-arabinose-inducible Para or L-rhamnose-
inducible Prha promoters that I had cloned as rfp promoter fusions did not detect inducible 
expression in Bartonella, while the constructs were functional as predicted in E. coli (Maxime 
Quebatte, unpublished). Since we reasoned that this may be caused by the reluctance of 
Bartonella use (and import?) sugars as a carbon source368, I decided to use a tetracycline-
inducible Ptet system instead. A suitable module encoding Ptet together with tetR that, in this 
system, acts as the inducer of the promoter, had previously been published by Nakashima 
and Tamura367 (Figure 32B). In this study the authors showed that their Ptet construct was 
far superior to other promoters with regard to the inducibility of the system (four orders of 
magnitude between expression in the absence and presence of induction). I have therefore 
                                                          
aRSF1010 is a mobilizable broad-host range plasmid that parasitizes a wide range of type IV secretion systems 
for its own conjugation363. However, it also interacts with host-targeting type IV secretion machineries to an 
extent that it impairs the secretion of their genuine substrates by blocking the coupling protein as shown for 
the Agrobacterium tumefaciens VirB/D4 T4SS364 and validly proposed for the Legionella pneumophila 
Dot/Icm T4SS365. Furthermore, RSF1010 seems to impair plasmid transfer by the AvhB conjugation system of 
Agrobacterium tumefaciens that is closely related to the Bartonella VirB/D4 T4SS366 (see below). 
A
B
Plac(#5) of Maxime Quebatte 
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begun to create a vector (deliberately named pBZ485_b) using the backbone of well-
established pPG100 that would contain the Ptet module upstream of the multiple cloning sites 
of pBZ485_a flanking ccdB. Like this, the same insert could be cloned into pBZ485_a and 
pBZ485_b using the same restriction sites. 
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“Evolution does not produce novelties from scratch. It works on what already 
exists, either transforming a system to give it new functions or combining 
several systems to produce a more elaborate one. (...) New functions 
developed as new proteins appeared. But these were merely variations on 
previous themes. (…) 
 
(Therefore, it) is not biochemical novelties that generated diversification of 
organisms. In all likelihood, it worked the other way around. It is the selective 
pressure resulting from changes in behavior or in ecological niches that led to 
biochemical adjustments and changes in molecular types. (...) The few big steps 
of evolution required acquisition of new information. But specialization and 
diversification occurred by using differently the same structural information. 
 
(For that reason, all) living organisms are historical structures: literally creations 
of history. They represent, not a perfect product of engineering, but a 
patchwork of odd sets pieced together when and where opportunities arose.” 
 
 
 
 
 
 
 
François Jacob, French biologist and Nobel laureate, in “Evolution and tinkering”. Science, Volume 
196, Number 4295, 10 June 1977, 1161-1166 (continuation of the quote ahead of this work). 
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My work builds up on previous research of Henri Saenz and Philipp Engel who had greatly 
advanced our understanding of the co-evolution of the VirB/D4 T4SS and its host-targeted 
effectors with Bartonella169,275. It is their “shoulders of giants” like in Newton’s famous quote 
that I could step upon and look back deeper into evolutionary history. Together, our studies 
suggest a model that describes – in a plausible way – the adaptive path from an ancestral 
conjugative machinery and an originally unrelated toxin-antitoxin module to the extant host-
interacting type IV secretion system with a diversified effector repertoire. Importantly, the 
model suggests that the emergence of an interbacterial type IV secreted effector was critical 
as an evolutionary “missing link” between bacterial conjugation and host interaction. 
In the words of Francis Crick369, 
“A good model in biology (…) not only should address the problem in hand but if at all 
possible should serve to unite evidence from several different approaches so that 
various sorts of tests can be made of it. This may not always be possible to do 
straight away – the theory of natural selection could not immediately be tested at the 
cellular and the molecular level – but a theory will always command more attention if 
it is supported by unexpected evidence, particularly evidence of a different kind.” 
I will therefore present and discuss the evolutionary model in this Perspective section from 
different angles and continuously refer to the underlying evidence and the contributions of 
others. Furthermore, I will indicate whenever the model generates testable hypotheses at 
important steps and outline how these could be addressed experimentally to confirm, refine, 
or refute it. 
7.1. Evolution of bacterial secretion systems 
Bacterial secretion denotes the transport of biomolecules (typically proteins) across 
membranes from the inside of the cell to a compartment located further outside or into the 
extracellular milieu. So far, seven main types of dedicated bacterial protein secretion 
systems have been described (exhaustively reviewed in a recent special issue of Biochimica 
et Biophysica Acta370,371), and a number of additional mechanisms like secretion via outer 
membrane vesicles has not yet been included in this systematic catalog372. Many of these 
machineries comprise representatives that serve genuine bacterial functions as well as 
others that have been exapted for host interaction in symbiotic, commensal, or pathogenic 
contexts. The two most well studied secretion systems that can have critical roles in host 
interaction are the type III and type IV machineries which are analogous in the aspect that 
they typically secrete effector proteins from the bacterial cytoplasm into the host cytosol 
where these manipulate cellular signaling in favor of the bacterium373,374. However, while type 
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III secretion systems evolved from the flagellar machinery that was exapted for host-targeted 
effector secretion only once375, host-interacting type IV secretion systems have repeatedly 
and independently evolved from bacterial conjugation systems303. This difference implies that 
the type IV secretion machinery may somehow be inherently prone to such an evolutionary 
event, likely because it already mediates the intercellular (yet inter-bacterial) transfer of 
(nucleo)protein complexes that can easily be modulated by adaptive tinkeringa. The model 
presented in this Perspective describes the exaptation of a classical conjugative type IV 
secretion system into a host-interacting machinery in Bartonella with particular focus on the 
de novo evolution of its secreted effector proteins. 
                                                          
a The other known machinery that mediates direct interbacterial DNA transfer, mycobacterial type VII secretion 
systems382,383, can also act as a virulence factor that delivers effector proteins into eukaryotic host cells, but the 
evolutionary connections have not yet been resolved (see the recent review by Houben et al.376). 
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7.2. Step I: Origin in bacterial conjugation systems 
7.2.1. Conjugative type IV secretion mediates DNA transfer 
Bacterial conjugation denotes the interbacterial transfer of DNA via type IV secretion, 
typically in the form of plasmids. Conjugative plasmid transfer has been suggested to be the 
most frequent mechanism of horizontal gene transfer that promotes the spread of diverse 
fitness traits such as antibiotic resistance, metabolic pathways, and machineries both for 
microscopic warfare as well as symbiotic, commensal, or pathogenic host interaction 
(recently reviewed by Guglielmini et al.377). 
Conjugative machineries consist of a type IV secretion system (T4SS) that constitutes the 
“mating pair formation” (Mpf) complex, and a “DNA transfer replication” (Dtr) module that 
provides and processes the DNA substrate. Mpf and Dtr are physically and functionally 
linked by the so-called type IV coupling protein (T4CP). The molecular mechanism of 
conjugative plasmid transfer has been extensively reviewed, but most knowledge comes 
from a few model systems like the machineries of plasmid RSF1010 or the E. coli 
F-plasmid304,363,378-380 (see a model in Figure 33). In short, the conjugation process is initiated 
in the donor cell upon receiving a dedicated signal that may be based on intercellular contact 
with potential recipients via the pilus of the Mpf machinery (1). Subsequently, the coupling 
protein docks to the type IV secretion machinery and recruits a Dtr / DNA complex that is 
called relaxasome. The relaxasome consists of a few accessory factors and a protein called 
relaxase that specifically binds to a DNA sequence called oriT (“origin of transfer”) where it 
cuts a single strand at the nic site. Subsequently, conjugative transfer begins with the 
assembly of Dtr, Mpf, and coupling protein, and essentially denotes the translocationa of the 
relaxase that stays attached to the 5’ end of the cleaved DNA single strand (2). 
Subsequently, this DNA strand is continuously pumped into the recipient cells (3), while the 
donor performs parallel “strand replacement synthesis” to substitute for it. DNA transfer itself 
is very fast (around 800 bp / s for the F-plasmid379). Because the ssDNA transfer into the 
recipient is initiated at the 5’ end, complementary strand synthesis resembles the 
discontinuous “lagging strand” during dsDNA replication with repeated initiation and DNA 
replication in short bursts (see Box 3 below). However, the molecular mechanism of 
complementary strand synthesis is not well understood. At the end of plasmid transfer, the 
                                                          
a It has remained a major riddle whether conjugative transfer occurs through the lumen of the pilus itself or 
whether the pilus merely establishes contact between donor and recipient cells. Though this riddle has 
remained unresolved in general, the field seems to favor a function of F-pili (found in, e.g., conjugation of the 
F-plasmid) as a conduit for conjugative transfer, while this seems not to be the case for P-pili found e.g., with 
the Agrobacterium VirB/D4 T4SS or the RP4 machinery379,381. This issue has been recently reviewed together 
with the molecular mechanism of bacterial conjugation in general382. 
 Perspective – Step I: Origin in bacterial conjugation systems 
325 
 
second half of the oriT enters the recipient cell and the plasmid is recircularized at nic by the 
relaxase (4). 
 
Figure 33: Simple model of bacterial conjugation. The process is explained in the running text from (1) to (4). 
Note that in this model the relaxase (MOB) is shown as staying attached to the channel of DNA transfer which 
has not been unambiguously demonstrated. The illustration was adapted from Bellanger et al.383. 
 
Conjugation generally either transfers plasmids or the plasmid-like state of integrative 
conjugative elements but, if a chromosomal oriT and dedicated mobilization functions are 
available, can also transfer whole bacterial chromosomes into the recipient384,385. Integrative 
conjugative elements (ICEs) are genomic islands encoding a conjugative type IV secretion 
system and can excise from the genome typically by site-specific recombination. After 
circularization, they conjugate in a transiently plasmid-like state (recently reviewed by 
Bellanger et al.383). There is no principal separation between ICEs and conjugative plasmids, 
but they are “essentially short-term variants of otherwise identical backbone elements”377,386. 
In contrast to conjugative “self-transmissible” entities, mobilizable plasmids or ICEs do not 
encode their own Mpf machinery but typically have dedicated Dtr functions. A recent study 
showed that mobilizable plasmids and ICEs outnumber conjugative ones386. 
7.2.2. Relatives of Bartonella plasmids and type IV machineries in Rhizobiales 
The maintenance of sometimes quite a number of extrachromosomal replicons ranging from 
small cryptic plasmids to secondary chromosomes as well as the presence of both 
conjugative and / or host-interacting type IV secretion systems is characteristic of the 
α-proteobacterial order of Rhizobiales387-389. In this respect, Bartonella is a rather typical 
representative of this group, and it is not difficult to construct links between rhizobial relatives 
and the Vbh or VirB/D4 type IV secretion systems as well as the plasmids often encoding the 
Vbh machinery. It had already been noted by Saenz, Engel et al. that the Vbh T4SS is not 
only closely related to the VirB/D4 T4SS, but that the pVbh Mpf and Dtr functions are very 
similar to counterparts encoded on a particular family of rhizobial plasmids in, e.g., 
(1) (2)
(3) (4)
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A. tumefaciens (pAT), Rhizobium etli (p42d), or Sinorhizobium meliloti (pSymA)275 (see 
examples in Figure 34). The conjugative function of the Vbh-like type IV secretion systems 
on these plasmids has been well documented366,390,391, and pSymA of S. meliloti as well as 
p42d of R. etli are classical symbiotic plasmids that carry genes important for plant 
interaction392,393. The pAT plasmid of A. tumefaciens appears not to have a critical role in the 
pathogenesis of this organisma and instead encodes various functions that confer a 
competitive advantage in soil395,396. According to a nomenclature that has been recently 
proposed, the Dtr functions of these plasmids (as well as pVbh) belong to type II of rhizobial 
conjugation systems387, and their relaxase is a classical representative of the MobQ family397. 
Marius Liesch had already noted earlier that the relaxase of pVbh in B. schoenbuchensis 
str. R1 is very similar to those of these other rhizobial plasmids but differs from them in that it 
contains only one and not two BID domains at its C-terminus319 (Figure 34A). oriT and nic of 
the relaxase encoded by p42d have been identified biochemically and were almost identical 
to obviously homologous sequences on other rhizobial plasmids of this group397 including 
pVbh of B. schoenbuchensis R1319 (Figure 34B). 
 
Figure 34: Similarity between conjugation functions of pVbh and rhizobial plasmids. A) TraA relaxase 
proteins of pVbh of B. schoenbuchensis R1 and the three rhizobial plasmids mentioned above have been aligned 
using ClustalW implemented in Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a BLOSUM cost 
matrix. The alignment was manually curated and BID domains as well as positively charged C-termini were 
annotated as described by Pérez-Mendoza et al.397. Coloring reflects amino acid similarity according to the cost 
matrix with black = 100% identity and white = <60% identity. It is clear that TraA of B. schoenbuchensis lacks one 
BID domain and adjacent sequence that is present in the other relaxase proteins. Alignment of the sequence 
present in TraA of B. schoenbuchensis str. R1 with the distal C-terminal region of the other relaxases consistently 
yielded the best results. B) The oriT region of p42d of R. etli as described by Pérez-Mendoza et al.397 was aligned 
to the corresponding sequence of pVbh and other rhizobial plasmids using a similar procedure as described for 
the protein alignment above (green = 100% identity). As already observed by Mariues Liesch319, the putative oriT 
of pVbh and related rhizobial plasmids are almost identical. 
 
                                                          
a Two major plasmids are co-resident in A. tumefaciens, pAT and pTi. While pAT is a conjugative plasmid and 
encodes functions that are mostly advantageous in an environmental lifestyle (see running text), pTi encodes 
the T-DNA that is transferred by the VirB/D4 T4SS into plant cells where it integrates into the host genome and 
promotes tumor formation. Secretion of the Ti-DNA is accompanied by a set of effector proteins that primarily 
guide its way into the nucleus as well as its genomic integration (recently reviewed by A. Pitzschke394. 
Additionally, pTi also encodes a second, conjugative type IV secretion system (see below). 
A
B
TraA of B. schoenbuchensis str. R1 pVbh
TraA of A. tumefaciens str. C58 pAT
TraA of S. meliloti str. 1021 pSymA
TraA of R. etli str. CFN42 p42d
pVbh of B. schoenbuchensis str. R1
pAT of A. tumefaciens str. C58
pSymA of S. meliloti str. 1021
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The conjugative type IV secretion system encoded on the three rhizobial plasmids mentioned 
above belongs to the MPFT family and is therefore distantly related to the archetypal VirB/D4 
T4SS of the Ti-plasmid of A. tumefaciens and other family members like RP4 or R388380. A 
recent phylogeny published by Guy et al. confirmed that the VirB/D4 and Vbh type IV 
secretion systems of Bartonella form a monophyletic group that is the sister clade of a group 
containing the conjugation systems of A. tumefaciens, R. etli, and S. meliloti284 (shown in 
Figure 35). Therefore, one can say that backbone and conjugation functions of the pVbh 
plasmid in Bartonella have no features that would distinguish it from a typical conjugative 
plasmid of Rhizobiales which may simply have entered the genus via bacterial conjugation. 
 
Figure 35: Phylogeny illustrating the evolutionary connections between type IV secretion systems of 
Bartonella. The phylogeny had been constructed on an alignment of VirB4 homologs and bootstrap support 
values higher than 90% of 100 are indicated at the branche. The four type IV secretion systems of Bartonella are 
indicated by color code and representative species are indicated. It is clearly apparent that VirB/D4 (virB, red) and 
Vbh (vbh, blue) machineries of Bartonella constitute a monophyletic group that is most closely related to a 
number of rhizobial conjugation systems mentioned in the running text. It is therefore likely that the VirB/D4 T4SS 
evolved in the genus Bartonella from a Vbh-like ancestor. Furthermore, the phylogeny illustrates the close 
relationship of the Trw T4SS (trw, green) to the machinery of conjugative plasmid R388 and the separate position 
of the B. australis Trw T4SS compare to those of L4 (see also Unpublished results related to Review article I). 
Another, rather elusive T4SS (“tra”, orange) encoded in genomic islands of some bartonellae (see below) is only 
0.4 substitutions per site
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B. rochalimae VirB4
B. schoenbuchensis VbhB4
A. tumefaciens AvhB4 (pAT)
B. australis VbhB4
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distantly related to the other machineries of Bartonella. Note that the phylogeny also shows complex relationships 
between type IV secretion systems of other Rhizobiales. For example, the host-interacting VirB/D4 T4SS of the 
A. tumefaciens plasmid pT is rather closely related to Vbh and VirB/D4 machineries of Bartonella, but the 
conjugative AvhB T4SS of the A. tumefaciens pAT plasmid is even closer. Furthermore, the conjugative Trb T4SS 
encoded on the Ti-plasmid is rather distantly related to all these machineries and instead shares a more recent 
ancestry with the (RP4) T4SS encoded on the E. coli RK2 plasmid and the tra machinery of Bartonella. The 
phylogeny was adapted from Guy et al.284. 
 
From a functional point of view, it has been shown that the relaxase of the conjugative AvhB 
T4SS encoded on pAT of A. tumefaciens is secreted by the VirB/D4 machinery of 
B. henselae, suggesting that secretion signals may be generally compatible among the type 
IV secretion systems discussed in this section311. Not unexpectedly, Marius Liesch found that 
pVbh of B. schoenbuchensis str. R1 can conjugate into B. henselae with considerable 
efficiency (around 10-3 per recipient in the experimental setup that was used). Though it has 
been argued that the Vbh T4SS – being the only type IV secretion system in L2 – could have 
a role in virulence, Mariues Liesch failed to detect any positive evidence for this idea. For 
example, the Vbh T4SS could not complement a B. henselae mutant lacking the VirB/D4 
machinery for effector secretion despite likely compatibility of secretion signals319. It is 
therefore not clear if the pVbh plasmid (at least in L2) has a direct function in Bartonella 
pathogenicity. An in silico analysis did not reveal obvious virulence factors on the pVbh 
plasmid of B. schoenbuchensis str. m07a (Figure 36), though a number of genes could not 
be conclusively assigned to any function. However, it appears that pVbh plasmids tend to 
harbor a considerable arsenal of toxin-antitoxin modules that may control persister formation 
at some point of the infection cycle similar to, e.g., TA modules of other pathogens33,39,94. 
Additionally, conjugative type IV secretion systems typically promote biofilm formation398 
which could also promote the colonization of niches in (arthropod or mammal) hosts. For 
example, it has been proposed that the ability to form biofilms in the flea fore gut was crucial 
for a Y. enterocolitica  - like ancestor of Y. pestis to become transmitted by these vectors399. 
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Figure 36: Full annotation of pVbh of B. schoenbuchensis str. m07a. Plasmid pVbh of B. schoenbuchensis 
str. m07a had been sequenced by Guy et al.284 as “pML”. The plasmid is nearly identical to pVbh of 
B. schoenbuchensis str. R1 that had been sequenced, yet not fully assembled, previously in our laboratory319. 
Importantly, pVbh of strain R1 is the source of the vbhAT module that has been characterized in Research articles 
I and III, but pVbh of strain m07a encodes genes with almost identical sequence. I manually annotated every 
gene on pVbh using different variants of BLAST, sequence comparisons, and literature mining. The plasmid 
encodes a complete conjugation system with Mpf, Dtr, and T4CP functions (highlighted in green), though the vbh 
locus encoding the T4SS contains a number of gene fragments (generally indicated by grey color). Similarly, 
pseudogenes that are obviously derived from other genes encoded on pVbh like repC or the partitioning functions 
can be found scattered over the plasmid in multiple copies. A surprising number of toxin-antitoxin modules (shown 
in blue) is scattered over the plasmid with sometimes unexpected combinations of toxin and antitoxin families, but 
the flexibility of these associations has been well described (see Figure 1C in the Introduction section). Genes 
encoding proteins involved in plasmid replication and partitioning are highlighted in yellow. Of those genes 
typically involved in replication via a repABC mechanism only repC could be safely identified. However, it has 
been shown that RepC alone is necessary and sufficient for plasmid replication, while RepA and RepB have 
rather accessory roles400. A number of genes could not be assigned to any function (shown in red). Five genes 
could be identified that are neither necessary for the functioning of a conjugative plasmid nor part of 
toxin-antitoxin modules (highlighted in magenta). Two copies of an apparently phage-derived UDP-GlcNAC 
synthesizing enzyme are encoded on pVbh. This gene is found in all bartonellae except for B. tamiae and 
B. australis, often in several copies and in chromosomal phage loci (personal observation). A ResP serine site-
specific recombinase is present on pVbh and all homologous replicons in Bartonella. It is possible that this protein 
is involved in plasmid multimer resolution, but it may also promote the frequent genomic integrations that are 
observed for vbh replicons as it is common among ICE recombinases386 (but see below). Furthermore, an elusive 
nuclease protein is encoded directly upstream of vbhB2 and conserved among the far majority of vbh as well as 
virB loci of Bartonella275. The function of this gene is unclear, but it could be involved in the functionality of the 
T4SS because both Vbh and VirB/D4 machineries lack the (not essential) VirB1 lytic transglycosylase that is 
involved in pilus biogenesis401. Plasmid pVbh also encodes an ssb single-strand binding protein that could be 
involved in complementary strand synthesis in the recipient cell as described for other conjugative plasmids402 
(but see below). 
 
Plasmid pVbh or chromosomal derivatives can be found in the majority of Bartonella species 
(Figure 37). While the plasmid copies in B. schoenbuchensis or B. grahamii (called 
pBGR3318) reveal the presence of an intact conjugative machinery, it has already been noted 
earlier by Saenz, Engel et al.275 that most chromosomal copies have been subject to 
considerable sequence deterioration and are obviously inactive with regard to bacterial 
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conjugation. These authors also revealed that – at an earlier state of their evolutionary 
history – additional species like B. quintana harbored a chromosomal vbh locus that has 
been largely reduced in the extant genomes. It is therefore highly unlikely that plasmid pVbh 
exhibits a facultatively ICE-like behavior as could have been imagined from the high 
frequency of genomic integration. Instead, pVbh appears to be a genuine conjugative 
plasmid that may simply suffer from genetic instability and inadvertent chromosomal 
integrations, e.g., due to recombinogenic sequences or regions with strong homologies to the 
chromosome like the Mpf locus (compare Figure 36). 
 
Figure 37: The distribution of chromosomal and extrachromosomal copies of pVbh in Bartonella. The 
phylogenetic tree (see details in Figure 15) illustrates the phylogenetic distribution of the Vbh T4SS in Bartonella 
(compare Figure 35 for their phylogenetic relations). Presence of absence of the Vbh T4SS was assessed by 
BLAST searches with the nucleotide sequence of the full vbh locus of B. schoenbuchensis str. R1 pVbh against 
the genus Bartonella. BLAST hits were manually inspected to determine whether the vbh locus forms a genomic 
island (g) or is encoded on a plasmid (p), but in many cases no clear result was obtained for vbh loci on small 
contigs. Note that – in contrast to previous findings of Saenz, Engel, et al.275 that were based on PCR 
amplification – I failed to detect any evidence of a vbh locus in any strain of B. bovis , suggesting that the 
sequences submitted to the databases may be incomplete or that a potential pVbh plasmid may have been 
omitted in genome sequencing. The presence of FIC domain proteins associated to the vbh locus is indicated by 
bold font (see also Figure 24 and linked running text in Appendix: Further results). While vbh loci in plasmids 
typically encode seemingly intact Mpf, Dtr, and T4CP, chromosomal loci are usually deteriorated and lack Dtr 
functions as well as T4CP in addition to deletions and pseudogenization of Mpf genes. All chromosomal copies 
are surrounded by homologs of plasmid replication or partitioning genes as well as scattered toxin-antitoxin 
modules that are all also found on pVbh, suggesting that chromosomal vbh loci are derived from the integration of 
a pVbh plasmid.  
 
 
 
 
 
 
 
 
 
 
 
A
0.03 substitutions per site
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In addition to pVbh a number of Bartonella species contain small, cryptic plasmids that 
encode not much more than essential replication functions and a relaxase (e.g., pBGR1 of 
B. grahamii403 or pMS of B. schoenbuchensis str. m07a284). Furthermore, genomic islands 
encoding an type IV secretion machinery that is related to the conjugative Trb T4SS of the 
A. tumefaciens virulence plasmid pTi have been described by Guy et al.284 as the “tra” T4SS 
(compare Figure 35). While the tra locus of B. sp. 1-1c has undergone considerable 
deterioration, more extended loci can be found in the genomes of B. vinsonii subsp. 
berkhoffii str. Winnie, B. rattimassiliensis str. 15908, and particularly in B. alsatica strain IBS 
382 (personal observation). Interestingly, these loci often encode a class II Fic protein that 
displays the characteristic FicN-FIC-wHTH domain architecture discussed in the Unpublished 
results related to Research article I. Furthermore, a number of additional replicons are found 
with a more restricted distribution among the bartonellae. For example, plasmid pNH4 was 
isolated from B  rattaustraliani and encodes no Mpf functions, but a Dtr locus that is very 
similar to the pVbh Dtr region. pNH4 can therefore be seen as a mobilizable derivative of 
pVbh and encodes only few additional genes including, e.g., another class II Fic protein. 
Interestingly, it has been claimed that the conjugation of pNH4 into B. henselae resulted in 
bacteria that had the ability to replicate in amoeba404, though the genetic basis of this 
phenomenon is unclear. 
With regard to the biological function of pVbh it would be interesting to follow up on early 
experiments of Marius Liesch and try to establish the bovine endothelial cell infection model 
of Guy et al.284 in our laboratory. Since they readily observed infection of these cells with 
B. bovis, it is tempting to speculate that closely related B. schoenbuchensis may also be able 
to invade these cells and traffic to the typical vacuolar niche of Bartonella (see Review 
article I). Such an in vitro infection model would allow to investigate whether the pVbh 
plasmid has a role in virulence and, if yes, which factors encoded on this replicon are 
involved in pathogenesis. 
7.3. Step II: A FIC domain protein enters the scene 
In the previous section I presented compelling evidence that a Vbh-like plasmid may have 
entered Bartonella from other Rhizobiales simply by conjugation using its own dedicated 
machinery and that such a plasmid may or may not have already promoted Bartonella 
virulence in one or the other way. However, none of the rhizobial plasmids that are closely 
related to pVbh encodes any FIC domain protein that would be particularly similar to the FIC 
domains of Bartonella effector proteins, while I could show that genomic islands derived from 
pVbh plasmids encode a FicTA toxin-antitoxin module that is closely related to the Beps 
(Figure 38A; see also Figure 24 in Appendix: Further results). The closest relatives of this 
FicTA module outside Bartonella are found in environmental proteobacteria, e.g., in a phage 
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island in the genome of plant-infecting γ–proteobacterium Xylella fastidiosa or on a family of 
conjugative plasmids isolated from soil-dwelling β-proteobacteria (Figure 38B). These 
plasmids comprise, e.g., pEST4011 of Achromobacter denitrificans or pIJB1 of Burkholderia 
cepacia and belong to the IncP-1 group of replicons405. Interestingly, the conjugative 
machinery encoded on these plasmids does not display considerable sequence similarity to 
the Vbh T4SS, but is more closely related to the tra machinery or the Trb T4SS of the 
A. tumefaciens virulence plasmid pTi (personal observation). In addition to a number of 
metabolic functions, pEST4011 and related replicons are loaded with insertion sequences 
and transposases, and vectors of the IncP-1 family are generally known as broad-host 
plasmids with highly mosaic accessory content that frequently engage in recombination406. It 
is therefore appealing that an ancestral FicTA module may have entered Bartonella not 
together with pVbh but rather on a different conjugative plasmid that was later largely lost 
from the genus, while the toxin-antitoxin module thrived in association with the Vbh T4SS 
(see below). 
 
Figure 38: Chromosomal FicTA modules in Bartonella and their relatives. A) Representative genomic 
islands containing a vbh locus are shown with Mpf functions highlighted in dark green (including pseudogenes) 
and other genes shown in green. FicTA modules are colored in blue. Note that ficAT loci are invariably found 
directly downstream of the Mpf machinery at the same position where the vbhAT genes are encoded on pVbh 
(compare Figure 36). FicTA homologs were only found at the vbh loci of B. tribocorum, B. elizabethae, B. birtlesii 
and, in form of a pseudogene, in B. washoensis (see Figure 24 in Appendix: Further results for a direct 
comparison of these proteins). Generally, the vbh loci in the chromosomes of Bartonella were never found to 
encode any Dtr functions and seem to be in different states of deterioration. B) BtrFicT was aligned to FicT 
homologs of Achromobacter denitrificans plasmid pEST4011 (NP_990877.1) and Xylella fastidiosa str. 9a5c 
(NP_298946.1) using ClustalW implemented in Geneious v7.1.7 with gap open / extend costs of 10 / 0.1 and a 
BLOSUM cost matrix. Coloring reflects amino acid similarity according to the cost matrix with black = 100% 
identity and white = <60% identity. The overall primary sequence identity between BtrFicT and any of the other 
proteins is >50%, while these exhibit more than 80% of sequence identity among each other. 
 
Generally, the presence of toxin-antitoxin modules on conjugative plasmids is a common 
feature of these and other mobile elements21,66,407 (see also the Introduction section). It is 
more difficult to determine whether they have a particular biological function in the organism 
that hosts these mobile elements, e.g., in persister formation, or whether they primarily act in 
post-segregational killing (PSK). The accumulation of PSK toxin-antitoxin modules on 
plasmids has been considered as a “Mafia trait” that prevents the emergence of plasmid-less 
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cheaters if the plasmid provides a public good like secreted virulence factors408. However, 
our limited knowledge on potential pathogenicity functions encoded on pVbh does not 
support hypotheses in this direction to explain the crowding of TA modules including an 
ancestral FicTA system. 
It would be possible to assess experimentally if the FicTA loci encoded in some bartonellae 
can act in post-segregational killing and / or bacterial persistence, but exhaustive 
experimentation in Bartonella could also be cut short by clarifying whether Escherichia coli 
may be a similarly suitable model organism. FicTA modules in general as well as the 
Bartonella BtrFicTA module in particular have already been studied in Research article III 
and in experiments shown in Appendix: Further results. 
7.4. Step III: de novo evolution of an intra-kingdom effector 
The last two sections illustrated how both components which later converged in the evolution 
of a primordial VirB/D4 T4SS of Bartonella probably entered the genus via horizontal gene 
transfer in form of bacterial conjugation, though likely not together. Genetic reshuffling via 
different recombination events may have created a state as it is represented by the vbh loci 
in the chromosomes of different Bartonella species, i.e., with a ficAT toxin-antitoxin module 
encoded downstream of the vbh T4SS locus adjacent to the relaxase of the system. A simple 
comparison of the primary sequences of BtrFicT, VbhT, Bartonella effector proteins, and a 
pVbh relaxase suggests that this genetic arrangement created the evolutionary opportunity to 
transfer a type IV secretion signal from the relaxase onto the toxin of such an ancestral 
FicTA module in a way reminiscent of “terminal reassortment”409 (Figure 39). Conspicuously, 
VbhT proteins are encoded at the same locus downstream of the Mpf machinery like the 
Bartonella FicT toxins, exhibit high sequence similarity to them in the FIC domain, and 
display a FIC-BID domain architecture as it would be the result of such a fusion. It is 
therefore reasonable to assume that VbhT homologs may be extant representatives of 
ancestral FicT-BID proteins as some kind of a “living fossil” that may provide unparalleled 
insight into the evolution of type IV secretion systems and their effectors in Bartonella. The 
primary sequences of the type IV secretion signal in VbhT and associated conjugative 
relaxases are nearly identical, and Marius Liesch showed that the VirB/D4 T4S of 
B. henselae translocates proteins based on the secretion signal of VbhT319. One can 
therefore safely assume that VbhT is secreted by the Vbh T4SS into recipient cells during 
bacterial conjugation and thus constitutes the first example of an interbacterial type IV 
secretion effector protein (see Figure 40 and below)a. 
                                                          
a All these considerations imply that VbhA is not secreted alongside VbhT. It seems likely that VbhA is stripped 
off from VbhT during substrate unfolding prior to translocation which appears to be a general feature of type IV 
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Figure 39: A single sequence reshuffling event created an ancestral VbhT effector. The illustration was 
created from a protein sequence alignment of BtrFicT of B. tribocorum (see Figure 24) and the VbhT effector as 
well as the (C-terminus of the) TraA relaxase encoded on pBGR3 of B. grahamii str. as4aup. Note that the full 
length of VbhT can be aligned both to BtrFicT (FIC domain) or the TraA relaxase (OB-BID module) with very high 
protein sequence identity. It is evident that the striking similarity between the bipartite secretion signal of VbhT 
and its cognate TraA relaxase may be the result of co-evolutionary forces and / or the adaptation to their common 
T4CP, because the sequence identity shared between VbhT of pBGR3 and the OB-BID module of TraA of pVbh 
of B. schoenbuchensis str. R1 is much lower (67%; not shown). Different direct homologs to VbhT of pVbh or 
pBGR3 are encoded in an identical genetic setup (see Figure 36) at the chromosomal vbh locus of B. grahamii 
str. as4aup and on plasmid pTT0105 (that is very similar to pBGR3). Another homolog can be found in B. taylorii, 
but it is unclear if this sequence constitutes a pseudogene because the open reading frame is terminated by an 
assembly gap (B. taylorii str. 8TBB contig 1.80). Unexpectedly, I failed to detect a homologous sequence to VbhT 
of pVbh in B. melophagi, another species of L2. Close inspection of the vbh locus of B. melophagi (contig 1.32 of 
strain K-2C, accession AIMA01000032) revealed a deletion between vbhB9 and traA that apparently removed 
vbhAT and some vbh genes (not shown). Importantly, Schulein et al. showed that BID domain and positively 
charged C-terminus of Bartonella effectors are sufficient as a secretion signal for the VirB/D4 type IV secretion 
system311. These results leave no room for an important function of the OB-fold in the context of protein 
translocation together with the BID domain and raise the possibility that the OB-fold was carried along in Bep 
evolution as a “hitchhiking” stretch of primary sequence. However, it is easily conceivable that the OB-fold 
between FIC domain and BID domain could serve as a linker supporting protein dynamics or that the OB-fold has 
secondarily acquired a functional role in host cell manipulation in some groups of Bartonella effectors. 
 
It is important to highlight that the terminal reassortment which likely generated an ancestral 
secreted FicT toxin was not some kind of an accelerated gradual evolution, but rather a 
random quantum leap without any original adaptive component409. One may therefore argue 
that – despite its plausibility given the genetic arrangement of vbh loci with single-domain Fic 
proteins – such an event would be highly unlikely and violate the principle of parsimony. 
However, while “Occam’s razor is a useful tool in the physical sciences, it can be very 
dangerous to implement in biology.”369 Much more important than the isolated probability of 
such a sequence reshuffling event is therefore whether natural selection could favor and 
propagate the result. More precisely, it is the critical question whether a secreted FicT toxin – 
a primordial VbhT protein – could be advantageous for a conjugative plasmid or its host 
bacterium. 
                                                                                                                                                                                     
secretion382. Note that, similar to VbhT (Research articles I and III), the adenylylation of host targets by Bep1 of 
B. rochalimae was found to be inhibited by its cognate FicA homolog (Appendix: Further results), suggesting 
that these are generally not translocated. 
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Figure 40: de novo evolution of a type IV secreted effector protein. The figure illustrates the evolutionary 
model that is presented in the running text. In short, an ancestral Vbh-like conjugation system and an ancestral 
ficT toxin gene likely entered the genus Bartonella separately via horizontal gene transfer, and a primordial FicTA 
module was acquired by a pVbh-like plasmid at a locus between its Mpf and Dtr functions. Subsequently, a 
sequence reshuffling event transferred a type IV secretion signal from the Vbh relaxase to the FicT toxin. It is 
tempting to speculate that the presence of only one BID domain in the relaxases of pVbh-like plasmids compared 
to two BID domains in rhizobial homologs is causally connected to this reshuffling event. The conservation of 
VbhT homologs among pVbh-like plasmids suggests that the FicT-OB-BID fusion proved to be useful as a type IV 
secreted interbacterial effector protein. The original conjugation system is illustrated as the AvhB machinery of the 
A. tumefaciens plasmid pAT that is closely related to the Vbh T4SS. 
 
7.4.1. Conjugative protein transfer, complementary strand synthesis, and SOS induction 
Generally, protein secretion via type IV secretion is obviously not a new concept, though it 
has been largely restricted to host-targeted effectors of bacterial pathogens that evolved to 
subvert signaling of the eukaryotic host cell in favor of the bacterium in a multitude of ways 
(recently reviewed by Voth et al.410). By analogy, it is the most trivial hypothesis that a 
secreted FicT toxin like VbhT could be used to damage other bacteria in a way similar to, 
e.g., contact-dependent inhibition systems (recently reviewed by Hayes et al.411) or type VI 
secretion systems active in microbial warfare412,413. However, one can nearly exclude this 
hypothesis for Vbh T4SS / VbhT because FicT toxins including VbhT are strictly 
bacteriostatic (see Research article III) and could therefore at most transiently affect potential 
target cells. Furthermore, in the context of bacterial conjugation it would be 
counterproductive for the mobile replicon to harm the recipient and thereby deliberately limit 
its own spread. Additionally, only a small subpopulation of bacteria harboring conjugative 
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plasmids functionally express the type IV machinery because the expression of Mpf functions 
is very costly (recently discussed by Koraimann and Wagner414), so that the secondary use 
of a conjugative T4SS for niche competition would be highly inefficient. Taken together, 
these considerations strongly suggest that the biological function of an ancestral secreted 
FicT or extant VbhT must be found in a different context. 
So far, the secretion of proteins on top of the relaxase (nucleo)protein complex during 
bacterial conjugation has only been demonstrated for a single factor, though in diverse 
arrangements. The primase encoded by IncP plasmid RP4 does not only promote vegetative 
plasmid replication, but is also transferred into recipient cells during conjugation and required 
for maximal conjugation efficiency into a broad panel of distinct species415,416. These results 
have been reproduced by others with plasmids of the IncQ family that encode a 
relaxase-primase fusion protein417,418, and it has been found that different IncQ plasmids 
harbor different variants of such a fusion, indicating that they have evolved 
independently419-424. Furthermore, conjugative transfer of a primase protein was also shown 
for plasmids of the IncI family425. Potential biological functions of this apparently rather 
widespread phenomenon have been reviewed by R. Meyer who concluded that the secretion 
of primase activities may facilitate complementary strand synthesis (see also Box 3) after 
transfer by physically “tethering” a primase close to the priming sites on the conjugated DNA 
single-strand363. He noted that in case of an RSF1010-like IncQ family model plasmid the 
primase domain fused to the relaxase as well as cognate priming sites were not required for 
conjugative transfer via the highly permissive RP4 machinery between E. coli cells. However, 
both were critical for the rather inefficient mobilization by an F-like conjugation system in 
isogenic experiments and also greatly improved conjugative transfer via RP4 into the 
heterologous recipient Salmonella426. It has therefore been suggested that the transfer of 
plasmid-encoded primase and cognate recognition sites on the plasmid are “an obvious 
adaptation for broad-host-range plasmids (while) narrow-host-range plasmids, such as F and 
ColE1, (would) probably use cellular mechanisms of priming” of the recipient419. This 
hypothesis is consistent with the fact that broad host-range machineries like the conjugation 
systems of IncQ or RP4, but not the narrow-host-range F-plasmid of E. coli secrete primase 
activities416. In the words of R. Meyer, the primase might serve as a “back-up system” for 
heterologous recipients that lack a maximally compatible machinery for the initiation of 
complementary strand synthesis363. Like this, the repeated initiation of Okazaki fragment 
synthesis would be performed by a cognate primase that is physically located close to the 
translocon which could make the conjugation process more tolerant to heterologous DNA 
replication machineries. 
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Another line of evidence for the importance of efficient complementary strand synthesis 
during bacterial conjugation has been generated by a more recent, originally unrelated study. 
In this work, Baharoglu et al. 
systematically confirmed the long-standing 
assumption that plasmid conjugation 
generally results in a transient activation 
of the SOS response427 (Figure 41A). This 
transcriptional program responds to 
exposed single-stranded DNA9 as it is 
typically transferred during bacterial 
conjugation370,417 (see also Box 1). Thus, a 
robust activation of the SOS response is 
an obvious consequence of inefficient 
complementary strand synthesis and 
either results in recombinatory absorption 
of the transferred DNA into the recipient 
genome or its degradation, particularly by 
the RecBCD (Exconuclease V) 
complex427-430. The SOS response is 
therefore both an indicator of problems 
with plasmid accommodation in the recipient cell as well as an obstacle to it. Furthermore, 
the lytic program of lysogenic phages is typically wired to the SOS response in a wide range 
of bacteria431-433. The failure to efficiently manage complementary strand synthesis during 
bacterial conjugation may therefore kill the recipient as well as a potentially susceptible donor 
and, in consequence, also eliminate the plasmid. 
Box 3: Discontinuous DNA synthesis. 
Due to the antiparallel orientation of the two 
strands of dsDNA, only one of them (the 
„leading strand“) can be synthesized 
continuously because DNA polymerases are 
limited to elongate DNA strands in 5‘-3‘ 
direction. The other strand (the „lagging 
strand“) is synthesized discontinuously – 
and opposite to replication fork movement – 
in form of short Okazaki fragments (1000-
2000 base pairs) that are finally assembled 
to a full DNA strand (recently reviewed by 
Kurth and O’Donnell8). Generally, it is the 
function of primase to initiate DNA synthesis 
by producing short RNA “primers” at 
dedicated initiation sites. These primers are 
critical for assembly and function of the 
replisome, because DNA polymerase itself 
is also unable to initiate DNA synthesis. 
Therefore, primase is particularly important 
for lagging strand synthesis where DNA 
replication needs to be repeatedly re-
initiated for each Okazaki fragment (recently 
reviewed by Corn and Berger10). 
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Figure 41: Secreted primases and PsiB during bacterial conjugation. A) Bacterial conjugation activates the 
SOS response which can be greatly amplified by problems with complementary strand synthesis. B) Secreted 
primase of the donor is thought to promote complementary strand synthesis in the recipient and should therefore 
prevent or minimize SOS induction. C) The psiB gene is expressed from the plasmid leader region in the recipient 
and inhibits SOS induction, thereby likely buying overtime for complementary strand synthesis. The original 
illustration was adapted from Bellanger et al.383. 
 
Consistently, conjugative plasmids have evolved dedicated factors to inhibit SOS induction 
like the PsiB protein that is expressed from the leading region of numerous E. coli 
plasmids427,434,435 (Figure 41B). Baharoglu et al. further reported that the conjugation of 
plasmid RP4 (lacking psiB) resulted in an only weak activation of the SOS response both in 
E. coli and in Vibrio as a heterologous host427. Conspicuously, RP4 was the only plasmid with 
a primase-secreting conjugation machinery that they tested, suggesting a causal connection 
between primase activity and only marginal SOS induction (Figure 41C), and it has been 
shown repeatedly in E. coli that a lack of primase activity triggers the SOS response436-438. 
I therefore propose to unite previous studies on primase secretion and SOS inhibitors 
because exposed ssDNA of the conjugated plasmids is likely the inducer of the SOS 
response during conjugation. It seems clear that both the secretion of a primase and the 
action of plasmidic SOS inhibitors promote complementary strand synthesis either by direct 
facilitation of that process or by the prevention of adverse effects if it is inefficient, 
respectivelya (compare Figures 41B and 41C). While such a function for primase secretion is 
                                                          
a Given the critical role of complementary strand synthesis for bacterial conjugation it seems likely that 
additional mechanisms on top of primase secretion or SOS inhibition may have evolved to increase its 
efficiency. For example, it has been shown that plasmid R46 of Salmonella Typhimurium and related pKM101 of 
E. coli encode a MucB lesion bypass DNA polymerase that seems to be activated by SOS induction439. Because 
this system is encoded close to the oriT of these vectors and thus presumably expressed early on in recipient 
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well established, others have proposed that an activation of the SOS response may have no 
negative effect on conjugation frequencies427. However, early work had clearly demonstrated 
that the deletion of psiB from the F-plasmid detectably decreased its ability to conjugate even 
among E. coli402, suggesting that it may even have a stronger effect in heterologous hosts. 
7.4.2. The biological function of VbhT in bacterial conjugation 
In the last section I proposed that the mechanisms of primase secretion or SOS inhibition by 
which bacterial conjugation systems promote productive plasmid transfer converge in 
improved complementary strand synthesis under unfavorable conditions such as conjugation 
into heterologous hosts. None of these factors to enhance the efficiency of plasmid transfer 
is found on pVbh and homologous repliconsa. It is therefore easily conceivable that the 
evolution of VbhT as a secreted FicT toxin may represent an independent solution to the 
problem that complementary strand synthesis is probably the most critical step in bacterial 
conjugation, but inherently out of reach for the donor cell and the conjugative machinery. Due 
to its type IV secretion signal VbhT would be secreted along with relaxase and ssDNA into 
the recipient where it could act until the vbhAT locus is transferred and VbhA is produced in 
the transconjugant. The position of vbhAT close to the oriT and opposite of the leading 
region on pVbh (see Figure 36) ensures that VbhT would be active throughout the whole 
process of conjugative DNA transfer and could thus promote complementary strand 
synthesis until the plasmid is recircularized in the recipient cell. 
Mechanistically, it is conceivable that VbhT as a strong inhibitor of topoisomerase IV may 
impair the progression of replication fork complexes on the recipient cell chromosome and 
thereby free additional resources for complementary strand synthesis (Figure 42; see also 
Research article III). In E. coli there are not more than 50-100 molecules of primase per cell 
that must be recycled for the synthesis of each and every primer during chromosome 
replication (compiled by Corn and Berger10). Similarly, various components of the replisome 
are present in only small numbers440,441, and the processivity of DNA polymerase (in E: coli) 
typically replicates 80-90 kilobases per initiation event442 which greatly limits the instances 
where competition between replication initiation on the incoming plasmid and the 
chromosome could take place at all. In contrast to this remarkable processivity on the 
chromosome, the synthesis of the complementary strand during conjugation relies entirely on 
Okazaki fragments and therefore needs to be re-initiated every one or two kilobases of 
plasmid sequence (Box 3). It is critical to note that the incoming plasmid itself would be the 
                                                                                                                                                                                     
cells (personal observation) it may also act to promote complementary strand synthesis, though this has not 
been demonstrated experimentally. 
a The orphan ssb on pVbh of B. schoenbuchensis str. m07a could potentially have a function in this context by 
shielding ssDNA as it was shown for homologs encoded together with psiB435. However, such an activity seems 
unlikely for pVbh because ssb is not encoded in the leading region and not found on homologous replicons 
such as pBGR3of B. grahamii str. as4aup318. 
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only DNA molecule in the recipient that is not disturbed by the activity of VbhT because it is 
not topologically closed (see the section on DNA topoisomerases in the Introduction). 
Instead, it seems likely that complementary strand synthesis would be greatly favored by 
access to a big pool of replication functions. In the absence of opposing evidence I therefore 
propose that it is the function of VbhT to promote complementary strand synthesis in the 
recipient cell analogous to the secretion of primase by other conjugative plasmids. However, 
VbhT is unique in its function as a real secreted effector protein because its activity is not 
confined to the replicating DNA itself but relies on the manipulation of the recipient’s DNA 
synthesis machinery (Figure 42). The remarkable conservation of the molecular target of 
VbhT may help it to expand the conjugative host range of the plasmids that it is encoded on 
(Research article III). 
 
Figure 42: VbhT may promote bacterial conjugation as an interbacterial effector protein. A) Bacterial 
conjugation critically relies on efficient complementary strand synthesis in the recipient cell. The failure to rapidly 
complete this process causes a robust activation of the SOS response and has a number of detrimental 
consequences (see running text). The secretion of primase activities by a number of conjugative plasmids 
evolved to promote complementary strand synthesis which should counteract SOS induction. B) I propose that 
the secretion of VbhT by the Vbh T4SS is an independent evolutionary solution to the problem of complementary 
strand synthesis. VbhT could act as an interbacterial effector protein that targets the recipient’s DNA topology in 
order to redirect the DNA synthesis machinery (cyan; on schematic nucleoid) to the incoming plasmid. 
Consequently, VbhT would favor complementary strand synthesis and act against SOS induction. The figure was 
adapted from Bellanger et al.383. 
 
One may ask whether there could be evolutionary intermediates in the evolution from FicT 
toxins to VbhT. For example, it would be conceivable that a FicT toxin could be expressed in 
the recipient cell from the leading region of a conjugative plasmid similar to SOS inhibitor 
PsiB (see above) or plasmidic anti-restriction proteins443. However, the ficAT loci of fossil vbh 
plasmids in the chromosomes of Bartonella are invariably encoded downstream of the Vbh 
T4SS at the same position as vbhT on pVbh (Figure 38A). This position is exactly opposite to 
the leading region and would therefore be transferred last into the recipient cell (see above). 
primase
(+)
SOS
???
 
  
 
VbhT
chromosome
replication
(+)
SOS
???
???
Donor Recipient
A
B
 Perspective – Step III: de novo evolution of an intra-kingdom effector 
341 
 
Furthermore, the association of ficT toxins with a ficA antitoxin gene in tight genetic coupling 
makes it difficult to imagine that an excess of toxin could be produced in the absence of 
targeted antitoxin degradation. 
7.4.3. Experimental approaches to study the biological function of VbhT 
A possible role of VbhT in complementary strand synthesis during bacterial conjugation is 
accessible via a wide range of experimental approaches. A dedicated study would be highly 
fruitful with regard to originality and impact, because VbhT is likely the first interbacterial type 
IV secreted effector protein and may represent a “missing link” in the evolution of a host-
interacting bacterial T4SS. However, one could think about making such a study even more 
attractive by trying to establish a functional link between primase secretion, SOS inhibition, 
and ultimately VbhT, in bacterial conjugation. 
For this purpose I propose to repeat a few critical experiments of Baharoglu et al.427 and test 
whether a deletion of the primase gene on plasmid RP4 relieves the inhibition of SOS 
induction upon conjugation of this plasmid. Furthermore, one could use plasmid pCD341, a 
derivative of RSF1010361, as a model for IncQ vectors that encode a relaxase-primase 
fusion. It would be interesting to test whether the deletion of this primase module causes 
increased SOS induction in recipient cells and restricts the conjugative host range as 
described by others (see above). In case any such phenotype could be detected or 
reproduced, one may be tempted to see if a FicT toxin fused to the pCD341 relaxase instead 
of its primase domain could restore at least part of the original host range and / or dampen 
SOS induction. 
Most importantly, it will be necessary to demonstrate the effect of VbhT on the conjugation of 
the plasmid that it is originally encoded on. For these assays I propose to use pBGR3 of 
B. grahamii318 as a model system. pBGR3 is nearly identical to pVbh of B. schoenbuchensis 
and encodes an intact vbhAT locus, but lacks a considerable number of TA modules as well 
as the numerous repeats of pseudogenes, so that it is only half the size of the latter replicon 
(28 kb). Simply tagging this plasmid with an antibiotic resistance gene should allow to 
determine conjugation frequencies of different mutant vectors under different experimental 
conditions. In order to increase the experimental throughput it would be desirable to use 
E. coli as a model donor species. Marius Liesch had already tried and failed to establish 
pVbh of B.schoenbuchensis str. R1 in E. coli319, but I propose that these attempts cannot be 
taken as evidence against the ability of pVbh or the Vbh T4SS to replicate and conjugate in 
E. coli, respectively. pVbh had been tagged with a transposon cassette that contained an 
R6K oriV which would promote plasmid replication to a highly unphysiological copy number 
in the DH5α (λpir) strain of E. coli that was used as a recipient. Considering the size of pVbh 
(58 kb), the expected increase in copy number would likely interfere with E. coli growth, and 
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the R6K oriV may also greatly compromise plasmid stability in case the genuine repBAC 
replication system of pVbh was active in E. coli, because dual replication initiation would 
cause repeated replication fork collisions. Additionally, DH5α (λpir) encodes the McrAB and 
Mrr type IV restriction systems that are known to recognize and cut a large number of 
adenine and cytosine methylation444, possibly including the methylation patterns genuine to 
B. schoenbuchensis. The general feasibility of DNA transfer into E. coli via the VbhT4SS is 
supported by the finding that the closely related B. henselae VirB/D4 T4SS can translocate a 
derivative of enterobacterial plasmid R388 into E.coli323. I am therefore confident that pBGR3 
will be able to replicate and conjugate in E. coli without major problems. However, in case of 
failure to obtain a genuine pVbh-like plasmid that is functional in E. coli, one could possibly 
substitute the replication functions for an analogous system of E. coli (e.g., of the F-plasmid). 
Additionally, one could probably functionally replace the Vbh T4SS with another MPF 
machinery. MobQ family Dtr modules are known to be quite promiscuous and, e.g., efficiently 
conjugated by the E. coli RP4 machinery (recently reviewed by Loftie-Eaton and 
Rawlings445). 
Technically, it is possible to follow the process of bacterial conjugation using fluorescence 
microscopy which could provide a valuable and highly vivid experimental readout. Others 
have shown previously that complementary strand synthesis during conjugation can be 
directly monitored using a SeqA-YFP translational fusiona,447. The quantification of bacterial 
conjugation may be easiest via an antibiotic resistance cassette and the counting of colony 
forming units. However, different assays using flow cytometry have been reported that are 
permissive for high-throughput experimentation or heterogeneous mixtures of recipients448,449 
and would also allow to monitor different physiological features of donors, recipients, and 
transconjugants in parallel. Furthermore, it would be essential as part of a dedicated study on 
VbhT to directly demonstrate the translocation of this protein into recipient cells. Suitable 
experimental systems for this purpose would be a bacterial derivative of the CRAfT (Cre 
Reporter Assay for Translocation)450 or possibly more novel, analogous systems that use the 
machinery of CRISPR451 (Clustered Regularly Interspaced Short Palindromic Repeats, 
originally an adaptive immunity system of bacteria452). Alternatively, one may use direct 
labeling with fluorescent protein fusions or via bimolecular fluorescence complementation 
that has both been used successfully to visualize the translocation of host-targeted effectors 
via the VirB/D4 T4SS of A. tumefaciens453. 
                                                          
a Unfortunately, this system requires the recipient cells to be dam-deficient which is known to result in a 
modest constitutive activation of the SOS response by itself446. One may therefore have to optimize this model 
by genetic tinkering for our particular experimental needs. 
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7.4.4. VbhT and conjugation – a unique association? 
If VbhT really represents an independent evolutionary solution to a critical problem in 
bacterial conjugation, it is valid to ask whether functionally related Fic proteins could exist 
associated to conjugative type IV secretion systems outside of Bartonella. Conspicuously, I 
identified a number of different FIC domain proteins that are encoded together with type IV 
secretion systems and may constitute translocated substrates. It has previously been 
described that different type IV secretion systems can use highly diverse translocation 
signals that are often poorly understood. However, they are almost always found at the 
C-terminus of the protein and include stretches with net positive charge (see the recent study 
of Alperi et al.454 and literature cited therein).  
Consistently, a group of FIC domain proteins that are genetically associated to bona fide 
conjugative type IV secretion systems on rhizobial plasmids harbor a C-terminal extension 
that is approximately 150 aa long and, at the distal site, aligns well with the highly positively 
charged C-terminus of the respective conjugative relaxase (not shown). It is therefore likely 
that these proteins are secreted effectors, though target cell and biological function remain 
unclear. Furthermore, they are not encoded together with FicA homologs and do not contain 
an (S/T)xxxE(G/N) motif in their FIC domain, suggesting that they are regulated very 
differently from other Fic proteins or do not act as toxins in any sense. Their FIC domain 
active site motifs are unremarkable, suggesting adenylylation as their molecular function. 
Intriguingly, it appears that these proteins contain a short sequence stretch at the position of 
the “Bep-element” in host-targeted effectors of Bartonella (Figure 43A) that is missing in all 
other Fic proteins. The overall sequence identity upon alignment to the FIC domains of Beps, 
VbhT, or BtrFicT is not high (approximately 25%), suggesting that these rhizobial Fic proteins 
are not ancestrally related to FIC domains in Bartonella (not shown). Consequently, they 
either must have evolved a Bep-element by convergent evolution or a gene conversion event 
must have transferred this sequence insert between an ancestor of these proteins and a 
common ancestor of all Beps, but not VbhT (see Figure 43A). 
Furthermore, two FIC domain proteins encoded together with a type IV secretion system at a 
genomic island of Campylobacter fetus subsp. veneralis were proposed to be secreted 
effector proteins. The type IV machinery was shown to be capable of acting as an Mpf 
complex in bacterial conjugation455 but also clearly contributed to cytotoxicity in host cells456. 
However, so far no significant evidence for a secretion of the two Fic proteins into eukaryotic 
or bacterial target cells could be found. 
Finally, plasmid p1METDI of the environmental Rhizobium Methylobacterium extorquens str. 
DM4 encodes a FIC domain protein together with a putative antitoxin in a ficAT-like 
arrangement, though the antitoxin obviously lacks a canonical (S/T)xxxE(G/N) inhibition 
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motif. The Fic protein contains a C-terminal extension of more than 200 aa of which the distal 
region does not align to the far C-terminus of the relaxase, but is clearly homologous to 
another region in the C-terminal half of that protein (not shown). Although the overall 
sequence similarity of this Methylobacterium Fic protein to FIC domains in Bartonella is low, 
the genetic arrangement together with the traA relaxase and the other Dtr genes is precisely 
identical (Figure 43B). 
 
Figure 43: Potential conjugative effector proteins of other type IV secretion systems. A) A family of 
plasmid-encoded FIC domain proteins of Rhizobiales (e.g., YP_006962993.1 of S. meliloti plasmid pHRC017, 
YP_002546551.1 on Agrobacterium vitis str. S4 plasmid pATS4a, or YP_001373060.1 of Ochrobactrum anthropi 
str. ATCC 49188 plasmid pOANT01) harbor a sequence stretch at the position of the Bep-element of host-
targeted effectors of Bartonella. The Fic proteins were aligned using ClustalW implemented in Geneious v7.1.7 
with gap open / extend costs of 10 / 0.1 and a BLOSUM cost matrix. Coloring reflects amino acid similarity 
according to the cost matrix with black = 100% identity and white = <60% identity (ignoring gaps). Note that – 
although the overall sequence similarity of this region to Bartonella proteins is very low – the glutamate-glycine 
pair that is at the tip of the Bep-element-hairpin and universally conserved among Beps (Figure 31D) is also found 
in these rhizobial sequences. B) The genetic arrangement of the vbhAT locus on pBGR3 of B. grahamii str. 
as4aup and the bona fide ficAT locus on p1METDI of M. extorquens str. DM4 are precisely identical, but the 
antitoxin of M. extorquens is not homologous to the FicA family. 
 
Taken together, it is therefore apparent that good candidates for other type IV secreted FIC 
domain effectors exist that may have a function in bacterial conjugation either similar to the 
proposed role of VbhT or in a completely different context. In any case, the poor sequence 
similarity to Bartonella Fic proteins strongly suggests that other potential interbacterial FIC 
domain effectors must have evolved by convergent evolution, i.e., that they originated from 
an independent terminal reassortment event. Although it would not make much sense to 
focus on these proteins in any way, it could be interesting to test one or more of them for 
comparison once a biological function of VbhT in bacterial conjugation has been firmly 
established.  
7.5. Step IV: From intra-kingdom to inter-kingdom effectors 
In the previous sections I described how an interbacterial effector protein may have been 
created de novo by a domain reshuffling event that fused a FicT toxin to a type IV secretion 
signal. Furthermore, I proposed that this effector – a prototypic VbhT protein – was the 
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translocated substrate of an ancestral Vbh-like conjugation system and served to promote 
plasmid transfer under adverse conditions. Importantly, the functional and genetic 
arrangement of this peculiar machinery is only a short step away from a host-interacting, 
effector secreting type IV secretion system. 
7.5.1. First contact: From bacterial conjugation to host interaction 
Intuitively, a physical interaction of the type IV secretion pilus with host cells is a necessary 
prerequisite for the evolution of host-targeted effector secretion. Such an interaction does not 
require substantial adaptation of a bacterial conjugation system, because the broad classes 
of molecular structures that are known to be targeted by interbacterial mating pair formation - 
lipids, sugars, and proteins457-461 – are obviously also present on eukaryotic cells. 
Consistently, type IV secretion systems are rather promiscuous in their target cell range and 
can conjugate DNA not only into other bacteria, but also into yeast462 as well as human, 
fungal, and plant cells463. It was even shown for the VirB/D4 T4SS of B. henselae that this 
machinery does not only secrete Beps311, but also supports the relaxase-dependent transfer 
of plasmids into human cells323,324. Intriguingly, the same type IV secretion system was also 
reported to be capable of conjugation into E. coli323. It seems therefore appropriate to adopt 
the view of type IV secretion as a “drilling machine”460 that requires little cooperation of the 
recipient and can easily be exapted for intercellular protein transfer in diverse functional 
contexts. A primordial Vbh-like conjugation system with an ancestral VbhT-like interbacterial 
effector may thus already have had the inherent capability of at least a basic interaction with 
host cells or could have easily reached this potential. Though a direct evolution into a 
host-interacting, effector-secreting machinery could be imagined, I do not wish to exclude the 
possibility of an intermediate, at least secondary function of the type IV secretion machinery 
itself in host interaction, e.g., by binding to some receptor on the cell surface. Such an 
interaction would open three evolutionary paths for an ongoing adaptation to host interaction: 
It is clear that a focused specialization in host cell interaction via the T4SS pilus could result 
in the loss of Dtr and T4CP functions, while components of the extracellular core machinery 
may be shaped by adaptive evolution. Such a scenario apparently happened for the Trw 
T4SS of Bartonella that evolved from a conjugative, R388-like machinery into an adhesin for 
red blood cells276,307. Alternatively, the type IV secretion machinery could adapt the 
conjugation process to host interaction and use the concept of DNA secretion to promote 
virulence like A. tumefaciens with its Ti DNA394. Furthermore, one could imagine that the type 
IV secretion machinery may lose its Dtr and DNA transfer functions but instead specialize in 
effector secretion, possibly along with an original direct function in host cell interaction via the 
pilus. One example of this evolutionary path is the Cag T4SS of H. pylori that does not only 
secrete the effector CagA, but also stimulates integrins on the cell surface in an effector-
independent manner to manipulate cellular signaling464. 
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Similarly, the obvious link between Bartonella FicT toxins, VbhT, and Beps (Figure 39) 
strongly suggests that the conjugative machinery ancestral to the Bartonella VirB/D4 T4SS 
adapted to effector secretion in some way. It is tempting to speculate that this evolutionary 
path may have been favored by the availability of a pre-evolved, interbacterial effector as raw 
material for adaptive “tinkering” that should have made the machinery even more prone to 
exaptation for protein secretion than it is anyhow already typical for type IV secretion 
systems303. Furthermore, the highly flexible nature of the FIC domain as a tunable enzymatic 
machinery must have greatly facilitated the adaptation of an original, VbhT-like effector to the 
manipulation of host proteins, because only few aspects of the Fic function are really hard-
coded in the catalytic core. This flexibility is also illustrated by the plethora of largely 
divergent host-targeted virulence factors that rely on the function of FIC domains (see a 
compilation in the Introduction).  
7.5.2. Copy & Paste as an adaptive strategy 
It is clear that the evolution of an originally interbacterial, VbhT-like effector protein into a 
host-targeted, prototypical Bep almost closes the gap to the analyses of Henri Saenz and 
Philipp Engel who demonstrated that all Bartonella effector proteins evolved from one single 
common ancestor with a FIC-BID domain architecture169,275. With regard to this evolutionary 
state one may ask whether the cognate type IV secretion system of this effector was already 
encoded as a genomic island like the extant VirB/D4 T4SS or, similar to the extant 
conjugative Vbh T4SS, on a plasmid. Several lines of evidence argue for the second 
scenario that essentially postulates a pVbh-related virulence plasmid in Bartonella similar to 
the diverse plasmids with symbiotic or pathogenic functions of other Rhizobiales. An early 
study on the genomic environment of the VirB/D4 T4SS in L4 indicated that it is encoded in a 
region which is likely a remnant of such a large replicon271,319. Consistently, the VirB/D4 
T4SS of L3 and L4 had integrated independently and into different loci of the genomes of 
common ancestors of these two lineages169. Given that, in the light of new phylogenetic 
studies267,284, these common ancestors must have been rather distantly related to each other, 
this dual integration is best explained with a circulating virulence plasmid that may have been 
similarly prone to chromosomal integration as pVbh is (see above). 
The evolutionary processes that link the acquisition of a primordial VirB/D4 T4SS and its 
single ancestral effector to the extant machineries with diversified effector cocktails have 
been described by others and were already summarized in the Introduction section (see also 
Figure 44). However, I still decided to shortly highlight the most important points at the end of 
this Perspective (see the work of Henri Saenz and Philipp Engel and literature cited 
therein169,275).  
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Figure 44: From one intra-kingdom effector to multiple inter-kingdom effectors. This illustration builds up on 
Figure 40 and now also illustrates the second major step in the evolution of the VirB/D4 T4SS and its host-
secreted effectors according to the model presented in the running text. In short, an interbacterial effector protein 
as an evolutionary “missing link” possibly constituted a pre-adaptation which greatly favored the exaptation of an 
ancestral Vbh-like T4SS to a host-interacting machinery. While the changes in mating pore formation between 
bacterial and eukaryotic target cell are trivial, the evolution of a prototypic Bep that targets host proteins instead of 
bacterial proteins by adenylylation may have been favored by the inherently flexible enzymatic core machinery of 
FIC domains. Subsequently, a series of effector gene duplication and diversification shaped the extant repertoires 
of L3 and L4. 
 
It is likely that the original duplications of an ancestral effector may have served to optimize 
its expression via simple gene dosage effects, but also provided the raw material for further 
adaptive evolution in different steps. A comparison of the effector phylogenies of L3 and L4 
(Figure 14A) shows effectors with adenylylation activity (BepA and Bep1) as the most 
deep branching lineages, confirming that this was likely the original state. Initial gene 
duplication and diversification events may have created adenylylating effectors with different 
molecular targets as, e.g., apparent from Bep1 and Bep2 of L3 (Figure 29). It seems likely 
that the emergence of extended sequence motifs in the β-hairpin flap (Figure 31) or other, 
yet unrecognized accessory modules were instrumental to guide the remarkable target 
specificity and diversification of these effectors. Subsequent steps of Bep evolution likely 
intervened more heavily with the typical FIC domain functioning, as can be seen by the loss 
of bona fide adenylylation-competent active site motifs in L4 and beyond Bep3 in L3 
(compare Figures 14A and 28). It is likely that the emergence of effectors with FicA-like 
“caps” at the N-terminus in Bep3-5 has to be seen in a similar context (Figure 30). Though 
one may speculate that at least some effectors may employ FIC domains with non-canonical 
active site motifs for novel (catalytic?) activities similar to, e.g., Doc or AnkX (see in the 
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Introduction), this hypothesis remains to be tested experimentally. Furthermore, the 
remarkable conservation of FicA-like antitoxins at virB/D4 loci in both lineages (Figure 26) 
suggests that these may play an important role in effector functioning, e.g., as molecular 
chaperones (see above). As a second level of effector evolution it has been shown that (at 
least in L4) the BID domains of many Beps acquired direct functions in host interaction which 
also resulted in effectors with several BID domains. Finally, in both lineages independently a 
novel type of effector emerged in which the FIC domain had been replaced by tyrosine-
containing motifs that get phosphorylated upon translocation into the host cell (Bep9 in L3 
and BepD/E/F/H in L4; Figure 14A). It seems likely that the evolution of different effector 
types which do not critically rely on the enzymatic activity of FIC domains reflects intrinsic 
limitations of the original FIC-BID domain architecture. For example, it is easily conceivable 
that the effectors with tandem-repeated tyrosine-containing motifs may act as signaling 
HUBs in the host cell and therefore be superior to FIC domains with regard to the 
manipulation of whole signaling networks. 
It is important to note that all this diversification of the effector repertoires likely occurred prior 
to the onset of the adaptive radiations of L3 and L4, because the different species within one 
lineage generally have very similar sets of effectors. The obvious conceptual parallelism in 
the evolution of the effector repertoires of L3 and L4 is a strong indication of comparable 
selective pressures imposed by the shared infection strategy of the bartonellae. It will 
therefore be interesting to see – as more and more effectors of both lineages are being 
investigated in detail – in which respect this parallel evolution left traces in the molecular 
activities of Bartonella effectors. 
7.6. Concluding remarks 
I chose to highlight two remarkable points about this work that deserve a few last words. 
First, the data presented throughout this study strongly suggest that an ancestral, VbhT-like 
interbacterial effector protein and the associated Vbh-like T4SS constitute an evolutionary 
“missing link” that connects the host-interacting, effector secreting VirB/D4 T4SS to its 
conjugative ancestors. It is the nature of such an evolutionary intermediate that it displays 
characteristic features of both of the two states that it connects. In this particular case, the 
conjugative Vbh-like T4SS of this intermediate state likely still performed bacterial 
conjugation as its central function just like the classical machineries from which it evolved. 
However, it had acquired a VbhT-like interbacterial effector protein by terminal reassortment 
that probably served to promote bacterial conjugation as an accessory factor (see Figures 44 
and 45). Though rather a gimmick than a revolution with view to the original conjugation 
system, this interbacterial effector was likely a pre-adaptation of the type IV secretion 
machinery to efficient host manipulation and made the Vbh-like T4SS prone to exaptation 
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into a plain protein-secreting and host-interacting machinery (see above). The importance of 
such evolutionary intermediates lies in the fact that they make adaptive processes 
transparenta, particularly if these are not easily conceivable from the original and the derived 
states alone. In this case the presence of a VbhT-like effector in the missing link establishes 
the concept of interbacterial effector secretion via type IV machineries which had never been 
observed before (see above) and could act as a “stepping stone” in the evolution of host-
interacting type IV secretion systems. Furthermore, the remarkable sequence similarity of 
extant Bartonella FicT toxins, VbhT, and the TraA relaxase (Figure 39) strongly supports the 
idea that these proteins are ancestrally related to the different players of this evolutionary 
process. In particular, VbhT may be seen as a “living fossil” that can not only reveal new 
perspectives on the mechanism of bacterial conjugation, but could also be instrumental to 
understand early stages in the evolution of the host-interacting Vir/D4 T4SS. 
 
Figure 45: The Vbh T4SS with VbhT represents a “missing link”. The illustration schematically compares the 
VirB/D4 T4SS of B. henselae, the Vbh T4SS of B. schoenbuchensis, and the AvhB T4SS of A. tumefaciens (as a 
representative of related classical conjugation systems). Note that the type IV machinery itself (green) as well as 
the T4CP (blue) are highly conserved in all three system, but that the region encoding substrates / Dtr functions 
(yellow) differs in a way that highlights the position of the Vbh T4SS as an evolutionary missing link: Like the 
conjugative AvhB system, the Vbh T4SS harbors a cognate Dtr region with a relaxase and oriT and is 
plasmid-encoded. Similar to the host-interacting VirB/D4 T4SS, the Vbh T4SS encodes an effector protein with 
FIC-BID domain architecture. FicA homologs are indicated in pale magenta. It is tempting to speculate that the 
reduction of the relaxase to a singe BID domain (compare Figure 34A) for the Vbh T4SS may be causally 
connected to the terminal reassortment event that transferred one such domain onto an ancestral ficT gene. The 
illustration was adapted from a drawing of Philipp Engel.  
 
Second, the evolutionary history of the VirB/D4 T4SS in Bartonella is different from many 
other complex bacterial virulence factors in that it had not been acquired as a ready-to-use 
package via horizontal gene transfer but appears to have evolved from an ancestral 
conjugation system within Bartonella itself. It is likely that this phenomenon is connected to 
                                                          
a Another example for a “missing link” in microbiology is the organism Bordetella petrii that bridges between 
pathogenic and host-restricted bordetellae like B. bronchiseptica on one side and related free-living, 
environmental β-proteobacteria like Achromobacter on the other side465. Like the latter, B. petrii displays 
metabolic versatility and is a facultative anaerobe, while it encodes a considerable arsenal of virulence factors 
including autotransporters and fimbriae and was reported to be an opportunistic pathogen. Therefore, B. petrii 
marks a stepping stone on a plausible adaptive path in which originally environmental ancestors acquired 
virulence factors by horizontal gene transfer and progressively lost metabolic capabilities with increasing host 
association. 
 
 
 
 
 
  
 
 
 
   
 
 
 
   
  
 
 
   
 
 Perspective – Concluding remarks 
350 
 
the lifestyle of Bartonella: While other pathogens can have extended environmental stages or 
thrive in multi-species communities like the skin or gut flora that are hotspots of horizontal 
gene transfer466-468, Bartonella may at most be able to participate in genetic exchange during 
passage through the arthropod vector. Consequently, it has been repeatedly shown that 
bacterial pathogens can acquire pre-evolved pathogenicity islands encoding full secretion 
machineries469 via horizontal gene transfer and may even receive occasional upgrades in the 
form of separate effector genes470-472. One example of such an organism is Salmonella 
where the pathogenic lifestyle is apparently driven “to a large extent by mobile or laterally 
acquired genetic elements”473. Conversely, I conclude that the evolution of the VirB/D4 T4SS 
in Bartonella has to be seen in exactly the opposite context. Though originally acquired 
horizontally as a conjugation system, the machinery evolved stepwise via series of effector 
gene duplication and diversification that were likely driven by constant selective pressure 
originating from the Bartonella infection strategy. Therefore, even the emergence of a 
full-blown VirB/D4 machinery with a diversified effector cocktail in extant species of L3 and 
L4 did not result in marked changes of the overall strategy. Instead, the modularity of the 
type IV secretion system and the evolvability inherent to the effector genes rather refined the 
ability of Bartonella to manipulate its host at the different stages of the infection cycle. It 
seems likely that this flexibility may greatly contribute to the increased host adaptability of 
bartonellae in L3 and L4. Furthermore, it will be interesting to see what kind of subtle 
differences in host interaction may be revealed in future studies with bartonellae of L4, L3, 
and species of the more host-restricted lineages L1 and L2. 
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